%PDF-1.3
%¬µ¬∂

1 0 obj
<</Type/Page/CropBox[0 0 612 792]/Parent 139 0 R/Contents 3 0 R/Rotate 0/MediaBox[0 0 612 792]/Thumb 128 0 R/Resources 2 0 R>>
endobj

2 0 obj
<</Font<</F12 119 0 R/F2 147 0 R/F5 150 0 R/F6 151 0 R/F10 168 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

3 0 obj
<</Length 18924>>
stream
/GS1 gs
BT
/F2 1 Tf
10.959 0 0 10.959 62.022 712.0628 Tm
0 0 0 rg
0 Tc
0 Tw
[(CHRONIC)-329.7(WOUNDS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 698.1163 Tm
[(Wounds)-403.5(that)-399.8(have)-399.8(not)-403.3(progressed)-402.9(through)-403.9(the)]TJ
-1.1435 -1.1869 TD
[(normal)-391.6(process)-395.4(of)-391.8(healing)-392(and)-391.9(are)-392.4(open)-393.7(for)-389.2(more)]TJ
0 -1.1923 TD
[(than)-441.8(a)-439.8(month)-438(are)-441.2(classiﬁed)-441.2(as)-437(chronic)-439.8(wounds.)]TJ
7.8454 0 0 6.9729 299.7921 677.877 Tm
(3)Tj
10.4607 0 0 10.4607 62.022 660.7557 Tm
[(There)-264.6(are)-262.4(varying)-262(etiologies)-259.5(of)-267.2(chronic)-260.9(wounds,)-260.9(all)]TJ
0 -1.1869 TD
[(of)-348.5(which)-348.3(burden)-348.4(the)-349.1(health)-350.6(care)-351.9(system.)-345.3(Patients)]TJ
0 -1.1923 TD
[(suffering)-367.9(from)-365.9(diabetes)-369.2(and)-364.8(obesity)-366.8(are)-370.8(at)-369.1(a)-363.9(high)]TJ
T*
[(risk)-254.9(of)-250.9(developing)-255(chronic)-250.1(wounds.)-255.5(A)-252.1(vast)-248.1(majority)]TJ
0 -1.1869 TD
[(of)-424.3(the)-419.5(people)-420.4(who)-424.6(have)-421.5(a)-423.5(prolonged)-422.6(open)-420.8(wound)]TJ
0 -1.1923 TD
[(usually)-439.5(also)-432.5(have)-437.8(other)-437.2(major)-435.8(health)-437.3(conditions.)]TJ
0 -1.1869 TD
[(The)-539.6(simultaneous)-537.9(presence)-536.1(of)-538.2(a)-542.8(combination)-537.8(of)]TJ
0 -1.1923 TD
[(chronic)-429(diseases)-422.7(is)-422.3(called)-426.7(a)-423.5(comorbidity.)-422.6(Chronic)]TJ
T*
[(wounds)-547.4(are)-544.2(often)-551.2(complicated)-542.6(by)-549.1(comorbidities,)]TJ
0 -1.1869 TD
[(making)-448.4(it)-446.5(difﬁcult)-443.2(to)-448.2(track)-443(chronic)-450.6(wounds)-444.4(as)-447.9(a)]TJ
0 -1.1923 TD
[(disease)-501.3(in)-499.4(itself.)]TJ
7.8454 0 0 6.9729 144.2267 540.9069 Tm
(3)Tj
10.4607 0 0 10.4607 153.7511 536.2581 Tm
[(As)-504.1(such,)-496.3(research)-500.7(funding)-502.6(di-)]TJ
-8.7689 -1.1923 TD
[(rectly)-413.8(addressing)-415.2(the)-414.1(study)-410.8(of)-413.5(chronic)-412.7(wounds)-411.9(is)]TJ
0 -1.1869 TD
[(disproportionately)-369.1(low)-368.9(compared)-364.7(with)-368.5(the)-370.8(overall)]TJ
0 -1.1923 TD
[(impact)-418.5(of)-418.9(chronic)-418.1(wounds)-417.3(as)-420.8(a)-418.1(health)-415.6(care)-422.4(prob-)]TJ
T*
(lem.)Tj
7.8454 0 0 6.9729 82.7149 491.0739 Tm
(4,5)Tj
10.4607 0 0 10.4607 97.3417 486.425 Tm
[(National)-361.7(Institutes)-366(of)-359.3(Health)-364.7(has)-359.6(recently)]TJ
-3.3764 -1.1869 TD
[(set)-364.2(up)-369.4(the)-365.3(ﬁrst)-366.8(consortium)-366(of)-364.7(its)-367.9(kind,)-364.9(a)-369.3(national)]TJ
0 -1.1923 TD
[(Diabetic)-440.5(Foot)-442(Consortium)-436.4(\(NIDDK;)-442.5(FOA:)-437.2(DK17-)]TJ
T*
[(014;)-382.6(NOT-DK-18-017\),)-379.7(aimed)-387.4(at)-385.4(bringing)-381(experts)]TJ
0 -1.1869 TD
[(across)-384.3(the)-381.6(United)-381.9(States)-379.3(together)-376.9(to)-383.2(improve)-383.5(the)]TJ
0 -1.1923 TD
[(care)-281.4(of)-278(diabetic)-280.9(foot)-276.4(ulcers)-284.1(\(DFUs\).)]TJ
1.1435 -1.1923 TD
-.0129 Tc
[(Chr)-12.9(o)7.4(nic)-427.6(w)-1.5(ound)-12.9(s)-419.1(a)2.6(r)-12.9(e)-420.8(mostly)-431.2(seen)-428.6(in)-428.6(the)-428.8(e)-.7(ld)-12.9(e)7.7(r).5(ly)]TJ
-1.1435 -1.1869 TD
0 Tc
[(p)13.8(o)12.2(pu)20.8(l)13.9(a)0(t)21.1(i)13.9(o)12.2(n)12.4(.)]TJ
7.8454 0 0 6.9729 115.2 403.9369 Tm
-.0191 Tc
(2,6)Tj
10.4607 0 0 10.4607 129.3165 399.2881 Tm
0 Tc
[(In)-329.5(t)11(h)12.4(e)-334.6(U)0(n)22.3(i)13.9(t)11(e)12.2(d)-338.5(S)12.6(t)11(a)0(t)26.5(e)12.2(s,)-328.7(3%)-327.6(o)12.2(f)-339(t)16.5(h)12.4(e)-340(p)0(o)26(p)0(-)]TJ
-6.4331 -1.1923 TD
-.0127 Tc
[(ul)-12.7(a)11.3(t)-1.7(ion)]TJ
/F10 1 Tf
3.4089 0 TD
0 Tc
(>)Tj
/F5 1 Tf
.5365 0 TD
[(65)-175(ye)22.1(a)15.5(r)0(s)-178.9(o)12.2(f)-192.7(a)15.5(ge)-178.4(h)12.4(a)0(v)25.3(e)-188.3(o)12.2(p)0(e)20.6(n)-188.1(w)11.4(o)12.2(u)12.4(n)12.4(d)13.8(s)13.6(.)-190.5(B)13.5(y)-190.6(20)25.5(20)20.1(,)]TJ
-3.9455 -1.1923 TD
-.0124 Tc
[(the)-309.1(U)2.9(S)-308.7(g)2.9(ov)-12.4(e)9.7(r)1(nment)-310.3(estima)-12.4(t)14.1(e)-.2(s)-307.7(t)-1.4(ha)-12.4(t)-294.8(t)-1.4(he)-309.1(e)5.3(l)-12.4(d)9.9(e)-.2(r)-12.4(l)9.5(y)-306(p)-12.4(o)13.6(p)-12.4(-)]TJ
0 -1.1869 TD
0 Tc
[(u)12.4(l)0(a)24(t)11(i)13.9(o)12.2(n)-567.5(w)11.4(i)13.9(l)0(l)-557.5(b)15.5(e)-567.7(o)12.2(ve)22.1(r)-566.5(5)15.5(5)-564.4(m)12.4(il)22.4(li)22.4(o)12.2(n)12.4(,)-564.5(s)0(u)20.6(g)15.3(ge)22.1(s)13.6(t)11(i)13.9(n)12.4(g)-570(t)11(h)12.4(a)15.5(t)]TJ
0 -1.1923 TD
[(c)13.4(h)0(r)20.4(o)12.2(n)12.4(i)13.9(c)-317.2(w)16.8(o)12.2(u)12.4(n)12.4(d)0(s)-303.2(w)11.4(i)13.9(l)0(l)-302.7(c)13.4(o)12.2(n)12.4(t)11(i)13.9(nu)19.4(e)-307.5(t)11(o)-312.9(b)0(e)-302.9(a)15.5(n)-312.8(i)13.9(nc)20.4(r)13.4(e)12.2(as)23.6(i)13.9(n)12.4(gl)23.8(y)]TJ
T*
[(p)13.8(e)12.2(rs)21.6(i)13.9(s)0(t)19.2(e)17.7(nt)-361.3(p)13.8(r)0(o)20.3(b)15.5(le)20.7(m)-366.9(i)0(n)-363.9(t)16.5(h)12.4(i)0(s)-362.7(p)13.8(o)12.2(p)0(u)20.8(l)13.9(at)26.5(io)20.7(n)12.4(.)]TJ
7.8454 0 0 6.9729 244.3464 341.6314 Tm
(7)Tj
10.4607 0 0 10.4607 252.5669 336.9826 Tm
-.0131 Tc
[(Ov)-13.1(e)9(r).3(a)-13.1(l)10.9(l,)-387.9(in)]TJ
-18.2153 -1.1869 TD
-.012 Tc
[(the)-341.2(U)-12(n)10.3(i)1.9(ted)-345.1(S).6(tates)]TJ
/F6 1 Tf
8.4492 0 TD
0 Tc
(*)Tj
/F5 1 Tf
.9864 0 TD
[(2)15.5(%)-332.2(o)12.2(f)-333.6(t)11(h)12.4(e)-329.2(t)11(o)12.2(t)11(a)15.5(l)-332.9(p)13.8(o)12.2(pu)20.8(l)13.9(a)0(t)26.5(i)0(o)20.7(n)-329(ar)23.5(e)]TJ
-9.4355 -1.1923 TD
-.0122 Tc
[(esti)-12.2(m)8.7(a)3.3(ted)-432(t)-1.2(o)-433.5(b)3.3(e)-433.5(a)-12.2(f)11.1(f)1(ec)-12.2(t)12.3(e)0(d)-437.4(b)3.3(y)-435.9(c)1.2(hr)-12.2(o)13.5(n)-12.2(i)8.7(c)-432.3(wounds)-12.2(.)]TJ
7.8454 0 0 6.9729 277.0015 316.7432 Tm
0 Tc
(8)Tj
10.4607 0 0 10.4607 285.7322 312.0944 Tm
-.0113 Tc
(The)Tj
-21.3858 -1.1923 TD
0 Tc
[(i)13.9(m)12.4(pa)23.8(ct)-197.7(o)12.2(f)-209(c)13.4(h)12.4(ro)25.7(ni)20.9(c)-208.8(w)11.4(o)17.7(u)0(n)19.4(d)13.8(s)-208.6(i)13.9(s)-208.6(a)15.5(ls)22.1(o)-210(a)15.5(d)13.8(v)0(e)22.1(r)13.4(se)-196.4(w)11.4(o)12.2(r)13.4(l)0(d)22.3(w)11.4(i)13.9(d)0(e)20.6(.)]TJ
0 -1.1869 TD
[(F)10.2(o)12.2(r)-263(e)12.2(x)15.3(a)0(m)22.5(p)13.8(le)20.7(,)-261(a)-260.9(20)25.5(16)-250.9(r)13.4(e)12.2(po)20.6(r)13.4(t)-259.9(fr)21.3(o)12.2(m)-264(W)14.3(a)15.5(le)20.7(s)-262.8(e)12.2(s)13.6(t)11(i)13.9(m)12.4(at)21.1(e)12.2(d)-262.6(a)]TJ
0 -1.1923 TD
-.0129 Tc
[(6)-12.9(%)-210.4(prev)-12.9(a)12.4(l)-12.9(e)7.8(n)-.5(ce)-222.9(of)-221.9(chroni)-12.9(c)-213.2(w)3.9(ou)-12.9(n)6.5(d).9(s)-221.5(w)-1.5(ith)-222.7(a)-219.6(5.)-12.9(5)12.6(%)-220.5(c)-12.9(o)7.3(st)-218.6(to)]TJ
T*
0 Tc
[(t)11(h)12.4(e)-269.6(N)15.3(at)21.1(i)13.9(o)12.2(n)12.4(a)15.5(l)-273.3(H)14.6(e)12.2(a)15.5(lt)19.6(h)-264(S)12.6(e)12.2(r)0(v)23.3(i)0(c)21.9(e)-269.6(\()13.2(N)15.3(HS)21.8(\))13.2(.)]TJ
7.8454 0 0 6.9729 230.2299 266.9102 Tm
(9)Tj
10.4607 0 0 10.4607 73.9842 249.8456 Tm
[(In)-389.1(t)11(h)12.4(e)-405.1(w)16.8(o)12.2(r)0(l)21.9(d)13.8(’s)-390.8(la)24(rg)23.3(e)12.2(s)0(t)-392.7(w)11.4(o)12.2(u)12.4(n)12.4(d)13.8(-)13.2(d)0(r)21.8(e)12.2(s)13.6(s)0(i)22.1(n)12.4(g)-402(m)12.4(ar)23.5(k)13.1(e)12.2(t)11(s)13.6(,)]TJ
-1.1435 -1.1923 TD
[(Un)22.3(i)13.9(t)11(e)12.2(d)-490.2(S)12.6(t)11(at)26.5(e)12.2(s)-495.9(a)15.5(n)12.4(d)-495.7(E)13.5(u)12.4(r)13.4(o)12.2(p)0(e)20.6(,)-488.6(t)11(h)12.4(e)12.2(r)13.4(e)-491.8(i)0(s)-481.9(a)-488.6(si)22.1(gn)22.3(i)13.9(ﬁ)12.4(ca)23.5(n)12.4(t)]TJ
T*
[(d)13.8(e)12.2(m)12.4(a)0(n)22.5(d)-306(f)13.2(o)12.2(r)-306.3(w)11.4(o)12.2(u)12.4(n)12.4(d)-306(c)13.4(a)0(r)23.5(e)-302.1(pr)21.8(o)12.2(d)13.8(uc)20.4(t)11(s)13.6(.)-304.3(G)11.4(l)13.9(o)12.2(ba)25.5(ll)22.4(y,)-294.4(t)11(h)12.4(e)-302.1(a)0(n)22.5(-)]TJ
0 -1.1869 TD
-.0129 Tc
[(nua)-12.9(l)-438.8(c).5(os)-12.9(t)-438.1(f)-12.9(o)7.2(r)-449.3(wound)-448.9(ca)-12.9(r)10.6(e)-450.5(was)-454.6(a)2.6(n)-450.3(a)-12.9(v)12.4(e)-.7(r)-12.9(a)10.6(g)-12.9(e)-440.6(of)-449.5($2)-12.9(.)7.2(8)]TJ
0 -1.1923 TD
0 Tc
[(bi)24(l)13.9(l)0(i)22.4(o)12.2(n)-177.3(i)0(n)-168.8(2)15.5(01)25.5(4.)-164.2(It)-168.3(i)13.9(s)-176.1(pr)21.8(o)12.2(j)0(e)21.4(c)13.4(t)11(e)12.2(d)-175.9(t)11(o)-177.5(r)13.4(is)22.1(e)-177.5(u)12.4(p)-175.9(t)11(o)-177.5($)15.5(3.)20.1(5)-174.2(b)0(i)24(l)13.9(li)22.4(o)12.2(n)]TJ
T*
-.0147 Tc
[(in)-229.9(20)-14.7(2)10.8(1)-14.7(.)]TJ
7.8454 0 0 6.9729 99.2126 192.1889 Tm
-.0173 Tc
(10)Tj
10.4607 0 0 10.4607 109.9275 187.5401 Tm
0 Tc
[(T)10.2(h)12.4(e)-210(2)15.5(01)25.5(8)-212.2(m)12.4(ar)23.5(k)13.1(e)12.2(t)-211.2(r)0(e)20.3(s)13.6(e)12.2(a)15.5(rc)21.4(h)-209.8(r)0(e)20.3(p)13.8(o)12.2(r)13.4(t)-211.2(p)0(r)21.8(e)12.2(d)13.8(i)0(c)21.9(t)11(s)]TJ
-4.5796 -1.1869 TD
[(t)11(h)12.4(at)-255.3(t)11(h)12.4(e)-269.6(g)0(l)23.8(o)12.2(ba)25.5(l)-273.3(w)11.4(o)17.7(u)0(n)19.4(d)13.8(-)13.2(c)0(l)21.9(o)12.2(s)13.6(u)12.4(re)-261.6(p)13.8(r)13.4(o)12.2(d)0(u)20.8(c)13.4(t)11(s)-268.2(m)12.4(a)0(r)23.5(k)13.1(e)12.2(t)-270.8(w)11.4(i)13.9(ll)]TJ
0 -1.1923 TD
[(e)12.2(x)0(c)23.3(e)12.2(e)12.2(d)-327.7($1)25.5(5)-326(b)0(i)24(l)0(l)22.4(i)13.9(o)12.2(n)-329(by)-316.1(20)25.5(22)25.5(.)]TJ
7.8454 0 0 6.9729 190.6015 167.3008 Tm
-.0173 Tc
(11)Tj
10.4607 0 0 10.4607 202.5637 162.6519 Tm
-.012 Tc
[(The)-335.8(a)-12(d)11.8(v)-12(a)13.3(n).4(c)-12(e)8.3(d)-339.7(w)-.6(ound)]TJ
-13.4352 -1.1923 TD
-.0127 Tc
[(ca)-12.7(r)10.8(e)-287.7(ma)-12.7(r)10.8(k).4(et)-288.9(tar)-12.7(g)10.6(eti)-12.7(n)8.2(g)-284.6(s).9(u)-12.7(r)7.7(g)-12.7(i)11.1(ca)-12.7(l)-276(w)-1.3(ounds)-291.8(a)2.8(nd)-291.6(chroni)-12.7(c)]TJ
0 -1.1869 TD
-.0129 Tc
[(ul)-12.9(c)9(e)-.7(rs)-497.9(is)-497.9(ex)-12.9(p)10.8(e)-.7(cted)-497.7(to)-493.8(ex)-12.9(c)10.4(eed)-497.7($2)-12.9(2)-486(b)-12.9(i)11.1(l)1(l)-12.9(i)9.5(on)-499.1(by)-496.2(2)-12.9(0)12.6(2)-12.9(4)12.6(,)]TJ
0 -1.1923 TD
[(dr)-13(i)8.9(v)-13(e)9.1(n)-477.5(b)-13(y)-470(technol)-13(o)7.7(gi)-13(c)8.9(a)-13(l)-471.4(a)2.5(dv)-13(a)6.9(n)-.6(cement,)-479.9(r).4(i)-13(s)9.1(in)-13(g)-473(i).9(nci)-13(-)]TJ
T*
0 Tc
[(d)13.8(e)12.2(nc)20.4(e)12.2(s)-425.4(o)12.2(f)-425.7(c)13.4(h)12.4(ro)25.7(ni)20.9(c)-425.6(w)11.4(o)12.2(u)12.4(n)12.4(d)13.8(s,)-415.4(i)13.9(n)12.4(cr)21.4(e)12.2(a)0(s)23.6(i)13.9(n)12.4(g)-429.1(g)15.3(o)12.2(ve)22.1(r)13.4(n)12.4(m)12.4(e)12.2(n)12.4(t)]TJ
0 -1.1869 TD
[(s)13.6(u)12.4(pp)22.1(o)12.2(r)0(t)24.5(,)-271.8(a)15.5(n)12.4(d)-268(a)-271.8(r)13.4(i)13.9(si)22.1(n)12.4(g)-266.5(ge)22.1(r)13.4(i)0(a)24(t)11(r)13.4(i)0(c)-259.9(p)13.8(o)12.2(p)13.8(ul)20.9(a)15.5(t)11(io)20.7(n)12.4(.)]TJ
7.8454 0 0 6.9729 259.7669 105.0519 Tm
-.0173 Tc
(12)Tj
/F2 1 Tf
10.959 0 0 10.959 62.022 66.3307 Tm
0 Tc
[(PRESSURE)-331.1(ULCERS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 52.3842 Tm
[(Pressure,)-235.6(or)-239.9(pressure)-236.7(in)-239.2(combination)-234.3(with)-238.4(shear)]TJ
-1.1435 -1.1923 TD
[(and/or)-491.7(friction,)-493.3(promotes)-484.3(the)-495.4(development)-487(of)-489.4(lo-)]TJ
25.4288 64.282 TD
[(calized)-202.4(ulcers)-202.8(called)-204.5(pressure)-198.7(ulcers)-202.8(\(PUs\).)-200.7(PU)-202.1(care)]TJ
0 -1.1923 TD
[(is)-411.5(expensive)-410.1(and)-408.2(costs)-413(more)-410.3(than)-409.3($11)-408.9(billion)-413.6(an-)]TJ
0 -1.1869 TD
[(nually)-501.8(in)-504.8(the)-500.8(United)-501.1(States)-498.5(per)-502.5(the)-500.8(Agency)-503.1(for)]TJ
0 -1.1923 TD
[(Healthcare)-386(Research)-386.9(and)-386.5(Quality)-388.8(\(AHRQ\))-381.2(statis-)]TJ
T*
(tics.)Tj
7.8454 0 0 6.9729 347.7542 667.162 Tm
(13)Tj
10.4607 0 0 10.4607 359.7731 662.5132 Tm
[(Cost)-329(of)-326.8(individual)-327.2(patient)-321.9(care)-330.2(ranges)-324(from)]TJ
-3.035 -1.1869 TD
[($20,900)-314.5(to)-323.6($151,700)-315.3(per)-318.2(PU.)]TJ
7.8454 0 0 6.9729 465.8456 654.7463 Tm
(13)Tj
10.4607 0 0 10.4607 477.8077 650.0975 Tm
-.0188 Tc
[(Apart)-300.4(f)5.3(rom)-299(h)4.5(os)5.6(pital)]TJ
-14.3186 -1.1923 TD
-.0202 Tc
[(costs,)-189(additional)-190.5(charges)-185.5(f)-1.5(or)-185.6(food,)-189(t)1.7(ransportation,)-189(and)]TJ
T*
-.0186 Tc
[(main)4.7(te)4.5(nan)4.7(c).2(e)-510.4(i).7(s)]TJ
/F6 1 Tf
7.5116 0 TD
0 Tc
(*)Tj
/F5 1 Tf
.9809 0 TD
-.0204 Tc
[($43,180)-514.4(per)-516.4(y).3(ear.)]TJ
7.8454 0 0 6.9729 502.1857 629.8014 Tm
-.0245 Tc
(13)Tj
10.4607 0 0 10.4607 515.792 625.1526 Tm
-.0201 Tc
[(Elderly)-514.2(p)-.9(a-)]TJ
-17.9498 -1.1869 TD
-.0185 Tc
[(t)3.4(i).8(en)4.8(ts;)-268.6(p).7(atie)4.6(nt)3.4(s)-275.9(w)3.8(it)3.4(h)-271.6(s).5(tr)5.8(oke)4.6(,)-274(diabe)4.6(te)4.6(s,)-274(de)4.6(me)4.6(nt)3.4(ia;)-274(a)2.4(nd)]TJ
0 -1.1923 TD
-.0196 Tc
[(those)-197.1(w)2.7(ith)-196.9(i)-.3(mpaired)5(/)-4.2(li)5.2(mited)-195.5(m)3.7(obil)5.2(ity)-194(o)3.5(r)-195.9(s)-.6(ensation)-191.4(are)]TJ
T*
-.0212 Tc
[(e)-3.5(x)-.5(trem)-3.3(ely)-509.9(v)-5.9(uln)-3.4(e)1.9(rable)-513(t).7(o)-507.6(P)-5.6(U.)-509.8(Prolo)-3.5(n)2.1(g)-5.9(e)1.9(d)-511.4(s)-2.2(ede)-3.5(n)2.1(t)-4.7(a)-.3(ry)]TJ
0 -1.1869 TD
-.0206 Tc
[(stays)-418.9(i)-1.3(n)-414.7(t)1.3(he)-414.8(intensiv)-5.3(e)-414.8(c)-1.8(are)-420.3(u)2.7(nit)-416(c)3.7(an)-420.1(also)-414.8(drive)-414.8(P)-5(U)]TJ
0 -1.1923 TD
-.0197 Tc
[(development)-258(i)-.4(n)-262(o)3.4(ther)4.6(wis)4.7(e)-262.2(healthy)-259.1(p)-.5(atients)4.7(.)]TJ
1.1435 -1.1923 TD
0 Tc
[(The)-387.8(incidence)-391.6(of)-386.4(PU)-391.8(increases)-383.7(with)-390.2(age)-390.6(and)-386.5(is)]TJ
-1.1435 -1.1869 TD
[(promoted)-207.7(by)-207.7(a)-212.2(lack)-209.6(of)-207.6(skin)-212.5(perfusion,)-208.7(moisture,)-208.4(and)]TJ
0 -1.1923 TD
(nutrition.)Tj
7.8454 0 0 6.9729 374.7401 530.192 Tm
(14)Tj
10.4607 0 0 10.4607 385.3416 525.5432 Tm
[(In)-183.1(the)-186.5(United)-186.8(States)-184.2(around)-185.8(2.5)-186.7(million)]TJ
-5.4792 -1.1923 TD
[(people)-387.9(develop)-383.4(PUs)-383.6(annually.)]TJ
7.8454 0 0 6.9729 473.8392 517.7195 Tm
(13)Tj
10.4607 0 0 10.4607 486.4818 513.0707 Tm
[(They)-388.8(are)-381.6(usually)]TJ
-15.1478 -1.1869 TD
[(preventable,)-194.7(but)-194.1(they)-192.9(can)-197.1(be)-194.5(lethal)-191.9(if)-195(proper,)-198.3(timely)]TJ
0 -1.1923 TD
[(care)-259.8(is)-265.1(not)-262.4(received.)]TJ
7.8454 0 0 6.9729 423.2125 492.8314 Tm
(15–19)Tj
10.4607 0 0 10.4607 447.5904 488.1826 Tm
[(The)-263.2(global)-260.5(market)-258.3(for)-264.6(PU)]TJ
-11.43 -1.1923 TD
[(care)-379(products)-378.6(is)-379(expected)-378.3(to)-377.8(reach)-377.4($4.5)-377.2(billion)-381.1(by)]TJ
0 -1.1869 TD
(2024.)Tj
7.8454 0 0 6.9729 354.0471 467.9432 Tm
(20)Tj
10.4607 0 0 10.4607 365.4991 463.2943 Tm
[(Factors)-268.2(that)-269.8(spur)-266.5(this)-268.8(increase)-267.2(include)-270.9(the)]TJ
-3.5824 -1.1923 TD
[(aging)-729.7(population)-725(and)-727.9(associated)-726.9(mobility)-731.8(and)]TJ
T*
[(neurological)-278(disorders.)]TJ
7.8454 0 0 6.9729 437.6125 442.9983 Tm
(20)Tj
/F2 1 Tf
10.959 0 0 10.959 328.0251 402.5196 Tm
(DIABETES)Tj
/F5 1 Tf
10.4607 0 0 10.4607 339.9873 388.5731 Tm
[(The)-241.5(Centers)-247.6(for)-242.9(Disease)-243.5(Control)-247.2(and)-240.1(Prevention)]TJ
-1.1435 -1.1923 TD
[(\(CDC\))-200.7(recently)-204.9(released)-202(a)-201.3(study)-199.4(that)-204.7(indicated)-199.7(that)]TJ
T*
[(more)-356.1(than)-360.5(100)-354.7(million)-357(adults)-358.7(are)-354.5(living)-359.6(with)-357.7(dia-)]TJ
0 -1.1869 TD
[(betes)-352.7(or)-348.3(prediabetes)-351.4(in)-353(the)-349.1(United)-354.8(States.)]TJ
7.8454 0 0 6.9729 533.0833 355.8613 Tm
(21)Tj
10.4607 0 0 10.4607 545.4424 351.2125 Tm
[(As)-352.3(of)]TJ
-20.7842 -1.1923 TD
[(2015,)-280.4(30.3)-279.6(million)-281.1(Americans)-280.6(\(9.4%)-278(of)-278(the)-284(US)-275.6(pop-)]TJ
T*
[(ulation\))-475.2(live)-470.3(with)-476.9(diabetes;)-467.5(besides,)-475(84.1)-469.3(million)]TJ
0 -1.1869 TD
[(have)-578.7(prediabetes,)-574.4(which)-575.9(if)-579.8(left)-578.2(untreated)-574.2(often)]TJ
0 -1.1923 TD
[(leads)-456.7(to)-453.6(type)-457.1(2)-456(diabetes)-455.9(\(T2D\))-451.2(within)-455.9(5)-456(years.)]TJ
7.8454 0 0 6.9729 561.4865 306.0283 Tm
(21)Tj
10.4607 0 0 10.4607 328.0251 288.907 Tm
[(Diabetes)-496.2(prevalence)-494.2(has)-500.5(been)-495(found)-499.5(to)-497(increase)]TJ
0 -1.1869 TD
[(with)-200.5(age.)-196.3(Four)-201(percent)-198.6(of)-196.7(adults)-196.1(aged)-203.4(18–44,)-194.5(17%)-198.3(of)]TJ
0 -1.1923 TD
[(adults)-196.2(aged)-197.9(45–64)-193.7(years,)-196.3(and)-196.8(25%)-192.9(of)-196.7(those)-193.2(aged)]TJ
/F10 1 Tf
21.4888 0 TD
(Ç)Tj
/F5 1 Tf
.5528 0 TD
(65)Tj
-22.0416 -1.1923 TD
[(years)-282.2(have)-275.2(diabetes.)]TJ
7.8454 0 0 6.9729 426.1038 256.1952 Tm
(21)Tj
10.4607 0 0 10.4607 339.9873 239.1306 Tm
[(Worldwide,)-364.1(there)-361.3(are)-365.3(an)-362.3(estimated)-366.5(400)-360.1(million)]TJ
-1.1435 -1.1923 TD
[(people)-404.1(living)-408.4(with)-401(diabetes.)]TJ
7.8454 0 0 6.9729 464.0881 231.307 Tm
(22)Tj
10.4607 0 0 10.4607 476.9573 226.6582 Tm
[(In)-405.3(reference)-405.3(to)-404.9(the)]TJ
-14.2373 -1.1923 TD
[(statistical)-346.7(studies)-348.4(by)-343.2(the)-349.1(World)-344.2(Health)-348.4(Organiza-)]TJ
0 -1.1869 TD
[(tion)-291.8(\(WHO\))-296.2(in)-293.4(91)-294.3(countries)-291.7(globally,)-291.7(it)-294.8(was)-295.5(identi-)]TJ
0 -1.1923 TD
[(ﬁed)-639(that)-632.9(a)-634.9(tiny)-635.6(island)-637.7(country)-635.9(in)-640.3(Micronesia,)]TJ
T*
[(Nauru,)-219(had)-223.9(the)-219(highest)-223.4(prevalence)-217.8(rate)-218.8(of)-223.8(30.9%)-216.2(in)]TJ
0 -1.1869 TD
(2010.)Tj
7.8454 0 0 6.9729 354.0471 169.0582 Tm
(23)Tj
10.4607 0 0 10.4607 366.1227 164.4094 Tm
[(This)-323.8(was)-322.6(projected)-327.6(to)-323.6(rise)-326.2(to)-323.6(33.4%)-324.6(by)-326.9(the)]TJ
-3.642 -1.1923 TD
[(year)-198.3(2030.)]TJ
7.8454 0 0 6.9729 377.4613 156.5858 Tm
(23)Tj
10.4607 0 0 10.4607 388.1763 151.9369 Tm
[(United)-192.2(Arab)-196.9(Emirates)-197.9(was)-198(next)-192.9(in)-201.3(line)]TJ
-5.7502 -1.1923 TD
[(with)-482.3(18.7%)-481.7(prevalence)-483.3(in)-483.1(2010,)-480.9(and)-484(a)-483.2(projected)]TJ
0 -1.1869 TD
[(increase)-424.4(to)-421.1(21.4%)-422.1(in)-423.5(2030.)]TJ
7.8454 0 0 6.9729 459.7227 131.6976 Tm
(23)Tj
10.4607 0 0 10.4607 472.8188 127.0488 Tm
[(The)-420.3(age)-423.1(of)-424.3(diabetes)]TJ
-13.8417 -1.1923 TD
[(onset)-214.8(in)-217.5(developing)-211.7(countries)-215.8(is)-216.4(45–64.)]TJ
7.8454 0 0 6.9729 511.1432 119.2252 Tm
(24)Tj
10.4607 0 0 10.4607 522.0849 114.5763 Tm
[(By)-215.1(2030)-214.5(it)]TJ
-18.5513 -1.1869 TD
[(is)-492.8(predicted)-494.7(that)-497.4(developing)-493.5(countries)-492.2(will)-494.2(have)]TJ
0 -1.1923 TD
[(more)-404.9(people)-409.5(\()]TJ
/F10 1 Tf
6.4331 0 TD
(>)Tj
/F5 1 Tf
.5528 0 TD
[(65)-408.1(years)-401.5(of)-408.1(age\))-409.8(with)-406.4(diabetes)-401.7(\(82)]TJ
-6.9859 -1.1923 TD
[(million\))-278.7(than)-279.2(developed)-281.5(countries)-280.8(\(48)-275.6(million\).)]TJ
7.8454 0 0 6.9729 550.6581 81.8646 Tm
(25)Tj
10.4607 0 0 10.4607 339.9873 64.8 Tm
[(The)-225.2(prevalence)-223.2(of)-229.2(foot)-222.2(ulcers)-224.4(\(FUs\))-227(is)-227.2(high)-222.3(in)-228.4(the)]TJ
-1.1435 -1.1923 TD
[(diabetic)-584.4(population)-589.5(and)-581.6(has)-587.2(a)-586.1(neuropathic)-588.8(ori-)]TJ
T*
(gin.)Tj
7.8454 0 0 6.9729 346.3369 44.5039 Tm
(26,27)Tj
10.4607 0 0 10.4607 367.9369 39.8551 Tm
[(The)-203.6(annual)-205.1(prevalence)-201.5(of)-202.1(FUs)-204.7(is)-200.1(estimated)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 758.6644 Tm
(40)Tj
/F12 1 Tf
9.9626 0 0 9.9626 290.5511 758.6644 Tm
[(EDITORI)-10.7(AL)]TJ
ET
62.022 753.902 508.082 .51025 re
f

endstream
endobj

4 0 obj
<</Type/Page/CropBox[0 0 612 792]/Parent 139 0 R/Contents 6 0 R/Rotate 0/MediaBox[0 0 612 792]/Thumb 129 0 R/Resources 5 0 R>>
endobj

5 0 obj
<</Font<</F12 119 0 R/F2 147 0 R/F5 150 0 R/F6 151 0 R/F9 167 0 R/F10 168 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

6 0 obj
<</Length 19785>>
stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 41.8394 712.3463 Tm
0 0 0 rg
0 Tc
0 Tw
[(to)-318.1(be)-313.7(4–10%,)-309.1(and)-316(the)-316.6(risk)-314.5(of)-316(development)-313.6(of)-316(these)]TJ
0 -1.1923 TD
[(ulcers)-506.3(in)-510.2(diabetics)-505.8(is)-503.6(estimated)-507.5(to)-507.8(be)-503.4(anywhere)]TJ
0 -1.1869 TD
[(from)-187.1(15%)-187.5(to)-193.5(25%.)]TJ
7.8454 0 0 6.9729 123.137 692.1069 Tm
(28)Tj
10.4607 0 0 10.4607 133.7385 687.4581 Tm
[(The)-187.3(management)-188.2(of)-191.3(DFUs)-187.9(costs)]TJ
-8.7852 -1.1923 TD
[($9–$13)-275.7(billion)-283.5(in)-277.1(the)-278.6(United)-278.9(States.)]TJ
7.8454 0 0 6.9729 213.6755 679.6345 Tm
(26)Tj
10.4607 0 0 10.4607 53.8015 662.5132 Tm
[(By)-502.4(2026,)-497.2(the)-500.8(T2D)-499.4(market)-502.1(is)-498.2(expected)-502.9(to)-502.4(rise)]TJ
-1.1435 -1.1869 TD
[(from)-425.6($28.6)-426.7(billion)-424.5(to)-426.5(an)-427.4(estimated)-426.2($64)-425.1(billion.)-425.3(A)]TJ
0 -1.1923 TD
[(compound)-450(annual)-449(growth)-449.8(of)-451.4(8.4%)-448.4(is)-449.4(expected)-448.7(in)]TJ
T*
[(the)-289.5(United)-284.4(States,)-287.9(France,)-286.7(Germany,)-287.4(Italy,)-287(Spain,)]TJ
0 -1.1869 TD
[(the)-365.3(United)-365.7(Kingdom,)-364.5(and)-370.2(Japan.)]TJ
7.8454 0 0 6.9729 204.0377 617.3857 Tm
(29)Tj
10.4607 0 0 10.4607 216.5102 612.7368 Tm
[(In)-367.4(the)-365.3(United)]TJ
-16.6978 -1.1923 TD
[(States,)-185(the)-181.1(demand)-185.4(for)-183.3(insulin)-183.7(pumps)-188.7(is)-183.8(expected)-183.2(to)]TJ
T*
[(rise)-201.5(to)-204.3(a)-201.3($3.8)-198.3(billion)-202.2(business)-201.6(by)-202.3(2022,)-199.1(driven)-200.7(by)-202.3(the)]TJ
0 -1.1869 TD
[(increasing)-259.4(number)-263(of)-261.8(people)-263.2(with)-260.1(diabetes,)-256.2(as)-263.6(well)]TJ
0 -1.1923 TD
[(as)-279.9(technological)-277.8(advances)-278.5(in)-282.6(treatment.)]TJ
7.8454 0 0 6.9729 232.8377 567.5526 Tm
(30)Tj
/F2 1 Tf
10.959 0 0 10.959 41.8394 527.0172 Tm
[(FOOT)-329.4(ULCERS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 53.8015 513.0707 Tm
[(An)-223.4(open)-220.3(sore)-219.5(on)-219.2(the)-219(foot)-222.2(is)-221.8(called)-220.7(a)-223(FU.)-219.1(It)-222.5(may)-216.9(be)]TJ
-1.1435 -1.1869 TD
[(shallow,)-395.6(conﬁned)-398.8(only)-395.9(to)-399.4(the)-397.9(surface)-399.3(of)-397.2(the)-397.9(skin.)]TJ
0 -1.1923 TD
[(Deep)-421.8(FUs)-421.5(can)-424.8(involve)-419.5(full)-423.4(thickness)-426.2(of)-418.9(the)-425(skin,)]TJ
T*
[(muscle,)-410.5(tendons,)-417.1(and)-408.2(bones.)-411.8(FUs)-416.1(are)-414.1(common)-407.1(in)]TJ
0 -1.1869 TD
[(people)-263.2(with)-265.5(diabetes)-260.8(and)-261.8(individuals)-264.8(with)-265.5(compro-)]TJ
0 -1.1923 TD
[(mised)-221.2(blood)-214.2(circulation.)]TJ
7.8454 0 0 6.9729 155.0551 455.4707 Tm
(31)Tj
10.4607 0 0 10.4607 166.0535 450.8219 Tm
[(Despite)-215.2(advanced)-218.7(health)]TJ
-11.8744 -1.1923 TD
[(care)-568.7(and)-570.7(pharmacotherapy)-572.6(techniques)-564.5(that)-573.3(are)]TJ
0 -1.1869 TD
[(widely)-537.2(available,)-530.8(the)-533.3(prevalence)-537.5(of)-532.7(FU)-538.1(has)-533(not)]TJ
0 -1.1923 TD
[(changed)-349.3(in)-353(the)-354.5(past)-347.2(two)-350.1(decades.)]TJ
7.8454 0 0 6.9729 204.3779 418.1101 Tm
(32)Tj
10.4607 0 0 10.4607 216.6803 413.4613 Tm
[(Fourteen)-353.5(per-)]TJ
-16.7141 -1.1923 TD
[(cent)-639.1(to)-643.3(24%)-637.3(suffer)-642.6(from)-636.9(amputation.)]TJ
7.8454 0 0 6.9729 235.0488 405.6377 Tm
(33)Tj
10.4607 0 0 10.4607 250.4125 400.9889 Tm
(Neuro-)Tj
-19.9388 -1.1869 TD
[(ischemic)-512.4(ulcers)-517.1(are)-511.7(particularly)-517.3(associated)-510.1(with)]TJ
0 -1.1923 TD
[(limb)-280.3(amputations.)]TJ
7.8454 0 0 6.9729 130.2236 380.7495 Tm
(27)Tj
10.4607 0 0 10.4607 53.8015 363.6283 Tm
[(R)13.4(e)12.2(ce)25.7(nt)23.5(ly)23.8(,)-282.6(a)-277.2(s)13.6(y)0(s)23.5(t)11(e)12.2(m)12.4(a)15.5(t)11(i)13.9(c)-279.2(re)20.3(v)15.3(i)0(e)20.7(w)-275.8(a)15.5(n)12.4(d)-278.9(m)12.4(e)12.2(t)11(a-)23.3(an)22.5(a)15.5(l)0(y)23.8(s)13.6(is)]TJ
-1.1435 -1.1869 TD
-.013 Tc
[(of)-449.6(the)-450.6(g)-13(l)10.8(o)-.8(b)-13(a)12.5(l)-454.3(e)-.8(pi)-13(d)9.3(e)-.8(miol)-13(o)7.7(g)2.3(y)-453(o)-.8(f)-449.6(F)-2.8(Us)-454.7(was)-454.7(p).8(erfor)-13(m)7.5(ed)]TJ
0 -1.1923 TD
0 Tc
[(u)12.4(s)13.6(in)20.9(g)-337(P)15.6(u)12.4(b)0(M)24.9(e)12.2(d,)-323(EM)22.9(B)13.5(A)0(S)20.6(E)13.5(,)-336.8(I)15.8(S)12.6(I)-336.5(W)14.3(e)12.2(b)-336.8(o)12.2(f)-333.6(S)12.6(ci)21.9(e)12.2(n)12.4(c)13.4(e)12.2(,)-336.8(a)0(n)22.5(d)]TJ
T*
[(C)13.5(o)12.2(ch)20.4(r)13.4(a)0(n)22.5(e)-372.6(da)23.8(t)11(a)0(b)25.5(a)0(s)23.6(e)-378(s)13.6(e)12.2(ar)23.5(c)13.4(h)12.4(e)12.2(s)0(.)-366.6(T)10.2(h)12.4(i)13.9(s)-376.6(w)11.4(a)15.5(s)-376.6(t)11(h)12.4(e)-378(l)13.9(ar)23.5(ge)22.1(s)13.6(t)]TJ
0 -1.1869 TD
[(an)22.5(a)15.5(l)0(y)23.8(s)0(i)22.1(s)-539.2(o)12.2(f)-539.6(i)13.9(t)11(s)-539.2(k)13.1(i)13.9(n)12.4(d,)-529(i)13.9(n)12.4(cl)21.9(u)12.4(d)0(i)22.3(n)12.4(g)]TJ
/F10 1 Tf
14.9256 0 TD
(>)Tj
/F5 1 Tf
.542 0 TD
[(8)15.5(0)0(0)25.5(,)0(0)20.1(0)15.5(0)-537.3(s)0(u)20.6(b)15.5(je)21.4(c)13.4(t)11(s)]TJ
-15.4676 -1.1923 TD
[(f)13.2(r)0(o)20.3(m)-301.9(33)-294.3(c)13.4(o)12.2(u)12.4(n)12.4(t)11(r)13.4(i)0(e)20.7(s)13.6(.)-304.3(T)10.2(h)12.4(e)-302.1(gl)23.8(o)12.2(b)0(a)25.5(l)-305.8(D)11.4(F)15.6(U)-304.4(p)0(r)21.8(e)12.2(va)25.3(le)20.7(n)12.4(c)13.4(e)-302.1(w)11.4(as)]TJ
T*
-.0135 Tc
[(found)-362.8(to)-359(b)-13.5(e)-348.9(6.)-13.5(3)12(%)-13.5(.)-346.5(T)-3.3(he)-359(lower)-357.8(p)-13.5(r)8.3(e)-1.3(v)-13.5(a)11.8(lenc)-13.5(e)-350.9(o)-1.3(f)-358(D)-2.1(FU)-361.3(in)]TJ
0 -1.1869 TD
0 Tc
[(E)13.5(u)12.4(ro)20.3(p)13.8(e)-817(\()13.2(5)0(.)25.5(1)0(%)24.7(\))-821.4(c)13.4(o)12.2(m)12.4(p)13.8(ar)23.5(e)12.2(d)-815.4(w)11.4(i)0(t)25(h)-822.2(N)15.3(o)12.2(r)13.4(t)11(h)-816.8(A)13.4(m)12.4(e)12.2(ri)21.9(ca)]TJ
0 -1.1923 TD
[(\()13.2(1)0(3)25.5(.)0(0)20.1(%)14.6(\))-485.4(p)0(r)21.8(e)12.2(s)13.6(e)12.2(n)12.4(t)11(s)-490.4(a)-488.6(s)13.6(t)11(r)13.4(i)13.9(ki)21.6(n)12.4(g)-488.7(d)13.8(i)0(f)21.7(f)13.2(e)12.2(r)13.4(e)12.2(n)12.4(ce)20.3(.)-488.6(O)16.8(ut)-480.5(o)12.2(f)-485.4(33)]TJ
T*
-.0133 Tc
[(coun)-13.3(t)10.2(r)-13.3(i)8.6(e)-1.1(s,)-252.6(Belg)-13.3(i)10.5(u)-.9(m)-250.2(h)-.9(ad)-254.2(the)-250.4(h)-.9(ig)-13.3(h)9(e)-1.1(st)-251.6(pr)-13.3(e)7(v)2(a)-13.3(l)10.7(ence)-250.4(with)]TJ
0 -1.1869 TD
0 Tc
[(16)25.5(.6)25.5(%)-267.2(a)0(n)22.5(d)-268(A)13.4(u)12.4(s)13.6(t)11(r)13.4(a)0(l)24(i)0(a)-257.9(t)16.5(h)12.4(e)-269.6(l)13.9(o)12.2(w)11.4(e)12.2(s)13.6(t)-265.4(w)11.4(i)0(t)25(h)-269.4(1)15.5(.)0(5)20.1(%)14.6(.)-266.4(M)0(e)27.1(n)-269.4(a)15.5(p)0(-)]TJ
0 -1.1923 TD
[(p)13.8(e)12.2(ar)23.5(e)12.2(d)-295.1(t)11(o)-285.8(be)-281.2(m)12.4(o)12.2(r)13.4(e)-291.3(pr)21.8(o)12.2(n)12.4(e)-291.3(t)11(o)-291.3(F)10.2(U)15.3(s)-289.9(t)11(h)12.4(an)-281(w)11.4(o)12.2(m)12.4(e)12.2(n)-291.1(\()13.2(4.)25.5(5%)]TJ
T*
-.0127 Tc
[(v)-12.7(s)10.8(.)-333.3(3)-12.7(.)12.8(5)-12.7(%)12(\)).5(.)-338.7(F)2.9(ur)-12.7(t)11.8(h)-12.7(e)12(r)-12.7(m)7.8(o)-.5(re,)-333.3(F)-2.5(Us)-335.1(were)-336.5(seen)-330.9(mor)-12.7(e)-323(often)]TJ
0 -1.1869 TD
0 Tc
[(i)13.9(n)-226(pa)23.8(t)11(i)13.9(e)12.2(n)12.4(t)11(s)-224.9(w)11.4(i)13.9(t)11(h)-226(T)10.2(2)15.5(D)-227(c)13.4(o)12.2(m)12.4(pa)23.8(r)13.4(e)12.2(d)-230.1(w)16.8(it)19.6(h)-220.6(t)11(yp)23.7(e)-226.2(1)-223(di)22.3(ab)25.5(e)12.2(t)11(e)12.2(s)]TJ
0 -1.1923 TD
[(\()13.2(6)0(.)25.5(4)0(%)-343.8(v)0(s)23.5(.)-353.1(5.)25.5(5%)24.7(\))13.2(.)]TJ
7.8454 0 0 6.9729 117.411 193.9464 Tm
-.0173 Tc
[(34,)-17.3(3)13.6(5)]TJ
10.4607 0 0 10.4607 140.1448 189.2976 Tm
-.0131 Tc
[(In)-369.2(g)-13.1(e)9(nera)-13.1(l)10.9(,)-366.2(pa)-13.1(t)8(i).8(ents)-368(with)-369.2(FU)-13.1(s)]TJ
-9.3976 -1.1923 TD
0 Tc
[(w)11.4(e)12.2(r)13.4(e)-470.1(o)12.2(l)13.9(de)20.6(r)13.4(,)-466.9(h)12.4(a)0(d)-458.5(a)-466.9(lo)20.7(w)16.8(e)12.2(r)-468.9(b)0(o)22.3(d)13.8(y)-472.5(m)12.4(a)15.5(s)13.6(s)-468.8(i)0(n)20.9(d)13.8(e)12.2(x)-472.5(\()13.2(B)13.5(MI)25.2(\))13.2(,)]TJ
0 -1.1869 TD
[(l)13.9(o)12.2(n)12.4(g)0(e)22.1(r)-181.7(di)22.3(a)15.5(b)0(e)22.3(t)11(e)12.2(s)-181.5(d)13.8(u)12.4(ra)23.5(t)11(i)13.9(o)12.2(n)12.4(,)-185.1(h)12.4(i)13.9(g)0(h)22.3(e)12.2(r)-181.7(h)12.4(yp)23.7(e)12.2(r)13.4(t)11(e)12.2(n)12.4(s)13.6(io)20.7(n)-182.7(r)13.4(a)15.5(t)11(e)12.2(s)13.6(,)]TJ
0 -1.1923 TD
[(h)12.4(i)0(g)23.8(h)12.4(e)12.2(r)-626.1(i)13.9(n)12.4(ci)21.9(de)20.6(n)12.4(c)13.4(e)-621.9(o)12.2(f)-626.3(d)13.8(ia)24(be)22.3(t)11(i)13.9(c)-626.1(r)13.4(e)12.2(t)11(i)13.9(n)0(o)24.7(p)0(a)23.8(t)11(h)12.4(y)0(,)-614.2(a)0(n)22.5(d)-625.7(a)]TJ
T*
-.0135 Tc
[(smok)-13.5(i)8.1(n)-1.1(g)-231.2(h)-1.1(is)-13.5(t)5.7(o)4.2(r)-13.5(y)9.8(,)-231.1(c)-13.5(o)6.8(m)-1.1(pa)-13.5(r)10(e)-1.3(d)-232.8(w)-2.1(ith)-228.7(t)-2.5(hose)-234.3(wi)-13.5(t)6.1(h)-1.1(out)-230.1(F)-3.3(Us.)]TJ
1.1435 -1.1869 TD
0 Tc
[(The)-295.7(global)-298.5(DFU)-293.6(market)-296.2(expects)-298.6(a)-298.9(positive)-295(6.6%)]TJ
-1.1435 -1.1923 TD
[(compound)-374.1(annual)-378.5(growth)-373.9(rate)-376(between)-373.6(2016)-377.1(and)]TJ
0 -1.1869 TD
[(2024.)-502.6(At)-512(this)-507.2(pace,)-504.1(the)-506.2(market’s)-508.2(valuation)-501(may)]TJ
0 -1.1923 TD
[(reach)-372($4.9)-366.3(billion)-370.3(by)-364.9(the)-370.8(end)-368(of)-370.1(2024.)-367.1(Regionally,)]TJ
T*
[(the)-300.3(United)-300.6(States)-298(dominated)-299.9(the)-300.3(global)-298.5(market)-296.2(in)]TJ
0 -1.1869 TD
[(2016)-415.1(with)-417.3(an)-416.5(estimated)-409.9(share)-415.2(of)-418.9(38.1%.)-412.1(It)-417.6(is)-416.9(ex-)]TJ
0 -1.1923 TD
[(pected)-449.2(to)-453.6(remain)-451.2(dominant)-449(through)-447.2(the)-452(forecast)]TJ
T*
[(period)-278.3(\(2024\).)]TJ
7.8454 0 0 6.9729 108.1133 44.5039 Tm
(36)Tj
/F2 1 Tf
10.959 0 0 10.959 307.8424 712.0628 Tm
[(VENOUS)-330.4(ULCERS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 319.8046 698.1163 Tm
-.0126 Tc
[(A)-389.4(v)-12.6(a)12.7(s)1(t)-391.8(m)-.2(a)-12.6(j)12(ori)-12.6(t)7(y)-387.5(\().6(7)-12.6(0)12.9(%)-12.6(\))-380.3(of)-389.6(lower-ex)-12.6(t)8.3(r).8(emity)-392.9(u)-.2(lcer)-12.6(s)]TJ
-1.1435 -1.1869 TD
0 Tc
[(ar)23.5(e)-258.7(c)13.4(a)15.5(u)0(s)20.6(e)12.2(d)-257.2(b)15.5(y)-261.1(c)13.4(h)12.4(r)13.4(o)12.2(n)12.4(ic)-249(ve)27.5(no)24.7(us)-245(in)20.9(s)13.6(u)12.4(fﬁ)20.3(c)13.4(i)13.9(e)12.2(n)12.4(cy)23.3(.)]TJ
7.8454 0 0 6.9729 510.066 690.3494 Tm
-.0173 Tc
(37)Tj
10.4607 0 0 10.4607 521.2912 685.7006 Tm
0 Tc
[(In)-242.8(t)11(h)12.4(e)]TJ
-20.4048 -1.1923 TD
-.0128 Tc
[(U)-12.8(n)9.5(ited)-329.6(States)-329.8(and)-329.6(E).7(u)-12.8(r)7.6(ope,)-328(p)-12.8(e)7.8(ople)]TJ
/F10 1 Tf
15.7277 0 TD
0 Tc
(>)Tj
/F5 1 Tf
.5365 0 TD
[(65)-305.1(ye)22.1(a)15.5(r)13.4(s)-317(o)12.2(f)-317.3(a)15.5(ge)]TJ
-16.2643 -1.1923 TD
.2205 Tc
[(a)220.5(r)244(ev)220.5(u)242.8(l)234.4(n)232.9(e)232.7(r)233.9(a)220.5(b)240.6(l)234.4(et)231.5(ov)220.5(e)242.6(n)232.9(o)232.7(u)232.9(su)232.9(l)234.4(c)220.5(e)240.7(r)233.9(s)234.1(.)]TJ
7.8454 0 0 6.9729 456.4912 665.4045 Tm
-.0173 Tc
(38)Tj
10.4607 0 0 10.4607 467.3196 660.7557 Tm
0 Tc
[(T)10.2(h)12.4(e)-220.8(p)0(r)21.8(e)12.2(va)25.3(l)13.9(e)12.2(n)12.4(c)0(e)-212.8(o)12.2(f)]TJ
-15.2454 -1.1869 TD
-.0128 Tc
[(v)-12.8(e)9.3(nous)-188.9(ul)-12.8(c)9.1(e)-.6(rs)-194.3(is)-194.3(1%)-193.3(of)-189.2(the)-190.3(p)1(op)-12.8(u)8(l)1.1(a)-12.8(t)8.3(ion)-190.1(g)-12.8(l)11(o)-.6(b)-12.8(a)12.7(l)-12.8(l)9.6(y)-192.6(a)2.7(mong)]TJ
0 -1.1923 TD
0 Tc
[(t)11(h)12.4(o)12.2(s)13.6(e)-220.8(a)15.5(ge)22.1(d)-219.3(1)15.5(8–)25.5(64)25.5(.)]TJ
7.8454 0 0 6.9729 390.8976 640.5164 Tm
-.0173 Tc
(39)Tj
10.4607 0 0 10.4607 401.7259 635.8676 Tm
-.0132 Tc
[(In)-233.8(the)-228.6(U)-13.2(n)9.1(i).7(ted)-232.5(S)-.6(tates,)-230.8(1)-13.2(0)12.3(–)-13.2(3)6.9(5%)-231.6(of)]TJ
-8.9749 -1.1923 TD
0 Tc
[(t)11(h)12.4(e)-280.4(p)13.8(o)12.2(p)0(u)20.8(l)13.9(at)21.1(i)13.9(o)12.2(n)-280.2(s)13.6(u)12.4(f)0(f)21.1(e)12.2(r)-279.2(f)0(r)21.3(o)12.2(m)-280.2(s)13.6(o)12.2(m)12.4(e)-280.4(k)13.1(in)20.9(d)-278.9(o)12.2(f)-284.8(c)13.4(h)12.4(r)13.4(o)12.2(n)12.4(ic)-270.7(ve)22.1(-)]TJ
0 -1.1869 TD
-.0127 Tc
[(nous)-421.8(i)-12.7(s)9.4(sues)-427.3(with)-423(4%)-426.2(\()]TJ
/F10 1 Tf
10.281 0 TD
0 Tc
(>)Tj
/F5 1 Tf
.542 0 TD
-.014 Tc
[(65)-426.7(ag)-14(e)-414.6(g)-14(r)9.3(o)-1.8(up\))-428.9(o)-1.8(f)-423.5(t)-3(he)-424.5(ca)-14(s)9.6(e)-1.8(s)]TJ
-10.823 -1.1923 TD
-.0136 Tc
[(ha)-13.6(v)11.7(i)-13.6(n)7.3(g)-253(ac)-13.6(t)10.9(i)-13.6(v)10.2(e)-256.1(ulc)-13.6(e)6.7(rs.)]TJ
7.8454 0 0 6.9729 404.5605 603.1558 Tm
-.0173 Tc
(40)Tj
10.4607 0 0 10.4607 415.559 598.507 Tm
-.0117 Tc
[(I)-11.7(n)-238.2(the)-254.2(U)3.6(ni)-11.7(t)13.3(e).5(d)-252.6(S).9(ta)-11.7(t)14.8(e).5(s)-252.8(a)3.8(n)-11.7(d)-240.2(the)]TJ
-10.2973 -1.1869 TD
0 Tc
[(Un)22.3(i)13.9(t)11(e)12.2(d)-213.8(K)11.4(i)13.9(n)12.4(g)0(d)23.7(o)12.2(m)12.4(,)-217.6(v)15.3(e)12.2(n)12.4(o)12.2(u)12.4(s)-214(le)20.7(g)-212.3(u)12.4(lc)21.9(e)12.2(r)13.4(s)-214(c)0(o)20.3(s)13.6(t)-216.6(a)15.5(ro)25.7(un)19.4(d)-213.8($)15.5(2.)20.1(5)]TJ
0 -1.1923 TD
[(bi)24(l)13.9(l)0(i)22.4(o)12.2(n)-524.1(a)15.5(n)12.4(d)-522.8(£)15.5(3)0(0)20.1(0)15.5(–6)25.5(00)-511(m)12.4(i)13.9(l)13.9(l)0(i)22.4(o)12.2(n)12.4(,)-521.1(r)13.4(e)12.2(sp)22(e)12.2(c)13.4(t)11(i)0(v)23.8(e)12.2(ly)23.8(.)]TJ
7.8454 0 0 6.9729 517.6062 578.2676 Tm
-.0173 Tc
(41)Tj
10.4607 0 0 10.4607 531.5526 573.6188 Tm
-.0113 Tc
(The)Tj
-21.3858 -1.1923 TD
-.0128 Tc
[(a)-12.8(n)9.7(nual)-356.6(e)-.6(xp)-12.8(e)7.8(n)-.4(di)-12.8(t)12.2(u)-12.8(r)7.6(e)-352.8(to)-352.8(trea)-12.8(t)-344(a)-349.6(v)-12.8(e)9.3(nous)-351.5(ul)-12.8(c)9.1(e)-.6(r)-357.1(i)1.1(s)-351.5(e)-.6(s)-12.8(t)11.8(i)-12.8(-)]TJ
0 -1.1869 TD
0 Tc
[(m)12.4(a)0(t)26.5(e)12.2(d)-235.5(a)15.5(t)-232.8($)15.5(10)25.5(,5)20.1(6)15.5(3)0(.)]TJ
7.8454 0 0 6.9729 391.5779 553.3794 Tm
-.0173 Tc
(42)Tj
10.4607 0 0 10.4607 402.5196 548.7306 Tm
-.0124 Tc
[(For)-242.9(c)-12.4(h)8(r)1(onic)-12.4(,)-232.8(n)0(onhea)-12.4(l)11.6(i)-12.4(n)8.5(g)-241(v)-12.4(e)9.7(n)0(ous)]TJ
-9.0508 -1.1923 TD
-.0129 Tc
[(ul)-12.9(c)9(e)-.7(rs,)-241.3(t)3.6(h)-12.9(e)-226.7(trea)-12.9(t)8.2(m)5(en)-12.9(t)-227.9(e)-.7(xp)-12.9(e)7.7(n)-.5(di)-12.9(t)12.1(u)-12.9(r)7.5(e)-233.7(i)-12.9(s)-229.3(estima)-12.9(t)13.6(e)-.7(d)-237.6(t)-1.9(o)-239.1(b)2.6(e)]TJ
/F6 1 Tf
T*
0 Tc
(*)Tj
/F5 1 Tf
.9864 0 TD
[($3)25.5(4,)25.5(00)20.1(0)-380.2(o)12.2(r)-382.2(h)12.4(i)13.9(g)0(h)22.3(e)12.2(r)13.4(.)]TJ
7.8454 0 0 6.9729 406.4881 528.4345 Tm
-.0173 Tc
(42)Tj
10.4607 0 0 10.4607 418.9605 523.7857 Tm
.3821 Tc
[(C)382.1(h)402.6(r)395.5(o)394.3(n)394.5(i)396(cv)382.1(e)404.2(n)394.5(o)394.3(u)394.5(su)394.5(l)396(c)382.1(e)402.4(r)395.5(sb)397.6(u)394.5(r)382.1(-)]TJ
-10.6224 -1.1869 TD
-.0127 Tc
[(den)-238.7(e)-.5(conomi)-12.7(c)-229.2(p)1.1(rod)-12.7(u)8.1(ctiv)-12.7(i)11.1(t)-1.7(y)-241.3(b)2.8(y)-235.9(r)-12.7(e)7.6(s).9(ulti)-12.7(n)8.2(g)-235.9(in)-238.7(the)-233.5(l)-12.7(o)8(s).9(s)-237.6(o)-.5(f)]TJ
0 -1.1923 TD
0 Tc
[(4.)25.5(6)-266.4(m)12.4(il)22.4(li)22.4(o)12.2(n)-269.4(w)16.8(o)12.2(rk)21.1(-)13.2(d)0(a)23.8(y)0(s)-258.3(p)13.8(e)12.2(r)-268.4(ye)22.1(a)15.5(r)0(.)]TJ
7.8454 0 0 6.9729 454.7337 503.5463 Tm
-.0173 Tc
(43)Tj
/F2 1 Tf
10.959 0 0 10.959 307.8424 461.5369 Tm
0 Tc
[(OVERWEIGHT)-331.4(AND)-328.2(OBESITY)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 319.8046 447.5904 Tm
[(According)-279.6(to)-274.8(a)-277.2(recently)-275.3(updated)-276(report)-276.1(from)-279.2(the)]TJ
-1.1435 -1.1923 TD
[(WHO,)-529.5(worldwide)-528.8(obesity)-524(has)-527.6(nearly)-529.6(tripled)-531.1(be-)]TJ
0 -1.1869 TD
[(tween)-260.4(1975)-257.9(and)-261.8(2016.)]TJ
7.8454 0 0 6.9729 412.3841 427.3511 Tm
(44)Tj
10.4607 0 0 10.4607 423.7794 422.7022 Tm
[(Excessive)-256.3(accumulation)-264.1(of)]TJ
-11.0831 -1.1923 TD
[(fat)-215(complicates)-212.1(numerous)-218.5(aspects)-210.3(of)-218.4(vital)-212.2(functions)]TJ
T*
[(within)-320.5(the)-322(body,)-323.4(causing)-320.7(illness)-323.7(and)-321.4(posing)-325.2(a)-320.6(risk)]TJ
0 -1.1869 TD
[(for)-286.3(an)-281(increase)-283.4(in)-288(additional)-281.3(health)-285.6(complications.)]TJ
0 -1.1923 TD
[(For)-229.7(adults,)-224.1(WHO)-225.2(deﬁnes)-226.8(overweight)-228.1(as)-225.7(a)-228.4(BMI)]TJ
/F10 1 Tf
21.2069 0 TD
(Ç)Tj
/F5 1 Tf
.5528 0 TD
(25.)Tj
-21.7598 -1.1923 TD
[(Obesity)-281(is)-281.4(deﬁned)-286.2(as)-279.9(a)-282.6(BMI)]TJ
/F10 1 Tf
12.9962 0 TD
(Ç)Tj
/F5 1 Tf
.5528 0 TD
(30.)Tj
7.8454 0 0 6.9729 464.0881 365.0456 Tm
(44)Tj
10.4607 0 0 10.4607 475.6534 360.3968 Tm
[(Estimates)-284.2(from)]TJ
-16.0421 -1.1869 TD
[(2016)-312.1(indicated)-313.5(that)-313.1(39%)-312.1(of)-310.5(adults)-315.4(\(1.9)-314.3(billion;)]TJ
/F10 1 Tf
21.4888 0 TD
(Ç)Tj
/F5 1 Tf
.5528 0 TD
(18)Tj
-22.0416 -1.1923 TD
[(years\))-279.8(worldwide)-284.9(were)-281.3(overweight,)-283.1(and)-278.1(13%)-285(\()]TJ
/F10 1 Tf
20.936 0 TD
(>)Tj
/F5 1 Tf
.5528 0 TD
(650)Tj
-21.4888 -1.1923 TD
[(million\))-370.9(were)-368(obese.)]TJ
7.8454 0 0 6.9729 405.5243 327.6849 Tm
(44)Tj
10.4607 0 0 10.4607 418.0534 323.0361 Tm
[(Among)-367.7(these,)-367.4(women)-367.4(were)]TJ
-10.5357 -1.1869 TD
[(more)-220.6(prone)-217.7(to)-220.6(overweight)-217.3(or)-218.2(obesity)-220.5(than)-219.6(men.)-218.4(The)]TJ
0 -1.1923 TD
[(threat)-385(of)-381(obesity)-377.7(is)-384.4(not)-381.6(a)-385.6(menace)-377(only)-385.1(for)-383.8(adults.)]TJ
T*
[(Globally,)-593.7(340)-587.7(million)-595.5(children)-593.5(and)-592.4(adolescents,)]TJ
0 -1.1869 TD
[(aged)-300.9(5–19,)-302.1(were)-302.9(overweight)-304(or)-304.9(obese)-302.8(in)-304.2(2016.)]TJ
7.8454 0 0 6.9729 527.414 277.9086 Tm
(44)Tj
10.4607 0 0 10.4607 539.2628 273.2598 Tm
(In)Tj
-22.1229 -1.1923 TD
(children)Tj
/F10 1 Tf
4.3628 0 TD
(<)Tj
/F5 1 Tf
.5474 0 TD
[(5)-542.8(years,)-537.8(41)-543.6(million)-541.3(were)-536(either)-542.5(over-)]TJ
-4.9102 -1.1923 TD
[(weight)-281.3(or)-277.8(obese.)]TJ
7.8454 0 0 6.9729 385.5684 252.9637 Tm
(44)Tj
10.4607 0 0 10.4607 319.8046 235.8992 Tm
[(Overweight)-521.6(and)-527.4(obese)-519.5(are)-522.5(at)-526.3(a)-521.1(high)-525.8(risk)-525.8(for)]TJ
-1.1435 -1.1923 TD
[(noncommunicable)-279.9(diseases)]TJ
7.8454 0 0 6.9729 437.8959 228.0755 Tm
(44–46)Tj
10.4607 0 0 10.4607 462.5007 223.4267 Tm
[(such)-278.7(as:)]TJ
/F9 1 Tf
-13.6899 -1.7831 TD
()Tj
/F5 1 Tf
.9972 0 TD
[(Cardiovascular)-1002.4(diseases)-1002.6(\(primarily)-999.2(heart)]TJ
0 -1.1923 TD
[(disease)-333.3(and)-332.3(stroke\))]TJ
/F9 1 Tf
-.9972 -1.4796 TD
()Tj
/F5 1 Tf
.9972 0 TD
[(Diabetes)-333.6(and)-332.3(associated)-331.3(chronic)-336.8(wounds)]TJ
/F9 1 Tf
-.9972 -1.4741 TD
()Tj
/F5 1 Tf
.9972 0 TD
[(Musculoskeletal)-332.7(disorders)]TJ
/F9 1 Tf
-.9972 -1.4741 TD
()Tj
/F5 1 Tf
.9972 0 TD
[(Some)-340.7(cancers)-344.9(\(including)-342.1(endometrial,)-345.4(breast,)]TJ
0 -1.1923 TD
[(ovarian,)-336.1(prostate,)-331.5(liver,)-333(etc\).)]TJ
-.9484 -1.7831 TD
[(Ch)9.6(il)11.6(dh)9.9(ood)-384.5(ob)11.4(esi)18.1(ty)]TJ
7.8454 0 0 6.9729 406.4314 119.5086 Tm
[(47)20.1(,48)]TJ
10.4607 0 0 10.4607 429.7888 114.8598 Tm
[(is)-384.4(ass)15.6(oci)12.5(ate)17.1(d)-392.7(wit)14.7(h)-388.6(a)-391(pre)12.4(-)]TJ
-11.6576 -1.1923 TD
[(di)11.5(spo)12.5(si)11.3(tio)10.1(n)-312.8(t)0(o)-307.3(bre)14(ath)17.3(in)10.1(g)-315.3(dif)13.9(ﬁc)9.6(ul)10.1(tie)10.1(s,)-307(in)10.1(cr)10.6(eas)14.2(ed)-310(te)12.5(n-)]TJ
T*
[(den)16.8(cy)-551.2(to)12.4(wa)10.6(rd)-552.7(fr)10.4(ac)12.6(tur)9.8(es,)-538.6(hyp)9(er)14.8(ten)14(sio)12.7(n,)-546.6(in)10.1(cre)12(as)12.8(ed)]TJ
0 -1.1869 TD
[(ri)11.1(sk)-423.1(of)-413.5(car)9.8(di)11.4(ov)11.3(asc)10(ul)10.1(ar)-415.5(dis)14.2(ea)11.4(se,)-414(in)10.1(sul)12.9(in)-418.1(res)12.2(is)11.3(tan)17.3(ce,)]TJ
0 -1.1923 TD
[(an)11.6(d)-278.9(p)0(s)11.1(ych)14.1(oso)16.4(cia)10.3(l)-273.3(i)0(m)10.1(pac)15.6(ts.)]TJ
7.8454 0 0 6.9729 431.2062 69.6756 Tm
[(49,)19.3(50)]TJ
10.4607 0 0 10.4607 319.8046 52.5543 Tm
[(In)-399.9(adults,)-402.9(the)-397.9(association)-400(between)-400.7(obesity)-399.4(and)]TJ
-1.1435 -1.1869 TD
[(multiple)-286.5(complications)-288.8(such)-289.5(as)-285.3(impaired)-286.6(or)-288.7(totally)]TJ
/F12 1 Tf
9.9626 0 0 9.9626 270.3684 757.8707 Tm
[(EDITORI)-10.7(AL)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 540.0565 757.8707 Tm
(41)Tj
ET
41.839 753.959 508.082 .51025 re
f

endstream
endobj

7 0 obj
<</Type/Page/CropBox[0 0 612 792]/Parent 139 0 R/Contents 9 0 R/Rotate 0/MediaBox[0 0 612 792]/Thumb 130 0 R/Resources 8 0 R>>
endobj

8 0 obj
<</Font<</F12 119 0 R/F13 122 0 R/F2 147 0 R/F5 150 0 R/F6 151 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

9 0 obj
<</Length 16703>>
stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 62.022 712.3463 Tm
0 0 0 rg
0 Tc
0 Tw
[(failed)-421.4(cutaneous)-415.8(wound)-420(healing,)-420(particularly)-425.2(fol-)]TJ
0 -1.1923 TD
[(lowing)-592.8(surgery,)-598.8(has)-592.6(been)-592.6(identiﬁed)-594.2(by)-597.9(various)]TJ
0 -1.1869 TD
(groups.)Tj
7.8454 0 0 6.9729 97.7386 692.1069 Tm
(51–60)Tj
10.4607 0 0 10.4607 126.822 687.4581 Tm
[(B)13.5(e)12.2(i)13.9(n)12.4(g)-700.1(o)12.2(ve)22.1(r)13.4(w)11.4(e)12.2(i)13.9(gh)22.3(t)-698.9(o)12.2(r)-696.5(o)12.2(be)22.3(s)13.6(e)-697.7(s)13.6(i)0(g)23.8(n)12.4(iﬁ)20.9(-)]TJ
-6.1946 -1.1923 TD
[(c)13.4(a)0(n)22.5(t)11(l)13.9(y)-407.4(i)13.9(n)12.4(cr)21.4(e)12.2(a)15.5(se)20.4(s)-403.7(t)11(h)12.4(e)-399.7(li)22.4(k)13.1(e)12.2(li)22.4(h)12.4(o)12.2(o)12.2(d)-403.5(o)12.2(f)-404.1(in)20.9(f)13.2(e)12.2(c)13.4(t)11(i)13.9(o)12.2(n)12.4(-)0(r)21.3(e)12.2(l)13.9(a)0(t)21.1(e)12.2(d)]TJ
T*
-.0126 Tc
[(comp)-12.6(l)9.7(i)-12.6(c)9.3(a)2.9(ti)-12.6(o)8.1(n)-.2(s)-210.4(c).8(ompa)-12.6(r)10.9(e)-.4(d)-210.2(w)-1.2(ith)-211.5(t)-1.6(hose)-206.3(wi)-12.6(t)12.4(h)-.2(i)-12.6(n)-197.6(a)-213.9(h)-.2(eal)-12.6(t)12.4(hy)]TJ
0 -1.1869 TD
-.0128 Tc
[(weig)-12.8(h)9.5(t)-424.5(ra)-12.8(n)9.7(g)2.5(e.)]TJ
7.8454 0 0 6.9729 128.4094 654.7463 Tm
-.0173 Tc
(61)Tj
10.4607 0 0 10.4607 141.222 650.0975 Tm
-.0127 Tc
[(There)-423.2(a)-12.7(r)10.8(e)-423.2(ma)-12.7(n)9.8(y)-425.6(fac)-12.7(t)6.4(o)5(r)-12.7(s)-413.8(t)-1.7(ha)-12.7(t)-408.9(c)-12.7(o)7.6(n)-.3(-)]TJ
-7.5712 -1.1923 TD
0 Tc
[(t)11(r)13.4(ib)24(u)12.4(t)11(e)-237.1(t)11(o)-231.6(t)11(h)12.4(e)-237.1(c)13.4(h)12.4(r)13.4(o)12.2(n)12.4(i)0(c)21.9(i)13.9(t)11(y)-239.4(o)17.7(f)-236.1(in)20.9(f)13.2(e)12.2(c)13.4(t)11(io)26.2(n)-236.9(i)0(n)-223(o)12.2(be)22.3(s)13.6(e)-231.7(pe)20.6(o)12.2(p)13.8(le)20.7(.)]TJ
T*
-.0126 Tc
[(Decr)-12.6(e)13.1(a)-12.6(s)11(e)-.4(d)-286.1(v)-12.6(a)12.7(s)-12.6(c)9(u)-.2(la)-12.6(r)10.9(i)-12.6(z)8.8(a)2.9(ti)-12.6(o)8.1(n)-282(of)-286.6(the)-282.2(a)-12.6(d)11.2(i)-12.6(p)9.7(o)-.4(se)-287.6(tiss)-12.6(u)8(e)-282.2(i)-12.6(s)-277.7(a)]TJ
0 -1.1869 TD
0 Tc
[(m)12.4(a)0(j)24.6(o)12.2(r)-528.5(c)0(a)23.5(u)12.4(se)-516.1(fo)20.1(r)-528.5(i)13.9(n)12.4(c)0(r)21.4(e)12.2(a)15.5(s)0(e)20.4(d)-528.2(i)13.9(n)12.4(fe)20.1(c)13.4(t)11(i)13.9(o)12.2(n)-529.5(i)13.9(n)-529.5(o)12.2(be)22.3(s)13.6(e)-529.7(p)13.8(a)0(-)]TJ
0 -1.1923 TD
-.0124 Tc
(tients.)Tj
7.8454 0 0 6.9729 91.8425 604.9132 Tm
-.0173 Tc
(53)Tj
10.4607 0 0 10.4607 104.9385 600.2644 Tm
-.0129 Tc
[(Suc)-12.9(h)-442.3(poor)-454.7(perf)-12.9(u)7.4(s).7(ion)-450.3(l)-12.9(i)9.5(m)-.5(i)-12.9(t)12.1(s)-454.6(t)-1.9(he)-450.5(supp)-12.9(l)9.4(y)-452.8(of)]TJ
-4.1026 -1.1923 TD
-.0128 Tc
[(host)-224(i)-12.8(m)8.2(mune)-222.8(cell)-12.8(s)-212.9(t)-1.8(hat)-224(r)-12.8(e)7.5(p)1(res)-12.8(e)13(n)-12.8(t)-211.5(k)-12.8(e)7.1(y)-219.7(c).6(omp)-12.8(o)7.8(nents)-221.4(o)-.6(f)]TJ
0 -1.1869 TD
-.0131 Tc
[(host)-283.9(defens)-13.1(e)7.3(s)-281.3(ag)-13.1(a)12.2(i)-13.1(n)7.8(s).5(t)-283.9(i).8(nfec)-13.1(t)11.4(i)-13.1(o)7.6(n)-.7(.)]TJ
7.8454 0 0 6.9729 209.4236 580.025 Tm
0 Tc
[(53)27.3(,)20.9(6)17.3(2–)27.3(6)17.3(4)]TJ
10.4607 0 0 10.4607 73.9842 562.9038 Tm
[(In)-210.2(obese)-210.6(individuals,)-211.4(intentional)-211.2(weight)-210.9(loss)-212.2(was)]TJ
-1.1435 -1.1923 TD
[(associated)-466.8(with)]TJ
/F6 1 Tf
7.7609 0 TD
(*)Tj
/F5 1 Tf
.9972 0 TD
[(15–18%)-460.8(reduction)-470.3(in)-466.8(all-cause)]TJ
-8.7581 -1.1869 TD
(mortality.)Tj
7.8454 0 0 6.9729 110.1543 542.6644 Tm
(65,66)Tj
10.4607 0 0 10.4607 132.3779 538.0156 Tm
[(Intragastric)-263.8(balloons)-259.2(\(IGBs\))-260.7(are)-262.4(the)]TJ
-6.7257 -1.1923 TD
[(leading)-407(treatment)-398(options)-403.9(for)-405.5(obesity)-404.8(and)-402.7(associ-)]TJ
T*
[(ated)-538.2(diseases.)-537.3(The)-534.2(growing)-540(acceptance)-533.6(of)-538.2(mini-)]TJ
0 -1.1869 TD
[(mally)-297.5(invasive)-299.7(surgical)-300.4(methods)-297(for)-297.1(IGB)-295.3(insertion)]TJ
0 -1.1923 TD
[(is)-308.5(expected)-302.4(to)-307.3(fuel)-305.9(the)-305.7(rising)-307.6(use)-308.6(of)-305.1(this)-306.7(methodol-)]TJ
T*
[(ogy.)-375.3(The)-371.6(IGB)-371.2(market)-372.1(value)-375.1(is)-373.5(expected)-372.8(to)-372.3(exceed)]TJ
0 -1.1869 TD
[($270)-279.6(million)-275.7(by)-283.6(2024.)]TJ
7.8454 0 0 6.9729 165.3165 467.9432 Tm
(67)Tj
/F2 1 Tf
10.959 0 0 10.959 62.022 432.5101 Tm
[(PERILS)-331.7(OF)-332.8(CHRONIC)-329.7(WOUNDS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 418.5637 Tm
[(Access)-305(and)-310.6(delivery)-307.2(of)-305.1(wound)-306.2(care)-308.5(are)-305.7(both)-306.5(sig-)]TJ
-1.1435 -1.1923 TD
[(niﬁcant)-223.2(problems)-223.5(that)-226.4(challenge)-225.5(patients)-221.6(suffering)]TJ
T*
[(from)-273.8(chronic)-277.2(wounds.)-271.8(Lack)-278.4(of)-272.6(access)-275.9(to)-274.8(specialized)]TJ
0 -1.1869 TD
[(wound)-355(care)-357.3(has)-354.1(resulted)-352.5(in)-358.4(amputations)-349.3(and)-359.4(loss)]TJ
0 -1.1923 TD
[(of)-413.5(work)-415.9(productivity.)]TJ
7.8454 0 0 6.9729 165.5433 373.3794 Tm
(8,68–70)Tj
10.4607 0 0 10.4607 198.0283 368.7306 Tm
[(In)-416.2(the)-414.1(United)-414.4(States,)]TJ
-13.0017 -1.1923 TD
[(chronic)-271.8(ulcers)-267.8(are)-267.8(conservatively)-270.8(estimated)-263.6(to)-269.4(cost)]TJ
0 -1.1869 TD
[(the)-359.9(health)-356(care)-357.3(system)-355.3($28)-354.7(billion)-354(each)-358.3(year)-355.4(as)-361.2(a)]TJ
0 -1.1923 TD
[(primary)-287(diagnosis)-282.2(and)-283.5(up)-288.1(to)-280.2($31.7)-285.8(billion)-283.5(as)-279.9(a)-288(sec-)]TJ
T*
[(ondary)-605.6(diagnosis.)]TJ
7.8454 0 0 6.9729 150.2362 323.5464 Tm
(71)Tj
10.4607 0 0 10.4607 165.2598 318.8976 Tm
[(According)-604.8(to)-605.4(the)-609.2(American)]TJ
-9.8691 -1.1869 TD
[(Diabetes)-647.9(Association)-645.9(\(ADA\),)-651.4(over)-645.9(9–12)-648.1(million)]TJ
0 -1.1923 TD
[(Americans)-356.5(suffer)-360.8(from)-355.1(chronic)-358.5(ulcers.)]TJ
7.8454 0 0 6.9729 246.7275 298.6582 Tm
(72)Tj
10.4607 0 0 10.4607 259.1432 294.0094 Tm
[(The)-355.3(mor-)]TJ
-18.844 -1.1923 TD
[(tality)-298.7(rate)-294.7(for)-297.1(leg)-294.6(ulcers)-300.3(after)-292.3(the)-294.9(ﬁrst)-301.8(amputation)]TJ
0 -1.1869 TD
[(has)-337.9(dramatically)-331(doubled)-334.3(from)-338.8(20%)-333.8(to)-334.4(50%)-333.8(in)-336.8(the)]TJ
0 -1.1923 TD
[(ﬁrst)-280.1(3)-282.6(years)-282.2(to)-280.2(70%)-279.6(after)-281.4(5)-282.6(years.)]TJ
7.8454 0 0 6.9729 221.9527 261.2975 Tm
(72)Tj
10.4607 0 0 10.4607 233.5747 256.6487 Tm
[(There)-280.9(is)-281.4(a)-282.6(pro-)]TJ
-16.3998 -1.1923 TD
[(found)-309.8(psychological)-303.3(impact)-310.1(on)-305.9(the)-305.7(patients)-308.3(suffer-)]TJ
0 -1.1869 TD
[(ing)-717.1(from)-718.2(chronic)-721.6(wounds,)-716.2(such)-717.7(as)-718.9(loneliness,)]TJ
0 -1.1923 TD
[(separation)-392.1(from)-393(an)-389.4(active)-395.5(social)-388.9(life,)-391.9(and)-391.9(depres-)]TJ
T*
[(sion.)-355.1(These)-356.6(psychosocial)-356.9(stressors)-354.7(further)-356.1(worsen)]TJ
0 -1.1869 TD
[(healing)-278.2(outcomes.)]TJ
7.8454 0 0 6.9729 148.7622 199.0488 Tm
(73,74)Tj
/F2 1 Tf
10.959 0 0 10.959 62.022 165.9968 Tm
[(ACUTE)-331.7(WOUNDS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 152.0504 Tm
[(Disruptions)-546.5(in)-548.1(the)-549.6(integrity)-548(of)-549(the)-549.6(skin)-548.5(that)]TJ
-1.1435 -1.1923 TD
[(heals)-290(uneventfully)-287.5(with)-287.2(time)-291.8(are)-289.5(considered)-291.6(acute)]TJ
0 -1.1869 TD
(wounds.)Tj
7.8454 0 0 6.9729 101.9905 131.811 Tm
(3)Tj
10.4607 0 0 10.4607 111.5149 127.1621 Tm
[(Surgical)-496.5(and)-500.3(traumatic)-493.7(wounds,)-499.4(abra-)]TJ
-4.7313 -1.1923 TD
[(sions,)-222.3(or)-218.2(superﬁcial)-223(burns)-219.9(are)-219(generally)-217.2(considered)]TJ
T*
[(acute)-287.7(wounds.)]TJ
7.8454 0 0 6.9729 131.1307 106.8661 Tm
(3)Tj
10.4607 0 0 10.4607 138.5007 102.2173 Tm
[(Every)-293.4(time)-286.4(the)-289.5(integrity)-293.2(of)-288.9(the)-289.5(cu-)]TJ
-7.3111 -1.1869 TD
[(taneous)-430.8(barrier)-428.3(is)-427.7(compromised,)-431.7(a)-429(wound)-425.5(is)-433.1(cre-)]TJ
0 -1.1923 TD
[(ated.)-419.8(Wound)-417.1(infections)-424.3(complicate)-420.8(recovery)-418.1(from)]TJ
T*
[(surgery)-700.9(and)-700.8(signiﬁcantly)-703.9(increase)-695.3(the)-701.3(cost)-703(of)]TJ
0 -1.1869 TD
[(wound)-235.8(care)-238.1(postsurgery.)-233.8(The)-236.1(development)-232.3(of)-234.7(novel)]TJ
0 -1.1923 TD
[(and)-364.8(practical)-363.8(concepts)-363.9(to)-366.9(prevent)-364.8(and)-359.4(treat)-364.9(these)]TJ
25.4288 64.2766 TD
[(wound)-322.5(infections)-321.3(are)-322(key)-322.5(to)-323.6(effective)-322.1(wound)-322.5(man-)]TJ
0 -1.1923 TD
(agement.)Tj
1.1435 -1.1869 TD
[(In)-405.4(20)25.5(14)25.5(,)-423.6(a)15.5(cu)20.4(t)16.5(e)-421.3(w)11.4(o)12.2(u)12.4(n)12.4(d)13.8(s)-420(r)13.4(e)12.2(s)0(u)20.6(l)13.9(t)11(e)12.2(d)-419.8(i)13.9(n)-421.2(1)15.5(7.)25.5(2)-423.5(m)12.4(i)13.9(l)13.9(l)0(i)22.4(o)12.2(n)]TJ
-1.1435 -1.1923 TD
[(h)12.4(o)12.2(s)13.6(p)0(i)22.3(t)11(al)-160.3(vi)23.8(s)13.6(i)0(t)19.6(s)13.6(,)-174.2(i)13.9(n)12.4(c)13.4(lu)20.9(d)13.8(i)0(n)20.9(g)-174.4(a)15.5(m)12.4(bu)22.5(l)13.9(a)0(t)21.1(o)17.7(ry)23.3(/o)22.3(u)12.4(t)11(p)13.8(a)0(t)21.1(i)13.9(e)12.2(n)12.4(t)-173.2(a)0(n)22.5(d)]TJ
T*
-.0127 Tc
[(in)-12.7(p)8.1(a)2.8(ti)-12.7(e)8(n)-.3(t)-370.2(s).9(ur)-12.7(g)10.6(i)-12.7(c)9.2(a)2.8(l)-372.7(v)-12.7(i)11.1(s).9(i)-12.7(t)6.9(s.)]TJ
7.8454 0 0 6.9729 444.4724 667.162 Tm
-.0173 Tc
(75)Tj
10.4607 0 0 10.4607 456.718 662.5132 Tm
0 Tc
[(T)10.2(h)12.4(e)-356.3(m)12.4(aj)24.6(o)12.2(r)13.4(it)19.6(y)-358.7(\()13.2(5)15.5(7)0(.)25.5(8)0(%)24.7(\))-360.7(o)12.2(f)]TJ
-12.3025 -1.1869 TD
-.0122 Tc
[(these)-406.4(v)-12.2(i)11.6(s)1.4(i)-12.2(t)12.8(s)-405.1(o)0(c)-12.2(c)9.2(ur)-12.2(r)9.2(e)0(d)-404.9(i)1.7(n)-406.3(h).2(os)-12.2(p)9.8(i)1.7(ta)-12.2(l)11.8(-)1(owned)-404.9(o)0(utpa)-12.2(t)8.9(i)1.7(ent)]TJ
0 -1.1923 TD
[(setting)-12.3(s)11.2(,)-354.6(whi)-12.3(l)10.1(e)-352.3(4)-12.3(2)13.2(.)-12.3(2)7.8(%)-349.9(were)-357.8(inp)-12.3(a)11.5(tient.)]TJ
7.8454 0 0 6.9729 505.814 642.2738 Tm
-.0173 Tc
(75)Tj
10.4607 0 0 10.4607 517.8896 637.625 Tm
-.0124 Tc
[(Outpa)-12.4(t)8.7(ient)]TJ
-18.1503 -1.1923 TD
0 Tc
[(vi)23.8(s)13.6(i)0(t)19.6(s)-268.2(w)11.4(e)12.2(re)-261.6(p)13.8(r)0(i)21.9(m)12.4(ar)23.5(i)13.9(l)0(y)-263.4(\()13.2(48)25.5(.6)20.1(%)14.6(\))-274(c)13.4(o)12.2(ve)22.1(r)13.4(e)12.2(d)-273.5(b)0(y)-261.9(p)13.8(r)13.4(i)0(v)23.8(a)0(t)21.1(e)-269.6(in)20.9(-)]TJ
0 -1.1869 TD
[(s)13.6(u)12.4(re)20.3(r)13.4(s)13.6(,)-456.1(w)11.4(h)12.4(i)13.9(l)13.9(e)-453.8(Me)21.7(d)13.8(i)13.9(ca)23.5(re)-440.4(pr)21.8(im)20.9(a)15.5(r)13.4(il)22.4(y)-456.2(\()13.2(4)15.5(3)0(.)20.1(4)15.5(%\))-443.6(c)13.4(o)12.2(v)15.3(e)12.2(re)20.3(d)]TJ
0 -1.1923 TD
[(i)13.9(n)0(p)20.8(a)15.5(t)11(i)0(e)20.7(n)12.4(t)-265.4(s)13.6(ur)20.4(gi)23.8(c)13.4(a)0(l)-257.9(s)13.6(t)11(a)0(y)25.3(s)13.6(.)]TJ
7.8454 0 0 6.9729 441.9211 604.9132 Tm
-.0173 Tc
(75)Tj
10.4607 0 0 10.4607 339.9873 587.792 Tm
0 Tc
[(Hospital)-894(discharge)-889.9(data)-892.7(derived)-897.1(from)-891.6(the)]TJ
-1.1435 -1.1869 TD
[(Healthcare)-456.4(Cost)-464.5(and)-456.9(Utilization)-460.8(Project)-460.1(\(HCUP\))]TJ
0 -1.1923 TD
[(from)-615.2(burn-related)-610.4(hospital)-614.4(inpatient)-615.4(stays)-613.9(and)]TJ
T*
[(emergency)-715.5(department)-717.5(visits)-720.7(identify)-717.9(that)-719.6(al-)]TJ
0 -1.1869 TD
[(though)-325.2(there)-318(have)-323.9(been)-321.6(signiﬁcant)-321.3(improvements)]TJ
0 -1.1923 TD
[(in)-542.7(treatment)-533.5(options)-539.4(for)-541(burn)-537(injuries,)-544.6(the)-538.8(fre-)]TJ
T*
[(quency)-433.6(and)-435.3(associated)-434.3(costs)-429.3(of)-435.2(these)-431.6(injuries)-435.4(re-)]TJ
0 -1.1869 TD
[(main)-547.3(high.)]TJ
7.8454 0 0 6.9729 383.1306 505.3038 Tm
(76)Tj
10.4607 0 0 10.4607 397.5306 500.655 Tm
[(Almost)-541.1(half)-546.5(million)-546.7(patients)-541.4(were)]TJ
-6.6444 -1.1923 TD
[(treated)-447.3(for)-443.4(burns)-447.5(in)-445.2(2011.)-443(Costs)-445.5(estimates)-442.6(show)]TJ
T*
(that)Tj
/F6 1 Tf
2.1787 0 TD
(*)Tj
/F5 1 Tf
1.0026 0 TD
[($1.5)-241.7(billion)-240.2(was)-246.8(spent)-240.4(in)-244.6(burn)-244.3(injury)-243.1(care)-243.5(in)]TJ
-3.1813 -1.1869 TD
[(2010.)-323.8(An)-326.4(additional)-324.7($5)-321.4(billion)-326.9(in)-325.9(costs)-326.3(was)-322.6(associ-)]TJ
0 -1.1923 TD
[(ated)-283.5(with)-287.2(lost)-285.2(work-hours.)-285.1(The)-284.9(length)-285.7(of)-283.4(inpatient)]TJ
T*
[(stay)-193.9(of)-191.3(burn)-195.5(patients)-189.1(was)-192.6(estimated)-193.1(to)-193.5(be)-189.1(twice)-192.7(that)]TJ
0 -1.1869 TD
[(of)-278(nonburn-related)-280.7(stays.)]TJ
7.8454 0 0 6.9729 449.5747 430.5826 Tm
(76)Tj
10.4607 0 0 10.4607 339.9873 413.4613 Tm
[(Surgical)-339.3(site)-344.8(infections)-343(\(SSI\))-339(represent)-340.8(a)-342.2(major)]TJ
-1.1435 -1.1923 TD
[(concern)-257.2(in)-255.5(overall)-250.3(health)-258.5(care)-254.3(in)-255.5(the)-251.5(United)-257.3(States)]TJ
0 -1.1869 TD
[(and)-310.6(worldwide.)]TJ
7.8454 0 0 6.9729 402.3495 393.2219 Tm
(77–79)Tj
10.4607 0 0 10.4607 427.181 388.5731 Tm
[(It)-309.2(is)-308.5(the)-305.7(second)-307.1(leading)-309.4(cause)]TJ
-9.4789 -1.1923 TD
-.0001 Tc
[(of)-603.3(hospital-acquired)-604.2(infections)-597.8(costing)-601.8($3.5–$10)]TJ
T*
0 Tc
[(billion)-435.3(per)-437.5(year.)]TJ
7.8454 0 0 6.9729 407.792 368.277 Tm
(80,81)Tj
10.4607 0 0 10.4607 431.8865 363.6283 Tm
[(Despite)-437.4(all)-433.6(efforts,)-437.5(SSI)-436(con-)]TJ
-9.9287 -1.1869 TD
[(tributes)-281.6(to)-280.2(mortality)-276.8(in)-282.6(75%)-274.2(of)-283.4(cases.)]TJ
7.8454 0 0 6.9729 505.077 355.8613 Tm
(82,83)Tj
10.4607 0 0 10.4607 339.9873 338.7401 Tm
[(Emergency)-470.4(wound)-474.2(care)-476.5(for)-470.5(acute)-477.3(wounds)-471.5(has)]TJ
-1.1435 -1.1923 TD
[(relevance)-578.4(in)-580.7(combat)-581.1(settings)-579.7(and)-581.6(preparedness)]TJ
0 -1.1869 TD
[(against)-509.8(natural)-512.8(disasters,)-514.2(terrorist)-508.8(attacks,)-514.6(and)]TJ
0 -1.1923 TD
[(other)-523.9(such)-522.6(events)-524.7(that)-519.1(result)-524.9(in)-521(acute)-526.1(injuries.)]TJ
T*
[(Survivors)-398(of)-391.8(bombings)-393.1(are)-397.9(primarily)-394.6(impacted)-397.9(at)]TJ
0 -1.1869 TD
[(the)-262.4(soft)-258.8(tissue)-259.2(and)-261.8(musculoskeletal)-259.2(system)-257.8(level.)]TJ
7.8454 0 0 6.9729 561.4865 281.1401 Tm
(84)Tj
10.4607 0 0 10.4607 328.0251 264.0188 Tm
[(Amputations)-264.6(are)-267.8(the)-262.4(unfortunate)-268(end)-265.1(result)-264.8(of)-267.2(the)]TJ
0 -1.1923 TD
[(most)-313.8(extreme)-306.7(of)-316(these)-307(injuries)-316.1(and)-310.6(reported)-309.7(to)-312.7(oc-)]TJ
0 -1.1869 TD
[(cur)-247.9(in)-244.6(1–3%)-237(of)-245.5(blast)-244.8(victims.)]TJ
7.8454 0 0 6.9729 462.5007 243.7795 Tm
(84,85)Tj
10.4607 0 0 10.4607 484.5542 239.1306 Tm
[(Acute)-246.3(wound)-241.2(care)]TJ
-14.9636 -1.1923 TD
[(accompanied)-393.3(by)-397.4(associated)-390.9(infections)-397.2(may)-395.8(highly)]TJ
T*
[(impact)-277.6(occupational)-284.6(health.)]TJ
/F2 1 Tf
10.959 0 0 10.959 328.0251 178.3559 Tm
(INFECTION)Tj
/F5 1 Tf
10.4607 0 0 10.4607 339.9873 164.4094 Tm
[(Bacteria)-411.8(rapidly)-420.7(colonize)-411.5(in)-412.6(open)-415.4(skin)-418.5(wounds)]TJ
-1.1435 -1.1923 TD
[(after)-351.9(burn)-352.7(injury)]TJ
7.8454 0 0 6.9729 411.4203 156.5858 Tm
(86–90)Tj
10.4607 0 0 10.4607 436.7054 151.9369 Tm
[(or)-353.7(surgical)-354.6(incisions.)]TJ
7.8454 0 0 6.9729 537.6188 156.5858 Tm
(51,91–96)Tj
10.4607 0 0 10.4607 328.0251 139.4645 Tm
[(Microorganisms)-292(colonizing)-290(these)-290.7(wounds)-292.6(are)-289.5(typi-)]TJ
0 -1.1869 TD
[(cally)-518.7(the)-517.1(patient’s)-512.2(normal)-516.2(ﬂora)]TJ
7.8454 0 0 6.9729 486.3683 131.6976 Tm
(97–101)Tj
10.4607 0 0 10.4607 517.7195 127.0488 Tm
[(or)-516.3(may)-515(be)]TJ
-18.134 -1.1923 TD
[(transferred)-359.7(via)-361.8(contact)-360.7(with)-357.6(contaminated)-358.9(water,)]TJ
0 -1.1869 TD
[(fomites,)-394.4(or)-397.1(the)-397.9(soiled)-397.2(hands)-393(of)-397.2(health)-394(care)-400.7(work-)]TJ
0 -1.1923 TD
(ers.)Tj
7.8454 0 0 6.9729 345.6566 94.337 Tm
(102–106)Tj
10.4607 0 0 10.4607 379.0487 89.6882 Tm
[(Gram-positive)-294(bacteria)-301.4(such)-295(as)]TJ
/F13 1 Tf
14.6546 0 TD
(Staphy-)Tj
-19.5323 -1.1923 TD
[(lococcus)-622.3(aureus)]TJ
/F5 1 Tf
7.5007 0 TD
(,)Tj
/F13 1 Tf
.8997 0 TD
(Enterococcus)Tj
/F5 1 Tf
6.6011 0 TD
[(spp.,)-621.7(and)-619.5(Gram-)]TJ
-15.0015 -1.1869 TD
[(negative)-336.5(organisms)-338.2(such)-343.7(as)]TJ
/F13 1 Tf
13.2076 0 TD
[(Pseudomonas)-343.8(aerugi-)]TJ
-13.2076 -1.1923 TD
(nosa)Tj
/F5 1 Tf
2.1353 0 TD
(,)Tj
/F13 1 Tf
.6124 0 TD
(Acinetobacter)Tj
/F5 1 Tf
6.5577 0 TD
[(spp.,)-334.4(fungi)-339.1(like)]TJ
/F13 1 Tf
7.3002 0 TD
(Candida)Tj
/F5 1 Tf
4.3736 0 TD
(spp.,)Tj
/F13 1 Tf
-20.9793 -1.1923 TD
(Aspergillus)Tj
/F5 1 Tf
5.6364 0 TD
[(spp.,)-415.7(are)-414.1(all)-411.9(among)-414.5(a)-412.7(list)-413.6(of)-413.5(common)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 758.6644 Tm
(42)Tj
/F12 1 Tf
9.9626 0 0 9.9626 290.5511 758.6644 Tm
[(EDITORI)-10.7(AL)]TJ
ET
62.022 753.902 508.082 .51025 re
f

endstream
endobj

10 0 obj
<</Type/Page/CropBox[0 0 612 792]/Parent 139 0 R/Contents 12 0 R/Rotate 0/MediaBox[0 0 612 792]/Thumb 131 0 R/Resources 11 0 R>>
endobj

11 0 obj
<</Font<</F12 119 0 R/F13 122 0 R/F2 147 0 R/F5 150 0 R/F10 168 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

12 0 obj
<</Length 17669>>
stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 41.8394 712.3463 Tm
0 0 0 rg
0 Tc
0 Tw
[(pathogens)-325.9(that)-324(can)-327.2(cause)-323(acute)-325.6(wound)-327.9(infections,)]TJ
0 -1.1923 TD
[(and)-278.1(several)-283.2(of)-278(them)-277(are)-278.6(resistant)-278.8(to)-280.2(antibiotics.)]TJ
7.8454 0 0 6.9729 270.1417 704.5227 Tm
(107)Tj
10.4607 0 0 10.4607 53.8015 687.4581 Tm
[(An)-407.7(important)-409.9(factor)-408.9(in)-412.6(the)-408.7(failure)-409.4(of)-408.1(a)-407.3(sore)-409.2(to)]TJ
-1.1435 -1.1923 TD
[(heal)-547.5(is)-547(the)-549.6(presence)-547(of)-549(polymicrobial)-546.7(consortia,)]TJ
T*
[(living)-424.6(cooperatively)-421.6(in)-423.5(highly)-420.7(organized)-420.2(bioﬁlms.)]TJ
0 -1.1869 TD
[(The)-360.7(bioﬁlm)-358.6(shields)-361.7(the)-359.9(pathogenic)-360.9(microbes)-359.3(from)]TJ
0 -1.1923 TD
[(antimicrobial)-462.4(therapy)-464.5(and)-462.3(the)-468.3(patient’s)-463.5(immune)]TJ
T*
[(response.)-471.7(Bioﬁlm)-474.4(infections)-473.1(have)-470.3(been)-473.3(linked)-473.4(to)]TJ
0 -1.1869 TD
[(wound)-219.5(chronicity.)]TJ
7.8454 0 0 6.9729 127.6157 617.3857 Tm
(89,90,108–112)Tj
10.4607 0 0 10.4607 181.9275 612.7368 Tm
[(Recent)-217.8(studies)-218.3(reveal)]TJ
-13.3919 -1.1923 TD
[(that)-394.4(bioﬁlm)-396.5(infection)-399.9(may)-395.8(directly)-396.9(hinder)-398.7(wound)]TJ
T*
[(closure)-223(or)-223.6(cause)-220.1(defective)-224(wound)-224.9(closure)-217.6(where)-225.5(the)]TJ
0 -1.1869 TD
[(wound)-430.9(site)-437(appears)-433.4(closed)-435.6(but)-432.6(the)-430.4(repaired)-433.7(skin)]TJ
0 -1.1923 TD
[(lacks)-353.2(barrier)-352.4(function.)]TJ
7.8454 0 0 6.9729 150.8598 567.5526 Tm
(87,89,90,112)Tj
10.4607 0 0 10.4607 200.1259 562.9038 Tm
[(Such)-350.2(observation)]TJ
-15.1316 -1.1923 TD
[(calls)-303.6(for)-302.5(a)-298.9(revision)-299.4(of)-305.1(the)-300.3(current)-301.8(wound)-300.8(care)-303.1(end-)]TJ
0 -1.1869 TD
[(point.)-262.6(Covering)-265.6(of)-261.8(a)-266.4(wound)-257.5(and)-267.2(a)-260.9(lack)-263.8(of)-261.8(discharge)]TJ
0 -1.1923 TD
[(may)-390.4(not)-392.4(be)-395(adequate)-390.5(criteria)-391.7(to)-394(declare)-393.2(a)-391(wound)]TJ
T*
[(closed.)-219.7(It)-217(is)-216.4(important)-220.2(to)-220.6(add)-217.1(that)-215.6(the)-219(repaired)-222.3(skin)]TJ
0 -1.1869 TD
[(must)-394.9(have)-389(physiological)-395(functionality.)-393.6(Thus,)-391.1(cov-)]TJ
0 -1.1923 TD
[(ering)-295.8(of)-294.3(the)-294.9(wound,)-296.2(a)-298.9(lack)-296.3(of)-294.3(discharge,)-294.5(and)-294.3(resto-)]TJ
T*
[(ration)-338.8(of)-337.6(barrier)-341.6(function)-337.8(should)-338.9(be)-335.4(considered)-340.4(as)]TJ
0 -1.1869 TD
[(criteria)-462.1(for)-459.7(wound)-463.4(closure)-461.5(in)-461.4(patients.)-460.9(It)-460.9(is)-465.7(sus-)]TJ
0 -1.1923 TD
[(pected)-492.5(that)-492(wounds)-493.2(that)-486.5(appear)-495.7(closed,)-490.7(but)-492.2(are)]TJ
T*
[(deﬁcient)-478.4(in)-483.1(barrier)-482.5(function,)-479.5(lend)-478.7(themselves)-477.9(to)]TJ
0 -1.1869 TD
[(wound)-653.1(recurrence.)-652.5(Patient-based)-653.6(studies)-651.9(\(NCT)]TJ
0 -1.1923 TD
[(02577120\))-475.5(are)-479.1(currently)-483.9(in)-477.7(progress)-483.1(to)-480.7(test)-477.8(this)]TJ
T*
(hypothesis.)Tj
/F2 1 Tf
10.959 0 0 10.959 41.8394 368.107 Tm
[(MALNUTRITIO)6.3(N)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 53.8015 354.1605 Tm
[(The)-246.9(process)-243.7(of)-245.5(wound)-246.6(healing,)-241.1(involving)]TJ
/F13 1 Tf
18.5622 0 TD
[(de)-245.1(novo)]TJ
/F5 1 Tf
-19.7057 -1.1869 TD
[(tissue)-709(generation,)-710.1(is)-715(a)-710.8(metabolic)-709(and)-706.2(calorie-)]TJ
0 -1.1923 TD
-.0001 Tc
[(demanding)-691.2(process.)-694.4(From)-688.8(a)-694.6(microenvironment)]TJ
T*
0 Tc
[(standpoint,)-234.2(energy)-238.8(needs)-233.8(to)-236.9(be)-237.9(generated)-234.1(to)-236.9(enable)]TJ
0 -1.1869 TD
[(cellular)-211(repair)-205(mechanisms,)-210.2(chemotactic)-205.7(responses)]TJ
0 -1.1923 TD
[(\(growth)-306.5(factors)-303.2(and)-305.2(cytokine)-302.7(response\),)-306.7(cell)-304.2(motil-)]TJ
T*
-.0002 Tc
[(ity,)-280.5(division,)-276.7(and)-283.7(differentiation.)]TJ
7.8454 0 0 6.9729 198.1984 284.0881 Tm
0 Tc
(113,114)Tj
10.4607 0 0 10.4607 229.2661 279.4393 Tm
-.019 Tc
[(At)-278.9(a)-279.9(m)-1.1(acro-)]TJ
-17.9172 -1.1869 TD
[(environment)-186.8(s)0(cale,)-187.8(p).2(atients)-189.7(w)3.3(ith)-185.4(n)-1.2(onhealing)-188(w)-2.2(ounds)]TJ
0 -1.1923 TD
-.0188 Tc
[(often)-445.4(s).2(uffe)4.3(r)-449.8(f)-.1(rom)-445.3(n)-1(u)4.5(t)-2.3(ritio)4.3(n)-1(al)-449.3(deﬁcie)4.3(ncies.)]TJ
7.8454 0 0 6.9729 239.0172 259.2 Tm
-.0245 Tc
(115)Tj
10.4607 0 0 10.4607 256.0818 254.5511 Tm
-.0167 Tc
[(Tho)6.4(s)2.3(e)]TJ
-20.4807 -1.1923 TD
-.018 Tc
[(wit)3.9(h)-.2(,)-322.3(c).9(o)5.1(m)-.1(pared)-324(w)4.3(ith)-319.9(t)3.9(hose)-320.1(w)4.3(i)1.3(tho)5.1(u)-.2(t,)-316.9(nut)3.9(rition)5.3(al)-318.4(def-)]TJ
0 -1.1869 TD
-.019 Tc
[(icits)-298.1(a)-3.5(re)-299.4(more)-304.8(likely)-301.8(t)-2.5(o)-299.4(d).2(evelop)-297.9(chronic)-298.2(w)-2.2(ounds)-303.5(t)2.9(hat)]TJ
0 -1.1923 TD
-.0194 Tc
[(are)-283.6(s)-.4(lower)-277(t)-2.9(o)-278.1(h)-1.6(eal.)]TJ
7.8454 0 0 6.9729 127.3322 221.8393 Tm
-.0245 Tc
[(116–1)7.2(18)]TJ
/F2 1 Tf
10.959 0 0 10.959 41.8394 178.3559 Tm
0 Tc
(STRESS)Tj
/F5 1 Tf
10.4607 0 0 10.4607 53.8015 164.4094 Tm
[(Another)-638.9(key)-636.8(determinant)-639.9(relating)-640.1(to)-637.9(wound)]TJ
-1.1435 -1.1869 TD
[(outcomes)-382.7(is)-389.8(psychosocial)-384(stress.)]TJ
7.8454 0 0 6.9729 197.8582 156.6425 Tm
(52,73,119–122)Tj
10.4607 0 0 10.4607 253.8708 151.9937 Tm
(Stress)Tj
-20.2694 -1.1923 TD
[(impairs)-434.5(cellular)-427.8(immunity,)-433.4(compromising)-431.5(wound)]TJ
T*
[(healing.)-219.4(The)-219.8(discipline)-222.7(of)-223.8(psychoneuroimmu)5.1(nology)]TJ
0 -1.1869 TD
[(\(PNI\))-333.2(is)-335.6(of)-332.2(direct)-334(relevance)-334.5(to)-334.4(wound)-333.3(healing)-332.4(out-)]TJ
0 -1.1923 TD
(comes.)Tj
7.8454 0 0 6.9729 73.9275 106.8094 Tm
(123,124)Tj
10.4607 0 0 10.4607 105.7889 102.1606 Tm
[(PNI)-354.3(provides)-352.4(a)-353.1(key)-349.6(insight)-357.2(into)-351.4(how)]TJ
-6.1133 -1.1923 TD
[(the)-251.5(immune)-249.3(system)-252.4(bi-directionally)-253.8(communicates)]TJ
0 -1.1869 TD
[(with)-449.8(the)-446.6(central)-450(nervous)-450.3(and)-446.1(endocrine)-452.9(systems)]TJ
0 -1.1923 TD
[(and)-679.1(how)-679.3(these)-680.9(communications)-680.2(impact)-678.6(health)]TJ
T*
(outcomes.)Tj
7.8454 0 0 6.9729 89.6315 56.9763 Tm
(123,124)Tj
10.4607 0 0 10.4607 122.0598 52.3275 Tm
[(Stress-induced)-414.4(immune)-406.4(dysregu-)]TJ
-7.6688 -1.1869 TD
[(lation)-251.6(results)-256.6(in)-250.1(impaired)-254.1(wound)-252(healing.)]TJ
7.8454 0 0 6.9729 240.6046 44.5606 Tm
(123,125,126)Tj
/F2 1 Tf
10.959 0 0 10.959 307.8424 712.0628 Tm
[(SCAR)-331(AND)-333.4(FIBROSIS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 319.8046 698.1163 Tm
[(S)12.6(c)13.4(ar)23.5(s)-420(a)0(n)22.5(d)-419.8(a)15.5(s)13.6(so)20.4(c)13.4(i)13.9(at)21.1(e)12.2(d)-419.8(f)13.2(u)12.4(n)12.4(c)13.4(t)11(i)0(o)20.7(n)12.4(a)15.5(l)-419.7(as)-409.9(w)16.8(e)12.2(ll)-411.1(a)15.4(s)-420(ae)22.3(s)13.6(-)]TJ
-1.1435 -1.1869 TD
-.0126 Tc
[(thetic)-335.2(conc)-12.6(e)7.7(r).8(ns)-335(rep)-12.6(r)9.2(esent)-332.2(a)-338.6(huge)-336.4(b)2.9(ur)-12.6(d)9.2(e)-.4(n)-336.2(o)-.4(n)-330.8(h)-.2(ea)-12.6(l)11.4(t)-1.6(h)]TJ
0 -1.1923 TD
-.0134 Tc
[(ca)-13.4(r)10.1(e)-1.2(.)]TJ
7.8454 0 0 6.9729 330.5196 677.877 Tm
-.0173 Tc
(127)Tj
10.4607 0 0 10.4607 348.3212 673.2281 Tm
0 Tc
[(B)13.5(u)12.4(r)13.4(n)-486.2(w)11.4(o)12.2(u)12.4(n)12.4(d)13.8(s)-485(u)12.4(s)13.6(u)12.4(al)24(l)13.9(y)-483.3(le)20.7(a)15.5(v)0(e)-471.1(h)12.4(yp)23.7(e)12.2(r)0(t)19.1(r)13.4(o)12.2(p)13.8(h)12.4(i)0(c)]TJ
-3.8696 -1.1923 TD
[(s)13.6(c)0(a)23.5(r)0(s)-260.2(a)15.5(f)13.2(t)11(e)12.2(r)-268.4(t)11(h)12.4(e)12.2(y)-271.9(h)12.4(a)15.5(ve)-259.7(h)12.4(e)12.2(a)15.5(l)13.9(e)12.2(d)0(.)-258(I)0(n)-259(p)13.8(ar)23.5(t)11(i)13.9(cu)20.4(l)13.9(a)0(r)23.5(,)-266.4(t)11(h)12.4(e)-269.6(f)13.2(ac)23.5(e)]TJ
0 -1.1869 TD
[(i)13.9(s)-338.7(h)12.4(i)13.9(gh)22.3(ly)-323.1(su)20.6(s)13.6(c)13.4(e)12.2(p)0(t)19.4(i)13.9(bl)24(e)-334.6(t)11(o)-334.6(e)12.2(xc)23.3(e)12.2(s)13.6(si)22.1(ve)-324.7(s)13.6(c)13.4(ar)23.5(ri)21.9(n)12.4(g)0(,)-327(c)13.4(au)22.5(s)13.6(i)13.9(n)12.4(g)]TJ
0 -1.1923 TD
[(f)13.2(u)12.4(n)12.4(c)0(t)19.1(i)13.9(o)12.2(n)12.4(al)-328.3(de)20.6(ﬁ)12.4(c)13.4(i)13.9(t)11(s)13.6(.)-342.3(S)12.6(o)12.2(m)12.4(e)-340(o)12.2(f)-344.5(t)11(h)12.4(e)-340(c)13.4(ri)21.9(t)11(i)13.9(ca)23.5(l)-343.8(f)13.2(ac)23.5(i)13.9(a)0(l)-333.7(c)13.4(h)12.4(a)15.5(r-)]TJ
T*
[(ac)23.5(t)11(e)12.2(r)13.4(i)13.9(st)19.2(i)13.9(c)13.4(s)-392.9(f)13.2(o)12.2(l)0(l)22.4(o)12.2(w)11.4(i)13.9(n)12.4(g)-391.2(t)11(h)12.4(e)12.2(r)0(m)20.5(a)15.5(l)-392.5(i)13.9(nj)21.6(u)12.4(r)0(y)-383.2(o)12.2(f)-387.8(t)11.1(h)12.4(e)-394.2(f)13.2(a)0(c)23.5(e)-388.8(in)20.9(-)]TJ
0 -1.1869 TD
-.0129 Tc
[(cl)-12.9(u)8(d).9(e)-212(e)-.7(ctrop)-12.9(i)9.4(on)-211.8(\(epi)-12.9(t)12.1(h)-12.9(e)6.3(lia)-12.9(l)11.1(-).3(oc)-12.9(u)7.5(l)1(a)-12.9(r)-200.8(junc)-12.9(t)6.2(i)1(on\),)-214.3(e)4.8(v)-12.9(e)9.2(r).5(s)-12.9(i)9.2(on)]TJ
0 -1.1923 TD
0 Tc
[(o)12.2(f)-474.5(t)11(h)12.4(e)-475.5(l)13.9(ip)-465.5(\()13.2(e)12.2(p)13.8(i)0(t)19.5(h)12.4(e)12.2(l)13.9(i)13.9(a)0(l)24(-)0(o)20.1(r)13.4(al)-463.8(j)14.6(u)12.4(n)12.4(c)0(t)19.1(i)13.9(o)12.2(n)12.4(\))13.2(,)-477.7(a)15.5(n)12.4(d)-479.4(e)12.2(x)15.3(c)0(e)20.2(s)13.6(s)13.6(i)13.9(ve)]TJ
0 -1.1869 TD
-.0127 Tc
[(sk)-12.7(i)8.9(n)-227.9(contra)-12.7(c)10.8(t)-1.7(ure.)-224.9(Deﬁci)-12.7(t)6.9(s)-221.3(s)-12.7(u)7.9(c).7(h)-227.9(a)2.8(s)-226.7(o)-.5(ra)-12.7(l)-216.4(i)1.2(nc)-12.7(o)7.6(m)-.3(petence)]TJ
0 -1.1923 TD
0 Tc
[(ar)23.5(e)-193.7(c)13.4(o)12.2(m)12.4(m)12.4(o)12.2(n)12.4(.)-190.5(S)12.6(u)12.4(ch)-180.1(di)22.3(s)13.6(o)12.2(rd)21.8(e)12.2(r)13.4(s)-192.4(c)0(a)23.5(u)12.4(se)-180.1(s)13.6(o)12.2(ci)21.9(al)24(,)-190.5(e)12.2(m)12.4(o)12.2(t)11.1(i)0(o)26.2(n)0(a)22.5(l)13.9(,)]TJ
T*
[(an)22.5(d)-186.7(p)13.8(s)13.6(y)0(c)23.3(h)0(o)24.7(l)0(o)20.7(g)15.3(ic)21.9(al)-176.6(b)15.5(u)0(r)20.4(d)13.8(e)12.2(n)12.4(s.)-176.9(P)10.2(a)15.5(t)11(i)13.9(e)12.2(n)12.4(t)11(s)-186.9(w)11.4(i)13.9(t)11(h)-188.1(s)13.6(u)12.4(ch)-180.1(f)13.2(a)15.5(ci)21.9(al)]TJ
0 -1.1869 TD
[(d)13.8(i)0(s)22.1(ﬁ)12.4(gu)22.3(r)13.4(a)0(t)21.1(i)13.9(o)12.2(n)12.4(s)-756(s)0(h)20.6(o)12.2(w)16.8(e)12.2(d)-761.2(s)13.6(ym)22.3(p)13.8(t)11(o)12.2(m)12.4(s)-756(o)12.2(f)-756.3(d)0(e)20.6(p)13.8(re)25.7(ss)21.8(i)13.9(o)12.2(n)12.4(,)]TJ
0 -1.1923 TD
[(an)22.5(x)15.3(i)0(e)20.7(t)16.5(y,)-478.7(a)15.5(n)12.4(d)-484.8(h)0(o)19.2(s)13.6(t)11(i)13.9(l)13.9(i)0(t)19.6(y)15.3(,)-488.6(c)13.4(o)12.2(m)12.4(p)13.8(a)0(r)23.5(e)12.2(d)-490.2(w)16.8(it)19.6(h)-480.8(a)-488.6(m)12.4(a)15.5(t)11(c)0(h)20.4(e)12.2(d)]TJ
T*
-.0127 Tc
[(norma)-12.7(l)-178.4(control)-188.5(g)-12.7(r)10.6(o)-.5(up,)-186.9(f).5(or)-189(a)-186.9(p)1.1(er)-12.7(i)9.2(o)-.5(d)-188.6(o)-.5(f)-183.7(u)-.3(p)-188.6(t)-1.7(o)-184.7(1)-186.9(y)-12.7(e)14.8(a)-12.7(r)-178.9(post)]TJ
0 -1.1869 TD
0 Tc
[(t)11(r)13.4(au)22.5(m)12.4(a)15.5(.)]TJ
7.8454 0 0 6.9729 345.8267 516.0188 Tm
-.0173 Tc
(128)Tj
10.4607 0 0 10.4607 362.4377 511.3699 Tm
-.0126 Tc
[(Other)-384(t)-1.6(ha)-12.6(n)-374.9(t)-1.6(he)-385.2(fa)-12.6(c)10.9(e)-.4(,)-387.4(s)1(ca)-12.6(r)10.9(r)-12.6(i)9.3(n)-.2(g)-387.5(i)1.3(s)-383.8(a)-387.4(sub)-12.6(-)]TJ
-5.2191 -1.1923 TD
0 Tc
[(s)13.6(t)11(an)22.5(t)11(i)13.9(al)-268.7(h)12.4(e)12.2(a)15.5(l)0(t)19.6(h)-280.2(c)13.4(a)0(r)23.5(e)-280.4(p)13.8(r)13.4(o)12.2(b)0(l)24(e)12.2(m)-280.2(t)11(o)12.2(d)13.8(ay)19.9(.)-277.2(T)10.2(h)12.4(e)-280.4(g)15.3(l)0(o)20.7(b)15.5(al)-268.7(s)13.6(k)0(i)21.6(n)]TJ
T*
[(s)13.6(c)0(a)23.5(r)-187.1(t)11(h)12.4(e)12.2(r)13.4(ap)23.8(y)-190.7(m)12.4(a)15.5(r)13.4(ke)19.9(t)-184.1(i)13.9(s)-186.9(e)12.2(xp)23.7(e)12.2(c)0(t)24.5(e)12.2(d)-186.7(t)11(o)-188.3(r)13.4(e)12.2(a)15.5(ch)-174.7(ar)23.5(o)12.2(u)12.4(n)12.4(d)-186.7($3)20.1(5)]TJ
0 -1.1869 TD
[(bi)24(l)13.9(l)0(i)22.4(o)12.2(n)-269.4(b)15.5(y)-271.9(2)15.5(02)25.5(3.)]TJ
7.8454 0 0 6.9729 379.8991 478.6581 Tm
-.0173 Tc
(129)Tj
/F2 1 Tf
10.959 0 0 10.959 307.8424 439.1432 Tm
0 Tc
[(PHYSICIAN)-330.6(EDUCATION)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 319.8046 425.14 Tm
[(Com)16.5(pre)12.4(he)13.8(nsi)12.9(ve)-384.4(edu)11.4(ca)12.6(tio)15.5(n)-394.1(i)0(s)-384.4(c)0(r)10.6(iti)11.8(ca)12.6(l)-392.6(for)-378.4(the)-381.6(de-)]TJ
-1.1435 -1.1869 TD
[(ve)11.3(lop)12.9(men)15.4(t)-373.7(o)0(f)-364.7(w)0(o)12.8(und)-367.8(ca)12.6(re)-370(ma)11.7(na)11.6(ge)11.3(men)15.4(t)-373.8(a)0(s)-366.6(a)-369.3(dis)14.2(ci-)]TJ
0 -1.1923 TD
[(pl)11.5(ine)-465.4(in)-472.3(ma)11.7(ins)12.9(tre)15(am)-470.7(med)16.8(ici)14.2(ne.)]TJ
7.8454 0 0 6.9729 460.1762 404.9007 Tm
(130)Tj
10.4607 0 0 10.4607 478.0345 400.2519 Tm
[(Fo)11.6(rm)9.6(al)-469.2(wou)14.4(nd)]TJ
-16.2697 -1.1869 TD
[(car)15.2(e)-264.2(edu)16.8(cat)12.8(ion)-254.1(in)-255.5(US)-259.3(med)16.8(ica)10.3(l)-262.5(s)0(c)10.8(hoo)15.2(ls)-259.7(is)-254.3(oft)14.9(en)-262.6(we)12.8(ak)]TJ
0 -1.1923 TD
[(at)-537.1(be)11.4(st.)-534.4(Of)-533.6(55)-538.1(sc)10.8(hoo)15.2(ls)-536.1(sur)12.4(ve)11.3(ye)11.3(d)-544.4(t)0(h)12.6(rou)11(gh)11.5(out)-533.3(th)12.6(e)]TJ
T*
[(Un)11.5(ite)15.5(d)-360.2(S)0(t)12.8(ate)11.7(s,)-350.3(onl)11.5(y)-353.2(sev)14(en)-354.7(of)14.6(fer)11.8(ed)-353.4(a)-353.1(for)11.8(ma)11.7(l)-354.6(wou)14.4(nd)]TJ
0 -1.1869 TD
[(hea)13(li)11.6(ng)-286.6(ele)11.3(ct)13.6(ive)14.4(.)]TJ
7.8454 0 0 6.9729 385.6818 355.1243 Tm
(131)Tj
10.4607 0 0 10.4607 401.6692 350.4755 Tm
[(Ty)14.7(pic)8.6(al)13.1(ly,)-285.9(edu)16.8(cat)12.8(ion)-281.2(an)11.6(d)-295.1(tra)12.8(in)10.1(-)]TJ
-8.9695 -1.1923 TD
[(in)10.1(g)-315.3(i)0(n)-309.7(w)0(o)12.8(und)-308.2(ca)12.6(re)-310.3(for)-307.9(th)12.6(e)-312.9(med)11.4(ic)11.1(al)-312(st)13.8(ude)11.4(nt)12.6(s)-317(wit)14.7(hi)10.1(n)]TJ
T*
[(the)-213.6(Un)11.5(ite)15.5(d)-224.7(Sta)17.4(tes)-212.4(do)-217.9(not)-213.6(exc)13.9(eed)]TJ
/F10 1 Tf
14.4649 0 TD
(>)Tj
/F5 1 Tf
.5474 0 TD
[(9.2)-154.2(h)-220.6(i)0(n)-217.5(the)-213.6(4-y)11.5(ea)11.4(r)]TJ
-15.0123 -1.1869 TD
[(cu)9.6(rr)10.6(icu)12.7(lu)10.1(m.)]TJ
7.8454 0 0 6.9729 364.0251 317.7637 Tm
(132)Tj
10.4607 0 0 10.4607 379.8424 313.1149 Tm
[(To)-281(he)13.8(lp)-281.2(add)15.9(res)12.2(s)-284.5(t)0(h)12.6(i)0(s)-281.4(gap)-275.2(in)-277.1(med)16.8(ica)10.3(l)]TJ
-6.8829 -1.1923 TD
[(tra)12.8(in)10.1(in)10.1(g,)-348.6(the)-343.7(Ame)16.5(ri)11.1(can)-343.5(Col)12.5(leg)14.4(e)-350.9(o)0(f)-348.5(Wou)11.9(nd)-347.7(He)10.6(al)13.1(in)10.1(g)]TJ
T*
[(an)11.6(d)-338.5(Tis)16.1(sue)-330.3(Rep)17.8(air)-331.1(wa)10.6(s)-338.7(f)0(o)14.6(und)11.5(ed)-331.7(to)-334.4(he)13.8(lp)-335.4(tra)12.8(in)-331.3(ph)9.9(y-)]TJ
0 -1.1869 TD
[(si)11.3(cia)10.3(ns)-250.4(sp)11.1(eci)12.5(al)13.1(iz)10.6(e)-258.7(i)0(n)-250(w)0(o)12.8(und)-243.2(car)9.8(e.)-248.7(Th)11.8(is)-248.9(ins)12.8(tit)14.3(uti)15.7(on)-251.7(is)]TJ
0 -1.1923 TD
[(cu)9.6(rr)10.6(ent)14(ly)-669.9(wo)12.8(rk)10.3(ing)-662.9(tow)13(ar)12.6(d)-674.5(a)0(c)12.6(cre)12(dit)11.7(ati)18.8(on)-669(by)-668.4(th)12.6(e)]TJ
T*
[(Ame)16.5(ric)13.7(an)-188.9(Boa)19.5(rd)-189.6(of)-185.9(Me)10.8(di)11.4(cal)-184.8(Sp)10.1(eci)17.9(alt)13.3(ies)-182.4(an)11.6(d)-192.2(h)0(o)13.8(pes)-182.6(to)]TJ
0 -1.1869 TD
[(ach)14.2(iev)14.4(e)-275(t)0(h)12.6(i)0(s)-270.6(b)0(y)-272.7(202)13.9(2.)]TJ
7.8454 0 0 6.9729 407.9054 243.0424 Tm
(130)Tj
10.4607 0 0 10.4607 319.8046 225.9212 Tm
-.02 Tc
[(In)-267.7(Europe,)-270.1(w)2.3(ound)-266.4(care)-262.5(educ)]TJ
12.438 0 TD
[(ation)-267.6(l)-.6(acks)-266.4(consensus)]TJ
-13.5816 -1.1923 TD
-.0205 Tc
[(in)-186.9(relation)-192.3(to)-187.1(the)-187.1(m)-2.6(inimum)-192.3(education)-192.3(n)2.8(eeded)-185.6(t)1.4(o)-192.5(b).4(e)-187.1(a).4(n)]TJ
0 -1.1869 TD
-.0192 Tc
[(expe)3.9(rt)-257.5(in)-256.1(wou)4.1(n)-1.4(d)-254.7(c)-.3(are.)]TJ
7.8454 0 0 6.9729 408.1888 205.6818 Tm
-.0317 Tc
[(13)-7.2(3)]TJ
10.4607 0 0 10.4607 423.2125 201.033 Tm
-.02 Tc
[(Various)-255.7(d)-.8(iploma)-259.3(and)-260.9(c)-1.1(ertif-)]TJ
-11.0289 -1.1923 TD
[(icate)-197.4(p)-.7(rograms)-196(a)1(re)-191.9(available)-197.4(i)-.6(n)-191.7(F)-4.3(rance,)-194.2(England,)-194.1(and)]TJ
T*
-.0192 Tc
[(Wale)3.9(s.)-280.2(The)-277.9(E)-.3(ur)5.1(ope)3.9(a)1.7(n)-283.2(W).5(o)3.9(u)-1.4(n)4.1(d)-281.8(Manage)3.9(me)3.9(nt)-279.1(Asso)3.9(cia-)]TJ
0 -1.1869 TD
-.0198 Tc
[(tion)-321.7(\(EWMA\))-320.9(is)-326(working)-324.3(t)-3.3(oward)-325.8(e)-2.2(s)4.6(t)-3.3(ablishing)-324.3(a)-324.1(c)-.9(ore)]TJ
0 -1.1923 TD
-.0191 Tc
[(standard)-314.2(for)-314.6(a)1.8(cce)4(ptable)-315.8(w)3.2(ou)4.2(nd)-314.2(manage)4(me)4(nt)-317(e)4(d).1(uca-)]TJ
T*
-.0206 Tc
(tion.)Tj
7.8454 0 0 6.9729 328.7054 143.3763 Tm
-.0317 Tc
[(13)-7.2(3)]TJ
10.4607 0 0 10.4607 345.6566 138.7275 Tm
-.0201 Tc
[(In)-446.7(Denmark,)-443.7(however,)-438.2(a)-443.6(2).8(-year)-440.2(a)-4.6(d)4.5(d)-.9(itional)]TJ
-3.6149 -1.1869 TD
-.0198 Tc
[(ed)4.8(ucational)-780.9(e)3.3(xperi)5(e)-2.1(nce)-777.2(f)-1.1(ollowing)-774.1(basic)-776(specialty)]TJ
0 -1.1923 TD
-.0211 Tc
[(train)-3.3(i)-1.8(ng)-260.5(h)-3.3(a)-.2(s)-262.2(b)-.2(ee)-3.4(n)-258(d)-1.9(e)-3.4(v)-.4(elo)-3.4(p)-1.9(ed)-262(for)-262.4(m)-3.2(edical)-261.9(docto)-3.4(r)-2.3(s.)]TJ
7.8454 0 0 6.9729 530.7023 118.4882 Tm
-.0317 Tc
[(13)-7.2(3)]TJ
/F2 1 Tf
10.959 0 0 10.959 307.8424 79.4834 Tm
0 Tc
[(NURSING)-327.6(EDUCATION,)-329.8(PHYSICAL)-333.6(THERAPY,)]TJ
0 -1.1381 TD
[(AND)-333.4(OSTOMY)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 319.8046 53.0645 Tm
[(Traditionally,)-178(wound)-181.6(healing)-180.7(has)-180.7(been)-180.7(under)-179.6(the)]TJ
-1.1435 -1.1923 TD
[(aegis)-308.8(of)-310.5(basic)-307.5(nursing)-307.5(practices,)]TJ
7.8454 0 0 6.9729 462.1605 45.2409 Tm
(134)Tj
10.4607 0 0 10.4607 478.3747 40.5921 Tm
[(such)-311.2(as)-307(wound)]TJ
/F12 1 Tf
9.9626 0 0 9.9626 270.3684 757.8707 Tm
[(EDITORI)-10.7(AL)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 540.0565 757.8707 Tm
(43)Tj
ET
41.839 753.959 508.082 .51025 re
f

endstream
endobj

13 0 obj
<</Type/Page/CropBox[0 0 612 792]/Parent 139 0 R/Contents 15 0 R/Rotate 0/MediaBox[0 0 612 792]/Thumb 132 0 R/Resources 14 0 R>>
endobj

14 0 obj
<</Font<</F12 119 0 R/F2 147 0 R/F5 150 0 R/F6 151 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

15 0 obj
<</Length 16331>>
stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 62.022 712.3463 Tm
0 0 0 rg
0 Tc
0 Tw
[(covering)-352.4(management,)-346.2(therapeutic)-351.7(nutrition,)-354(and)]TJ
0 -1.1923 TD
[(mobility)-395.7(and)-391.9(psychosocial)-394.8(support.)-392.8(Nu)22.3(r)13.4(s)0(e)20.4(s)-382(p)13.8(l)0(a)24(y)-385.8(a)]TJ
0 -1.1869 TD
[(c)13.4(r)0(u)20.4(c)13.4(ia)24(l)-175.8(r)0(o)20.3(l)13.9(e)-177.5(i)13.9(n)-177.3(h)12.4(a)15.5(n)12.4(dl)22.3(in)20.9(g)-174.4(a)15.5(nd)-168.9(m)12.4(a)15.5(n)12.4(a)0(g)25.3(i)0(n)20.9(g)-174.4(ac)23.5(u)12.4(t)11(e)-177.5(w)16.8(o)12.2(u)12.4(n)12.4(d)0(s)]TJ
0 -1.1923 TD
[(an)22.5(d)-430.6(c)13.4(h)12.4(r)0(o)20.3(n)12.4(i)13.9(c)-431(w)11.4(o)12.2(u)12.4(n)12.4(d)13.8(s)-430.8(s)13.6(uc)20.4(h)-432(a)15.5(s)-430.8(P)10.2(U)15.3(s)0(,)-420.8(b)0(e)27.7(d)0(s)22(o)12.2(r)13.4(e)12.2(s,)-420.8(F)10.2(U)15.3(s)13.6(,)]TJ
T*
-.0132 Tc
[(a)-13.2(n)9.3(d)-433(v)-13.2(e)8.9(n)-.8(ous)-438.6(u)-.8(lcer)-13.2(s)8.4(.)-436.7(The)-440(W)1.1(ound)-438.4(Os)-13.2(t)6(o)4.5(my)-436.9(a)-13.2(n)9.3(d)-438.4(C).3(on-)]TJ
0 -1.1869 TD
-.013 Tc
[(tinenc)-13(e)-225.8(N)2.3(ur)-13(s)8.6(e)-.8(s)-232.5(\()-13(W)9.1(O)-1.6(CN)-13(\))-222.9(S)-.4(oci)-13(e)7.7(ty)-236.2(i)-13(s)-223.9(the)-233.8(o)-.8(ld)-13(e)7.6(s).6(t)-235(w)-1.6(ound)]TJ
0 -1.1923 TD
0 Tc
[(c)13.4(a)0(r)23.5(e)-616.4(s)13.6(o)12.2(ci)21.9(e)12.2(t)11(y)-613.4(t)11(h)12.4(a)0(t)-607.6(h)12.4(a)15.5(s)-615.1(bo)22.3(a)15.5(r)0(d)21.8(-)13.2(ce)20.3(r)13.4(t)11(i)13.9(ﬁ)12.4(e)12.2(d)-620.3(o)17.7(v)0(e)22.1(r)-615.2(6,)25.5(00)20.1(0)]TJ
T*
-.0124 Tc
[(nur)-12.4(s)9.2(e)-.2(s)-345.7(w)-1(or)-12.4(l)9.5(d)1.4(wid)-12.4(e)8.2(.)]TJ
7.8454 0 0 6.9729 148.8755 629.8014 Tm
0 Tc
[(13)27.3(4)]TJ
10.4607 0 0 10.4607 165.1464 625.1526 Tm
[(T)10.2(h)12.4(e)12.2(y)-337(a)15.5(r)0(e)-326.6(c)13.4(o)12.2(n)12.4(si)22.1(de)26(re)20.3(d)-338.5(t)16.5(h)12.4(e)-340(g)15.3(o)12.2(ld)]TJ
-9.8583 -1.1869 TD
-.0128 Tc
[(sta)-12.8(n)9.7(da)-12.8(r)10.7(d)-194.1(for)-189.1(c).6(er)-12.8(t)6.3(i)1.1(ﬁca)-12.8(t)8.3(ion)-190.1(i)-12.8(n)-181.6(w)4(ou)-12.8(n)6.6(d)-188.7(nurs)-12.8(i)9.3(ng)-12.8(,)-182.6(a)2.7(nd)-194.1(thi)-12.8(s)]TJ
0 -1.1923 TD
-.013 Tc
[(pr)-13(o)7.3(c).4(ess)-189.1(r).4(equi)-13(r)8.9(e)-.8(s)-183.7(c)-13(o)7.3(m)-.6(pleti)-13(o)13.2(n)-184.8(o)-.8(f)-184(a)-187.2(ri)-13(g)10.8(o)-.8(r)-13(o)7.3(us)-183.7(cur)-13(r)8.4(ic)-13(u)7.4(l).9(um)]TJ
T*
0 Tc
[(f)13.2(o)12.2(ll)22.4(o)12.2(w)11.4(e)12.2(d)-230.1(b)15.5(y)-228.6(st)24.6(ri)21.9(n)12.4(g)0(e)22.1(n)12.4(t)-227.4(r)0(e)20.3(c)13.4(e)12.2(r)13.4(t)11(i)13.9(ﬁc)20.4(a)15.5(t)11(io)20.7(n)-226(p)0(r)21.8(o)12.2(c)13.4(e)12.2(s)13.6(s)0(e)20.4(s)13.6(.)]TJ
7.8454 0 0 6.9729 278.4755 592.4408 Tm
-.0173 Tc
(134)Tj
10.4607 0 0 10.4607 293.5558 587.792 Tm
0 Tc
(In)Tj
-22.1337 -1.1869 TD
[(20)25.5(10)25.5(,)-634.9(t)11(h)12.4(e)-638.1(O)11.4(r)13.4(ga)25.3(n)12.4(i)0(z)21.4(a)15.5(t)11(i)13.9(o)12.2(n)-637.9(o)12.2(f)-637.1(W)14.3(o)12.2(u)12.4(n)12.4(d)-636.6(C)13.4(a)0(r)23.5(e)-638.1(N)15.3(u)12.4(rs)21.6(e)12.2(s)]TJ
0 -1.1923 TD
[(\()13.2(O)11.4(W)14.3(C)0(N)23.4(\))-414.9(w)11.4(a)0(s)-404.5(e)12.2(s)13.6(t)11(ab)25.5(li)22.4(s)13.6(h)12.4(e)12.2(d)0(.)]TJ
7.8454 0 0 6.9729 185.896 567.5526 Tm
-.0173 Tc
[(13)-17.3(5)]TJ
10.4607 0 0 10.4607 203.0173 562.9038 Tm
-.0136 Tc
[(It)-430.7(p)-13.6(r)8.2(ov)-13.6(i)10.2(d).2(es)-433.6(th)-13.6(e)-422.5(f)-.4(oun-)]TJ
-13.4786 -1.1923 TD
-.0129 Tc
[(da)-12.9(t)8.2(i)1(on)-358.2(a)-12.9(n)9.6(d)-356.8(f).3(ree-)-12.9(o)7.2(f-cos)-12.9(t)-345.9(t)-1.9(ra)-12.9(i)11.1(n)-.5(i)-12.9(n)8(g)-355.3(f).3(or)-362.6(al)-12.9(l)-348.2(t)-1.9(he)-352.9(l)-12.9(i)9.5(cen)-12.9(s)7.7(ed)]TJ
0 -1.1869 TD
0 Tc
[(n)12.4(u)12.4(r)0(s)21.6(e)12.2(s)-241.1(w)16.8(ho)-230.1(ar)23.5(e)-242.5(p)13.8(r)13.4(a)0(c)23.5(t)11(i)13.9(c)0(i)21.9(n)12.4(g)-239.4(i)0(n)-228.4(d)0(i)22.3(f)13.2(fe)20.1(r)13.4(e)12.2(n)12.4(t)-238.3(ca)23.5(re)-229(se)25.8(t)11(t)11(i)0(n)20.9(g)15.3(s)13.6(.)]TJ
0 -1.1923 TD
[(W)14.3(o)12.2(u)12.4(n)12.4(d)-522.8(c)13.4(a)0(r)23.5(e)-518.9(a)15.5(n)12.4(d)-517.3(o)12.2(st)19.2(o)17.7(m)12.4(y)-521.2(e)12.2(d)13.8(u)12.4(ca)23.5(t)11(i)13.9(o)12.2(n)-518.7(pr)21.8(o)12.2(g)0(r)23.3(a)15.5(m)12.4(s)-522.9(f)13.2(o)12.2(r)]TJ
T*
[(n)12.4(u)12.4(r)0(s)21.6(e)12.2(s)-447.1(a)0(r)23.5(e)-448.4(in)20.9(c)13.4(r)13.4(e)12.2(as)23.6(in)20.9(g)15.3(l)0(y)-442.3(b)15.5(e)12.2(c)13.4(o)12.2(m)12.4(in)20.9(g)-450.8(a)15.5(va)25.3(il)22.4(ab)25.5(le)-439.9(i)13.9(n)-448.2(an)]TJ
0 -1.1869 TD
[(e)12.2(f)13.2(fo)25.5(rt)-257.3(t)11(o)-269.6(i)13.9(m)12.4(pr)21.8(o)12.2(v)15.3(e)-269.6(n)12.4(u)12.4(r)0(s)21.6(i)13.9(n)12.4(g)-271.9(s)13.6(e)12.2(r)13.4(v)0(i)23.8(c)13.4(e)-269.6(q)0(u)22.5(a)15.5(li)22.4(t)11(y)0(.)]TJ
7.8454 0 0 6.9729 255.0047 505.3038 Tm
-.0173 Tc
(136)Tj
10.4607 0 0 10.4607 73.9842 488.1826 Tm
0 Tc
[(Appropriate)-297.8(professional)-295.1(use)-297.8(of)-299.7(multiple)-297.3(wound)]TJ
-1.1435 -1.1923 TD
[(care)-742.1(disciplines)-745.7(may)-742.6(markedly)-741.2(impact)-743.7(wound)]TJ
0 -1.1869 TD
(care.)Tj
7.8454 0 0 6.9729 85.3228 467.9432 Tm
(137–139)Tj
10.4607 0 0 10.4607 119.5653 463.2943 Tm
[(Physical)-374(therapy)-377.8(represents)-376(one)-375(such)]TJ
-5.5009 -1.1923 TD
[(major)-327.4(discipline.)-331.9(Trained)-325.8(physical)-332.5(therapists)-330.1(may)]TJ
T*
[(employ)-575.8(numerous)-570.8(treatment)-571.5(regimens,)-572.6(such)-576.8(as)]TJ
0 -1.1869 TD
[(wound)-474.2(debridement,)-470.2(modalities,)-475.2(edema)-470.4(manage-)]TJ
0 -1.1923 TD
[(ment,)-429.6(positioning,)-425(orthotic)-431.3(use,)-428.6(and)-424.4(mobility)-428.3(im-)]TJ
T*
[(provement.)-433(Occupational)-431.7(therapists)-427.6(may)-433.7(provide)]TJ
0 -1.1869 TD
[(edema)-161.4(management,)-156.5(wound)-159.9(debridement,)-161.3(position-)]TJ
0 -1.1923 TD
[(ing,)-495.7(toileting)-501.7(programs,)-492.7(self-feeding,)-497.2(and)-500.3(wheel-)]TJ
T*
[(chair)-375.7(management)-367.1(as)-372(relevant)-376.3(to)-372.3(the)-370.8(need)-372(of)-375.6(the)]TJ
0 -1.1869 TD
[(patient.)-284.8(Addressing)-281.8(supportive)-285.5(interventions)-283.5(such)]TJ
0 -1.1923 TD
[(as)-209.4(physical)-207.9(and)-207.6(occupational)-208.7(therapy)-204.4(and)-213(nutrition)]TJ
T*
[(management)-594.7(are)-593(likely)-595(to)-594.5(promote)-590(the)-593(rate)-598.2(of)]TJ
0 -1.1869 TD
[(wound)-311.6(healing,)-317(thereby)-308.9(lowering)-317.8(the)-311.1(overall)-315.4(costs)]TJ
0 -1.1923 TD
[(of)-527.3(wound)-523(care.)-531.6(After)-521.9(all,)-526.6(the)-527.9(longer)-527.4(a)-526.5(patient’s)]TJ
T*
[(healing)-278.2(time,)-281.7(the)-278.6(higher)-277.9(the)-278.6(cost)-280.3(to)-280.2(the)-278.6(facility.)]TJ
1.1435 -1.1869 TD
[(Wou)17.3(nd)10(,)-293.5(ost)15.2(om)13.8(y,)-289(an)11.6(d)-289.7(con)11(ti)14.1(nen)10(ce)-283.2(nur)16.6(ses)12.3(,)-288.1(i)0(n)-288(a)0(d)13(di-)]TJ
-1.1435 -1.1923 TD
[(tio)15.5(n)-253.1(t)0(o)-242.3(b)0(e)11.4(ing)-245.6(edu)16.8(cat)12.9(ed)-245(an)11.6(d)-251.8(tra)12.8(in)10.1(ed)-245(to)-247.7(pr)11(ov)11.3(ide)-241.9(acu)14.2(te)]TJ
T*
[(an)11.6(d)-571.5(reh)16.4(abi)17.8(lit)11.8(ati)13.3(ve)-563.2(ca)12.6(re,)-560.5(rep)17.8(res)12.2(ent)-555(an)-562.9(im)10.1(por)12.4(tan)17.3(t)]TJ
0 -1.1869 TD
[(com)16.4(pon)11.4(en)13.8(t)-617.6(o)0(f)-614(t)0(h)12.6(e)-616.4(wou)14.4(nd)-613.3(car)15.2(e)-616.4(eco)16.2(sys)10(te)12.4(m.)]TJ
7.8454 0 0 6.9729 274.1101 243.7795 Tm
[(140)15.7(–14)22.9(2)]TJ
10.4607 0 0 10.4607 62.022 226.6582 Tm
[(Ost)14.4(omi)16.9(es,)-332.7(sto)15.2(mas)14.4(,)-342.3(acu)14.2(te)-339.8(an)11.6(d)-343.9(c)0(h)9.6(ron)16.4(ic)-341.2(wo)12.8(und)11.5(s,)-334.1(and)]TJ
0 -1.1923 TD
[(ur)9.6(in)10.1(ary)-210.5(an)11.6(d)-219.3(fec)17.2(al)-214.5(in)10.1(con)11(ti)14.1(nen)15.4(ce)-212.8(oft)14.9(en)-213.8(pre)12.4(sen)16.6(t)-216.6(sev)14(ere)]TJ
0 -1.1869 TD
[(ph)10(ysi)15.7(cal)-320.3(ch)9.6(all)16.2(eng)12.9(es)-321(to)-323.6(wo)12.8(und)-319.1(pat)13.2(ien)16.9(ts.)-317.6(Th)11.8(ese)-319.6(lea)14.5(d)]TJ
0 -1.1923 TD
[(to)-534.9(em)13.8(oti)15.5(ona)13(l)-538.9(a)0(n)11.6(d)-539(soc)17.6(ial)-531.2(is)11.3(sue)16.6(s)-539.2(tha)11.8(t)-536.3(m)0(a)11.7(y)-537.5(be)-530.5(ad-)]TJ
T*
[(dr)11(ess)12.3(ed)-353.4(by)-359.4(pr)11(ope)16.6(rly)-353(tra)12.8(in)10.1(ed)-353.4(all)10.8(ied)-350.3(med)16.8(ica)10.3(l)-360(p)0(r)11(ofe)16(s-)]TJ
0 -1.1869 TD
[(si)11.3(ona)13(ls)11.3(.)-223(Lim)14.9(ita)13.3(tio)15.5(ns)-217.9(in)-217.5(we)12.8(ll-)14(str)11(uc)9.6(tur)15.2(ed)-217.9(edu)11.4(ca)12.6(tio)15.5(n)-226(o)0(f)]TJ
0 -1.1923 TD
[(wo)12.8(und)-362.4(ca)12.6(re)-364.5(pr)11(ov)11.3(ide)12.8(rs)-363.2(ma)11.7(y)-364.1(b)0(e)-362.5(vie)14.4(we)12.8(d)-371(a)0(s)-361.2(a)-363.9(si)11.3(gni)14.6(ﬁ-)]TJ
0 -1.1869 TD
[(can)14.2(t)-249.1(bar)17.3(rie)12.5(r)-252.1(t)0(o)-242.3(uni)17.1(for)11.8(m)-247.7(e)0(v)11.3(ide)12.8(nc)9.6(e-b)13.8(as)12.8(ed)-245(wou)14.4(nd)-244.8(car)15.2(e)]TJ
0 -1.1923 TD
[(thr)15.2(oug)12.9(hou)15.4(t)-276.2(t)0(h)12.6(e)-275(cou)11(nt)12.6(ry.)]TJ
/F2 1 Tf
10.959 0 0 10.959 62.022 91.1621 Tm
[(PATIENT)-332(EDUCATION)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 77.2157 Tm
[(Literature)-486.9(addressing)-491.1(patient-centered)-489.7(wound)]TJ
-1.1435 -1.1869 TD
[(care)-438.6(has)-435.4(mostly)-441.7(focused)-434.7(on)-441.4(quality)-433.6(of)-440.6(life)-439.9(\(QoL\),)]TJ
0 -1.1923 TD
[(pain,)-384.2(adherence,)-387.1(and)-381.1(coping.)-385.8(A)-387.6(key)-382.1(concern)-387.3(from)]TJ
T*
[(the)-284(patients’)-284.6(perspective)-283.1(is)-286.8(improved)-283(provider)-287.5(rec-)]TJ
25.4288 64.2875 TD
[(ognition)-427.6(of)-424.3(patients’)-425.5(concerns)-427.9(in)-428.9(treatment)-425.1(plan-)]TJ
0 -1.1923 TD
[(ning)-655.9(and)-657.5(request)-652(for)-654.8(personalized)-658.4(approaches.)]TJ
0 -1.1869 TD
[(The)-718.4(evolution)-718.8(to)-719.2(shared)-721.2(wound)-718.1(care)-720.4(decision)]TJ
0 -1.1923 TD
[(making)-334.6(is)-341(what)-334.4(patients)-335.4(are)-338.2(seeking.)]TJ
7.8454 0 0 6.9729 509.6125 679.6345 Tm
(143,144)Tj
10.4607 0 0 10.4607 541.3038 674.9856 Tm
(Enga-)Tj
-20.3886 -1.1923 TD
[(ging)-783.1(patients’)-788.6(awareness)-779.8(and)-782.1(involvement)-783.2(in)]TJ
0 -1.1869 TD
[(wound)-333.3(management)-334.6(is)-335.6(key)-333.3(to)-334.4(ensuring)-333.2(successful)]TJ
0 -1.1923 TD
[(healing)-278.2(outcomes.)]TJ
7.8454 0 0 6.9729 414.7652 642.2738 Tm
(145)Tj
/F2 1 Tf
10.959 0 0 10.959 328.0251 607.7479 Tm
[(COMBAT)-331.2(WOUND)-331.1(CARE)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 339.9873 593.8014 Tm
[(In)-551.7(the)-549.6(military)-551.7(and)-554.5(related)-552.8(defense)-549.7(services,)]TJ
-1.1435 -1.1923 TD
[(wounds)-498.6(and)-494.9(trauma)-499.6(are)-495.4(a)-499.4(common)-493.8(problem.)-498(In)]TJ
T*
[(2017,)-659.8(the)-658(National)-654.3(Academies)-659.8(of)-657.4(Science,)-658.4(En-)]TJ
0 -1.1869 TD
[(gineering,)-199.3(and)-202.2(Medicine)-196.7(reported)-201.3(a)-201.3(new)-197(vision)-200.4(for)-205(a)]TJ
0 -1.1923 TD
[(national)-202(trauma)-201.5(care)-200.1(system)-203.6(with)-200.5(the)-202.8(ultimate)-201(aim)]TJ
T*
[(of)-288.9(‘)50.8(‘zero’)44.1(’)-285.2(preventable)-286(deaths)-284.5(after)-286.8(injury)-286.4(to)-291(beneﬁt)]TJ
0 -1.1869 TD
[(those)-290.7(in)-288(combat.)]TJ
7.8454 0 0 6.9729 407.1117 523.729 Tm
(146)Tj
10.4607 0 0 10.4607 423.1558 519.0802 Tm
[(This)-285.8(vision)-292.5(is)-286.8(based)-292.6(on)-289.7(studies)]TJ
-9.0941 -1.1923 TD
[(conducted)-183.2(between)-173.1(2001)-182(and)-180.5(2011,)-177.4(which)-180.2(identiﬁed)]TJ
T*
(that)Tj
/F6 1 Tf
2.3359 0 TD
(*)Tj
/F5 1 Tf
.9972 0 TD
[(75%)-404.3(of)-397.2(combat)-396.8(deaths)-403.8(were)-400.5(caused)-396(by)-402.8(ex-)]TJ
-3.3331 -1.1869 TD
[(plosions)-414.5(and)-419(lack)-415.6(of)-413.5(timely)-419.7(and)-413.6(appropriate)-415(care)]TJ
0 -1.1923 TD
[(before)-511.9(the)-511.7(patient)-517.1(reached)-508.5(a)-515.7(medical)-511.8(treatment)]TJ
T*
(facility.)Tj
7.8454 0 0 6.9729 364.3653 461.4235 Tm
(146)Tj
10.4607 0 0 10.4607 339.9873 444.3589 Tm
.0134 Tc
[(The)-321.2(D)3.1(ep)5.5(artme)4(n)-1.3(t)-322.4(o)4(f)-325.6(D)3.1(ef)5(en)4.1(se)-321.2(\(DoD\))-325.6(a)1.8(n)4.1(d)-325.1(the)-321.2(U)1.6(S)]TJ
-1.1435 -1.1923 TD
.0125 Tc
[(Dep)4.6(a).9(rtment)-301.6(of)-304.9(V)4.3(e)-2.4(terans)-304.5(Aff)4.1(a).9(irs)-304.5(\()-1.4(V)4.3(A)-1.2(\))-304.8(a).9(re)-300.4(the)-305.9(t)1.9(wo)]TJ
T*
.0107 Tc
[(federal)-376.4(g)-1.1(o)-4.2(v)-1.1(ernm)-4(en)-4(t)-373.9(i)-2.5(n)-4(s)2.6(tit)-5.4(u)1.4(tion)-4(s)-376.8(i)-2.5(nvo)-4.2(l)-2.5(ved)-376.6(i)-2.5(n)-377.9(p)-2.6(ro)-4.2(-)]TJ
0 -1.1869 TD
.0113 Tc
[(viding)-331.1(health)-334(care)-334.2(to)-334.2(the)-328.7(3)-.3(.9)-330.9(million)-334(U)-.5(S)-333.8(m)2.1(ilit)-4.8(a)-.3(ry)]TJ
0 -1.1923 TD
.0121 Tc
[(members)-716.8(w)1.8(ho)-712.7(served)-711.2(in)-718(Operation)-718(E)-1.5(nduring)]TJ
T*
[(Freedom)-625.9(a).4(nd)-624.6(Operatio)]TJ
11.327 0 TD
[(n)-625.9(I).7(raqi)-629.9(Freedom)-625.9(\(OEF/)]TJ
-11.327 -1.1869 TD
[(OIF\),)-324.8(t)1.4(he)-322.6(17)-324.8(milli)4.2(on)-322.4(veterans)-321.3(from)-322.4(prior)-321.4(p)-1.3(eriods)3.9(,)]TJ
0 -1.1923 TD
.0119 Tc
[(and)-510.9(t)1.3(he)-512.4(1.3)-509.2(m)2.7(illion)-512.2(a).3(cti)4.1(v).1(e)-512.4(p)-1.4(ersonnel)-510.7(and)-510.9(t)1.3(heir)]TJ
T*
.0123 Tc
(families.)Tj
7.8454 0 0 6.9729 370.4314 349.3416 Tm
.0116 Tc
[(14)-7.3(7)]TJ
10.4607 0 0 10.4607 339.9873 332.2771 Tm
0 Tc
[(The)-225.2(DoD)-225.1(covers)-223.2(active)-227.5(service)-225.6(members,)-223.3(and)-229.3(the)]TJ
-1.1435 -1.1923 TD
[(VA)-439.2(provides)-433.6(medical)-441.3(support)-435.4(to)-437.4(eligible)-436.4(retirees.)]TJ
0 -1.1869 TD
[(The)-382.4(TRICARE)-389(for)-383.8(Life)-383.9(program)-386.2(is)-384.4(a)-385.6(wraparound)]TJ
0 -1.1923 TD
[(plan)-453.8(meant)-451.2(to)-459.1(supplement)-452(Medicare)-454.3(coverage)-454(of)]TJ
T*
[(military)-340.4(retirees)-336.8(and)-337.7(to)-339.8(pay)-340.2(for)-340.5(military)-334.9(hospitals)]TJ
0 -1.1869 TD
[(and)-554.5(health)-556.6(care)-552.4(workers.)]TJ
7.8454 0 0 6.9729 457.0015 274.6771 Tm
(148)Tj
10.4607 0 0 10.4607 475.7668 270.0283 Tm
.0203 Tc
[(The)-552.8(V)1.2(A)-557(e)0(stima)3.2(t)-1.2(es)]TJ
-14.1235 -1.1923 TD
.0199 Tc
[(that)-380.9(around)-378.2(25%)-382.8(o)5(f)-384.2(m)-.2(ilitary)-382.1(veterans)-383.8(have)-379.8(dia-)]TJ
T*
.0217 Tc
[(be)6.8(tes)]TJ
7.8454 0 0 6.9729 354.1038 249.7322 Tm
.0266 Tc
(149,150)Tj
10.4607 0 0 10.4607 389.4235 245.0834 Tm
.0198 Tc
[(\(compared)-546.3(w)4.1(ith)-547.7(9)2.7(%)-545.5(o)4.9(f)-546.9(t)-1.7(he)-542.4(civilian)]TJ
-5.8694 -1.1869 TD
0 Tc
[(adult)-421.1(population\).)-414.5(The)-414.9(economic)-417.9(burden)-418.8(of)-418.9(lower)]TJ
0 -1.1923 TD
[(limb)-448.3(amputations)-452.3(in)-450.6(diabetic)-448.9(veterans)-452.5(was)-447.3($206)]TJ
T*
(million.)Tj
7.8454 0 0 6.9729 364.9322 212.3716 Tm
(151)Tj
10.4607 0 0 10.4607 339.9873 195.307 Tm
[(The)-203.6(Combat)-207.1(Casualty)-203.6(Care)-211(Research)-202.6(Program)-205.5(is)]TJ
-1.1435 -1.1923 TD
[(a)-255.5(collaborative,)-256.3(multidisciplinary)-262.5(partnership)-255.5(that)]TJ
T*
[(utilizes)-340.4(clinical)-339.4(and)-337.7(translational)-335(research)-338.1(to)-339.8(pro-)]TJ
0 -1.1869 TD
[(vide)-286.2(state-of-the-art)-288.9(wound)-284.5(care.)]TJ
7.8454 0 0 6.9729 485.8581 162.5952 Tm
(152)Tj
10.4607 0 0 10.4607 501.8455 157.9464 Tm
[(With)-284.3(an)-291.9(effort)]TJ
-16.6165 -1.1923 TD
[(to)-491.6(maximize)-487.5(restoration)-487.6(of)-489.4(function)-495(and)-489.5(QoL)-486.4(in)]TJ
T*
[(service)-550.8(members)-553.1(with)-547.3(combat-related)-551.6(extremity)]TJ
0 -1.1869 TD
[(trauma,)-316.2(the)-322(VA)-314.5(and)-321.4(DoD)-317.2(have)-318.5(increased)-318.4(their)-316.3(re-)]TJ
0 -1.1923 TD
[(search)-309.6(and)-310.6(clinical)-312.3(care)-308.5(efforts)-306.6(with)-308.9(a)-309.7(focus)-314.4(on)-305.9(re-)]TJ
T*
[(generative)-278.3(medicine.)]TJ
7.8454 0 0 6.9729 428.3715 100.2897 Tm
(153)Tj
/F2 1 Tf
10.959 0 0 10.959 328.0251 66.7842 Tm
[(CLOSING)-329(REMARKS)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 339.9873 52.8378 Tm
[(B)13.5(a)0(s)23.6(e)12.2(d)-208.4(o)12.2(n)-204.4(e)12.2(st)24.6(im)20.9(a)15.5(t)11(e)12.2(s)-208.6(o)12.2(r)13.4(ig)23.8(in)20.9(a)15.5(t)11(i)13.9(n)0(g)-199.9(f)13.2(r)13.4(o)12.2(m)-209.8(i)13.9(n)12.4(d)0(e)26(p)0(e)20.6(n)12.4(d)13.8(e)12.2(n)12.4(t)]TJ
-1.1435 -1.1923 TD
[(sources,)-213.3(it)-213.5(is)-216.4(clear)-213.3(that)-215.6(the)-208.2(magnitude)-216.9(of)-213(wounds)-211.3(as)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 758.6644 Tm
(44)Tj
/F12 1 Tf
9.9626 0 0 9.9626 290.5511 758.6644 Tm
[(EDITORI)-10.7(AL)]TJ
ET
62.022 753.902 508.082 .51025 re
f

endstream
endobj

16 0 obj
<</Type/Page/CropBox[0 0 612 792]/Annots[17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]/Parent 139 0 R/Contents[193 0 R 37 0 R 194 0 R 195 0 R 196 0 R 197 0 R]/Rotate 0/MediaBox[0 0 612 792]/Thumb 133 0 R/Resources 36 0 R>>
endobj

17 0 obj
<</Type/Annot/Subtype/Link/Rect[74.778 157.606 199.049 165.543]/A<</URI(http://www.futureofpersonalhealth.com/prevention-and-treatment/are-you-at-risk-for-chronic-wounds)/S/URI>>/Border[0 0 0]>>
endobj

18 0 obj
<</Type/Annot/Subtype/Link/Rect[57.6 147.628 198.992 155.565]/A<</URI(http://www.futureofpersonalhealth.com/prevention-and-treatment/are-you-at-risk-for-chronic-wounds)/S/URI>>/Border[0 0 0]>>
endobj

19 0 obj
<</Type/Annot/Subtype/Link/Rect[254.948 406.658 374.57 414.595]/A<</URI(http://www.pm360online.com/a-robust-market-rich-with-opportunities-advanced-wound-dressings)/S/URI>>/Border[0 0 0]>>
endobj

20 0 obj
<</Type/Annot/Subtype/Link/Rect[232.498 396.68 374.343 404.674]/A<</URI(http://www.pm360online.com/a-robust-market-rich-with-opportunities-advanced-wound-dressings)/S/URI>>/Border[0 0 0]>>
endobj

21 0 obj
<</Type/Annot/Subtype/Link/Rect[253.871 351.836 374.74 359.83]/A<</URI(http://www.financeswire.com/wound-closure-products-market-share-2018-industry-analysis-growth-and-forecast-to-2022)/S/URI>>/Border[0 0 0]>>
endobj

22 0 obj
<</Type/Annot/Subtype/Link/Rect[232.498 341.915 374.287 349.852]/A<</URI(http://www.financeswire.com/wound-closure-products-market-share-2018-industry-analysis-growth-and-forecast-to-2022)/S/URI>>/Border[0 0 0]>>
endobj

23 0 obj
<</Type/Annot/Subtype/Link/Rect[232.498 331.937 316.12 339.874]/A<</URI(http://www.financeswire.com/wound-closure-products-market-share-2018-industry-analysis-growth-and-forecast-to-2022)/S/URI>>/Border[0 0 0]>>
endobj

24 0 obj
<</Type/Annot/Subtype/Link/Rect[260.22 277.115 374.683 285.109]/A<</URI(http://www.abnewswire.com/pressreleases/advanced-wound-care-market-outlook-forecasts-2018-to-2024-global-industry-research-demand-and-future-industry-growth-analysis_201175.html)/S/URI>>/Border[0 0 0]>>
endobj

25 0 obj
<</Type/Annot/Subtype/Link/Rect[232.498 267.194 374.57 275.131]/A<</URI(http://www.abnewswire.com/pressreleases/advanced-wound-care-market-outlook-forecasts-2018-to-2024-global-industry-research-demand-and-future-industry-growth-analysis_201175.html)/S/URI>>/Border[0 0 0]>>
endobj

26 0 obj
<</Type/Annot/Subtype/Link/Rect[232.498 257.216 374.683 265.153]/A<</URI(http://www.abnewswire.com/pressreleases/advanced-wound-care-market-outlook-forecasts-2018-to-2024-global-industry-research-demand-and-future-industry-growth-analysis_201175.html)/S/URI>>/Border[0 0 0]>>
endobj

27 0 obj
<</Type/Annot/Subtype/Link/Rect[232.498 247.238 374.343 255.231]/A<</URI(http://www.abnewswire.com/pressreleases/advanced-wound-care-market-outlook-forecasts-2018-to-2024-global-industry-research-demand-and-future-industry-growth-analysis_201175.html)/S/URI>>/Border[0 0 0]>>
endobj

28 0 obj
<</Type/Annot/Subtype/Link/Rect[473.046 278.362 549.751 286.356]/A<</URI(http://www.strategyr.com/MarketResearch/Pressure_Ulcer_Relief_Treatment_Devices_Market_Trends.asp)/S/URI>>/Border[0 0 0]>>
endobj

29 0 obj
<</Type/Annot/Subtype/Link/Rect[407.849 268.441 548.56 276.378]/A<</URI(http://www.strategyr.com/MarketResearch/Pressure_Ulcer_Relief_Treatment_Devices_Market_Trends.asp)/S/URI>>/Border[0 0 0]>>
endobj

30 0 obj
<</Type/Annot/Subtype/Link/Rect[407.849 258.463 496.12 266.4]/A<</URI(http://www.strategyr.com/MarketResearch/Pressure_Ulcer_Relief_Treatment_Devices_Market_Trends.asp)/S/URI>>/Border[0 0 0]>>
endobj

31 0 obj
<</Type/Annot/Subtype/Link/Rect[486.368 212.372 549.921 220.365]/A<</URI(https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html)/S/URI>>/Border[0 0 0]>>
endobj

32 0 obj
<</Type/Annot/Subtype/Link/Rect[407.849 202.394 549.864 210.387]/A<</URI(https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html)/S/URI>>/Border[0 0 0]>>
endobj

33 0 obj
<</Type/Annot/Subtype/Link/Rect[472.025 166.28 549.921 174.274]/A<</URI(https://finance.yahoo.com/news/ligand-lgnd-diabetes-candidate-positive-140302194.html)/S/URI>>/Border[0 0 0]>>
endobj

34 0 obj
<</Type/Annot/Subtype/Link/Rect[407.849 156.359 549.751 164.296]/A<</URI(https://finance.yahoo.com/news/ligand-lgnd-diabetes-candidate-positive-140302194.html)/S/URI>>/Border[0 0 0]>>
endobj

35 0 obj
<</Type/Annot/Subtype/Link/Rect[407.849 146.381 454.45 154.318]/A<</URI(https://finance.yahoo.com/news/ligand-lgnd-diabetes-candidate-positive-140302194.html)/S/URI>>/Border[0 0 0]>>
endobj

36 0 obj
<</Font<</F12 119 0 R/F14 125 0 R/F1 146 0 R/F2 147 0 R/F5 150 0 R/F8 163 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

37 0 obj
<</Length 15383>>
stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 41.8394 712.3463 Tm
0 0 0 rg
0 Tc
0 Tw
[(a)-288(health)-291(care)-292.3(problem)-285.8(is)-292.2(sharply)-286.9(rising.)-292.2(Resources)]TJ
0 -1.1923 TD
[(allocated)-442.1(to)-437.4(the)-441.2(education,)-442(care,)-444.8(and)-440.7(research)-441.1(of)]TJ
0 -1.1869 TD
[(wounds)-233(continues)-238.5(to)-236.9(be)-232.4(disproportionately)-233.6(low)-238.8(and)]TJ
0 -1.1923 TD
[(deserves)-251.3(strategic)-254.5(attention.)-252(A)-252.1(key)-252(challenge)-252.6(in)-250.1(all)]TJ
T*
[(of)-413.5(these)-415.4(three)-415.5(domains—education,)-415.8(care,)-417.7(and)-413.6(re-)]TJ
0 -1.1869 TD
-.0001 Tc
[(search—is)-425.7(the)-430.5(ability)-426.7(to)-432.1(recruit)-430.4(interdisciplinary)]TJ
0 -1.1923 TD
0 Tc
[(talent)-303.2(that)-307.7(would)-304.7(work)-307.5(together)-306.5(cohesively)-304.3(as)-307(one)]TJ
T*
(team.)Tj
/F2 1 Tf
10.959 0 0 10.959 41.8394 587.792 Tm
[(ACKNOWLEDGME)7.3(NTS)]TJ
0 -1.1329 TD
[(AND)-333.4(FUNDING)-327.5(SOURCES)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 53.8015 561.4298 Tm
[(Work)-494.3(on)-495.6(wound)-490.5(care)-492.8(in)-499.4(this)-491(program)-494.6(is)-498.2(sup-)]TJ
-1.1435 -1.1923 TD
[(ported)-232.4(by)-234.8(the)-235.3(National)-231.6(Institutes)-230.5(of)-234.7(Health)-229.2(awards)]TJ
25.4288 15.6193 TD
[(R01NR015676,)-214.2(R01GM077185,)-216.8(R01GM108014,)-211.3(R0)]TJ
0 -1.1923 TD
[(1DK114718,)-276.2(U01DK119099,)-272.5(and)-283.5(R01NR013898)8.8(.)]TJ
/F2 1 Tf
10.959 0 0 10.959 307.8424 668.9762 Tm
[(AUTHOR)-331.3(DISCLOSURE)-329(AND)-333.4(GHOSTWRITIN)7.7(G)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 319.8046 655.0298 Tm
[(No)-281.4(competing)-284.2(ﬁnancial)-286.1(interests)-282.1(exist.)-287(The)-284.9(con-)]TJ
-1.1435 -1.1869 TD
[(tent)-446.4(of)-446(this)-447.6(article)-443.1(was)-447.3(expressly)-445.6(written)-445.6(by)-446.2(the)]TJ
0 -1.1923 TD
[(author)-280.6(listed.)]TJ
/F2 1 Tf
10.959 0 0 10.959 307.8424 600.2644 Tm
[(ABOUT)-330.3(THE)-335.4(AUTHOR)]TJ
/F14 1 Tf
10.4607 0 0 10.4607 319.8046 586.318 Tm
[(Chandan)-640.2(K.)-641.3(Sen,)-639.3(PhD,)]TJ
/F5 1 Tf
13.1588 0 TD
[(is)-639.1(the)-641.7(Director)-641.3(of)]TJ
-14.3024 -1.1923 TD
[(Indiana)-605.3(Center)-602.6(for)-606(Regenerative)-604.8(Medicine)-608.6(and)]TJ
0 -1.1869 TD
[(Engineering,)-195.1(and)-196.8(is)-194.7(J.)-191.3(Stanley)-194.2(Battersby)-193.3(Chair)-196.8(and)]TJ
0 -1.1923 TD
[(Professor)-281.4(of)-278(Surgery)-279.2(at)-277(Indiana)-280.1(University.)]TJ
ET
41.839 468.737 508.082 .45355 re
f
BT
/F1 1 Tf
11.9551 0 0 11.9551 41.8394 444.6424 Tm
(REFERENCES)Tj
/F8 1 Tf
7.9702 0 0 7.9702 49.7763 428.5416 Tm
[(1.)-316.6(Sen)-348.7(CK,)-346.9(Gordillo)-344.5(GM,)-348.2(Roy)-346.7(S,)-349(et)-346.1(al.)-354.7(Human)-343.2(skin)]TJ
.9816 -1.2448 TD
[(wounds:)-592.1(a)-598.6(major)-594.2(and)-593.8(snowballing)-599.3(threat)-590.1(to)]TJ
0 -1.2519 TD
[(public)-398.7(health)-401.8(and)-401.7(the)-404.1(economy.)-399.1(Wound)-402.1(Repair)]TJ
T*
[(Regen)-329.6(2009;17:76)7.3(3ñ771.)]TJ
-.9816 -1.8708 TD
[(2.)-316.6(Nussbaum)-486.8(SR,)-489.2(Carter)-494.5(MJ,)-488.8(Fife)-490(CE,)-492.4(et)-495.5(al.)-489.8(An)]TJ
.9816 -1.2519 TD
[(economic)-484.5(evaluation)-483.9(of)-495.5(the)-489.5(impact,)-482(cost,)-489.1(and)]TJ
T*
[(medicare)-595.6(policy)-603(implications)-595.1(of)-602.2(chronic)-605.2(non-)]TJ
T*
[(healing)-330.8(wounds.)-328.9(Value)-331(Health)-332.3(2018;21:2)8.4(7ñ32.)]TJ
-.9816 -1.8708 TD
[(3.)-316.6(S)16.3(e)0(n)-350.8(C)0(K)25.5(,)-365.3(R)16.3(o)0(y)-355.9(S)16.3(,)-365.3(G)0(o)24.5(r)17.8(di)17.7(ll)23.4(o)-363.9(G)18.5(.)-365.3(W)15(ou)26.2(nd)-357.9(H)18.5(e)0(a)26.2(l)0(i)23.4(n)0(g)-357.9(\()0(N)28.2(e)0(-)]TJ
.9816 -1.2519 TD
[(li)23.4(ga)26.2(n)-335.4(P)0(l)17.7(a)0(s)28.2(t)0(i)22.4(c)-340.5(S)16.3(u)0(r)23.8(g)0(e)26.2(r)0(y)25.8(:)-343.9(V)16.3(o)0(l)24.8(u)0(m)24.7(e)-342.6(O)18.5(n)0(e)19.1(\))18.8(.)-699.6(A)18.5(ms)26.7(te)23.8(rd)23.8(am)24.7(,)]TJ
T*
-.0251 Tc
[(N)-8.6(e)-25.1(th)-25.1(er)-25.1(la)-25.1(nd)-25.1(s)-4(:)-340.6(E)-25.1(l)-.3(s)-25.1(e)-4(v)-10(i)-25.1(er)-25.1(,)-337(2)-25.1(01)-25.1(7.)]TJ
-.9816 -1.8708 TD
0 Tc
[(4.)-316.6(Richmond)-426.4(NA,)-429.9(Lamel)-433.3(SA,)-430(Davidson)-427.8(JM,)-431.9(et)-431.4(al.)]TJ
.9816 -1.2519 TD
[(US-Natio)11(nal)-758.8(Institutes)-749.9(of)-758.6(Health-funded)-750.5(re-)]TJ
T*
[(search)-417.7(for)-420.7(cutaneous)-414(wounds)-418.8(in)-423.3(2012.)-419.6(Wound)]TJ
0 -1.2448 TD
[(Repair)-327.4(Regen)-329.6(2013;21:789ñ7)7.1(92.)]TJ
-.9816 -1.8779 TD
[(5.)-316.6(Baquerizo)-238.5(Nole)-237.2(KL,)-248.5(Yim)-237.8(E,)-245.5(Van)-242(Driessche)-237.2(F,)-243.5(et)-239.4(al.)]TJ
.9816 -1.2519 TD
[(Wound)-373.6(research)-379.7(funding)-374.5(from)-380.7(alternative)-376(sour-)]TJ
0 -1.2448 TD
[(ces)-518.6(of)-516.8(federal)-519.1(funds)-518.2(in)-515.8(2012.)-519.2(Wound)-515.9(Repair)]TJ
0 -1.2519 TD
[(Regen)-329.6(2014;22:29)7.3(5ñ300.)]TJ
-.9816 -1.8779 TD
[(6.)-316.6(Gould)-279(L,)-286.1(Abadir)-282.5(P,)-288.2(Brem)-275.5(H,)-289.9(et)-282.1(al.)-283.6(Chronic)-283.9(wound)]TJ
.9816 -1.2448 TD
[(repair)-269(and)-273.7(healing)-273.8(in)-266.8(older)-272.6(adults:)-274.2(current)-269.2(status)]TJ
0 -1.2519 TD
[(and)-323.5(future)-326.9(research.)-332.4(J)-328.3(A)0(m)-325.6(Geriatr)-324(Soc)-332.5(2015;63:)]TJ
T*
[(427ñ438)9.5(.)]TJ
-.9816 -1.8779 TD
.0164 Tc
[(7)16.4(.)-300.2(Sere)-6.1(na)-255(T)-6.1(E)1(.)-256.4(A)-.7(re)-262.1(you)-262.1(a)1(t)-257.4(r)-1.4(isk)-260.1(f)-1.4(or)-257.4(chronic)-260.1(w)-.5(ou)-6.1(nds?)]TJ
.9816 -1.2448 TD
-.0268 Tc
[(2015.)-285.4(www.f)5.2(u).5(tureofpersonalh)-6.6(ealt)5.2(h)-6.6(.com/prevention-)]TJ
0 -1.2519 TD
0 Tc
[(an)19.1(d-)16.7(tr)14.3(ea)19.1(tm)15.2(ent)22.7(/a)18.9(re-)20.3(yo)14(u-)16.7(at)16.7(-r)14.3(is)19.7(k-)18.7(for)20.3(-c)18.7(hr)16.7(oni)16.6(c)15.1(-)0(w)15.2(oun)25.1(ds)]TJ
T*
[(\(l)16.3(as)14(t)-337.8(a)0(c)14(c)0(e)14(s)0(s)16(e)0(d)-329.5(S)0(e)15.2(p)0(t)16.7(e)0(m)17.6(ber)-325.9(6,)-338(20)19.1(15\))23.7(.)]TJ
-.9816 -1.8708 TD
[(8.)-316.6(Ja)]TJ
1.508 .0284 TD
(®)Tj
.3628 -.0284 TD
[(rbrink)-380.8(K,)-377.4(Ni)-384.3(G,)-375.2(So)]TJ
6.4801 .0284 TD
(®)Tj
.3628 -.0284 TD
[(nnergren)-376.6(H,)-382.3(et)-381.7(al.)-383.1(The)-380.4(hu-)]TJ
-7.732 -1.2519 TD
[(manistic)-815.4(and)-821.4(economic)-818.8(burden)-813(of)-822.7(chronic)]TJ
T*
[(wounds:)-250.6(a)-257.2(protocol)-247.9(for)-257.1(a)-257.2(systemati)9.5(c)-255.2(review.)-254.4(Syst)]TJ
T*
[(Rev)-325.4(2017;6:15ñ15.)]TJ
-.9816 -1.8708 TD
[(9.)-316.6(Phillips)-339.7(CJ,)-350.1(Humphreys)-338.9(I,)-346.4(Fletcher)-338.4(J,)-352.2(Harding)-340.6(K,)]TJ
.9816 -1.2519 TD
[(Chamberl)10.2(ain)-403.1(G,)-396.6(Macey)-400.3(S.)-398.8(Estimating)-395.3(the)-397(costs)]TJ
T*
[(associated)-528.3(with)-543.3(the)-532.2(management)-536(of)-538.1(patients)]TJ
0 -1.2448 TD
[(with)-365.5(chronic)-363.3(wounds)-369(using)-367.8(linked)-370.3(routine)-362.6(data.)]TJ
0 -1.2519 TD
[(Int)-327.3(Wound)-331(J)-335.4(2016;13:11)7.3(93ñ1197.)]TJ
20.5214 48.7463 TD
[(10.)-310.6(Settipalli)-423.8(S.)-427.2(A)-429.6(Robust)-423.6(market)-423.6(rich)-426(with)-422.4(oppor-)]TJ
1.4226 -1.2448 TD
[(tunities:)-486.5(advanced)-481.6(wound)-483.7(dressings.)-487(June)-481.1(13,)]TJ
0 -1.2519 TD
-.0001 Tc
[(2015.)-810.9(www.pm360on)8.5(line.com/a-robust-market-)]TJ
T*
0 Tc
[(ri)29.5(c)15.1(h)0(-)23.8(w)18.7(it)29.5(h-)23.8(o)20.2(p)0(p)26.2(o)0(r)30.9(t)0(u)23.8(n)20.2(it)22.4(i)18.8(e)0(s)28.2(-)0(a)23.8(d)20.2(v)15.1(a)0(n)26.2(c)15.1(ed)26.2(-)17.8(w)0(o)24.7(u)20.2(nd)26.2(-)17.8(d)0(r)23.8(e)0(s)28.2(s)15.1(i)18.8(n)0(g)26.2(s)]TJ
0 -1.2448 TD
[(\(l)23.4(a)20.2(s)15.1(t)-323.6(a)0(c)28.2(c)15.1(es)28.2(s)15.1(e)0(d)-301(S)16.3(ep)26.2(t)17.8(e)0(m)24.7(b)0(e)33.3(r)-323.6(20)33.3(,)-322.6(2)0(0)26.2(1)20.2(5\))24.8(.)]TJ
-1.4226 -1.8779 TD
[(11.)-310.6(Wound)-565.7(Closure)-568.4(Products)-564.6(Market)-564.7(Share)-566.8(2018)]TJ
1.4226 -1.2519 TD
[(Industry)-331.3(analysis,)-328.3(growth,)-328.6(and)-330.6(forecast)-325.2(to)-331.9(2022.)]TJ
T*
.017 Tc
[(2)-5.5(0)1.6(1)-5.5(8)-5.5(.)-575.9(www.)-6.8()-5.5(n)1.6(a)-5.5(n)1.6(ce)-5.5(swir)-7.9(e.)-6.8(co)-5.5(m/)-5.7(wo)-5.5(un)-5.5(d)-5.5(-)-.8(clo)-5.5(s)-3.5(ure)-5.5(-)]TJ
0 -1.2448 TD
.0206 Tc
[(prod)5.2(ucts-m)3.7(arke)5.2(t-sh)5.2(are-)]TJ
8.9056 0 TD
.0218 Tc
[(20)6.4(18)6.4(-i)5.1(nd)6.4(ustry-ana)6.4(ly)8.5(sis-)]TJ
-8.9056 -1.2519 TD
0 Tc
[(growth-and-f)8.5(orecast-to-2022)-245.4(\(last)-250.6(accessed)-242.8(April)]TJ
T*
[(23,)-332(2018\).)]TJ
-1.4226 -1.8708 TD
[(12.)-310.6(Advanced)-355.2(Wound)-352.3(Care)-352.2(Market)-351.3(Outlook)-359.9(&)-353.4(Fore-)]TJ
1.4226 -1.2519 TD
[(casts)-478.6(2018)-481.1(to)-474.1(2024:)-483.6(Global)-473.6(industry)-480.6(research,)]TJ
T*
[(demand)-563.1(and)-558.2(future)-554.6(industry)-558.9(growth)-560.8(analysis.)]TJ
T*
.0087 Tc
[(20)-6.7(18.)-1423.6(w)8.7(w)-3.7(w.ab)-6.7(news)8.7(w)-7.3(ire.c)-4.6(o).5(m/pres)-4.6(s)8.7(r)-8.2(eleas)-4.6(es)-4.6(/)]TJ
0 -1.2448 TD
0 Tc
[(a)-8.2(dvanc)-15.8(ed-wo)-16.7(und)-10.5(-ca)-10.9(re-m)-10.8(ark)-10.9(et-o)-16.4(utlo)-15.4(ok-)-10.9(forec)-15.5(ast)-10.9(s-)]TJ
0 -1.2519 TD
.0089 Tc
[(20)-6.5(18-to-2024-gl)-7.8(obal-indu)-6.5(s)8.9(t)-8(ry)8.9(-)-8(r)-1.7(es)8.9(e)-12.7(a).7(rc)8.9(h)-5.6(-)-1.7(de)-6.5(m)8.9(a)-9.1(nd-)]TJ
T*
0 Tc
[(and)18(-fu)13.2(tur)13.1(e-)16.7(ind)16.6(ustr)21.2(y-g)17.6(row)14.1(th-)13.2(ana)17.9(lys)20.6(is_)14.7(201)18(175.)15.4(ht)16.7(ml)]TJ
0 -1.2448 TD
[(\(la)15.2(st)-322.7(acc)14.9(es)14(sed)-321.5(Ap)17.4(ril)-321.5(23,)-317.7(201)18(8\).)]TJ
-1.4226 -1.8779 TD
[(13.)-310.6(Berlowitz)-272.3(D,)-268.5(VanDeusen)-269.8(Lukas)-269.9(C,)-270.7(Parker)-272.7(V,)-270.7(et)-267.8(al.)]TJ
1.4226 -1.2519 TD
[(Preventing)-285.8(pressure)-280.1(ulcers)-291(in)-288.2(hospitals;)-284.1(A)-287.3(toolkit)]TJ
0 -1.2448 TD
[(for)-321.2(improving)-313.6(quality)-316.9(of)-317.6(care.)-320.4(In:)-319.1(Affairs)-314.9(USDoV,)]TJ
0 -1.2519 TD
[(ed.)-317.7(Agency)-303.2(for)-314.1(Healthcare)-308.8(Research)-310.1(and)-316.4(Quality)]TJ
T*
[(\(AHRQ\),)-369.6(U.S.)-368.5(Department)-370.2(of)-367.4(Health)-367.9(and)-373.3(Human)]TJ
T*
(Services.)Tj
-1.4226 -1.8708 TD
[(14.)-310.6(Coleman)-320.6(S,)-320.5(Gorecki)-315.2(C,)-320.5(Nelson)-315.7(EA,)-319.4(et)-317.6(al.)-326.2(Patient)]TJ
1.4226 -1.2519 TD
[(risk)-651.6(factors)-651.2(for)-648.4(pressure)-650(ulcer)-654.7(developmen)9.2(t:)]TJ
T*
[(systematic)-252.8(review.)-254.4(Int)-263.2(J)-257.2(Nurs)-250.5(Stud)-259.8(2013;50:974)6.2(ñ)]TJ
0 -1.2448 TD
(1003.)Tj
-1.4226 -1.8779 TD
[(15.)-310.6(Beckrich)-722(K,)-726(Aronovitch)-726.4(SA.)-721.7(Hospital-aquired)]TJ
1.4226 -1.2519 TD
[(pressure)-337(ulcers:)-343.3(a)-342.6(compari)10.2(son)-342.8(of)-339(costs)-343.4(in)-338(medi-)]TJ
T*
[(cal)-280.2(vs.)-278.1(surgical)-273.3(patients.)-278.9(Nurs)-278.9(Econ)-272.8(1999;17:263.)]TJ
-1.4226 -1.8708 TD
[(16.)-310.6(Berlowitz)-279.4(D,)-289.9(Vandeusen)-282.4(Lukas)-277(C,)-285(Parker)-287(V,)-285(et)-282.1(al.)]TJ
1.4226 -1.2519 TD
[(Preventing)-755.2(Pressure)-756.7(Ulcers)-755.1(in)-757.6(Hospitals:)-755.3(A)]TJ
T*
[(Toolkit)-373.8(for)-370.9(Improving)-370.5(Quality)-375.5(of)-374.5(Care.)-369(Rockville,)]TJ
0 -1.2448 TD
[(MD:)-248.6(Agency)-246.3(of)-253.6(Healthcare)-244.8(Research)-246(and)-252.3(Quality,)]TJ
0 -1.2519 TD
(2011.)Tj
20.5783 48.7463 TD
-.02 Tc
[(1)-20(7)-20(.)-330.6(Lyder)-222.7(CH)5.6(,)-228.8(P).2(reston)-220.3(J,)-228.8(G)5.6(r)-2.2(ady)-218.3(JN,)-221.7(e).2(t)-222.7(a).2(l.)-221.7(Quali)5.9(t)-2.2(y)-225.4(o).2(f)-222.7(c)2.2(are)]TJ
1.4226 -1.2448 TD
-.0202 Tc
[(for)-301.1(hospital)5.7(i)-1.4(zed)-305.9(M)-.3(edi)5.7(c)-5.1(a)0(re)-305.9(pati)5.7(ents)-303.8(a)0(t)-301.1(r)-2.4(isk)-303.8(f)-2.4(or)-301.1(pres-)]TJ
0 -1.2519 TD
-.02 Tc
[(sure)-255.9(ulcers.)-264.4(A)5.6(rch)-263(I)5.9(ntern)-255.9(M)-.1(ed)-255.9(2001;161:1549ñ1554.)]TJ
-1.4226 -2.0344 TD
0 Tc
[(18.)-310.6(Brem)-275.5(H,)-275.6(Maggi)-277.6(J,)-281.1(Nierman)-273(D,)-275.6(et)-275(al.)-283.5(High)-277.9(cost)-273.2(of)]TJ
1.4226 -1.2448 TD
[(stage)-383(IV)-391.7(pressure)-379.7(ulcers.)-386(Am)-382.5(J)-392.3(Surg)-380.7(2010;200:)]TJ
0 -1.2519 TD
(473ñ477.)Tj
-1.4226 -2.0344 TD
[(19.)-310.6(Black)-391(JM,)-396.3(Edsberg)-392.4(LE,)-401.1(Baharesta)11.6(ni)-402(MM,)-389.5(et)-395.9(al.)]TJ
1.4226 -1.2448 TD
[(Pressure)-415.2(ulcers:)-421.6(avoidable)-416.4(or)-417.2(unavoidable?)-417.7(Re-)]TJ
0 -1.2519 TD
[(sults)-560.2(of)-559.5(the)-567.7(national)-561.9(pressure)-557.5(ulcer)-562.2(advisory)]TJ
T*
[(panel)-625.9(consensus)-613.8(conference.)-619.2(Ostomy)-620.1(Wound)]TJ
T*
[(Manage)-327.2(2011;57:24.)]TJ
-1.4226 -2.0272 TD
-.02 Tc
[(2)-20(0)-20(.)-330.6(Agi)5.9(n).2(g)-476.4(population,)-470.6(grow)5.8(ing)-476.4(a).2(w)5.8(a).2(reness)-474.4(and)-469.3(inno-)]TJ
1.4226 -1.2519 TD
-.0207 Tc
[(vations)-674.2(drive)-676.2(t)-2.9(he)-669.1(global)-677.6(pres)-5.6(sure)-676.2(ulcer)-678.6(r)4.2(elief)]TJ
T*
[(products)-247.3(mark)-5.5(et.)-250.7(2017.)-243.6(ww)5.2(w.strategyr.com)5.2(/)-.6(Market)]TJ
0 -1.2448 TD
.0291 Tc
[(Rese)6.6(arc)8.6(h)-.5(/Pressu)6.6(re)6.6(_Ul)5.3(c)1.5(er_Reli)5.3(ef_T)6.6(re)6.6(atmen)6.6(t)-2.9(_)]TJ
0 -1.2519 TD
.0283 Tc
[(Device)5.8(s_Ma)5.8(rket_Tren)5.8(d)-1.3(s.a)5.8(s).7(p)-776.6(\()4.4(last)-764.8(accesse)5.8(d)]TJ
T*
.0296 Tc
[(A)5.4(p)0(ril)-328.6(23,)-328.6(2018)7.1(\).)]TJ
-1.4226 -2.0273 TD
0 Tc
[(21.)-310.6(Centers)-235.1(for)-228.7(Disease)-234.6(Control)-231.4(and)-238.1(Prevention.)-231.4(New)]TJ
1.4226 -1.2519 TD
[(CDC)-254.7(report:)-258.3(more)-250.3(than)-263(100)-252.3(million)-256.8(have)-258.6(diabetes)]TJ
T*
[(or)-865.3(prediabetes.)-865.6(2018.)-874.8(https://ww)9.6(w.cdc.gov/)]TJ
0 -1.2448 TD
[(medi)13.9(a/r)15.4(elea)15.4(ses/)13.6(2017)16.8(/p07)16.6(18-d)14.4(iabe)15.4(tes-)14(rep)15.6(ort.h)16.6(tml)]TJ
0 -1.2519 TD
[(\(las)16.1(t)-330.7(acc)14.9(esse)13.7(d)-328.3(Janu)16.8(ary)-323.9(5,)-323.7(2019\))14.3(.)]TJ
-1.4226 -2.0343 TD
[(22.)-310.6(Ligand)-546.7(\(LGND\))-541(diabetes)-544.3(candidate)-545.4(positive)-543.6(in)]TJ
1.4226 -1.2519 TD
[(Phase)-288.2(II)-296.7(Study.)-282.7(2017.)-291.6(https://nance.)7.6(yahoo.com/)]TJ
0 -1.2448 TD
.0164 Tc
[(ne)-6.1(ws)-4.1(/li)-7.4(gan)-6.1(d-l)-7.4(gnd)-6.1(-di)-7.4(a)1(b)-6.1(e)1(tes-can)-6.1(d)1(id)-6.1(ate)-6.1(-)-1.3(po)-6.1(si)-7.4(tive-)]TJ
0 -1.2519 TD
0 Tc
[(140302194.htm)8.5(l)-336.8(\(last)-328.9(accessed)-335.3(April)-325.5(23,)-332(2018\).)]TJ
-1.4226 -2.0344 TD
[(23.)-310.6(Shaw)-472.3(JE,)-481.3(Sicree)-474.8(RA,)-472.7(Zimmet)-475.9(PZ.)-481.3(Global)-473.6(esti-)]TJ
1.4226 -1.2448 TD
[(mates)-441.4(of)-445.7(the)-446.8(prevalence)-437.8(of)-445.7(diabetes)-444.7(for)-442.1(2010)]TJ
0 -1.2519 TD
[(and)-252.3(2030.)-256(Diabetes)-254.3(Res)-254.2(Clin)-260.1(Pract)-250.3(2010;87:4ñ14.)]TJ
-1.4226 -2.0344 TD
[(24.)-310.6(King)-365.5(H,)-361(Aubert)-361.8(RE,)-364.3(Herman)-360.9(WH.)-360.2(Global)-366.9(burden)]TJ
1.4226 -1.2448 TD
[(of)-438.6(diabetes,)-440.1(1995ñ20)9.5(25:)-438.7(prevalence,)-440.3(numerical)]TJ
0 -1.2519 TD
[(estimates,)-315.1(and)-323.5(projections.)-317.2(Diabetes)-311.2(Care)-316.7(1998;)]TJ
T*
(21:1414ñ1431.)Tj
-1.4226 -2.0272 TD
[(25.)-310.6(Wild)-453.5(S,)-455.7(Roglic)-452.4(G,)-453.5(Green)-457.9(A,)-453.5(Sicree)-453.5(R,)-455.7(King)-450.8(H.)]TJ
1.4226 -1.2519 TD
[(Global)-288.6(prevalence)-288.5(of)-296.3(diabetes:)-290.7(estimates)-284.1(for)-292.7(the)]TJ
/F12 1 Tf
9.9626 0 0 9.9626 270.3684 757.8707 Tm
[(EDITORI)-10.7(AL)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 540.0565 757.8707 Tm
(45)Tj
ET
41.839 753.959 508.082 .51025 re
f

endstream
endobj

38 0 obj
<</Subtype/Type1C/Length 1051/Filter/FlateDecode>>
stream
hﬁ§ëmL[e«Ô-Ω˜é ∆∏dˆ‚ΩëÕ≠ÅÕç˜¬Ä∂∞AYAÍ`–RyÇ•õBxFD@&Hƒ¡»¿Åºåv≤ŒR]ñ9âàdB2‹C≥òåh<≈É—"”h‚7üˇ‰9'Áw~…!	©Ñ I“+:.RwLëy6~OphHpÙz’◊¡ìﬂ'|0œ˝Z∫j¶ ƒ7∑¯J€Ω	I¶Ë#
ãç9YŸ&˘…gÙ'w ÉBCûWÆÁæ?3d=CÉ‰ô:É<±∏»d»/í«æ¢/03LÜÃ π<‚ÙiπzùQ$Wä∆≥ŒÍ?<úè$‹	‚i¬üPAƒ‚0M®àX‚8¡:Ì	)¡œQD+ÒyåÏí∏Jåíœ\‹]Ù.◊~g◊∂≤3xîzÓ”˘%Ÿùóo∆§æd8û5®µ-õ˘Ê¶˙ölm¬âëµ‹„íÕ6õy¬fK7''ßß'Ï Íãé$ÆF©Z≠°ÜSz^‡1√p/Êb1<Ö€¡qèÓCÃòﬂA°OQËnt„—;bÚ†–õ¿ÿY‹Ñ[ÜD¿Ó¯ôª⁄“=õH¡lR$£[LyõY¿a$8G Ì‰mÉ-P©Ë
Jl◊5⁄ﬁRa◊⁄CmÖF8E≥d∑è√”n†5µÌ£"lgæ{ ~XFΩU—\U-+≠>ßä5ªùNz≥¶ÈÃ0ñ9§[øú£V~ú∞Ûv\“Ù0”Â≈•uei"f°âÇò—ñvª0j_Û¸èÖã‡˝∑Ò—8|Ì)èÎòÜ°·Ü!É“{A¶ºãGƒ5’_P5pÊÓ÷iêö3êD◊$rÇöfÀoUs˙ŒmÍ‘'_ùY‰aˇ2HÄO’ÜãËyâ⁄›e3ÀÊÓ~ûﬂ")n–Â.ïNk¥‘HRB◊Q˝–#¸Áõ-ÆºF}]z%?^~(7eJ'é÷Zö=‚ê¿8á≠ÈQ'Çe˚og-ﬂ˚¢◊2)Ëﬁ˘®– OMçè∑’6Wã≈µ•%|iUÁu“pGr]—?41*i¬Ù°m‡ÚàpŸx°S÷y±À:›ˇj§Äa“]öFgºdûÔ˜^Å-át(ÁæÔ[ZXË
48`\z ‡°˝*¿„÷Ã˚3CB„AJ⁄(k>ìQ’vU\•|£í“N0oWÍD‘3ì∫¥˜‚y‰NÉm"+wå¡ÎÏj˚Éy‹Å^;QâJ⁄;Äûøƒ§ò÷MÖÈSÚxÖvvYÏa¨“˘˛˚s∂+˙}Ö5Á
∂ı¢LY+Èƒ˙fÁ’ûeY?æyΩœê$`.c®ØK*µŒ~…„æâ7’≈¡Ñuûp“XÈÿ\ÿò(°ˇuÒ_PÏ˝
Cﬁ´·‹ $„Y

endstream
endobj

39 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFMN+AdvP42982E/FontFile3 38 0 R/Flags 34/Descent -204/FontBBox[-156 -239 1000 802]/Ascent 737/CapHeight 722/XHeight 475/ItalicAngle 0/CharSet(/space/C/h/a/n/d/K/period/S/e/comma/P/D)>>
endobj

40 0 obj
<</Type/Page/CropBox[0 0 612 792]/Annots[41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R]/Parent 139 0 R/Contents[198 0 R 68 0 R 199 0 R 200 0 R 201 0 R 202 0 R]/Rotate 0/MediaBox[0 0 612 792]/Thumb 134 0 R/Resources 67 0 R>>
endobj

41 0 obj
<</Type/Annot/Subtype/Link/Rect[122.683 562.394 219.458 570.331]/A<</URI(http://www.pmlive.com/pharma_news/type_2_diabetes_market_set_to_soar,_says_globaldata_1202514)/S/URI>>/Border[0 0 0]>>
endobj

42 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 552.416 218.948 560.409]/A<</URI(http://www.pmlive.com/pharma_news/type_2_diabetes_market_set_to_soar,_says_globaldata_1202514)/S/URI>>/Border[0 0 0]>>
endobj

43 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 542.438 140.145 550.431]/A<</URI(http://www.pmlive.com/pharma_news/type_2_diabetes_market_set_to_soar,_says_globaldata_1202514)/S/URI>>/Border[0 0 0]>>
endobj

44 0 obj
<</Type/Annot/Subtype/Link/Rect[155.395 487.672 219.345 495.609]/A<</URI(https://globenewswire.com/news-release/2017/08/25/1100546/0/en/United-States-3-8-Billion-Insulin-Pump-Market-2017-2022-with-Insulet-Corporation-Medtronic-Roche-Animas-Corporation-and-Tandem-Diabetes-Care-Dominating.html)/S/URI>>/Border[0 0 0]>>
endobj

45 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 477.694 219.288 485.688]/A<</URI(https://globenewswire.com/news-release/2017/08/25/1100546/0/en/United-States-3-8-Billion-Insulin-Pump-Market-2017-2022-with-Insulet-Corporation-Medtronic-Roche-Animas-Corporation-and-Tandem-Diabetes-Care-Dominating.html)/S/URI>>/Border[0 0 0]>>
endobj

46 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 467.716 218.268 475.71]/A<</URI(https://globenewswire.com/news-release/2017/08/25/1100546/0/en/United-States-3-8-Billion-Insulin-Pump-Market-2017-2022-with-Insulet-Corporation-Medtronic-Roche-Animas-Corporation-and-Tandem-Diabetes-Care-Dominating.html)/S/URI>>/Border[0 0 0]>>
endobj

47 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 457.795 219.345 465.732]/A<</URI(https://globenewswire.com/news-release/2017/08/25/1100546/0/en/United-States-3-8-Billion-Insulin-Pump-Market-2017-2022-with-Insulet-Corporation-Medtronic-Roche-Animas-Corporation-and-Tandem-Diabetes-Care-Dominating.html)/S/URI>>/Border[0 0 0]>>
endobj

48 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 447.817 219.005 455.754]/A<</URI(https://globenewswire.com/news-release/2017/08/25/1100546/0/en/United-States-3-8-Billion-Insulin-Pump-Market-2017-2022-with-Insulet-Corporation-Medtronic-Roche-Animas-Corporation-and-Tandem-Diabetes-Care-Dominating.html)/S/URI>>/Border[0 0 0]>>
endobj

49 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 437.839 138.784 445.833]/A<</URI(https://globenewswire.com/news-release/2017/08/25/1100546/0/en/United-States-3-8-Billion-Insulin-Pump-Market-2017-2022-with-Insulet-Corporation-Medtronic-Roche-Animas-Corporation-and-Tandem-Diabetes-Care-Dominating.html)/S/URI>>/Border[0 0 0]>>
endobj

50 0 obj
<</Type/Annot/Subtype/Link/Rect[185.839 412.951 219.458 420.888]/A<</URI(http://www.drugs.com/health-guide/foot-ulcers.html)/S/URI>>/Border[0 0 0]>>
endobj

51 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 402.973 173.48 410.967]/A<</URI(http://www.drugs.com/health-guide/foot-ulcers.html)/S/URI>>/Border[0 0 0]>>
endobj

52 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 208.687 218.324 216.68]/A<</URI(https://www.prnewswire.com/news-releases/diabetic-foot-ulcers-and-pressure-ulcers-market-to-reach-us49-billion-by-2024-immobility-in-patients-due-to-chronic-ailments-to-fuel-demand-for-treatments-says-tmr-617648423.html)/S/URI>>/Border[0 0 0]>>
endobj

53 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 198.765 219.061 206.702]/A<</URI(https://www.prnewswire.com/news-releases/diabetic-foot-ulcers-and-pressure-ulcers-market-to-reach-us49-billion-by-2024-immobility-in-patients-due-to-chronic-ailments-to-fuel-demand-for-treatments-says-tmr-617648423.html)/S/URI>>/Border[0 0 0]>>
endobj

54 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 188.787 218.664 196.724]/A<</URI(https://www.prnewswire.com/news-releases/diabetic-foot-ulcers-and-pressure-ulcers-market-to-reach-us49-billion-by-2024-immobility-in-patients-due-to-chronic-ailments-to-fuel-demand-for-treatments-says-tmr-617648423.html)/S/URI>>/Border[0 0 0]>>
endobj

55 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 178.809 219.061 186.803]/A<</URI(https://www.prnewswire.com/news-releases/diabetic-foot-ulcers-and-pressure-ulcers-market-to-reach-us49-billion-by-2024-immobility-in-patients-due-to-chronic-ailments-to-fuel-demand-for-treatments-says-tmr-617648423.html)/S/URI>>/Border[0 0 0]>>
endobj

56 0 obj
<</Type/Annot/Subtype/Link/Rect[77.329 168.831 170.872 176.825]/A<</URI(https://www.prnewswire.com/news-releases/diabetic-foot-ulcers-and-pressure-ulcers-market-to-reach-us49-billion-by-2024-immobility-in-patients-due-to-chronic-ailments-to-fuel-demand-for-treatments-says-tmr-617648423.html)/S/URI>>/Border[0 0 0]>>
endobj

57 0 obj
<</Type/Annot/Subtype/Link/Rect[252.68 676.63 393.959 684.623]/A<</URI(https://www.phlebolymphology.org/ii-primary-chronic-venous-disease)/S/URI>>/Border[0 0 0]>>
endobj

58 0 obj
<</Type/Annot/Subtype/Link/Rect[252.68 666.708 320.428 674.646]/A<</URI(https://www.phlebolymphology.org/ii-primary-chronic-venous-disease)/S/URI>>/Border[0 0 0]>>
endobj

59 0 obj
<</Type/Annot/Subtype/Link/Rect[316.857 506.098 394.639 514.035]/A<</URI(https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)/S/URI>>/Border[0 0 0]>>
endobj

60 0 obj
<</Type/Annot/Subtype/Link/Rect[252.68 496.12 393.449 504.113]/A<</URI(https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)/S/URI>>/Border[0 0 0]>>
endobj

61 0 obj
<</Type/Annot/Subtype/Link/Rect[485.688 365.669 570.104 373.663]/A<</URI(https://www.healthline.com/health/diabetes/diabetes-and-wound-healing)/S/URI>>/Border[0 0 0]>>
endobj

62 0 obj
<</Type/Annot/Subtype/Link/Rect[428.031 355.691 554.4 363.685]/A<</URI(https://www.healthline.com/health/diabetes/diabetes-and-wound-healing)/S/URI>>/Border[0 0 0]>>
endobj

63 0 obj
<</Type/Annot/Subtype/Link/Rect[428.031 210.047 568.857 218.041]/A<</URI(https://globenewswire.com/news-release/2017/03/08/933250/0/en/Intragastric-Balloon-Market-to-surpass-270mn-by-2024-Global-Market-Insights-Inc.html)/S/URI>>/Border[0 0 0]>>
endobj

64 0 obj
<</Type/Annot/Subtype/Link/Rect[428.031 200.069 569.594 208.063]/A<</URI(https://globenewswire.com/news-release/2017/03/08/933250/0/en/Intragastric-Balloon-Market-to-surpass-270mn-by-2024-Global-Market-Insights-Inc.html)/S/URI>>/Border[0 0 0]>>
endobj

65 0 obj
<</Type/Annot/Subtype/Link/Rect[428.031 190.148 568.516 198.085]/A<</URI(https://globenewswire.com/news-release/2017/03/08/933250/0/en/Intragastric-Balloon-Market-to-surpass-270mn-by-2024-Global-Market-Insights-Inc.html)/S/URI>>/Border[0 0 0]>>
endobj

66 0 obj
<</Type/Annot/Subtype/Link/Rect[428.031 180.17 449.688 188.107]/A<</URI(https://globenewswire.com/news-release/2017/03/08/933250/0/en/Intragastric-Balloon-Market-to-surpass-270mn-by-2024-Global-Market-Insights-Inc.html)/S/URI>>/Border[0 0 0]>>
endobj

67 0 obj
<</Font<</F12 119 0 R/F8 163 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

68 0 obj
<</Length 22141>>
stream
/GS1 gs
BT
/F8 1 Tf
7.9702 0 0 7.9702 77.3291 713.8203 Tm
0 0 0 rg
0 Tc
0 Tw
[(year)-488.6(2000)-481.1(and)-487.1(projections)-478.3(for)-484.8(2030.)-483.6(Diabetes)]TJ
0 -1.2519 TD
[(Care)-330.9(2004;27:1047ñ1)6(053.)]TJ
-1.4226 -1.8708 TD
[(26.)-310.6(Rag)14(hav)-229(A,)-225.8(Kha)14(n)-235.9(ZA,)-227(Lab)12.9(ala)-225.3(RK,)-226(Ahm)21.9(ad)-237(J,)-231.3(Noo)14.2(r)-238.3(S)0(,)]TJ
1.4226 -1.2519 TD
[(Mis)18.3(hra)-176.5(BK.)-169.1(Fin)18.6(anc)12.9(ial)-169.7(bur)15.6(den)-174.1(of)-175.4(diab)15.4(et)16.7(ic)-179.4(foo)15.6(t)-181.4(ulce)17.5(rs)]TJ
T*
[(to)-346.1(wor)14(ld:)-340.5(a)-349.7(pro)15.6(gre)15.6(ssi)13.5(ve)-341.7(top)15.6(ic)-350.2(to)-346.1(dis)18.6(cus)14.9(s)-347.7(alw)15.1(ays)14.9(.)]TJ
T*
[(Ther)21.5(ap)-251.2(Adv)-244.9(End)18(oc)14(rin)14.2(ol)-252.6(Met)22.3(ab)-251.2(201)18(8;9:)14.1(29ñ)21.2(31.)]TJ
-1.4226 -1.8708 TD
[(27.)-310.6(Alexiadou)-311.4(K,)-313.4(Doupis)-313.7(J.)-309.5(Management)-307.2(of)-317.6(diabetic)]TJ
1.4226 -1.2519 TD
[(foot)-336.5(ulcers.)-329.1(Diabetes)-325.5(Ther)-334.1(2012;3:4ñ4.)]TJ
-1.4226 -1.8779 TD
[(28.)-310.6(Amin)-407.4(N,)-405.7(Doupis)-406.2(J.)-402(Diabetic)-405.1(foot)-407.6(disease:)-406.1(from)]TJ
1.4226 -1.2448 TD
[(the)-325.9(evaluation)-327.4(of)-324.7(the)-318.8(ë)61.5(ëfoot)-324.8(at)-324.7(riskí)64.4(í)-329.7(t)0(o)-324.7(the)-325.9(novel)]TJ
0 -1.2519 TD
[(diabetic)-588.3(ulcer)-583.6(treatment)-583.2(modalities.)-581.8(World)-583.7(J)]TJ
T*
[(Diabetes)-332.6(2016;7:153ñ1)8.2(64.)]TJ
-1.4226 -1.8708 TD
[(29.)-310.6(Type)-457.7(2)-463.5(diabetes)-458.9(market)-452.1(set)-459(to)-459.9(soar)-460.1(to)-459.9($64bn)]TJ
1.4226 -1.2519 TD
[(by)-284.8(2026.)-277.3(2017.)-284.4(www.pmli)9.2(ve.com/phar)7.5(ma_news/)]TJ
T*
.0221 Tc
(type_2_diabetes_market_)Tj
10.1504 0 TD
.0217 Tc
[(set_to_soar,_sa)-7.9(ys_)]TJ
-10.1504 -1.2519 TD
.0223 Tc
[(globaldata_1202514)-448.3(\(last)-450.7(acces)-5.3(s)1.9(ed)-448.3(April)-449.7(23,)]TJ
0 -1.2448 TD
.0228 Tc
(2018\).)Tj
-1.4226 -1.8779 TD
0 Tc
[(30.)-310.6(Un)24.5(it)22.4(ed)-429(St)19.9(at)30.9(es)-434.1($3)26.2(.8)-437.5(B)16.3(i)0(l)23.4(l)0(i)23.4(o)0(n)-436.2(I)0(n)24.8(s)15.1(ul)24.8(in)-437.5(Pu)26.2(mp)-430.6(Ma)25.9(rk)25.8(et)]TJ
1.4226 -1.2519 TD
[(20)19.1(17)26.2(ñ)16.3(2)0(0)26.2(2)0(2)-429(w)18.7(it)22.4(h)-435(I)0(n)24.8(s)0(u)21.1(l)0(e)24.8(t)-437.4(C)16.3(o)0(r)23.8(p)0(o)26.2(r)0(a)23.8(t)0(i)22.4(o)0(n)26.2(,)-436.4(Me)25.9(dt)23.8(r)17.8(o)0(n)19.1(i)0(c)26.8(,)]TJ
0 -1.2448 TD
[(Ro)22.3(c)15.1(h)0(e)26.2(,)-279.9(An)24.5(im)23.3(as)-263.4(C)16.3(o)0(r)23.8(p)0(o)26.2(r)0(a)23.8(t)0(i)22.4(o)0(n)-265.4(a)0(n)26.2(d)-278.5(Ta)26.2(nd)26.2(em)-267(D)18.5(i)0(a)17.7(b)0(e)26.2(t)17.8(es)]TJ
0 -1.2519 TD
[(Ca)22.3(re)-630.6(Do)24.5(mi)23.3(na)26.2(t)17.8(i)0(n)17.7(g)0(.)-629.6(2)0(0)26.2(1)0(7)26.2(.)-649.8(ht)30.9(tp)23.8(s:)19.7(//)25.8(gl)24.8(ob)26.2(en)26.2(ew)24.7(s)15.1(w)0(i)23.3(r)0(e)]TJ
T*
.0085 Tc
[(.)-8.2(c)8.5(o)-13.1(m)-1.2(/n)-6.9(ew)-8.4(s)8.5(-)-8.4(re)-6.9(le)-6.9(as)-4.8(e/)-7(20)-6.9(17)-6.9(/0)-6.9(8/)-7(25/)-7(11)-6.9(00)-6.9(54)-6.9(6/)-7(0/e)-6.9(n).3(/)]TJ
T*
.0114 Tc
[(United-States-3-8-Bil)-5.3(l)1.8(i)]TJ
8.3935 0 TD
.0097 Tc
[(on-)-8.1(Insu)-5.7(lin)-5.7(-Pu)-5.7(m)0(p-)-8.1(Marke)-5.7(t)-.9(-)]TJ
-8.3935 -1.2448 TD
.009 Tc
[(2)-6.4(0).8(1)-6.4(7).8(-2)-6.4(02)-6.4(2-w)-7.9(i)-.6(th-)-8.8(I)-.6(ns)-4.3(u)-6.4(l)-.6(et)]TJ
8.7349 0 TD
.0111 Tc
[(-C)11.1(o)-9.3(r).5(poration-Medtroni)-5.6(c)11.1(-)]TJ
-8.7349 -1.2519 TD
0 Tc
[(Ro)22.3(c)15.1(h)0(e)26.2(-)0(A)22.1(n)0(i)24.8(m)0(a)24.7(s)15.1(-C)27(or)23.8(po)26.2(ra)23.8(ti)22.4(on)26.2(-a)23.8(nd)26.2(-T)23.8(an)26.2(de)26.2(m-)22.3(Di)23.1(ab)26.2(et)23.8(es)28.2(-)]TJ
T*
[(Ca)22.3(re)23.8(-)17.8(D)0(o)24.5(m)0(i)23.3(n)0(a)26.2(t)0(i)22.4(n)0(g)26.2(.)0(h)24.8(t)0(m)22.3(l)-649.8(\(l)23.4(as)21.1(t)-650.8(a)0(c)21.1(c)15.1(es)28.2(se)21.1(d)-655.5(A)18.5(pr)23.8(il)-645.2(23)26.2(,)]TJ
0 -1.2448 TD
[(20)19.1(18)26.2(\).)]TJ
-1.4226 -1.8779 TD
[(31.)-310.6(Publications)-371.7(HH.)-370.9(Foot)-367.7(Ulcers.)-373.5(2015.)-369.8(www.drugs)]TJ
1.4226 -1.2519 TD
-.0196 Tc
[(.c)-4.5(om/h)-19.6(e)13.7(a).6(lth-g)-19.6(u)13.7(ide)-19.6(/)13.5(foot-ulc)-4.5(ers.)-19.6(h)12.3(t)-1.8(ml)-555.6(\(las)-4.5(t)-556.6(ac)-4.5(ce)-19.6(s)15.7(s)-4.5(ed)]TJ
0 -1.2448 TD
-.0198 Tc
[(Oc)-4.7(tober)-336.3(18)-19.8(,)-322.2(2014)-19.8(\))12.1(.)]TJ
-1.4226 -1.8779 TD
0 Tc
[(32.)-310.6(Baba)-570.4(M,)-565.9(Davis)-559.5(WA,)-566.5(Norman)-562.1(PE,)-566.7(Davis)-566.6(TM.)]TJ
1.4226 -1.2519 TD
[(Temporal)-391.3(changes)-395.1(in)-387.7(the)-397(prevalence)-388(and)-394.6(asso-)]TJ
T*
[(ciates)-333.7(of)-339(foot)-336.5(ulceration)-329.8(in)-338(type)-332.1(2)-342.6(diabetes:)-333.4(the)]TJ
0 -1.2448 TD
[(Fremantle)-456.8(Diabetes)-446.4(Study.)-453.5(J)-456.4(Diabetes)-453.5(Compli-)]TJ
0 -1.2519 TD
[(cations)-334.9(2015;29:35)7.3(6ñ361.)]TJ
-1.4226 -1.8779 TD
[(33.)-310.6(Tresierra-Ayala)-283(MA)]TJ
8.1801 .249 TD
(¥)Tj
.4197 -.249 TD
[(,)-279.9(Garcia)-287.6(Rojas)-279.2(A.)-282.7(Association)]TJ
-7.1772 -1.2448 TD
[(between)-267.9(peripheral)-267.8(arterial)-267.9(disease)-268.4(and)-273.7(diabetic)]TJ
0 -1.2519 TD
[(foot)-500.1(ulcers)-497.3(in)-494.4(patients)-496.9(with)-500.6(diabetes)-494.5(mellitus)]TJ
T*
[(type)-332.1(2.)-338(Med)-330.9(Univ)-325.7(2017;19:123ñ12)6(6.)]TJ
-1.4226 -1.8708 TD
[(34.)-310.6(Zhang)-468(P,)-458.9(Lu)-469.7(J,)-458.9(Jing)-468.2(Y,)-462.8(Tang)-459.8(S,)-469.9(Zhu)-458.6(D,)-467.7(Bi)-462.8(Y.)]TJ
1.4226 -1.2519 TD
[(Global)-352.7(epidemiology)-351.5(of)-353.2(diabetic)-353.6(foot)-350.7(ulceration:)]TJ
T*
[(a)-605.7(systematic)-594.2(review)-600.4(and)-608(meta-anal)10.6(ysis.)-607(Ann)]TJ
T*
[(Med)-330.9(2017;49:106ñ11)6(6.)]TJ
-1.4226 -1.8708 TD
[(35.)-310.6(Sc)24.3(hr)23.8(em)24.7(l)-258.6(S)16.3(,)-258.6(B)16.3(er)23.8(ne)26.2(bu)19.1(r)17.8(g)-257.2(M.)-245.8(Th)26.2(e)-257.2(g)0(l)24.8(o)0(b)26.2(a)0(l)-245.5(b)0(u)26.2(r)0(d)23.8(e)0(n)-244.1(o)0(f)-246.5(d)0(i)24.8(-)]TJ
1.4226 -1.2519 TD
[(ab)19.1(et)30.9(ic)-236.4(wo)24.7(un)26.2(ds)21.1(.)-244.4(B)0(r)-236.2(J)-250.1(D)18.5(e)0(r)23.8(m)0(a)24.7(t)0(o)23.8(l)-251.5(20)26.2(17)26.2(;1)24.8(76)26.2(:8)24.8(45)19.1(ñ)16.3(8)0(4)26.2(6)0(.)]TJ
-1.4226 -1.8708 TD
.0165 Tc
[(3)16.5(6)16.5(.)-294.1(h)-6(ttp)-6(s:/)-6.2(/)1(w)-7.5(ww.)-7.3(pr)-8.4(ne)-6(wswi)-7.3(re.)-7.3(c)-3.9(om)-7.5(/n)-6(ew)-7.5(s-)-8.4(rel)-7.3(e)-6(ase)-6(s)3.2(/)]TJ
1.4226 -1.2519 TD
0 Tc
[(di)31.9(ab)33.3(et)30.9(ic)33.9(-f)28.5(o)20.2(o)0(t)30.9(-)17.8(ul)31.9(c)15.1(e)20.2(rs)32.9(-a)30.9(nd)33.3(-)17.8(p)0(r)30.9(e)0(s)35.3(s)15.1(ur)30.9(e-)30.9(u)20.2(l)0(c)33.9(e)0(r)30.9(s)15.1(-)17.8(m)18.7(ar)30.9(k)15.1(e)20.2(t-)28.5(t)17.8(o)20.2(-)]TJ
T*
[(re)16.7(ac)21.1(h-)16.7(us)21.1(49)19.1(-b)16.7(il)16.3(li)16.3(on)19.1(-b)23.8(y-)18.7(20)19.1(24)19.1(-i)15.3(mm)23.2(ob)19.1(il)16.3(it)15.3(y-)18.7(in)17.7(-p)23.8(at)16.7(ie)17.7(nt)16.7(s)15.1(-)]TJ
T*
[(due-to-chronic)5.7(-ailments-to-fue)8(l-demand-for-tr)6.1(eat)]TJ
0 -1.2448 TD
-.0001 Tc
[(ments-says-tm)9.1(r-617648423.html)-609.9(\(last)-606.4(accessed)]TJ
0 -1.2519 TD
0 Tc
[(January)-335.5(5,)-330.8(2019\).)]TJ
-1.4226 -1.8779 TD
-.0196 Tc
[(3)-19.6(7)-19.6(.)-330.2(Aga)-19.6(l)12.3(e)-468.9(S)3.8(V.)-463.1(Chroni)-19.6(c)-448(l)-19.6(e)12.3(g)-461.7(u)-19.6(l)12.3(ce)-19.6(r)18.4(s)-4.5(:)-463.1(e)-19.6(p)13.7(i)-.8(de)-19.6(m)12.2(i)-.8(olog)-19.6(y)15.7(,)-470.2(ae-)]TJ
1.4226 -1.2448 TD
[(tio)-19.5(p)13.8(atho)-19.5(g)13.8(ene)-19.5(s)15.8(i)-.7(s)-4.4(,)-313.6(and)-312.3(mana)-19.5(g)13.8(e).7(men)-19.5(t)18.5(.)-313.6(J)-312.3(Ulc)-4.4(e).7(rs)-310.2(201)-19.5(3)13.8(;)]TJ
0 -1.2519 TD
-.0202 Tc
[(2)-20.2(0)13.1(13:)-20.2(9)11.7(.)]TJ
-1.4226 -1.8779 TD
0 Tc
[(38.)-310.6(Xie)-399.9(T,)-402(Ye)-404.5(J,)-402(Rerkasem)-396.9(K,)-398.8(Mani)-397.4(R.)-398.8(The)-401.7(venous)]TJ
1.4226 -1.2519 TD
[(ulcer)-476.9(continues)-472.3(to)-474.1(be)-478.8(a)-477.7(clinical)-472.9(challenge:)-475.8(an)]TJ
0 -1.2448 TD
[(update.)-331.8(Burns)-330(Trauma)-330.8(2018;6:18.)]TJ
-1.4226 -1.8779 TD
[(39.)-310.6(Asaf)-433.4(M,)-437.9(Salim)-426.4(N,)-434.1(Tuffaha)-432.4(M.)-437.9(Challenging)-433(the)]TJ
1.4226 -1.2519 TD
[(use)-300.1(of)-296.3(bandage)-292.4(compression)-289.1(as)-299(the)-297.4(baseline)-294.3(for)]TJ
0 -1.2448 TD
[(evaluating)-384.3(the)-382.8(healing)-380.6(outcomes)-385.9(of)-381.7(venous)-379.7(leg)]TJ
22.0009 82.4981 TD
[(ulcer-related)-850.1(compression)-851(therapies)-853.7(in)-850.1(the)]TJ
0 -1.2519 TD
[(community)-254.8(and)-259.5(outpatient)-261.7(setting:)-256.4(an)-258.3(integrative)]TJ
T*
[(review.)-332.6(Dubai)-328.8(Med)-330.9(J)-335.4(2018;1:19ñ2)9.4(5.)]TJ
-1.4226 -1.9063 TD
.0167 Tc
[(4)16.7(0)16.7(.)-293.9(h)-5.8(t)6.1(tp)-5.8(s:)-7.1(//www.ph)-5.8(leb)-5.8(o)1.3(lympho)-5.8(logy.o)-5.8(rg/ii-p)-5.8(r)-1.1(imary-)]TJ
1.4226 -1.2519 TD
0 Tc
[(chronic-venou)6.5(s-disease)-264(\(last)-264.9(accessed)-257(December)]TJ
T*
[(29,)-332(2018\).)]TJ
-1.4226 -1.9134 TD
[(41.)-310.6(OíDonnell)-437.4(TF,)-436.6(Jr.,)-443.6(Passman)-432.2(MA,)-440.7(Marston)-437.8(WA,)]TJ
1.4226 -1.2519 TD
[(et)-296.3(al.)-290.7(Management)-292.9(of)-289.2(venous)-294.4(leg)-289.3(ulcers:)-293.6(clinical)]TJ
0 -1.2448 TD
[(practice)-423.7(guidelines)-418.9(of)-424.3(the)-425.5(Society)-417(for)-427.9(Vascular)]TJ
0 -1.2519 TD
[(Surgery)-370.2(\(R\))-365.7(and)-373.3(the)-368.6(American)-369.7(Venous)-364.3(Forum.)-372.8(J)]TJ
T*
[(Vasc)-331.6(Surg)-330.9(2014;60\(2)-333(Suppl\):3sñ59s)5.8(.)]TJ
-1.4226 -1.9134 TD
-.0191 Tc
[(4)-19.1(2)-19.1(.)-329.7(Ma)-212.3(H,)-213.7(OíDonn)-19.1(e)14.2(l)-.3(l)-213.7(T)1.1(F,)-213.7(Ro)-19.1(s)16.2(e)1.1(n)-212.3(N)-2.6(A,)-213.7(Iafrati)-213.7(MD.)-213.7(The)-212.3(re)-19.1(a)14.2(l)]TJ
1.4226 -1.2448 TD
-.0195 Tc
[(c)-4.4(o).7(st)-392.9(of)-385.8(treating)-390.5(v)2.7(e)-19.5(n)13.8(ous)-388.5(ulc)-4.4(e).7(rs)-388.5(in)-383.4(a)-390.5(c)2.7(on)-19.5(t)11.4(e).7(mpora)-19.5(r)18.5(y)]TJ
0 -1.2519 TD
-.0197 Tc
[(v)-4.6(a).5(sc)-4.6(ula)-19.7(r)-244.9(prac)-4.6(tic)-4.6(e).5(.)-256.9(J)-262.7(Vas)-4.6(c)-260.7(Surg)-262.7(20)-19.7(1)13.6(4).5(;2)-19.7(:)12.2(355)-19.7(ñ)16.8(3).5(6)-19.7(1)13.6(.)]TJ
-1.4226 -1.9134 TD
0 Tc
[(43.)-310.6(Spentzouris)-291(G,)-289.9(Labropoulos)-289.6(N.)-291.9(The)-295(evaluati)9.2(on)-293.9(of)]TJ
1.4226 -1.2519 TD
[(lower-extremi)7.5(ty)-486.3(ulcers.)-485.6(Semin)-481.9(Intervent)-486.2(Radiol)]TJ
0 -1.2448 TD
[(2009;26:286ñ29)6(5.)]TJ
-1.4226 -1.9134 TD
[(44.)-310.6(World)-235.2(Health)-239.9(Organization.)-231.8(Fact)-237.6(sheet)-240.8(on)-237(obesity)]TJ
1.4226 -1.2519 TD
-.0192 Tc
[(an)-19.2(d)-242(o)1(verweigh)-19.2(t)11.7(.)-256.4(2015)-19.2(.)-243.3(h)1(ttps://www.who.)-19.2(i)11.3(n)1(t/ne)-19.2(w)12.6(s)3(-)]TJ
T*
0 Tc
[(room/f)-13.3(a)-8.2(ct-she)-14.6(ets/de)-14.5(tail/)-11(obe)-10.5(sity-a)-16(nd-ove)-14.3(rwei)-9.8(ght)]TJ
0 -1.2448 TD
[(\(la)-13.3(st)-337(access)-12.9(ed)-336.6(Ja)-9.4(nuary)-340.3(2)-8.2(,)-336.8(2019\).)]TJ
-1.4226 -1.9134 TD
[(45.)-310.6(Lauby-Secreta)8.7(n)-755.1(B)0(,)-747.3(Scoccianti)-747(C,)-747.3(Loomis)-745.4(D,)]TJ
1.4226 -1.2519 TD
[(Grosse)-255.8(Y,)-263.6(Bianchini)-250.9(F,)-264.8(Straif)-254(K.)-256.5(Body)-262.5(Fatness)-253.2(and)]TJ
T*
[(canceróview)7.9(point)-1040.8(of)-1043.2(the)-1037.2(IARC)-1039.7(Working)]TJ
0 -1.2448 TD
-.0002 Tc
[(Group.)-332.5(N)-332.2(Engl)-333.3(J)-328.5(Med)-331.1(2016;375:794ñ798.)]TJ
-1.4226 -1.9134 TD
0 Tc
[(46.)-310.6(Nyberg)-266.9(ST,)-257.6(Batty)-268.4(GD,)-257.1(Pentti)-269(J,)-266.8(et)-260.7(al.)-269.3(Obesity)-258.3(and)]TJ
1.4226 -1.2519 TD
[(loss)-371.7(of)-367.4(disease-free)-366.6(years)-366.8(owing)-364.2(to)-367.4(major)-373.7(non-)]TJ
T*
[(communicabl)7.2(e)-634.2(diseases:)-625.7(a)-627.1(multicohort)-626.5(study.)]TJ
T*
[(Lancet)-332.3(Public)-327.6(Health)-332.3(2018;3:e490ñe4)6(97.)]TJ
-1.4226 -1.9063 TD
[(47.)-310.6(Gu)]TJ
2.0557 .0213 TD
(®)Tj
.3628 -.0213 TD
(ngo)Tj
.9816 .0285 TD
(®)Tj
.3628 -.0285 TD
[(r)-366.3(NK.)-368(Overweight)-360.1(and)-373.3(obesity)-363.3(in)-366.4(children)]TJ
-2.3402 -1.2519 TD
[(and)-408.8(adolesc)9(ents.)-405.7(J)-406.6(Clin)-402.4(Res)-403.6(Pediatr)-405.3(Endocrinol)]TJ
T*
[(2014;6:129ñ143)6(.)]TJ
-1.4226 -1.9134 TD
[(48.)-310.6(Yanovski)-363.9(JA.)-369.2(Pediatric)-371.4(obesity.)-365.8(An)-366.7(introduction.)]TJ
1.4226 -1.2448 TD
[(Appetite)-329.9(2015;93:3ñ12.)]TJ
-1.4226 -1.9134 TD
[(49.)-310.6(Kalra)-525.5(G,)-531.7(De)-523.2(Sousa)-526.8(A,)-524.6(Sonavane)-530.2(S,)-526.8(Shah)-527.7(N.)]TJ
1.4226 -1.2519 TD
[(Psychologica)6(l)-585.8(issues)-585.4(in)-579.8(pediatric)-584.8(obesity.)-579.2(Ind)]TJ
T*
[(Psychiatry)-329.5(J)-335.4(2012;21:11)7.3(ñ17.)]TJ
-1.4226 -1.9134 TD
[(50.)-310.6(Rankin)-351.5(J,)-359.3(Matthews)-348(L,)-357.3(Cobley)-351.5(S,)-356.1(et)-353.2(al.)-361.8(Psycho-)]TJ
1.4226 -1.2448 TD
[(logical)-358.6(consequence)7.9(s)-361.9(o)0(f)-353.2(childhood)-359.5(obesity:)-351.6(psy-)]TJ
0 -1.2519 TD
[(chiatric)-667(comorbidity)-664.7(and)-664.9(prevention.)-665.3(Adolesc)]TJ
T*
[(Health)-332.3(Med)-330.9(Ther)-334.1(2016;7:12)8.4(5ñ146.)]TJ
-1.4226 -1.9134 TD
-.0191 Tc
[(5)-19.1(1)-19.1(.)-329.7(Sand)-19.1(y)16.2(-)-1.3(Hodg)-19.1(e)14.2(tts)-274.3(K,)-277.7(Carville)-276.3(K,)-270.6(Lesli)-19.1(e)-257.5(GD.)-277.7(D)6.5(e)-19.1(t)11.8(e)1.1(rmin-)]TJ
1.4226 -1.2448 TD
-.0199 Tc
[(in)-19.9(g)-370.7(r)-2.1(isk)-388.9(f)-2.1(actors)-388.9(for)-386.2(s)2.3(urg)-19.9(i)12(ca)-19.9(l)-372.1(w)5.9(o)-19.9(u)13.4(nd)-383.8(d)-19.9(e)13.4(his)-4.8(c)2.3(e)-19.9(n)13.4(ce)-19.9(:)-372.1(a)]TJ
0 -1.2519 TD
-.0195 Tc
[(lite)-19.5(r)11.4(ature)-262.5(r)-1.7(evie)-19.5(w)12.3(.)-256.7(In)-19.5(t)-244.7(W)2.6(o)-19.5(u)13.8(nd)-262.5(J)-262.5(201)-19.5(5)13.8(;)-.7(12)-19.5(:)12.4(265ñ27)-19.5(5)13.8(.)]TJ
-1.4226 -1.9134 TD
0 Tc
[(52.)-310.6(Guo)-552.8(S,)-555.3(Dipietro)-551.8(LA.)-559.3(Factors)-547.2(affecting)-557.3(wound)]TJ
1.4226 -1.2519 TD
[(healing.)-333.3(J)-335.4(Dent)-328.7(Res)-332.5(Mar)-326.2(2010;89:219ñ22)6(9.)]TJ
-1.4226 -1.9134 TD
[(53.)-310.6(Anderson)-644.2(K,)-647.7(Hamm)-649.4(RL.)-646.8(Factors)-646.8(that)-649.5(impair)]TJ
1.4226 -1.2448 TD
[(wound)-398.4(healing.)-397.3(J)-392.3(A)0(m)-396.7(Coll)-395.3(Clin)-402.4(Wound)-395(Special)]TJ
0 -1.2519 TD
(2012;4:84ñ91.)Tj
-1.4226 -1.9134 TD
[(54.)-310.6(Doyle)-390.8(SL,)-390.8(Lysaght)-395.5(J,)-387.8(Reynolds)-394.4(JV.)-392.8(Obesity)-386.3(and)]TJ
1.4226 -1.2519 TD
[(post-operativ)6.8(e)-413.7(complications)-407.9(in)-409.1(patients)-404.4(under-)]TJ
0 -1.2448 TD
[(going)-405.4(non-bariatric)-409.1(surgery.)-402.4(Obes)-402.5(Rev)-403.6(2010;11:)]TJ
0 -1.2519 TD
(875ñ886.)Tj
-1.4226 -1.9134 TD
[(55.)-310.6(Pierpont)-399.3(YN,)-403.6(Dinh)-405.9(TP,)-403.1(Salas)-400.1(RE,)-399.9(et)-403(al.)-404.5(Obesity)]TJ
1.4226 -1.2519 TD
[(and)-444.4(surgical)-436.9(wound)-441.1(healing:)-440(a)-442.1(current)-439.9(review.)]TJ
7.9702 0 0 7.9702 252.6802 81.411 Tm
[(ISRN)-330.4(Obes)-331.4(2014;2014:6)6.2(38936.)]TJ
-1.4226 -1.9134 TD
[(56.)-310.6(Shipman)-469.9(AR,)-472.7(Millington)-474.8(GW.)-466.9(Obesity)-471.7(and)-472.9(the)]TJ
1.4226 -1.2519 TD
[(skin.)-331.6(Br)-335.8(J)-328.3(Dermatol)-331.4(2011;165:7)7.3(43ñ750.)]TJ
20.5783 82.5124 TD
[(57.)-310.6(Stevens)-415.6(SM,)-421.6(OíConnell)-418.2(BP,)-414.1(Meyer)-418.9(TA.)-419(Obesity)]TJ
1.4226 -1.2519 TD
[(related)-711.2(complicat)8.5(ions)-715.2(in)-707.8(surgery.)-708.3(Curr)-710.3(Opin)]TJ
T*
[(Otolaryngol)-325.5(Head)-333.4(Neck)-331.4(Surg)-330.9(2015;23:341)6.1(ñ347.)]TJ
-1.4226 -1.9063 TD
[(58.)-310.6(Goutos)-464.1(I,)-474.5(Sadideen)-469.6(H,)-467.7(Pandya)-467.1(AA,)-470.5(Ghosh)-467.7(SJ.)]TJ
1.4226 -1.2519 TD
[(Obesity)-471.7(and)-472.9(burns.)-470.9(J)-470.6(Burn)-473.2(Care)-473.2(Res)-467.6(2012;33:)]TJ
T*
(471ñ482.)Tj
-1.4226 -1.9205 TD
[(59.)-310.6(Houdek)-419(MT,)-424.8(Grifn)-420.1(AM,)-419.3(Ferguson)-427.1(PC,)-421.2(Wunder)]TJ
1.4226 -1.2448 TD
[(JS.)-442.6(morbid)-438.9(obesity)-441.5(increases)-441.8(the)-446.8(risk)-438.1(of)-445.7(post-)]TJ
0 -1.2519 TD
[(operative)-512.2(wound)-505.1(complications,)-510(infection,)-509(and)]TJ
T*
[(repeat)-417(surgical)-408.5(procedures)-410.4(following)-416.5(upper)-413.5(ex-)]TJ
T*
[(tremity)-613.5(limb)-620.5(salvage)-617(surgery)-620.4(for)-619.9(soft)-619(tissue)]TJ
0 -1.2448 TD
[(sarcoma.)-330.4(Hand)-326.3(\(N)-334.6(Y\))-334.8(2018:155894)7.5(4718797336.)]TJ
-1.4226 -1.9134 TD
[(60.)-310.6(Montgomery)-293.3(C,)-299.2(Harris)-297.2(J,)-302.4(Siegel)-298(E,)-295.3(et)-303.4(al.)-297.8(Obesity)]TJ
1.4226 -1.2519 TD
[(is)-421.3(associated)-421.6(with)-422.4(larger)-425.5(soft-tissue)-415.7(sarcomas,)]TJ
T*
[(more)-357(surgical)-351.6(complications,)-353.5(and)-359(more)-357(complex)]TJ
0 -1.2448 TD
[(wo)24.7(un)26.2(d)-235.9(c)15.1(lo)24.8(s)15.1(u)0(r)23.8(e)0(s)-220.7(\()0(o)24.8(b)0(e)26.2(s)0(i)19.7(t)17.8(y)-233.8(l)0(e)24.8(a)0(d)26.2(s)-233.8(to)-218(la)24.8(rg)23.8(er)-218(so)21.1(ft)28.5(-t)21.4(is)26.8(s)15.1(u)0(e)]TJ
0 -1.2519 TD
[(s)15.1(a)0(r)23.8(c)0(o)21.1(m)18.7(as)21.1(\).)-310.9(J)-321.2(S)16.3(ur)23.8(g)-321.2(O)0(n)24.5(c)15.1(ol)-309.5(20)26.2(18)26.2(;1)24.8(18)19.1(:1)24.8(84)26.2(ñ)16.3(1)0(9)19.1(1)0(.)]TJ
-1.4226 -1.9277 TD
[(61.)-310.6(Thelwall)-263.6(S,)-270.7(Harrington)-263.4(P,)-266.8(Sheridan)-265.7(E,)-273.9(Lamagni)-264.8(T.)]TJ
1.4226 -1.2448 TD
[(Impact)-294.6(of)-296.3(obesity)-292.2(on)-293.9(the)-297.4(risk)-295.9(of)-296.3(wound)-291.7(infection)]TJ
0 -1.2519 TD
[(following)-587.3(surgery:)-580.2(results)-586.2(from)-579.9(a)-584.4(nationwide)]TJ
T*
[(pr)23.8(os)28.2(pe)19.1(c)15.1(t)0(i)22.4(v)15.1(e)-399.5(m)18.7(ul)24.8(ti)22.4(c)15.1(e)0(n)19.1(t)17.8(re)-388.8(c)15.1(o)0(h)26.2(o)0(r)23.8(t)-394.7(st)25.8(ud)19.1(y)-390.3(i)0(n)-387.8(E)0(n)26.2(g)0(l)24.8(a)0(n)19.1(d)0(.)]TJ
T*
-.0246 Tc
[(C)-8.3(l)-24.6(in)-473.9(Mi)-24.6(c)-4.9(r)-24.6(ob)-24.6(io)-24.6(l)-455(I)-24.6(nf)-24.6(ec)-9.5(t)-469.1(2)-24.6(01)-24.6(5)-5.5(;)-24.6(21)-24.6(:1)-24.6(00)-24.6(8.)-24.6(e1)-24.6(00)-24.6(1)-5.5(ñ)-8.3(e)-24.6(1)1.6(0)-24.6(0)1.6(8)]TJ
0 -1.2448 TD
0 Tc
[(.e)24.8(10)26.2(08)19.1(.)]TJ
-1.4226 -1.9277 TD
[(62.)-310.6(Allen)-543.6(DB,)-551(Maguire)-538.4(JJ,)-552.5(Mahdavian)-543.3(M,)-544.6(et)-545.2(al.)]TJ
1.4226 -1.2519 TD
[(Wound)-572.8(hypoxia)-574.3(and)-579.6(acidosis)-574.8(limit)-575.6(neutrophil)]TJ
0 -1.2448 TD
[(bacterial)-492.3(killing)-488(mechanisms.)-488.7(Arch)-490.3(Surg)-487.4(1997;)]TJ
0 -1.2519 TD
(132:991ñ996.)Tj
-1.4226 -1.9277 TD
[(63.)-310.6(Th)19.1(om)24.7(as)-462.6(He)24.5(ss)-467.7(C)16.3(.)-472(Ch)22.3(ec)21.1(kl)19.7(is)19.7(t)-473(f)0(o)16.7(r)-465.9(fa)16.7(c)15.1(t)0(o)16.7(r)0(s)-457.9(a)0(f)16.7(f)0(e)23.8(c)0(t)18.7(i)0(n)24.8(g)]TJ
1.4226 -1.2519 TD
[(wo)24.7(un)19.1(d)-157.6(h)0(e)19.1(a)0(l)24.8(i)0(n)17.7(g)0(.)-145.9(A)0(d)24.5(v)-155.6(Sk)17.2(in)-145.9(W)15(o)0(u)19.1(n)0(d)-144.5(C)0(a)22.3(r)0(e)-146.9(2)0(0)26.2(1)0(1)19.1(;)0(2)17.7(4)0(:)24.8(1)0(9)19.1(2)0(.)]TJ
-1.4226 -1.9063 TD
[(64.)-310.6(Dening)-379.7(J.)-387.7(Whatís)-383.6(the)-382.8(connection)-380.9(between)-381.7(dia-)]TJ
1.4226 -1.2519 TD
[(betes)-568(and)-565.3(wound)-569.1(healing?)-564.6(In:)-568.1(Butler)-564.6(N,)-569.3(ed.)]TJ
T*
-.0001 Tc
[(Healthline.)-641(2017.)-647.3(https://ww)9.5(w.healthline.com/)]TJ
T*
0 Tc
[(he)33.3(al)24.8(t)17.8(h)0(/)33.1(d)0(i)24.8(a)20.2(be)26.2(t)17.8(e)0(s)28.2(/)20(di)31.9(ab)26.2(e)20.2(t)0(e)30.9(s)15.1(-a)30.9(nd)26.2(-)17.8(w)18.7(ou)26.2(n)20.2(d)0(-)30.9(h)0(e)26.2(a)0(l)31.9(i)0(n)31.9(g)-470.6(\(l)30.6(as)28.2(t)]TJ
0 -1.2448 TD
[(accessed)-328.2(December)-325.6(29,)-339.1(2018\).)]TJ
-1.4226 -1.9277 TD
[(65.)-310.6(Kritchevsky)-410.7(SB,)-418(Beavers)-408.5(KM,)-414.4(Miller)-419.1(ME,)-410.5(et)-417.2(al.)]TJ
1.4226 -1.2519 TD
[(Intentional)-249(weight)-246.8(loss)-243.7(and)-252.3(all-cause)-246(mortality:)-249.7(a)]TJ
0 -1.2448 TD
[(meta-analysis)-295.1(of)-303.4(randomized)-301.3(clinical)-302.2(trials.)-306.4(PLoS)]TJ
0 -1.2519 TD
[(One)-332.3(2015;10:e01)6.1(21993.)]TJ
-1.4226 -1.9277 TD
[(66.)-310.6(Ma)-422.3(C,)-427.2(Avenell)-422.9(A,)-432.1(Bolland)-420(M,)-430.7(et)-424.3(al.)-425.8(Effects)-423.6(of)]TJ
1.4226 -1.2448 TD
[(weight)-531.3(loss)-535.3(interventi)9.2(ons)-534.9(for)-534.6(adults)-527.8(who)-531.3(are)]TJ
0 -1.2519 TD
[(obese)-352.2(on)-357.9(mortality,)-349.3(cardiovascular)-349.6(disease,)-356.3(and)]TJ
T*
[(cancer:)-569.6(systematic)-572.8(review)-572(and)-572.4(meta-analysis.)]TJ
T*
[(BMJ)-327.7(2017;359:j4849.)]TJ
-1.4226 -1.9205 TD
[(67.)-310.6(Intragastric)-391.7(Balloon)-391.6(Market)-394(to)-388.8(surpass)-395.5($270mn)]TJ
1.4226 -1.2519 TD
[(by)-654.6(2024:)-661.4(Global)-651.4(Market)-657.2(Insights)-657.5(Inc.)-652.5(2017.)]TJ
T*
[(https://globe)7.9(newswire.com/n)6.8(ews-release/201)7.7(7/)]TJ
0 -1.2448 TD
[(03/08/933250)7.4(/0/en/Intragastr)8(ic-Balloon-Mar)6.2(ket-)]TJ
0 -1.2519 TD
-.0205 Tc
(to-surpass-270mn-by-2024-)Tj
9.4747 0 TD
[(G)5.1(l)-1.7(obal-Market-Insights-)]TJ
-9.4747 -1.2519 TD
-.0202 Tc
[(Inc.htm)5.6(l)-335.7(\(last)-329.6(acc)-5.1(e)0(ssed)-334.3(A)-1.7(p)7.1(r)-2.4(il)-335.7(23,)-328.6(2018\).)]TJ
-1.4226 -1.9277 TD
0 Tc
[(68.)-310.6(Augustin)-247.2(M,)-245.8(Brocatti)-247.1(LK,)-248.5(Rustenbac)8.9(h)-250.1(SJ,)-250.5(Schafer)]TJ
1.4226 -1.2448 TD
[(I,)-246.9(Herberger)-246.7(K.)-249.4(Cost-of-illness)-241.9(of)-253.6(leg)-246.6(ulcers)-248.4(in)-245.5(the)]TJ
0 -1.2519 TD
[(community)8.4(.)-336.8(Int)-334.4(Wound)-331(J)-328.3(2014;11:283ñ29)6(2.)]TJ
-1.4226 -1.9277 TD
[(69.)-310.6(Kim)-479.6(PJ,)-488.5(Evans)-478.2(KK,)-482(Steinberg)-482.6(JS,)-478.1(Pollard)-482.5(ME,)]TJ
1.4226 -1.2448 TD
[(Attinger)-552.8(CE.)-549.3(Critical)-553.3(elements)-552.9(to)-552.4(building)-553.8(an)]TJ
0 -1.2519 TD
[(effective)-327.7(wound)-327.3(care)-325(center.)-332.2(J)-328.3(Vasc)-324.5(Surg)-323.8(2013;)]TJ
T*
(57:1703ñ1709.)Tj
-1.4226 -1.9205 TD
[(70.)-310.6(Driver)-368.3(VR,)-368.2(Fabbi)-374.9(M,)-373.8(Lavery)-365.9(LA,)-374.3(Gibbons)-364.6(G.)-375.2(The)]TJ
1.4226 -1.2519 TD
[(costs)-272.3(of)-275(diabetic)-275.4(foot:)-275(the)-269(economic)-278.2(case)-270.8(for)-271.4(the)]TJ
T*
[(limb)-257.7(salvage)-261.3(team.)-252.8(J)-264.3(Vasc)-253.3(Surg)-259.8(2010;52\(3Supp)7.1(l\):)]TJ
T*
(17Sñ22S.)Tj
/F11 1 Tf
8.9663 0 0 8.9663 62.022 758.6644 Tm
(46)Tj
/F12 1 Tf
9.9626 0 0 9.9626 290.5511 758.6644 Tm
[(EDITORI)-10.7(AL)]TJ
ET
62.022 753.902 508.082 .51025 re
f

endstream
endobj

69 0 obj
<</Type/Page/CropBox[0 0 612 792]/Annots[70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R]/Parent 139 0 R/Contents[203 0 R 85 0 R 204 0 R 205 0 R 206 0 R 207 0 R]/Rotate 0/MediaBox[0 0 612 792]/Thumb 135 0 R/Resources 84 0 R>>
endobj

70 0 obj
<</Type/Annot/Subtype/Link/Rect[84.076 691.88 199.276 699.874]/A<</URI(https://www.apwca.org/news/53104492017)/S/URI>>/Border[0 0 0]>>
endobj

71 0 obj
<</Type/Annot/Subtype/Link/Rect[57.146 681.959 71.376 689.896]/A<</URI(https://www.apwca.org/news/53104492017)/S/URI>>/Border[0 0 0]>>
endobj

72 0 obj
<</Type/Annot/Subtype/Link/Rect[177.562 666.708 199.276 674.646]/A<</URI(https://www.brhmedical.com/healthcare-professionals/#economics)/S/URI>>/Border[0 0 0]>>
endobj

73 0 obj
<</Type/Annot/Subtype/Link/Rect[57.146 656.731 197.008 664.724]/A<</URI(https://www.brhmedical.com/healthcare-professionals/#economics)/S/URI>>/Border[0 0 0]>>
endobj

74 0 obj
<</Type/Annot/Subtype/Link/Rect[57.146 646.753 91.162 654.746]/A<</URI(https://www.brhmedical.com/healthcare-professionals/#economics)/S/URI>>/Border[0 0 0]>>
endobj

75 0 obj
<</Type/Annot/Subtype/Link/Rect[76.195 185.499 199.105 193.493]/A<</URI(https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf)/S/URI>>/Border[0 0 0]>>
endobj

76 0 obj
<</Type/Annot/Subtype/Link/Rect[57.146 175.521 106.923 183.515]/A<</URI(https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf)/S/URI>>/Border[0 0 0]>>
endobj

77 0 obj
<</Type/Annot/Subtype/Link/Rect[178.242 115.143 199.162 123.137]/A<</URI(https://cdn.ymaws.com/www.amtrauma.org/resource/resmgr/TIIDE/Blast_InjuryExtremities.pdf)/S/URI>>/Border[0 0 0]>>
endobj

78 0 obj
<</Type/Annot/Subtype/Link/Rect[57.146 105.222 199.276 113.159]/A<</URI(https://cdn.ymaws.com/www.amtrauma.org/resource/resmgr/TIIDE/Blast_InjuryExtremities.pdf)/S/URI>>/Border[0 0 0]>>
endobj

79 0 obj
<</Type/Annot/Subtype/Link/Rect[57.146 95.244 180.624 103.181]/A<</URI(https://cdn.ymaws.com/www.amtrauma.org/resource/resmgr/TIIDE/Blast_InjuryExtremities.pdf)/S/URI>>/Border[0 0 0]>>
endobj

80 0 obj
<</Type/Annot/Subtype/Link/Rect[407.452 457.795 549.751 465.732]/A<</URI(http://healthcare-executive-insight.advanceweb.com/Features/Articles/Chronic-Wounds-Infectious-Diseases-That-Wont-Go-Away-2.aspx#AnchorComment)/S/URI>>/Border[0 0 0]>>
endobj

81 0 obj
<</Type/Annot/Subtype/Link/Rect[407.452 447.817 548.731 455.754]/A<</URI(http://healthcare-executive-insight.advanceweb.com/Features/Articles/Chronic-Wounds-Infectious-Diseases-That-Wont-Go-Away-2.aspx#AnchorComment)/S/URI>>/Border[0 0 0]>>
endobj

82 0 obj
<</Type/Annot/Subtype/Link/Rect[407.452 437.839 549.127 445.833]/A<</URI(http://healthcare-executive-insight.advanceweb.com/Features/Articles/Chronic-Wounds-Infectious-Diseases-That-Wont-Go-Away-2.aspx#AnchorComment)/S/URI>>/Border[0 0 0]>>
endobj

83 0 obj
<</Type/Annot/Subtype/Link/Rect[407.452 427.861 434.948 435.855]/A<</URI(http://healthcare-executive-insight.advanceweb.com/Features/Articles/Chronic-Wounds-Infectious-Diseases-That-Wont-Go-Away-2.aspx#AnchorComment)/S/URI>>/Border[0 0 0]>>
endobj

84 0 obj
<</Font<</F12 119 0 R/F15 126 0 R/F8 163 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

85 0 obj
<</Length 22151>>
stream
/GS1 gs
BT
/F8 1 Tf
7.9702 0 0 7.9702 45.8079 713.8203 Tm
0 0 0 rg
0 Tc
0 Tw
[(71.)-310.6(Carver)-262.4(T.)-266.8(New)-264.7(study)-260.1(demonstrates)-260.1(the)-261.9(economic)]TJ
1.4226 -1.2519 TD
[(costs;)-516.6(medicare)-517.3(policy)-510.5(implications)-516.9(of)-516.8(chronic)]TJ
T*
[(wounds.)-321.8(https://www.apw)6.7(ca.org/news)7.5(/5310449)]TJ
0 -1.2448 TD
[(2017)-331.7(\(last)-336(accessed)-328.2(January)-328.4(5,)-330.8(2019\).)]TJ
-1.4226 -1.9134 TD
[(72.)-310.6(ADA.)-409.3(Economics)-405.3(of)-403(wound)-405.5(care.)-412.9(2015.)-405.4(https://)]TJ
1.4226 -1.2519 TD
[(www.brhmed)7.3(ical.com/health)5.9(care-profession)6.6(als/)]TJ
T*
[(#economics)-328.2(\(last)-336(accessed)-328.2(December)-325.6(15,)-332(2018\).)]TJ
-1.4226 -1.9134 TD
[(73.)-310.6(Gouin)-592(J-P,)-591.6(Kiecolt-Glaser)-583.5(JK.)-591.9(The)-593.8(impact)-586.2(of)]TJ
1.4226 -1.2448 TD
[(psychological)-288.2(stress)-282.9(on)-293.9(wound)-284.6(healing:)-290.6(methods)]TJ
0 -1.2519 TD
[(and)-487.1(mechanisms.)-481.6(Immunol)-483.2(Allergy)-482.2(Clin)-487.8(N)-488.5(A)0(m)]TJ
T*
(2011;31:81ñ93.)Tj
-1.4226 -1.9134 TD
-.0226 Tc
[(7)-22.6(4)-22.6(.)-333.2(Kiecolt-Glas)6.7(e)-2.4(r)-623.6(J)-2.4(K,)-622.6(Ma)]TJ
9.7308 0 TD
-.0244 Tc
[(rucha)-630.1(P)-4.2(T,)-631.5(Malarkey)-628.1(WB,)]TJ
-8.3081 -1.2448 TD
-.021 Tc
[(Me)6.3(rcad)6.3(o)-164.4(A)4.6(M)6(,)-165.8(G)4.6(l)4.9(ase)6.3(r)-159.7(R.)-165.8(S)9.5(l)-2.2(o)6.3(w)-2.3(i)4.9(n)-.8(g)-157.3(o)-.8(f)-159.7(w)4.8(ou)6.3(nd)-157.3(hea)6.3(l)4.9(i)-2.2(n)6.3(g)-164.4(by)]TJ
0 -1.2519 TD
[(psy)8.4(c)1.3(ho)6.4(lo)6.4(gi)5(cal)-258.1(s)1.3(tre)6.4(ss.)-258.1(La)6.4(nce)6.4(t)-259.2(19)6.4(95)6.4(;3)6.4(46)6.4(:1)6.4(194)6.4(ñ11)6.4(9)-.7(6)6.4(.)]TJ
-1.4226 -1.9134 TD
0 Tc
[(75.)-310.6(Ste)25.9(in)17.7(er)-410.1(CA)20.6(,)-408(K)0(a)15.2(r)0(a)16.7(c)0(a)-405.7(Z)0(,)-402(M)0(o)18.8(o)0(r)16.7(e)-413.7(BJ)22.3(,)-415.1(I)0(m)16.2(s)0(h)21.1(aug)-401.7(MC)22(,)]TJ
1.4226 -1.2519 TD
[(Pic)25.7(ke)14(ns)-384.3(G.)-382.3(Su)15.2(rg)16.7(er)16.7(ie)17.7(s)-390.3(i)0(n)-387.7(H)0(o)17.4(s)0(p)21.1(i)0(t)15.3(a)0(l)17.7(-Ba)25.9(se)14(d)-392.4(A)0(m)15.9(b)0(u)19.1(l)0(a)17.7(-)]TJ
0 -1.2448 TD
[(to)16.7(ry)-223.1(Su)15.2(rg)16.7(er)16.7(y)-226.7(a)0(n)19.1(d)-228.7(Ho)17.4(sp)14(it)15.3(al)-217(Inp)23.7(at)16.7(ie)17.7(nt)-225.2(Se)22.3(tt)14.3(in)17.7(gs)-220.7(201)25.1(4.)]TJ
0 -1.2519 TD
[(Ro)15.2(ck)16(vi)19.7(ll)16.3(e,)-409.1(MD)17.1(:)-408(A)0(g)17.4(enc)20(y)-411.7(f)0(o)16.7(r)-416.1(He)17.4(al)17.7(th)16.7(Ca)22.3(re)-410.1(Re)22.3(se)14(ar)16.7(ch)]TJ
T*
[(and)-309.3(Qu)17.4(al)17.7(it)15.3(y)-326.3(\()0(A)16(H)0(R)20.6(Q)0(\))16(,)-322.6(201)25.1(8.)]TJ
-1.4226 -1.9134 TD
[(76.)-310.6(McDermott)-367.4(KW,)-369.6(Weiss)-371(AJ,)-376.3(Elixhauser)-368.1(A.)-375.2(Burn-)]TJ
1.4226 -1.2448 TD
[(Related)-307.2(Hospital)-305.5(Inpatient)-302.2(Stays)-306.7(and)-309.3(Emergency)]TJ
0 -1.2519 TD
[(Department)-555.2(Visits,)-562(2013.)-561.9(Rockville)9.2(,)-564.4(Maryland:)]TJ
T*
[(Agency)-594.8(for)-598.6(Healthcare)-593.3(Research)-594.6(and)-600.9(Quality)]TJ
T*
[(AHRQ,)-329(2016.)]TJ
-1.4226 -1.9063 TD
[(77.)-310.6(Badia)-373.7(JM,)-375(Casey)-375.4(AL,)-374.3(Petrosillo)-373.9(N,)-370.1(Hudson)-376.3(PM,)]TJ
1.4226 -1.2519 TD
[(Mitchell)-440.7(SA,)-437.2(Crosby)-435.8(C.)-441.4(Impact)-436.8(of)-438.6(surgical)-444.1(site)]TJ
T*
[(infection)-449.6(on)-443.3(healthcare)-442.2(costs)-443(and)-451.5(patient)-440.9(out-)]TJ
T*
[(comes:)-574.7(a)-577.3(systematic)-572.8(review)-572(in)-579.8(six)-576.9(European)]TJ
0 -1.2448 TD
[(countries.)-334.9(J)-328.3(Hosp)-331.4(Infect)-331(2017;96:1ñ15.)]TJ
-1.4226 -1.9134 TD
[(78.)-310.6(Shepard)-284.5(J,)-288.2(Ward)-282.4(W,)-279.2(Milstone)-282.8(A,)-289.9(et)-282.1(al.)-283.6(Financial)]TJ
1.4226 -1.2519 TD
[(impact)-429.7(of)-424.3(surgical)-422.7(site)-433.1(infections)-420.3(on)-429(hospitals:)]TJ
T*
[(the)-582(hospital)-574.1(management)-578.6(perspecti)9(ve.)-586(JAMA)]TJ
0 -1.2448 TD
[(Surg)-330.9(2013;148:907ñ9)6(14.)]TJ
-1.4226 -1.9134 TD
-.0267 Tc
[(7)-26.7(9)-26.7(.)-337.3(W)-4.6(o).6(rld)-205.7(H)-1.1(ea)-6.5(lth)-205.7(O)-1.1(rgani)-7.9(zation)-6.5(.)-207(G)-1.1(loba)-6.5(l)-207(G)6(u)-6.5(i)-.8(del)-7.9(ines)-210.7(for)-208.1(t)-1.8(he)]TJ
1.4226 -1.2519 TD
[(P)-6.5(r)-1.8(eve)-6.5(n).6(tion)-291(of)-293.4(Su)-6.5(rgica)-6.5(l)-285.3(Site)-291(Infe)-6.5(ction)-6.5(.)-285.3(Ge)-6.5(nev)-4.5(a,)-292.4(Swit-)]TJ
T*
0 Tc
[(zerland:)-249.1(WHO)-239.6(\(World)-237.7(Health)-247(Organization\),)-241.4(2016.)]TJ
-1.4226 -1.9134 TD
[(80.)-310.6(Ban)-412.7(KA,)-408.7(Minei)-407.1(JP,)-410.2(Laronga)-406.6(C,)-405.9(et)-410.1(al.)-411.6(American)]TJ
1.4226 -1.2448 TD
[(College)-384.5(of)-381.7(Surgeons)-383.2(and)-380.4(Surgical)-386(Infection)-378.5(So-)]TJ
0 -1.2519 TD
[(ciety:)-569.8(surgical)-565(site)-568.2(infection)-570.5(guidelines,)-563.6(2016)]TJ
T*
[(update.)-331.8(J)-335.4(A)0(m)-332.7(Coll)-331.3(Surg)-330.9(2017;224:)8.4(59ñ74.)]TJ
-1.4226 -1.9134 TD
[(81.)-310.6(Anderson)-608.6(DJ,)-604(Podgorny)-606.9(K,)-612.2(Berr)]TJ
14.0627 .0356 TD
(¥)Tj
.249 -.0356 TD
[(os-Torres)-603.7(SI,)]TJ
-12.889 -1.2448 TD
[(et)-403(al.)-404.5(Strategies)-398.8(to)-403(prevent)-394.8(surgical)-401.4(site)-397.5(infec-)]TJ
0 -1.2519 TD
[(tions)-249.3(in)-252.6(acute)-247.9(care)-253.9(hospitals:)-248.5(2014)-246.4(update.)-246.4(Infect)]TJ
T*
[(Control)-331(Hosp)-331.4(Epidemiol)-328.8(2014;35:605ñ62)6(7.)]TJ
-1.4226 -1.9134 TD
[(82.)-310.6(Centers)-626.3(for)-627(Disease)-625.8(Control)-622.6(and)-629.3(Prevention.)]TJ
1.4226 -1.2448 TD
[(Surgical)-727.4(site)-724.7(infection)-719.9(\(SSI\))-721.8(event.)-727(Atlanta:)]TJ
0 -1.2519 TD
[(Centers)-626.3(for)-627(Disease)-625.8(Control)-622.6(and)-629.3(Prevention.)]TJ
T*
-.019 Tc
[(2)-19(0)14.3(13.)-476.7(https://www.cdc.gov/nhsn/p)-19(d)14.3(fs/)-19(p)14.1(scmanua)-19(l)12.9(/)]TJ
T*
-.0204 Tc
[(9ps)-5.3(cssicurrent.pdf)-208.9(\(las)-5.3(t)-201.8(a)-.2(c)-5.3(c)1.8(essed)-206.5(January)-204.4(13,)-207.8(2019\).)]TJ
-1.4226 -1.9134 TD
0 Tc
[(83.)-310.6(Waltz)-427.4(PK,)-421.2(Zuckerbraun)-425.7(BS.)-418(Surgical)-428.6(site)-418.8(infec-)]TJ
1.4226 -1.2448 TD
[(tions)-484(and)-487.1(associated)-485.6(operative)-483.8(characterist)10(ics.)]TJ
0 -1.2519 TD
[(Surg)-330.9(Infect)-331(2017;18:447ñ45)6(0.)]TJ
-1.4226 -1.9134 TD
[(84.)-310.6(Ce)22.3(nt)23.8(er)23.8(s)-283.6(f)0(o)23.8(r)-295.2(D)18.5(i)0(s)19.7(e)0(a)26.2(s)15.1(e)-292.8(C)16.3(on)26.2(tr)21.4(ol)-281(an)26.2(d)-285.7(P)0(r)23.8(e)0(v)21.1(e)0(n)26.2(t)0(i)22.4(o)0(n)26.2(.)-287(Bl)20.9(as)28.2(t)]TJ
1.4226 -1.2519 TD
[(in)24.8(ju)17.7(r)17.8(i)0(e)24.8(s)0(.)-535.1(F)0(a)21.1(c)15.1(t)-551.2(s)15.1(he)26.2(et)23.8(s)-546.8(f)0(o)23.8(r)-551.2(pr)23.8(of)23.8(es)28.2(s)15.1(i)0(o)24.8(n)0(a)19.1(l)0(s)26.8(.)-550.2(ht)23.8(t)17.8(p)0(s)21.1(:)0(/)24.6(/)]TJ
0 -1.2448 TD
.0167 Tc
[(cdn.ym)7(a)-5.8(w)7(s.com/www.amtrauma.org/resource/)]TJ
0 -1.2519 TD
.0157 Tc
[(res)-4.8(m)-1.2(gr/TIIDE/Bl)-8.1(ast_In)-6.8(juryExtremities)-4.8(.)-1(pdf)-720.5(\()-8.1(l)-1(ast)]TJ
T*
.0149 Tc
[(a)-7.6(cce)-7.6(sse)-7.6(d)-334.8(January)-339.9(3)-.5(,)-336.2(2019\).)]TJ
-1.4226 -1.9134 TD
0 Tc
[(85.)-310.6(G)18.5(u)20.2(er)30.9(m)18.7(a)20.2(z)20(i)-272.8(A)18.5(,)-272.8(H)18.5(a)20.2(y)15.1(a)20.2(s)22.2(h)0(i)-259.7(D)18.5(,)-272.8(S)23.4(m)18.7(i)18.8(t)17.8(h)-271.4(S)16.3(E)20.2(,)-272.8(P)20.2(al)31.9(m)18.7(e)20.2(r)-273.8(W)22.1(,)-272.8(K)16.3(a)20.2(t)17.8(z)]TJ
1.4226 -1.2448 TD
[(JN)36.7(.)-144.8(I)18.8(m)18.7(a)0(g)33.3(i)18.8(n)20.2(g)-143.4(of)-125.6(bl)31.9(a)20.2(s)15.1(t)-138.7(i)18.8(nj)31.9(u)20.2(r)17.8(i)18.8(e)20.2(s)-148.5(t)17.8(o)-143.4(t)17.8(h)20.2(e)-143.4(l)18.8(o)20.2(w)18.7(e)0(r)-125.6(e)0(x)35.3(t)17.8(r)17.8(e)20.2(m)18.7(i)18.8(t)17.8(i)18.8(es)]TJ
0 -1.2519 TD
-.0191 Tc
[(s)-4(u)1.1(s)-4(t)5.8(a)-19.1(i)12.8(ned)-176.7(in)-176.7(the)-176.7(B)4.3(o)-19.1(s)16.2(ton)-176.7(m)-.4(arath)-19.1(o)14.2(n)-176.7(bombin)-19.1(g)14.2(.)-178.1(A)6.5(rth)-19.1(r)18.9(i)-19.1(t)17.5(i)-19.1(s)]TJ
T*
-.0197 Tc
[(Care)-262.7(Re)-19.7(s)-247.6(\()-.9(Hobo)-19.7(k)15.6(e).5(n)-19.7(\))-243.8(20)-19.7(1)13.6(3).5(;6)-19.7(5)13.6(:)-.9(18)-19.7(9)13.6(3).5(ñ1898)-19.7(.)]TJ
20.5783 84.2764 TD
0 Tc
[(86.)-310.6(Church)-274.2(D,)-275.6(Elsayed)-268.4(S,)-277.8(Reid)-273(O,)-275.6(Winston)-271(B,)-270.7(Lindsay)]TJ
1.4226 -1.2519 TD
[(R.)-512.6(Burn)-508.7(wound)-505.1(infections.)-508.1(Clin)-509.1(Microbiol)-512.9(Rev)]TJ
T*
[(2006;19:403ñ4)7.1(34.)]TJ
-1.4226 -1.8708 TD
[(87.)-310.6(Barki)-438.1(KG,)-430(Das)-437(A,)-439.2(Dixith)-431.3(S,)-441.4(et)-431.4(al.)-440(Electric)-432.2(eld)]TJ
1.4226 -1.2519 TD
[(based)-345.1(dressing)-350.2(disrupts)-345.5(mixed-speci)8.3(es)-348.8(bacterial)]TJ
T*
[(biolm)-373.8(infection)-364.2(and)-373.3(restores)-367.9(functional)-372.5(wound)]TJ
0 -1.2448 TD
[(healing.)-902.3(Ann)-901.3(Surg)-907.1(2017.)-903.3(DOI:10.109)9.6(7/SLA)]TJ
0 -1.2519 TD
[(.000000000000)5.3(2504)]TJ
-1.4226 -1.8779 TD
[(88.)-310.6(Chaney)-314.5(SB,)-311.3(Ganesh)-312.3(K,)-320.5(Mathew)10.3(-Steiner)-313.2(S,)-320.5(et)-310.5(al.)]TJ
1.4226 -1.2448 TD
[(Histopatholog)6.5(ical)-930(compariso)9.9(ns)-924.9(of)]TJ
/F15 1 Tf
14.3828 0 TD
(Staphylo-)Tj
-14.3828 -1.2519 TD
[(coccus)-646(aureus)]TJ
/F8 1 Tf
6.1813 0 TD
(and)Tj
/F15 1 Tf
1.9846 0 TD
[(Pseudomonas)-643(aeruginosa)]TJ
/F8 1 Tf
-8.1659 -1.2519 TD
[(experimental)-696.4(infected)-703.2(porcine)-699.6(burn)-696.9(wounds.)]TJ
T*
[(Wound)-331(Repair)-327.4(Regen)-336.8(2017;25:5)8.4(41ñ549.)]TJ
-1.4226 -1.8708 TD
[(89.)-310.6(Roy)-503.2(S,)-498.4(Elgharably)-498.1(H,)-503.3(Sinha)-494.6(M,)-501.9(et)-502.6(al.)-497(Mixed-)]TJ
1.4226 -1.2519 TD
[(species)-387.3(biolm)-388(compromises)-390.2(wound)-384.2(healing)-394.8(by)]TJ
T*
[(disrupting)-457.8(epidermal)-457.9(barrier)-457.5(function.)-456.7(J)-456.4(Pathol)]TJ
0 -1.2448 TD
-.0003 Tc
(2014;233:331ñ343.)Tj
-1.4226 -1.8779 TD
0 Tc
[(90.)-310.6(Roy)-410.7(S,)-413(Santra)-406.7(S,)-413(Das)-415.6(A,)-410.8(et)-410.1(al.)]TJ
/F15 1 Tf
13.6501 0 TD
[(Staphylococcu)7(s)]TJ
-12.2275 -1.2519 TD
(aureus)Tj
/F8 1 Tf
3.0871 0 TD
[(biolm)-637(infection)-634.5(compromis)8.4(es)-640.4(wound)]TJ
-3.0871 -1.2448 TD
[(healing)-501.5(by)-498.2(causing)-496.1(deciencies)-492.8(in)-501.6(granulation)]TJ
0 -1.2519 TD
[(tissue)-419.1(collagen.)-410.6(Ann)-417.6(Surg)-416.3(2019.)-412.5(DOI:)-416.1(10.1097/)]TJ
T*
[(SLA.000000000)8.8(0003053.)]TJ
-1.4226 -1.8779 TD
[(91.)-310.6(Hawn)-406.1(MT,)-403.4(Vick)-404.1(CC,)-403.8(Richman)-403.9(J,)-402(et)-410.1(al.)-404.5(Surgical)]TJ
1.4226 -1.2448 TD
[(site)-397.5(infection)-392.7(prevention:)-387.8(time)-393.9(to)-395.9(move)-388.1(beyond)]TJ
0 -1.2519 TD
[(the)-574.8(surgical)-572.1(care)-573.9(improve)10.2(ment)-577.5(program.)-564.4(Ann)]TJ
T*
-.0002 Tc
[(Surg)-331.1(2011;254:494ñ501.)]TJ
-1.4226 -1.8708 TD
0 Tc
[(92.)-310.6(Young)-265.6(PY,)-271.9(Khadaroo)-264.3(RG.)-266.4(Surgical)-265(site)-262.3(infections.)]TJ
1.4226 -1.2519 TD
[(Surg)-330.9(Clin)-331.3(N)-332(A)0(m)-332.7(2014;94:124)6.2(5ñ1264.)]TJ
-1.4226 -1.8779 TD
[(93.)-310.6(Anderson)-317(DJ.)-319.4(Surgical)-314.8(site)-312.1(infections.)-316.1(Infect)-316.8(Dis)]TJ
1.4226 -1.2448 TD
[(Clin)-331.3(N)-332(A)0(m)-332.7(2011;25:135)6.2(ñ153.)]TJ
-1.4226 -1.8779 TD
[(94.)-310.6(Garner)-233.8(BH,)-230.9(Anderson)-231.6(DJ.)-227(Surgical)-236.6(site)-226.8(infections:)]TJ
1.4226 -1.2519 TD
[(an)-407.7(update.)-395.8(Infect)-402.2(Dis)-402.8(Clin)-402.4(N)-403.2(A)0(m)-403.8(2016;30:909)6.2(ñ)]TJ
0 -1.2448 TD
(929.)Tj
-1.4226 -1.8779 TD
[(95.)-310.6(Co)22.3(op)26.2(er)-303.4(R)16.3(A)0(.)-304.1(S)16.3(ur)23.8(gi)24.8(ca)21.1(l)-315.5(s)15.1(it)22.4(e)-314.1(i)0(n)24.8(f)0(e)23.8(c)0(t)25.8(i)0(o)24.8(n)0(s)21.1(:)-315.5(ep)26.2(id)24.8(em)24.7(io)24.8(lo)24.8(gy)]TJ
1.4226 -1.2519 TD
[(an)26.2(d)-321.2(m)18.7(ic)19.7(r)17.8(o)0(b)19.1(i)0(o)24.8(l)0(o)24.8(g)0(i)24.8(c)15.1(al)-309.5(as)28.2(pe)26.2(ct)25.8(s)-319.2(i)0(n)-302.4(t)0(r)28.5(a)0(u)19.1(m)18.7(a)-321.2(a)0(n)26.2(d)-314.1(or)23.8(th)23.8(o-)]TJ
0 -1.2448 TD
[(pa)26.2(ed)19.1(ic)-229.2(s)15.1(u)0(r)23.8(g)0(e)26.2(r)0(y)25.8(.)-244.4(In)24.8(t)-245.4(W)15(ou)19.1(nd)-229.9(J)-243(2)0(0)26.2(1)0(3)26.2(;)0(1)24.8(0)-243(Su)22.3(pp)26.2(l)-244.4(1)0(:)24.8(3)0(ñ)22.3(8)0(.)]TJ
-1.4226 -1.8779 TD
[(96.)-310.6(Gottrup)-528.9(F.)-535.1(Trends)-533.5(in)-537.1(surgical)-536.5(wound)-526.4(healing.)]TJ
1.4226 -1.2519 TD
[(Scand)-334.7(J)-328.3(Surg)-330.9(2008;97:220ñ2)7.1(25.)]TJ
-1.4226 -1.8708 TD
[(97.)-310.6(Findley)-234.2(K,)-235.2(Grice)-229.6(EA.)-234.1(The)-231(skin)-229.5(microbiome:)-233.4(a)-228.8(focus)]TJ
1.4226 -1.2519 TD
[(on)-500.2(pathogens)-494.2(and)-494.2(their)-495.5(association)-495.2(with)-493.5(skin)]TJ
T*
-.0001 Tc
[(disease.)-335.1(PLoS)-326.6(Pathog)-329.4(2014;10:e1004436.)]TJ
-1.4226 -1.8707 TD
0 Tc
[(98.)-310.6(Grice)-542.6(EA.)-547.1(The)-551.1(skin)-542.5(microbiome:)-546.3(potential)-544.1(for)]TJ
1.4226 -1.2519 TD
[(novel)-360.7(diagnostic)-353.8(and)-359(therapeutic)-360.4(approaches)-351.1(to)]TJ
T*
[(cutaneous)-670.1(disease.)-669.3(Semin)-674(Cutan)-673.5(Med)-665.2(Surg)]TJ
T*
[(2014;33:98ñ10)7.1(3.)]TJ
-1.4226 -1.8707 TD
[(99.)-310.6(Grice)-286.5(EA,)-283.9(Segre)-282.2(JA.)-283.9(The)-280.8(human)-284.6(microbiome:)-276(our)]TJ
1.4226 -1.2519 TD
[(second)-422.4(genome.)-423.4(Annu)-418.8(Rev)-424.9(Genom)-421.4(Hum)-419.2(Genet)]TJ
T*
[(2012;13:151ñ1)7.1(70.)]TJ
-1.9205 -1.8708 TD
[(100.)-311.8(Grice)-407.4(EA,)-419(Segre)-410.3(JA.)-411.9(The)-408.8(skin)-414.4(microbiome.)-411.2(Nat)]TJ
1.8708 -1.2519 TD
[(Rev)-332.5(Microbiol)-328(2011;9:244)7.3(ñ253.)]TJ
-1.8708 -1.8779 TD
[(101.)-311.8(M)19.9(i)18.8(s)22.2(i)0(c)-328.8(A)18.5(M)19.9(,)-336.8(G)18.5(a)0(r)]TJ
7.2056 0 TD
-.02 Tc
[(dner)-365(SE)-20(,)-350.8(G)5.6(ric)-4.9(e)-362.6(EA.)-363.9(The)-362.6(wou)-20(n)13.3(d)-362.6(m)-1.3(i-)]TJ
-5.3349 -1.2448 TD
-.0196 Tc
[(cro)-19.6(b)13.7(iome:)-498.7(m)-.9(o)-19.6(d)13.7(ern)-497.3(a).6(p)-19.6(p)13.7(roac)-4.5(hes)-502.4(to)-497.3(exa)-19.6(m)12.2(ining)-497.3(t)-1.8(h)-19.6(e)]TJ
0 -1.2519 TD
-.0193 Tc
[(role)-319.2(of)-314.5(mic)-4.2(r)-1.5(oorga)-19.3(n)14(i)-.5(s)-4.2(m)-.6(s)-310(i)-19.3(n)-300.4(i)-.5(mp)-19.3(a)14(i)-.5(red)-319.2(c)2.9(h)-19.3(r)18.7(o)-19.3(n)14(ic)-317.2(woun)-19.3(d)]TJ
T*
-.0195 Tc
[(hea)-19.5(l)12.4(i)-.7(ng.)-335(Ad)-19.5(v)-318.5(W)2.6(ou)-19.5(n)13.8(d)-333.6(Care)-333.6(201)-19.5(4)13.8(;)-.7(3:5)-19.5(0)13.8(2ñ510)-19.5(.)]TJ
-1.8708 -1.8708 TD
0 Tc
[(102.)-311.8(Otter)-320.4(JA,)-319.4(Yezli)-318.4(S,)-320.5(French)-318.1(GL.)-324.5(The)-316.4(role)-321.3(played)-326.2(by)]TJ
1.8708 -1.2519 TD
[(contamina)7.9(ted)-539.3(surfaces)-541.3(in)-537.1(the)-539.3(transmission)-535.8(of)]TJ
T*
[(nosocomial)-367.2(pathogens.)-375.8(Infect)-366.6(Control)-373.6(Hosp)-374.1(Epi-)]TJ
T*
[(demiol)-331.1(2011;32:687)6.1(ñ699.)]TJ
-1.8708 -1.8708 TD
[(103.)-311.8(Suleyman)-497.5(G,)-503.3(Alangade)9.2(n)-506.2(G)0(,)-503.3(Bardossy)-493(AC.)-501.2(The)]TJ
1.8708 -1.2519 TD
[(role)-712.5(of)-716(environme)7.9(ntal)-719.6(contamin)9(ation)-713.6(in)-715(the)]TJ
7.9702 0 0 7.9702 407.4518 713.8203 Tm
[(transmiss)9.5(ion)-829.9(of)-829.8(nosocomial)-822.4(pathogens)-828.6(and)]TJ
T*
[(healthcare-)9.5(associated)-343.3(infections.)-344.5(Curr)-340.4(Infect)-345.3(Dis)]TJ
T*
[(Rep)-327.4(2018;20:12.)]TJ
-1.8708 -1.8708 TD
[(104.)-311.8(Weber)-418.7(DJ,)-419(Rutala)-419.9(WA,)-424.3(Miller)-419.1(MB,)-421.5(Huslage)-421.5(K,)]TJ
1.8708 -1.2519 TD
[(Sickbert-B)11.9(ennett)-367.2(E.)-366.4(Role)-365.5(of)-367.4(hospital)-367.8(surfaces)-363.4(in)]TJ
T*
[(the)-766.9(transmission)-770.6(of)-765.8(emerging)-768.3(health)-771.7(care-)]TJ
0 -1.2448 TD
[(associated)-770.1(pathogens:)-774.2(norovirus,)-768.8(Clostridium)]TJ
0 -1.2519 TD
[(difcile,)-321.9(and)-323.5(Acinetobacter)-319.7(species.)-325.8(Am)-325.5(J)-321.2(Infect)]TJ
T*
[(Control)-331(2010;38\(5)-325.9(Suppl)-331(1\):S25ñS33.)]TJ
-1.8708 -1.8708 TD
[(105.)-311.8(Wille)-363.6(I,)-360.7(Mayr)-360.9(A,)-368.1(Kreidl)-364.4(P,)-359.3(et)-367.4(al.)-368.9(Cross-sec)10.6(tional)]TJ
1.8708 -1.2519 TD
[(point)-493.1(prevalence)-487.6(survey)-493.9(to)-495.5(study)-494.8(the)-496.6(environ-)]TJ
T*
[(mental)-389.1(contamination)-391.6(of)-395.9(nosocomial)-388.5(pathogens)]TJ
T*
[(in)-295.3(intensive)-288.7(care)-296.5(units)-291.9(under)-292.6(real-life)-291.8(conditions.)]TJ
0 -1.2448 TD
[(J)-328.3(Hosp)-331.4(Infect)-331(2018;98:90ñ95.)]TJ
-1.8708 -1.8779 TD
[(106.)-311.8(Yezli)-361(S,)-363.2(Barbut)-356.9(F,)-364.4(Otter)-363.1(JA.)-362.1(Surface)-356(contamina-)]TJ
1.8708 -1.2519 TD
[(tion)-228.8(in)-238.4(operating)-229.7(rooms:)-230.5(a)-235.9(risk)-231.9(for)-228.7(transmission)-230(of)]TJ
0 -1.2448 TD
[(pathogens?)-329.8(Surg)-330.9(Infect)-331(2014;15:6)8.4(94ñ699.)]TJ
-1.8708 -1.8779 TD
[(107.)-311.8(Norbury)-448.3(W,)-449.9(Herndon)-453(DN,)-451.2(Tanksley)-452.5(J,)-451.8(Jeschke)]TJ
1.8708 -1.2519 TD
[(MG,)-334(Finnerty)-338.4(CC.)-339.8(Infection)-342.9(in)-338(Burns.)-339.7(Surg)-338(Infect)]TJ
0 -1.2448 TD
[(2016;17:25)7.3(0ñ255.)]TJ
-1.8708 -1.8779 TD
(108.)Tj
1.8708 0 TD
-.0205 Tc
[(Thom)5.3(as)-417.9(JG)5.1(,)-414.2(M)-.6(antlagh)-412.9(H.)-414.2(Chronic)-417.9(w)5.3(ounds:)-414.2(i)-1.7(nfec-)]TJ
0 -1.2519 TD
[(tious)-332.6(diseases)-332.6(that)-329.9(w)5.3(onít)-329.9(g)-.3(o)-334.6(a)-.3(way.)-328.9(Wounds,)-336(gau-)]TJ
T*
-.0199 Tc
[(zes)-367.6(and)-376.7(bio)7.4(lms)-374.7(c)2.3(omb)7.4(i)-1.1(ne)-376.7(for)-372(a).3(n)-376.7(ugly)-367.6(tri)6(ad.)-378.1(2012.)]TJ
0 -1.2448 TD
.0089 Tc
[(http://hea)-6.5(lthc)8.9(a)-5.6(r)-1.7(e-ex)-4.4(ec)-4.4(utiv)8.9(e)-5.6(-)-1.7(ins)-4.4(i)-.7(ght.ad)-6.5(v)8.9(a)-5.6(n).7(c)-4.4(e).7(web)]TJ
0 -1.2519 TD
-.0202 Tc
[(.com)5.6(/F)-5.1(eatures/A)5.4(rticles/C)]TJ
8.6069 0 TD
-.0206 Tc
[(hroni)5.3(c)-5.5(-)4.3(Wounds-Infec)-5.5(tious-)]TJ
-8.6069 -1.2519 TD
.0284 Tc
[(D)4.2(i)-2.6(se)5.9(ases-Tha)5.9(t-Wo)5.9(nt-G)4.2(o-Aw)4.4(ay-2.)4.6(a)-1.2(spx#)5.9(Anch)5.9(or)]TJ
0 -1.2448 TD
0 Tc
[(Comment)-323.1(\(last)-336(accessed)-328.2(January)-328.4(13,)-332(2019\).)]TJ
-1.8708 -1.8779 TD
[(109.)-311.8(Rahim)-254.3(K,)-256.5(Saleha)-253.9(S,)-256.5(Zhu)-259.5(X,)-256.5(Huo)-254(L,)-257.7(Basit)-253.2(A,)-254.3(Franco)]TJ
1.8708 -1.2519 TD
[(OL.)-850.9(Bacterial)-851.8(contribution)-853.7(in)-857.2(chronicity)-852.1(of)]TJ
0 -1.2448 TD
[(wounds.)-328.9(Microb)-329(Ecol)-331.1(2017;73:710ñ7)7.1(21.)]TJ
-1.8708 -1.8779 TD
-.0197 Tc
[(110.)-306.7(Cooper)-485.6(RA)5.9(,)-491.7(B)3.7(jarnsholt)-492.7(T).5(,)-491.7(A)5.9(lhede)-490.3(M.)-491.7(Biolm)6.1(s)-495.4(i)6.2(n)]TJ
1.7854 -1.2519 TD
-.0203 Tc
[(wounds:)-300.2(a)-298.8(review)-293.2(of)-301.2(pres)-5.2(ent)-294.1(knowledge.)-300.2(J)-298.8(W)1.8(oun)7(d)]TJ
T*
[(Care)-263.3(2014;23:)5.6(570,)-264.7(572ñ574,)-257.5(576ñ580)-256.2(passim.)]TJ
-1.7854 -1.8708 TD
0 Tc
[(111.)-311.8(Omar)-401.3(A,)-396.6(Wright)-402.3(JB,)-407(Schultz)-397.9(G,)-403.7(Burrell)-403.5(R,)-398.8(Nad-)]TJ
1.8708 -1.2519 TD
[(worny)-285(P.)-288.2(Microbial)-278.2(biolms)-287.6(and)-287.9(chronic)-285.1(wounds.)]TJ
T*
[(Microorgani)10.2(sms)-335.2(2017;5:pii:)-332.3(E9.)]TJ
-1.8708 -1.8708 TD
[(112.)-311.8(Ganesh)-291(K,)-292.1(Sinha)-288.3(M,)-295.6(Mathew-Ste)11.3(iner)-292.8(SS,)-297.1(Das)-287.6(A,)]TJ
1.8708 -1.2519 TD
[(Roy)-446.3(S,)-455.7(Sen)-448.3(CK.)-453.6(Chronic)-447.5(wound)-448.2(biolm)-452.1(model.)]TJ
T*
[(Adv)-330.3(Wound)-331(Care)-330.9(2015;4:38)8.4(2ñ388.)]TJ
-1.8708 -1.8708 TD
[(113.)-311.8(Brown)-611(KL,)-618.4(Phillips)-617.2(TJ.)-616.5(Nutrition)-614.2(and)-622.2(wound)]TJ
1.8708 -1.2519 TD
[(healing.)-333.3(Clin)-331.3(Dermatol)-324.3(2010;28:432ñ4)7.1(39.)]TJ
-1.8708 -1.8779 TD
[(114.)-311.8(D)18.5(e)20.2(m)18.7(l)18.8(i)18.8(n)20.2(g)-314.1(R)16.3(H)18.5(.)-308.4(N)16.5(u)20.2(t)17.8(r)17.8(i)18.8(t)17.8(i)18.8(o)20.2(n)0(,)]TJ
10.2145 0 TD
-.0197 Tc
[(anab)-19.7(o)13.6(lis)-4.6(m,)-328.1(a)-19.7(n)13.6(d)-333.8(t)-1.9(he)-333.8(wound)]TJ
-8.3437 -1.2448 TD
-.0199 Tc
[(hea)-19.9(l)12(i)-1.1(ng)-177.5(proc)-4.8(ess)-4.8(:)-171.8(a)-19.9(n)-157.3(ov)-4.8(erv)-4.8(i)-1.1(ew.)-171.8(E)-19.9(p)13.4(l)-1.1(as)-4.8(ty)-168.4(2)-19.9(0)13.4(09;)-19.9(9)12(:)-1.1(e9)-19.9(ñ)16.6(e).3(9)-19.9(.)]TJ
-1.8708 -1.8779 TD
0 Tc
[(115.)-311.8(A)18.5(r)24.9(no)33.3(l)18.8(d)-299.9(M)19.9(,)-294.2(B)23.4(a)0(r)30.9(b)20.2(u)20.2(l)-294.2(A)18.5(.)-294.2(N)16.5(u)20.2(t)17.8(r)17.8(i)18.8(t)17.8(i)18.8(on)-279.7(a)20.2(n)0(d)-279.7(w)18.7(o)20.2(u)20.2(n)0(d)-279.7(h)20.2(ea)33.3(l)18.8(i)18.8(n)20.2(g.)]TJ
1.8708 -1.2519 TD
-.0191 Tc
[(Plast)-335.6(R)4.3(econstr)-335.6(Surg)-333.2(2)-19.1(0)14.2(06;)-19.1(1)12.8(17\()-19.1(7)-321.5(S)4.3(up)-19.1(p)14.2(l\):4)-19.1(2)-149.4(s)-4(-58)-169.6(s)3.1(.)]TJ
-1.8708 -1.8707 TD
0 Tc
[(116.)-311.8(Molnar)-501.7(JA,)-504.4(Vlad)-507.7(LG,)-509.5(Gumus)-497.7(T.)-508.7(Nutrition)-507.5(and)]TJ
1.8708 -1.2519 TD
[(chronic)-598(wounds:)-599.2(improving)-598.1(clinical)-608(outcomes.)]TJ
T*
[(Plast)-313.3(Reconstr)-305.3(Surg)-316.7(2016;138\(3)-312.8(Suppl\):71Sñ81S)7.1(.)]TJ
-1.8708 -1.8708 TD
[(117.)-311.8(Molnar)-288.3(JA,)-291(Underdown)-293.2(MJ,)-289.6(Clark)-295.8(WA.)-289.1(Nutrition)]TJ
1.8708 -1.2519 TD
[(and)-423.1(chronic)-420.2(wounds.)-414.2(Adv)-422.7(Wound)-416.3(Care)-423.4(2014;3:)]TJ
T*
(663ñ681.)Tj
-1.8708 -1.8708 TD
[(118.)-311.8(Patel)-400.7(GK.)-401.6(The)-401.7(role)-406.6(of)-403(nutrition)-397.1(in)-409.1(the)-397(manage-)]TJ
1.8708 -1.2519 TD
[(ment)-349.9(of)-346.1(lower)-352.4(extremity)-350.5(wounds.)-343.1(Int)-355.7(J)-349.7(Low)-351.4(Ex-)]TJ
T*
[(trem)-330.9(Wounds)-330.1(2005;4:12)8.4(ñ22.)]TJ
-1.8708 -1.8708 TD
[(119.)-311.8(Brown)-354.9(J.)-352.2(The)-359(impact)-351.5(of)-360.3(stress)-354.1(on)-357.9(acute)-354.6(wound)]TJ
1.8708 -1.2519 TD
[(healing.)-603.6(Br)-606.1(J)-605.7(Commun)-604.1(Nurs)-606.1(2016;21\(Sup)9.4(12\):)]TJ
T*
(S16ñs22.)Tj
-1.8708 -1.8708 TD
[(120.)-311.8(House)-353.9(SL.)-355.2(Psycholog)8.7(ical)-360.9(distress)-350.6(and)-359(its)-353.7(impact)]TJ
1.8708 -1.2519 TD
[(on)-621.1(wound)-626(healing:)-624.9(an)-621.1(integrative)-625(review.)-617.2(J)]TJ
T*
[(Wound)-281.2(Ostomy)-278.6(Continence)-287.3(Nurs)-278.9(2015;42:38ñ41.)]TJ
/F12 1 Tf
9.9626 0 0 9.9626 270.3684 757.8707 Tm
[(EDITORI)-10.7(AL)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 540.0565 757.8707 Tm
(47)Tj
ET
41.839 753.959 508.082 .51025 re
f

endstream
endobj

86 0 obj
<</Subtype/Type1C/Length 1467/Filter/FlateDecode>>
stream
hﬁåTyLTGoŸy]©ÆB|éÈ<œ"ıG#*ràä≤nÂ(Ë≤ª¬"∞vE¡ä- ™(ÇÄ´-x†R)ÿF¥cl5Z£µÒ¯ñé6z•Mˇi^2ì˘Ê;~ﬂÔ}ø·9•Ç„yﬁyvX‹†˜ÇYë>ﬁ¡ﬁ3}˙≠#Ïò∑èËBß—uø¥ÙmEê=∂9ïè¥ŒúÇÁmµ¡ÊåŸîîlï‹ı„%œ©æS&∞u™ßd0'%Mé≈jL≥HÛ“ıf9√,Î¨F√$I
JMï¢˙£,Rî—bî≥òUõn 2 …dëtílL2±HŸhê¨≤Œ`L”…À%Û2iÅ)›lÕ…0N1≤As%]∫a≤YñL,ìeE¢≈d0Èdì—2È}p<˚85«yr;Õ‰∏Y
.D¡Ö)9çÀq.åN…	ú ÌÁU¸"˛(ˇ´"O—¨∏Æ¯ﬁaÜÉ’·ú“M9CY™Ï@
4äﬁRKÍ%p
ƒmM÷D!uáKáp~@†`»Âk0ˆ3”õ∆oâ¿4V8´¡Q∏tz-úI(≤ƒ,¡ÙmA¡ˆÛˆ&Ò˘û¸á‘SGœ≈‘I&y¡ñÇ˙˝˚°ÌÊ¨Ò*ﬂúòÑ)òä[ÔÙÓ$Û:2©%Fbp˛Ó
àd?H>ª:Ê¥iÀj^©ÓVùØøÖüThΩrâ^¬4q^ﬁú∞98,ªÂ‚6RÉaË⁄{e™h∫Uº"ln+o‹“t6ªÇX?jS4ˆˆ5z»§ChØ<Y˜V&Âí›Ëutf’2:€Õ;ª)‚>ærÆ¶ıR*®€Ì”·µ¯≤>ˆ§ûñúH≤åŸ~≈®®Sf:∏ÂŸQK"Ñ‹¨?<©=ÿElù’]ï5™√’á™„.€í˝P3>ÁÎ˜B‰Qé{´ü á•S)≠êd{"∆Zh|ﬁ(^Jvn<Pq
\˚ÆB≠..AG¨â’ÒòNN¶S=VÍ([Èá€ök[èë≤§∂k†Pè∆:p¢31EÅ!t\*…§Cùò“k∫áü›8ÍdÅ07Ô√∏@<°‰a˜v≤Â™hAY€ÿ˘?ﬁBïÜ¥›û$^8©i%©‘Ω¿j5®,´)1òÚ5/^Ï!7vÏÉ°œ1(e±®ùX_ç«F˚e≠%≤∂∏X¶T,Õ*ÍcqÎô™ÊCåIÍ±|˝: kí^⁄¡ÿä^ΩŸú1åiΩ5‰Å›oS]˘ﬁ V∑H61É\:°™Ωz¯Óﬁ∂(2ü“ó®]Ë;∫f+Hù∞6!Mg$EB4¢ÅN|≥©%ÈÚ ^ Œ“ÎRK˚Üã;zPêê«LÏ[ˆ∑3<ÇÖpKºf;—”É€ 51ƒüæaE∫‡˙Øµ◊>›∂-ø4kb”cí…©B˝æ≈Xüöò¬PÿÆ"≠@π◊eÃSë–-˛?ÙïW˛€ñQ¿ÙMk 5¿#∂ÎoRG&ô`:ÃL¨îGl? é¯ô=C|Z‰€o¶ÆÊ_wÏ^v\jºÛ´!Nã‡TÛ¯¸o«E˙ÛV-πßƒÖu jüÖOJãQ\ıÅUá1àóáPà°mÄw®÷k≥bu‰„bƒûÑ’ˆRÒ/Ãå™™ªùßÔ∫U^F·ëiq…¨'&∏âM0ÉÊõÍ¡Yu‚”£Õ¯Î
SËG§M∏π3ßÎ]Ï=+eR6I¢”!ˇ†ô∫™4kíSbˇı_vm'·Çdi\<~ÙUÀèª	´˘Å=^Ïˇa˘;ìo„]ªKJ™»÷3®(?Øx%é€∞£”F∫‡&˙Y®hEcÖpôóπb4ö&¨çc∫gÄ©%ØKòÜ}Í^⁄ »∑#>Äˆ°©´*ü„«ˆ4gc∫FÉŒ˝#§nÔ¶Qbõ }}°˝#£ÌÖäÑdªö/úeΩ3πe”Ûõ  1Ÿ¡™

endstream
endobj

87 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCGAN+AdvP43C3B4/FontFile3 86 0 R/Flags 32/Descent -194/FontBBox[-166 -239 1062 770]/Ascent 722/CapHeight 722/XHeight 505/ItalicAngle 0/CharSet(/space/S/t/a/p/h/y/l/o/hyphen/c/u/s/r/e/P/d/m/n/g/i)>>
endobj

88 0 obj
<</Type/Page/CropBox[0 0 612 792]/Annots[89 0 R 90 0 R 91 0 R 92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R 103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R 109 0 R 110 0 R 111 0 R]/Parent 139 0 R/Contents[208 0 R 113 0 R 209 0 R 210 0 R 211 0 R 212 0 R]/Rotate 0/MediaBox[0 0 612 792]/Thumb 136 0 R/Resources 112 0 R>>
endobj

89 0 obj
<</Type/Annot/Subtype/Link/Rect[76.932 412.951 219.061 420.888]/A<</URI(https://www.psmarketresearch.com/press-release/global-scar-treatment-market)/S/URI>>/Border[0 0 0]>>
endobj

90 0 obj
<</Type/Annot/Subtype/Link/Rect[76.932 402.973 161.688 410.967]/A<</URI(https://www.psmarketresearch.com/press-release/global-scar-treatment-market)/S/URI>>/Border[0 0 0]>>
endobj

91 0 obj
<</Type/Annot/Subtype/Link/Rect[373.096 677.423 394.753 685.417]/A<</URI(https://woundcarenurses.org)/S/URI>>/Border[0 0 0]>>
endobj

92 0 obj
<</Type/Annot/Subtype/Link/Rect[252.283 667.502 314.362 675.439]/A<</URI(https://woundcarenurses.org)/S/URI>>/Border[0 0 0]>>
endobj

93 0 obj
<</Type/Annot/Subtype/Link/Rect[335.905 633.09 394.753 641.083]/A<</URI(https://www.woundsource.com/blog/improving-outcomes-through-wound-care-staff-education)/S/URI>>/Border[0 0 0]>>
endobj

94 0 obj
<</Type/Annot/Subtype/Link/Rect[252.283 623.168 394.753 631.105]/A<</URI(https://www.woundsource.com/blog/improving-outcomes-through-wound-care-staff-education)/S/URI>>/Border[0 0 0]>>
endobj

95 0 obj
<</Type/Annot/Subtype/Link/Rect[252.283 613.19 332.674 621.184]/A<</URI(https://www.woundsource.com/blog/improving-outcomes-through-wound-care-staff-education)/S/URI>>/Border[0 0 0]>>
endobj

96 0 obj
<</Type/Annot/Subtype/Link/Rect[284.995 332.617 394.753 340.611]/A<</URI(http://www.sawc.net/spring/<!?A3B2 tlsb=0.007w?>content/emphasizing-fundamentals-and-patient-education-diabetic-foot-care)/S/URI>>/Border[0 0 0]>>
endobj

97 0 obj
<</Type/Annot/Subtype/Link/Rect[252.283 322.696 394.583 330.633]/A<</URI(http://www.sawc.net/spring/<!?A3B2 tlsb=0.007w?>content/emphasizing-fundamentals-and-patient-education-diabetic-foot-care)/S/URI>>/Border[0 0 0]>>
endobj

98 0 obj
<</Type/Annot/Subtype/Link/Rect[252.283 312.718 301.209 320.712]/A<</URI(http://www.sawc.net/spring/<!?A3B2 tlsb=0.007w?>content/emphasizing-fundamentals-and-patient-education-diabetic-foot-care)/S/URI>>/Border[0 0 0]>>
endobj

99 0 obj
<</Type/Annot/Subtype/Link/Rect[342.425 253.814 394.639 261.808]/A<</URI(https://www.aranzmedical.com/uncategorized/outcomes-delivered-patient-engagement-patients-healthcare-providers)/S/URI>>/Border[0 0 0]>>
endobj

100 0 obj
<</Type/Annot/Subtype/Link/Rect[251.66 243.893 394.583 251.83]/A<</URI(https://www.aranzmedical.com/uncategorized/outcomes-delivered-patient-engagement-patients-healthcare-providers)/S/URI>>/Border[0 0 0]>>
endobj

101 0 obj
<</Type/Annot/Subtype/Link/Rect[251.66 233.915 394.696 241.909]/A<</URI(https://www.aranzmedical.com/uncategorized/outcomes-delivered-patient-engagement-patients-healthcare-providers)/S/URI>>/Border[0 0 0]>>
endobj

102 0 obj
<</Type/Annot/Subtype/Link/Rect[532.516 701.858 570.104 709.852]/A<</URI(https://www.defensemedianetwork.com/stories/wound-care-and-healing)/S/URI>>/Border[0 0 0]>>
endobj

103 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 691.88 568.516 699.874]/A<</URI(https://www.defensemedianetwork.com/stories/wound-care-and-healing)/S/URI>>/Border[0 0 0]>>
endobj

104 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 681.959 461.82 689.896]/A<</URI(https://www.defensemedianetwork.com/stories/wound-care-and-healing)/S/URI>>/Border[0 0 0]>>
endobj

105 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 621.184 569.083 629.121]/A<</URI(https://www.gomedigap.com/blog/tricare-for-life-and-medicare)/S/URI>>/Border[0 0 0]>>
endobj

106 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 611.206 466.129 619.143]/A<</URI(https://www.gomedigap.com/blog/tricare-for-life-and-medicare)/S/URI>>/Border[0 0 0]>>
endobj

107 0 obj
<</Type/Annot/Subtype/Link/Rect[553.72 560.409 570.104 568.346]/A<</URI(https://www.research.va.gov/pubs/docs/va_factsheets/Diabetes.pdf)/S/URI>>/Border[0 0 0]>>
endobj

108 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 550.431 569.877 558.368]/A<</URI(https://www.research.va.gov/pubs/docs/va_factsheets/Diabetes.pdf)/S/URI>>/Border[0 0 0]>>
endobj

109 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 540.453 463.294 548.447]/A<</URI(https://www.research.va.gov/pubs/docs/va_factsheets/Diabetes.pdf)/S/URI>>/Border[0 0 0]>>
endobj

110 0 obj
<</Type/Annot/Subtype/Link/Rect[483.534 459.779 570.047 467.716]/A<</URI(https://mrmc.amedd.army.mil/index.cfm?pageid=medical_r_and_d.ccc.overview)/S/URI>>/Border[0 0 0]>>
endobj

111 0 obj
<</Type/Annot/Subtype/Link/Rect[427.635 449.801 569.027 457.795]/A<</URI(https://mrmc.amedd.army.mil/index.cfm?pageid=medical_r_and_d.ccc.overview)/S/URI>>/Border[0 0 0]>>
endobj

112 0 obj
<</Font<</F12 119 0 R/F2 147 0 R/F8 163 0 R/F9 167 0 R/F11 117 0 R>>/ProcSet[/PDF/Text]/ExtGState<</GS1 155 0 R>>>>
endobj

113 0 obj
<</Length 16482>>
stream
0 0 0 rg
/GS1 gs
412.724 370.375 157.379 .51025 re
f
412.724 225.921 157.379 .51024 re
f
412.724 225.921 .51022 144.964 re
f
569.65 225.921 .45349 144.964 re
f
BT
/F8 1 Tf
7.9702 0 0 7.9702 62.022 713.8203 Tm
0 Tc
0 Tw
[(121.)-311.8(Lucas)-753.6(VS.)-759.5(Psychologic)7.1(al)-764.7(stress)-752.4(and)-757.4(wound)]TJ
1.8708 -1.2519 TD
[(healing)-565.5(in)-558.5(humans:)-563.6(what)-556.1(we)-565.7(know.)-561.3(Wounds)]TJ
T*
[(2011;23:76ñ83)7.1(.)]TJ
-1.8708 -1.8708 TD
[(122.)-311.8(Vileikyte)-635.4(L.)-641.8(Stress)-637.4(and)-643.6(wound)-633.1(healing.)-639.1(Clin)]TJ
1.8708 -1.2519 TD
[(Dermatol)-331.4(2007;25:49)7.3(ñ55.)]TJ
-1.8708 -1.8779 TD
[(123.)-311.8(Godbout)-474.4(JP,)-474.2(Glaser)-472.6(R.)-477(Stress-induc)8.5(ed)-478.8(immune)]TJ
1.8708 -1.2448 TD
[(dysregulation:)-511.5(implicatio)9.8(ns)-512.4(for)-513.2(wound)-512.2(healing,)]TJ
0 -1.2519 TD
[(infectious)-406(disease)-403.6(and)-408.8(cancer.)-406(J)-406.6(Neuroimm)8.9(une)]TJ
T*
[(Pharmacol)-326.4(2006;1:421ñ427.)]TJ
-1.8708 -1.8708 TD
[(124.)-311.8(Glaser)-401.5(R,)-398.8(Kiecolt-Glaser)-398.6(JK.)-399.9(Stress-induced)-399.2(im-)]TJ
1.8708 -1.2519 TD
[(mune)-454.2(dysfunctio)9.9(n:)-458.9(implication)8.6(s)-454.3(for)-456.3(health.)-447(Nat)]TJ
T*
[(Rev)-332.5(Immunol)-326.7(2005;5:243ñ251)6(.)]TJ
-1.8708 -1.8708 TD
[(125.)-311.8(G)18.5(o)20.2(u)20.2(i)0(n)-281(J)20.2(P)20.2(,)-294.1(K)16.3(i)18.8(e)20.2(c)15.1(o)20.2(l)18.8(t)17.8(-)17.8(G)18.5(l)18.8(a)20.2(s)15.1(e)20.2(r)-295.2(J)20.2(K)16.3(,)-294.1(M)19.9(a)20.2(l)18.8(a)20.2(r)17.8(k)15.1(e)20.2(y)-290.7(W)15(B)23.4(,)-294.1(G)18.5(l)18.8(a)20.2(s)15.1(e)20.2(r)]TJ
1.8708 -1.2519 TD
-.0201 Tc
[(R.)-449.4(T)-20.1(h)13.2(e)-455.1(i)-1.3(nu)-20.1(e)13.2(n).1(c)-5(e)-448(o)-20.1(f)-437.3(an)-20.1(g)13.2(e).1(r)-457.5(e).1(xp)-20.1(r)10.8(e).1(ss)-5(ion)-455.1(o).1(n)-455.1(w)-1.4(ou)-20.1(n)13.2(d)]TJ
T*
-.0197 Tc
[(he)-19.7(a)13.6(ling)-19.7(.)-322.1(Brain)-340.9(B)3.7(eh)-19.7(a)13.6(v)-331.8(Immu)-19.7(n)-320.7(2008)-19.7(;)12.2(22:6)-19.7(9)13.6(9ñ708)-19.7(.)]TJ
-1.8708 -1.8708 TD
0 Tc
[(126.)-311.8(Kiecolt-Glaser)-370.1(JK,)-371.4(Loving)-374(TJ,)-374.6(Stowell)-374.1(JR,)-371.4(et)-381.7(al.)]TJ
1.8708 -1.2519 TD
[(Hostile)-332.8(marital)-329.9(interaction)8.1(s,)-335.9(proinammat)6.8(ory)-331(cy-)]TJ
T*
[(tokine)-300.2(production,)-295.4(and)-302.1(wound)-298.8(healing.)-304.8(Arch)-298.2(Gen)]TJ
T*
[(Psychiatry)-329.5(2005;62:137)6.2(7ñ1384.)]TJ
-1.8708 -1.8708 TD
[(127.)-311.8(Wadman)-305.2(M.)-309.8(Scar)-307.6(prevention:)-309.6(the)-304.5(healing)-309.4(touch.)]TJ
1.8708 -1.2519 TD
-.0002 Tc
[(Nature)-328.5(2005;436:1079ñ1080.)]TJ
-1.8708 -1.8779 TD
0 Tc
[(128.)-311.8(Bisson)-292.6(JI,)-297.8(Shepherd)-299.9(JP,)-296.4(Dhutia)-296.8(M.)-295.6(Psycholog)8.7(ical)]TJ
1.8708 -1.2448 TD
[(sequelae)-463.6(of)-467(facial)-465.2(trauma.)-463.7(J)-463.5(Trauma)-465.9(1997;43:)]TJ
0 -1.2519 TD
(496ñ500.)Tj
-1.8708 -1.8779 TD
[(129.)-311.8(Prescient)-368(Strategic)-362.1(Intelligence.)-370.5(Scar)-364.5(Treatment)]TJ
1.8708 -1.2448 TD
[(Market)-458(to)-467(Reach)-462.8($34.9)-462.3(billion)-461.5(by)-469.7(2023.)-462.3(2018.)]TJ
0 -1.2519 TD
-.0187 Tc
[(http)-18.7(s)16.6(:).1(/)-18.7(/)14.2(www.psmarketresea)-18.7(r)12.2(ch)-18.7(.)13.2(c)3.5(o)-18.7(m)13.1(/pre)-18.7(s)16.6(s)-3.6(-rele)-18.7(a)14.6(s)3.5(e)-18.7(/)]TJ
T*
0 Tc
[(global-scar-tre)7.9(atment-market)-1180(\(last)-1182.5(accessed)]TJ
0 -1.2448 TD
[(January)-328.4(3,)-338(2019\).)]TJ
-1.8708 -1.8779 TD
[(130.)-311.8(Ennis)-424.7(WJ.)-422.6(Wound)-416.3(care)-424.6(specialization:)-420.7(the)-425.5(cur-)]TJ
1.8708 -1.2519 TD
[(rent)-258.3(status)-249.4(and)-259.5(future)-255.8(plans)-254(to)-260.7(move)-253(wound)-256.1(care)]TJ
T*
[(into)-442.2(the)-446.8(medical)-436.9(community.)-442.2(Adv)-437(Wound)-444.8(Care)]TJ
0 -1.2448 TD
[(2012;1:184ñ18)7.1(8.)]TJ
-1.8708 -1.8779 TD
[(131.)-311.8(Yim)-294.7(E,)-302.4(Sinha)-295.5(V,)-299.2(Diaz)-299.4(SI,)-294.6(Kirsner)-293.4(RS,)-297.1(Salgado)-297.7(CJ.)]TJ
1.8708 -1.2519 TD
[(Wound)-395(healing)-401.9(in)-402(US)-392(medical)-401.4(school)-395.3(curricula.)]TJ
0 -1.2448 TD
-.0002 Tc
[(Wound)-331.2(Repair)-327.6(Regen)-329.8(2014;22:467ñ472.)]TJ
-1.8708 -1.8779 TD
0 Tc
[(132.)-311.8(Patel)-272.6(NP,)-264.6(Granick)-265.4(MS,)-272.2(Kanakaris)-262.8(NK,)-268.5(Giannoudis)]TJ
1.8708 -1.2519 TD
[(PV,)-343(Werdin)-335.9(F,)-343.1(Rennekam)8.9(pff)-342.5(H-O.)-338.9(Comparison)-331.4(of)]TJ
0 -1.2448 TD
[(wound)-633.1(education)-637.9(in)-636.7(medical)-636.1(schools)-629.2(in)-643.8(the)]TJ
0 -1.2519 TD
[(United)-474.6(States,)-471.2(United)-474.6(Kingdom,)-472.5(and)-472.9(Germany.)]TJ
T*
[(Eplasty)-327.7(2008;8:e8ñe8.)]TJ
-1.8708 -1.8707 TD
[(133.)-311.8(Gottrup)-408(F.)-407.1(Education)-410.3(in)-409.1(wound)-412.6(managem)10.4(ent)-411.2(in)]TJ
1.8708 -1.2519 TD
[(Europe)-606.7(with)-607.3(a)-605.7(special)-611.2(focus)-601.5(on)-614(the)-603.3(Danish)]TJ
T*
[(Model.)-329.9(Adv)-330.3(Wound)-331(Care)-330.9(2012;1:133ñ13)7.1(7.)]TJ
20.1302 61.2512 TD
[(134.)-311.8(Corbett)-502.7(LQ.)-502.4(Wound)-508.8(care)-502.8(nursing:)-503(professional)]TJ
1.8708 -1.2519 TD
[(issues)-265.3(and)-259.5(opportunities)5.8(.)-265.7(Adv)-266.3(Wound)-259.8(Care)-266.9(2012;)]TJ
T*
(1:189ñ193.)Tj
-1.8708 -1.8067 TD
[(135.)-311.8(Organization)-556.5(of)-559.5(Wound)-558.6(Care)-558.5(Nurses.)-559.1(https://)]TJ
1.8708 -1.2519 TD
[(woundcaren)8.1(urses.org)-303.9(\(last)-300.4(accessed)-292.6(January)-299.9(13,)]TJ
T*
(2019\).)Tj
-1.8708 -1.8138 TD
[(136.)-311.8(H)-17.1(o)-22.5(v)-20.5(a)-15.4(n)-385.2(H)-24.2(.)-386.6(I)-16.7(m)-24(p)-15.4(r)-17.8(o)-22.5(v)-20.4(i)-16.7(n)-22.5(g)-385.2(o)-22.5(u)-15.4(t)-24.9(c)-13.3(o)-22.5(m)-16.9(e)-22.5(s)-383.2(t)-24.9(h)-15.4(r)-24.9(o)-15.4(u)-22.5(g)-15.4(h)-392.4(w)-16.9(o)-15.4(u)-22.5(n)-22.5(d)]TJ
1.8708 -1.2448 TD
[(c)-20.5(a)-15.4(r)-24.9(e)-264.3(s)-20.5(t)-17.8(a)-22.5(f)-17.8(f)-273.8(e)-15.4(d)-22.5(u)-15.4(c)-20.5(a)-22.5(t)-17.8(i)-16.7(o)-22.5(n)-22.5(.)-265.7(2)-22.5(0)-15.4(1)-22.5(7)-22.5(.)-265.7(https://www.w)8.9(ound)]TJ
0 -1.2519 TD
.0218 Tc
[(so)6.4(urce.)5.1(c)1.3(om)4.9(/)6.3(b)-.7(l)5.1(og/)6.3(im)4.9(p)6.4(r)-3.1(o)6.4(v)1.4(in)6.4(g-ou)6.4(tc)8.5(om)4.9(es-throu)6.4(g)-.7(h)6.4(-)]TJ
T*
0 Tc
[(wound-care-)9.3(staff-education)-431.7(\(last)-428.5(accessed)-434.9(Jan-)]TJ
T*
[(uary)-332.1(13,)-332(2019\).)]TJ
-1.8708 -1.8067 TD
[(137.)-311.8(Ennis)-261.1(WJ,)-251.8(Lee)-264.6(C,)-256.5(Gellada)-254.2(K,)-263.6(Corbiere)-253.9(TF,)-258.8(Koh)-256.3(TJ.)]TJ
1.8708 -1.2519 TD
[(advanced)-382(technolog)9.4(ies)-386.9(to)-381.7(improve)-381.1(wound)-377(heal-)]TJ
T*
[(ing:)-298.9(electrical)-293.6(stimulation,)-300.8(vibration)-293.1(therapy,)-297.7(and)]TJ
T*
[(ultrasound-w)6.8(hat)-318.8(is)-314.6(the)-318.8(evidence?)-318.5(Plast)-313.3(Reconstr)]TJ
0 -1.2448 TD
[(Surg)-330.9(2016;138\(3)-327(Suppl\):94sñ104s.)]TJ
-1.8708 -1.8139 TD
[(138.)-311.8(Lindholm)-409.6(C,)-413(Searle)-405.7(R.)-413(Wound)-409.2(managemen)8.2(t)-416.1(for)]TJ
1.8708 -1.2519 TD
[(the)-475.3(21st)-467.3(century:)-473.5(combining)-467.7(effectiveness)-470.4(and)]TJ
T*
[(efciency.)-330.5(Int)-327.3(Wound)-331(J)-335.4(2016;13)-329.4(Suppl)-331(2:5ñ15.)]TJ
-1.8708 -1.8067 TD
[(139.)-311.8(Yim)-294.7(E,)-295.3(Kirsner)-286.3(RS,)-297.1(Gailey)-286.6(RS,)-297.1(Mandel)-293(DW,)-289.1(Chen)]TJ
1.8708 -1.2519 TD
[(SC,)-261.5(Tomic-Can)11.1(ic)-264.8(M.)-260(Effect)-253.8(of)-260.7(physical)-261.8(therapy)-259.6(on)]TJ
T*
[(wound)-490.9(healing)-494.4(and)-494.2(quality)-494.7(of)-495.5(life)-500.5(in)-494.4(patients)]TJ
T*
[(with)-536.2(venous)-536.2(leg)-545.4(ulcers:)-535.4(a)-541.7(systematic)-537.3(review.)]TJ
0 -1.2448 TD
-.0002 Tc
[(JAMA)-328.5(Dermatol)-324.5(2015;151:320ñ327.)]TJ
-1.8708 -1.8139 TD
0 Tc
[(140.)-311.8(Gallagher)-237.5(S.)-235.2(Outcome)-232(research)-237.4(and)-238.1(WOC)-234.7(nursing)]TJ
1.8708 -1.2519 TD
[(practice.)-639.6(J)-641.3(Wound)-636.8(Ostomy)-641.4(Continence)-635.8(Nurs)]TJ
T*
[(2002;29:278)6.1(ñ282.)]TJ
-1.8708 -1.8067 TD
[(141.)-311.8(G)18.5(r)17.8(a)20.2(y)-241(M)19.9(,)-244.4(B)16.3(l)18.8(i)18.8(s)22.2(s)-248.1(D)18.5(Z)20.2(,)-244.4(B)23.4(o)20.2(ok)35.3(ou)33.3(t)-238.3(K)16.3(,)-244.4(e)20.2(t)-245.4(a)20.2(l)18.8(.)-244.4(E)20.2(v)15.1(i)18.8(d)20.2(e)20.2(n)0(c)35.3(e)0(-)38(b)0(a)33.3(s)22.2(ed)]TJ
1.8708 -1.2519 TD
-.0196 Tc
[(nurs)-4.5(i)-.8(ng)-412(prac)-4.5(tice)-19.6(:)-393.1(a)-412(prime)-19.6(r)-394.1(for)-414.4(t)-1.8(he)-412(WOC)-408.7(nurs)-4.5(e).6(.)-413.3(J)]TJ
T*
-.0199 Tc
[(Wou)-19.9(n)13.4(d)-241.5(O)-1.4(s)-4.8(t)-2.1(omy)-246.6(C)3.5(on)-19.9(t)11(i)-1.1(nenc)-4.8(e)-241.5(N)-3.4(urs)-246.6(200)-19.9(2)13.4(;)-1.1(29)-19.9(:)12(283ñ28)-19.9(6)13.4(.)]TJ
-1.8708 -1.8138 TD
0 Tc
[(142.)-311.8(Pontieri-Le)8.1(wis)-438.2(V.)-434.3(Basics)-432.8(of)-438.6(ostomy)-433.4(care.)-434.2(Med-)]TJ
1.8708 -1.2448 TD
[(surg)-332.1(Nurs)-328.7(2006;15:199)6.1(ñ202.)]TJ
-1.8708 -1.8281 TD
[(143.)-311.8(P)20.2(e)20.2(r)24.9(r)17.8(y)-354.8(M)19.9(a)20.2(y)22.2(e)20.2(r)-359.2(M)27(,)-358.2(B)23.4(C)16.3(h)20.2(,)-351.1(C)16.3(C)23.4(F)22.2(P)20.2(.)-358.2(E)20.2(m)]TJ
13.2802 0 TD
-.0199 Tc
[(phas)-4.8(i)6(z).1(ing)-376.7(t)-2.1(he)-369.6(fun-)]TJ
-11.4095 -1.2519 TD
[(dame)7.3(n).2(tals)-403.2(and)-412.3(patient)-407.6(educati)5.9(o).2(n)-412.3(i)-1.2(n)-405.2(d).2(iabetic)-403.2(foot)]TJ
0 -1.2448 TD
0 Tc
[(care.)-156.8(2015.)-163.5(http://www.saw)7.8(c.net/spring/con)8.5(tent/)]TJ
0 -1.2519 TD
[(em)24.7(ph)19.1(as)21.1(iz)17.5(in)24.8(g-)16.7(fu)23.8(nd)19.1(am)24.7(en)19.1(ta)16.7(ls)26.8(-a)16.7(nd)19.1(-p)23.8(at)23.8(ie)17.7(nt)23.8(-e)16.7(du)19.1(c)15.1(a)0(t)16.7(i)0(o)24.8(n)0(-)]TJ
T*
-.0198 Tc
[(dia)-19.8(b)13.5(etic)-4.7(-fo)-19.8(o)13.5(t-care)-234.3(\(las)-4.7(t)-229.6(ac)-4.7(ces)-4.7(s)2.4(e)-19.8(d)-214.1(Ja)-19.8(n)13.5(uary)-232.3(13,)-235.7(2019)-19.8(\))12.1(.)]TJ
-1.8708 -1.8139 TD
0 Tc
[(144.)-311.8(Corbett)-360.4(LQ,)-360.1(Ennis)-360.7(WJ.)-358.5(What)-360.7(do)-357.9(patients)-361.7(want?)]TJ
1.8708 -1.2448 TD
[(Patient)-419.5(preference)-414.8(in)-416.2(wound)-419.7(care.)-412.9(Adv)-415.6(Wound)]TJ
0 -1.2519 TD
[(Care)-330.9(2014;3:537ñ5)8.2(43.)]TJ
-1.8708 -1.8281 TD
-.0202 Tc
[(145.)-314.3(A)5.4(r)-2.4(anz.)-691.3(H)-1.7(ow)-691.5(can)-697.1(pati)5.7(ent)-699.5(engage)7.1(ment)-692.4(improv)-5.1(e)]TJ
1.7925 -1.2448 TD
-.0197 Tc
[(w)6.1(ound)-490.3(care)-483.2(outcomes?)-488.3(2017.)-484.6(http)7.6(s)-4.6(:)-.9(/)7.4(/).3(www)6.1(.aranz)]TJ
0 -1.2519 TD
0 Tc
[(me)-10.9(di)-10.8(cal)-17(.c)-8.7(o)-8.2(m)0(/)-11.1(u)0(n)-9.4(cat)-18(eg)-9.4(o)-8.2(riz)-14.5(ed)-9.4(/)-8.4(o)0(u)-9.4(t)0(c)-9.8(o)-8.2(me)-10.9(s-)-9.8(de)-9.4(l)-9.6(i)0(v)-8.7(e)-8.2(red)-12.9(-)]TJ
T*
[(pa)19.1(ti)15.3(en)19.1(t-)14.3(en)19.1(ga)19.1(gem)23.6(en)19.1(t-)14.3(pa)19.1(ti)15.3(ent)22.7(s-)18.7(he)19.1(alt)21.3(hc)14(ar)16.7(e-)16.7(pr)16.7(ov)21.1(id)17.7(er)16.7(s)]TJ
T*
[(\(l)16.3(as)21.1(t)-323.6(a)0(c)14(c)0(e)14(s)0(s)23.1(e)0(d)-322.3(M)0(a)18.8(y)-319.2(1,)-323.7(20)19.1(18)19.1(\).)]TJ
20.2084 61.2156 TD
[(146.)-311.8(Collins)-405.2(C.)-413(Wound)-409.2(care)-410.3(and)-408.8(healing:)-411.5(aiming)-409.4(for)]TJ
1.8708 -1.2519 TD
[(zero)-668.6(preventable)-671(deaths.)-671.2(2018.)-668.5(https://www)]TJ
T*
[(.defensem)7.9(edianetwork.co)7.6(m/stories/woun)7.1(d-care-)]TJ
0 -1.2448 TD
[(and-healing)-330.6(\(last)-328.9(accessed)-328.2(January)-335.5(5,)-330.8(2019\).)]TJ
-1.8708 -1.9419 TD
[(147.)-311.8(Amara)-324.2(JH.)-333.7(Military)-322.1(and)-330.6(veteransí)-332.4(health,)-326(health)]TJ
1.8708 -1.2448 TD
[(care,)-341.7(and)-351.9(wellbeing.)-345.5(Defence)-344.3(Peace)-345.1(Econ)-343.9(2018;)]TJ
0 -1.2519 TD
(29:1ñ5.)Tj
-1.8708 -1.9419 TD
[(148.)-311.8(Struve)-326.4(M.)-331.2(TRICARE)-321.5(for)-328.3(life)-336.9(and)-330.6(medicar)10.2(e.)-338(2017.)]TJ
1.8708 -1.2448 TD
-.0223 Tc
[(h)-22.3(t)1.5(t)-22.3(p)-5.6(s)-7.2(:)-22.3(/)-4.8(/)-22.3(ww)-22.3(w.)-22.3(g)-4.6(o)-22.3(me)-22.3(di)-22.3(g)-4.6(a)-22.3(p.)-22.3(co)-22.3(m)-4.7(/)-22.3(bl)-22.3(og)-22.3(/t)-22.3(ri)-22.3(ca)-22.3(re)-22.3(-)-5.6(f)-22.3(or)-22.3(-l)-22.3(i)-6(f)-22.3(e-)]TJ
0 -1.2519 TD
0 Tc
[(an)19.1(d-)23.8(me)24.7(di)17.7(ca)21.1(re)-275(\(l)23.4(as)21.1(t)-280.9(a)0(c)21.1(c)0(e)21.1(s)0(s)23.1(e)0(d)-272.6(D)0(e)17.4(c)15.1(em)17.6(be)19.1(r)-280.9(1)0(2)26.2(,)-287(20)19.1(18)26.2(\).)]TJ
-1.8708 -1.9348 TD
[(149.)-311.8(Liu)-280.2(Y,)-285(Sa)15.2(yam)-280.3(S,)-285(Sh)15.2(ao)-286.8(X,)-285(et)-289.2(al.)-276.5(Pre)15.6(vale)17.5(nc)14(e)-292.8(o)0(f)-282.1(and)]TJ
1.8708 -1.2519 TD
[(tr)14.3(end)18(s)-212.5(i)0(n)-202.8(diab)15.4(ete)15.6(s)-205.4(amo)16.4(ng)-208.5(ve)14(ter)13.2(ans)20(,)-208.8(Uni)14.9(ted)-197.8(Stat)22.4(es,)]TJ
T*
[(200)18(5ñ)15.2(2014)16.8(.)-230.1(Pre)15.6(v)-233.8(Chr)18.8(onic)-224.4(Di)16(s)-233.8(201)18(7;1)16.6(4:E1)15.4(35ñ)21.2(E135)16.8(.)]TJ
-1.8708 -1.9348 TD
[(150.)-311.8(Veterans)-250.5(Affairs.)-253.4(VA)-249.7(research)-258.8(on)-251.2(diabetes.)-255.1(https:)]TJ
1.8708 -1.2519 TD
[(//)25.8(ww)23.2(w.)23.3(re)23.8(s)15.1(e)0(a)19.1(r)0(c)25.8(h)0(.)24.8(v)0(a)21.1(.)0(g)24.8(o)0(v)21.1(/)0(p)26(u)0(b)19.1(s)15.1(/d)26(oc)21.1(s/)20.9(v)15.1(a)0(_)22.3(f)0(a)23.8(c)15.1(ts)18.7(he)26.2(et)23.8(s/)]TJ
T*
[(Di)23.1(ab)26.2(et)23.8(es)21.1(.p)24.8(df)-310.5(\(l)23.4(as)21.1(t)-323.6(a)0(c)28.2(c)0(e)21.1(s)15.1(se)21.1(d)-321.2(J)0(a)26.2(n)0(u)19.1(a)0(r)23.8(y)-319.2(3,)-309.5(20)19.1(19)26.2(\).)]TJ
-1.8708 -1.9348 TD
[(151.)-311.8(Franklin)-330.2(H,)-332.5(Rajan)-338.1(M,)-331.2(Tseng)-330.8(CL,)-333.9(Pogach)-332(L,)-335.9(Sinha)]TJ
1.8708 -1.2519 TD
[(A,)-240.1(Mph)-238.4(M.)-245.8(Cost)-236.4(of)-246.5(lower-limb)-236.6(amputation)-239.5(in)-245.5(U.S.)]TJ
T*
[(veterans)-571.7(with)-571.7(diabetes)-572.7(using)-574.1(health)-579.6(services)]TJ
0 -1.2448 TD
[(data)-234.5(in)-238.4(scal)-237.7(years)-231.6(2004)-239.3(and)-238.1(2010.)-234.6(J)-235.9(Rehabil)-235.1(Res)]TJ
0 -1.2519 TD
[(Dev)-330.3(2014;51:13)7.3(25ñ1330.)]TJ
-1.8708 -1.9348 TD
[(152.)-311.8(US)20.6(AMR)19.1(MC)14.9(.)-692.5(Com)19.7(bat)-688.6(Ca)15.2(su)14(al)17.7(ty)-692.6(Ca)15.2(re)-694.6(Re)15.2(se)14(ar)16.7(ch)]TJ
1.8708 -1.2519 TD
[(Pr)16.7(ogr)15.5(am)-487.5(\(C)13.8(CC)18.4(RP)15.2(\).)-488.7(htt)20.3(ps)14(://)16.2(mr)15.2(mc.)24.2(ame)16.4(dd.)23.7(arm)14(y.)19.7(mil)13.7(/)]TJ
T*
[(in)17.7(dex)20(.cf)16.2(m?p)18.5(ag)19.1(eid)16.6(=m)17.6(edi)16.6(ca)14(l_)13.8(r_a)18.8(nd_)21.2(d.)17.7(ccc)16.9(.ov)18.6(er)16.7(vie)18.6(w)]TJ
T*
[(\(l)16.3(as)14(t)-330.7(a)0(c)14(c)0(e)14(s)0(s)16(e)0(d)-322.3(D)0(e)17.4(c)0(e)14(mbe)16.4(r)-323.6(12,)-317.7(20)19.1(18\))16.6(.)]TJ
-1.8708 -1.9348 TD
[(153.)-311.8(Rose)-369.2(LF,)-377.7(Wolf)-376.3(EJ,)-374.7(Brindle)-372.6(T,)-373.5(et)-381.7(al.)-376(The)-373.3(conver-)]TJ
1.8708 -1.2519 TD
[(gence)-409.1(of)-417.2(regenerati)8.6(ve)-412.8(medicine)-409.6(and)-415.9(rehabilita-)]TJ
0 -1.2448 TD
[(tion:)-238.4(federal)-248.8(perspecti)9(ves.)-243.7(NPJ)-241.8(Regen)-244.3(Med)-245.6(2018;)]TJ
0 -1.2519 TD
(3:19ñ19.)Tj
/F2 1 Tf
8.9663 0 0 8.9663 426.6707 357.5621 Tm
[(Abbreviations)-337.5(and)-331.9(Acronyms)]TJ
/F8 1 Tf
7.9702 0 0 7.9702 435.4581 344.5227 Tm
(BMI)Tj
/F9 1 Tf
1.8281 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(body)-336.8(mass)-329.2(index)]TJ
-2.9164 -1.2519 TD
(DFU)Tj
/F9 1 Tf
1.821 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(diabetic)-332.3(foot)-329.4(ulcer)]TJ
-2.9804 -1.2519 TD
(DoD)Tj
/F9 1 Tf
1.885 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(Department)-327.6(of)-331.9(Defense)]TJ
-2.3687 -1.2519 TD
(FU)Tj
/F9 1 Tf
1.2733 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(foot)-336.5(ulcer)]TJ
-2.6959 -1.2448 TD
(IGB)Tj
/F9 1 Tf
1.6004 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(intragastric)-327.7(balloon)]TJ
-2.7101 -1.2519 TD
(PNI)Tj
/F9 1 Tf
1.6147 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
-.0002 Tc
(psychoneuroimmunology)Tj
-2.4256 -1.2519 TD
0 Tc
(PU)Tj
/F9 1 Tf
1.3302 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(pressure)-329.9(ulcer)]TJ
-2.8097 -1.2519 TD
(QoL)Tj
/F9 1 Tf
1.7143 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(quality)-331.1(of)-331.9(life)]TJ
-2.6461 -1.2448 TD
(SSI)Tj
/F9 1 Tf
1.5507 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(surgical)-330.2(site)-333.5(infection)]TJ
-2.8737 -1.2519 TD
(T2D)Tj
/F9 1 Tf
1.7783 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(type)-332.1(2)-335.4(diabetes)]TJ
-2.4825 -1.2519 TD
(VA)Tj
/F9 1 Tf
1.3871 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(Veterans)-328.7(Affairs)]TJ
-3.3645 -1.2448 TD
(WHO)Tj
/F9 1 Tf
2.2691 0 TD
(º)Tj
/F8 1 Tf
1.0954 0 TD
[(World)-334.7(Health)-325.2(Organization)]TJ
/F11 1 Tf
8.9663 0 0 8.9663 62.022 758.6644 Tm
(48)Tj
/F12 1 Tf
9.9626 0 0 9.9626 290.5511 758.6644 Tm
[(EDITORI)-10.7(AL)]TJ
ET
62.022 753.902 508.082 .51025 re
f

endstream
endobj

114 0 obj
[/Indexed/DeviceRGB 255 115 0 R]
endobj

115 0 obj
<</Length 428/Filter[/ASCII85Decode/FlateDecode]>>
stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#s<Xl5FH@[<=!#6V)uDBXnIr.F>oRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0I<jlL.oXisZ;SYU[/7#<&37rclQKqeJe#,UF7Rgb1
VNWFKf>nDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j<etJICj7e7nPMb=O6S7UOH<
PO7r\I.Hu&e0d&E<.')fERr/l+*W,)q^D*ai5<uuLX.7g/>$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj

116 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFHM+AdvP6EC5/FontFile3 121 0 R/Flags 32/Descent -216/FontBBox[-166 -218 1000 770]/Ascent 718/CapHeight 718/XHeight 532/ItalicAngle 0/CharSet(/space/four/zero/one/two/three/five/six/seven/eight)>>
endobj

117 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 116 0 R/LastChar 56/Widths[552 552 552 552 552 552 552 552 552]/BaseFont/EMCFHM+AdvP6EC5/FirstChar 48/Encoding/WinAnsiEncoding>>
endobj

118 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFHN+AdvPAC39/FontFile3 120 0 R/Flags 32/Descent -191/FontBBox[-145 -239 1000 750]/Ascent 722/CapHeight 722/XHeight 502/ItalicAngle 0/CharSet(/space/E/D/I/T/O/R/A/L)>>
endobj

119 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 118 0 R/LastChar 84/Widths[666 0 0 718 614 0 0 0 281 0 0 552 0 0 781 0 0 666 0 552]/BaseFont/EMCFHN+AdvPAC39/FirstChar 65/Encoding/WinAnsiEncoding>>
endobj

120 0 obj
<</Subtype/Type1C/Length 435/Filter/FlateDecode>>
stream
hﬁ<èOhQág•˚^´Úb≈]°¡l⁄ .•!A∞P–‘%®ÕAHE∞HeK.ΩHA≈&xãÑZ™<xË≈CDÙ(*∏à=î¸s ¡ª`/ø∑Œ.∫Ò–˘`Ü˘fÉˆëaáŒ^,üÛ/y•∑™•rq∫Ôlù=hÛ∑˛‹çöÊf¶7º¢´á˚ì°Ωµ4:Nc4N.MRûätíˆß'iÄÃ¥©Sì⁄‘•ü∆åQM&îzåV-µá|ÏôqûW≠o®ô`ÒùkÊ∂‡◊Q`û¸*	Lı	˘–“ø~K\_¡$◊G∏rä|é#◊J‘$ñëÖB-N+/;Íö~cáq/±Ú.ûj
„RHÖ3vTØ$u©Fı∫Úﬂ»≠¸˜
«êX(Ï† ˛˙î”‰≥_Ne!ß∑m4X¬„Ö…7∏….R$\4rÈw3˙ÑÖ'ó[∞◊ÿ·ãáS;≥Œ][‚ÈÆ”ôÎÃ=ª:¯U,ΩÌºøè°fÔˆÁ©Ó‡#Ÿ{˛·„èë≠õÔÆº»m\Æu.d˘Al
5ä∂˝E¥#◊ƒù0^ü≈=°∞q$ö∞˛	0 ÓÓÕ0

endstream
endobj

121 0 obj
<</Subtype/Type1C/Length 828/Filter/FlateDecode>>
stream
hﬁ<èmLw«Ô¿ª6*'Ø…zr˝'í∏!¬ö˘- É-ÖÇúò—‘ﬁQNjè^¥L|Å¢R5æ@ó9ß	ö∫∑´≤±9Y|òÉ≈`¯F„Ci…˜;¸ıÖe/ñoÚyÒMæﬂ|ø45/É¢i:€QWÈt’≠(ó¢ıkï´Á<Ah}ÈBñ`‡]«l/¡E∞/Á‰Ïƒb*É¶OU©∂«4≈◊&z?"÷‚u´Ê∏ˆ?œ±¯cR.©ªd≤%
À{B§:‡UµvUÛÑe©êêrøü4Ã5ÑHÉíµh⁄u…˛®Vº¢ÑàáÑ5è$ÔÒhmDm!µJ@«⁄eR^E<©H’àíŒÜ"ªBä§x4E˛Å¢”¢rå‘ÇÙE*ìb©2™â:K˝EÁ“^˙˝(£ípP¡¿„Sh ÿ¶¿ qà€¡Ä6¥Ÿ—ÄqÚL‡æ0>=}¡ântG6[‰pã‹∏ﬁ…Ci™»l3ÿm›>
¬^ñÉı˙N~§Á¯√◊¬Xˇ÷Ì∂F.)¥`!ŒÎZuhùQèA6ﬁbøHÃ‹3é_õ∫úÚêö∆•µX∫˜ã(póˇmÊpæΩYﬁ≤Ú‡£ÀñûsYÇ´„wXˆfÃêU<®ù„ÜÔøL&Ôõ!sÆ‡™≤¸@€wÏŸÀ…”5¡¢ıá=b$Ω Áxp¬(g#›òâefPMvΩ?aÒÛ‘F≥ ÅV `ù2pô>…√ÃOôŸÊîr∫ò.]Ô9'LÙªk7HÆ:ˇw£]$,.;Ld
 Éı¨≈Ö˜
úm—X–¬È«ıK¸ÅùÁ•À∆oZKzç·A–1ÑU–π/˛Ü¢∑`pπΩuwpüÂHúy~Ú¸?œÑëã™˜ÑÂﬁ‡Wló];oL>˘9Ò”ï—ÄU‰ÙæŸM|™õÌ∆lﬁ≤õ›Ëƒh!è=øB¥åM9–K¯Õ˛´C#âoÔ$ï≠çm-üZ‡˙¯Ár≤ÍkÒfﬂ»-ÛÎ“«∏≥Û+0´∫«/™àT”±ï>s˛ún®ÀSÛ∫¯fµ∂¬-%«&á?˛yqSSz»í˘˜ ª˜yû

endstream
endobj

122 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 124 0 R/LastChar 121/Widths[333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 708 0 718 0 718 0 0 0 0 0 0 0 0 0 0 666 0 0 666 0 0 0 0 0 0 0 0 0 0 0 0 0 572 552 447 614 447 0 541 614 333 0 0 333 885 614 500 572 0 447 447 354 614 520 0 0 500]/BaseFont/EMCFIO+AdvP44F905/FirstChar 45/Encoding/WinAnsiEncoding>>
endobj

123 0 obj
<</Subtype/Type1C/Length 2242/Filter/FlateDecode>>
stream
hﬁåUiPTW~‹◊≠1m©yözœº◊$„5Äë(7(‡† "≤uÀ÷Õ“≤odµQ°Ÿ˜0¢ÄqDP@å∑òƒ§≤81‚hôƒ8ì”ÊP…4∆$¶j2ïzUÁ«≠{œ˜}Á|Á<eeAâD¢©ŒnNÎ\7Õ_ªyÒ‚u∂ˆ„ß3Mú»4s“t¥≈å’èª	,ù;¶œúh=ï≤â|Çúî*ùf∑\°ï˘ÕÚõ'≥sXjø`<.y∆£ÉùlM∞20DÊ•ã÷ÜDFÀ\£ÇîïR≥K¸öL∂&"BÊ9û#ZÊ¢â5ü>√Éô?JJQ/S‘ﬂ(j6EŸQ‘bär¥¢÷[PnVîóÂKQúYeEâ©)uJ‰ ™˝di1d9—2…rƒ*‹Í2ôK"»èÙv˙†¯9±´∏^|_≤S“:Å{$≈O§ÿÈ‡œ‘\'H«:Èw7¡ÖÒ
Û_±ÜKÒ'`†À{âöéÃ;YdËù˜8@◊"!)Öââld\F4ÔOè_ÏøF{gV¶
8ŸÙ3	¢ÂhÀ·	Ç1¥,M?=ñ1É!.Õ.Í–	31W˝Ä¿ñ|vÊå¡bÌÔ¥'s8}Û(<ÛoClÉY58≠ˆ	]Ù &äÒd yÏ¿Ù–Õ∆ºp52cæ∫ı¬ÓÙå¯Ìúrúçiîæ	π¡%≠Wz∏‚rŒÉVÜÁÅô0M0“óéhú£≥µŸZ·X÷]∏PHVFÔÚ∂Êv”F◊Y“$1ññUù‰∫h ◊p£˙‰ê±+¥t¯ˇC√x!v>¡+oãvò"º›–ë{îÉ9∞ˆ8¨Öπ8πß
ÿMÉJôKÜB˝á‹C·68˜µ`‰’⁄º}1ÇtxÔÙv˙‚≤m‡ÜÍCd0„cX(@é≠É%ÏÌ´'æÑ)}—ä◊àª2á°ú»iwo2‡ÁR∑ñ√i≤8=_»«4¯œe\≈Œ]`á3ùFA ≈A%D™Äpì±ﬂÜ°hïœªÁ´∫áŸ—≥‡œùÆÿŒ√´∏öIVì†8˘V9óíπˇ`UQEqç–t'XvÄ•d9nOrÈsÈﬁ«6q8ÔUÙƒã˙ùˇuæØ°ØC(†}+Tß/˜ﬂ8◊ÃóVÈ∏h≤aﬁ´Ò⁄:{=n¿Á7hN~{6√dï–¬Ù“µµy1â{Sˆ&(õD24{ﬁ“∞≥.˚ﬂÉe0f√˜v|<kìgòüÇœ•ÅÇG∏%ëH·.0åü“m´∑.j`‰—ÿ S™ªRbSS≥RrÑÑÏ§D-Yøßµ…ÿxÍ „fúç°Ïï°`Ò≈’3Ô˜“”gècsætyJ$;>S+l@çY·@¨£7áØ·$\Ö÷≥Œ∫>iˇá—,q€°≥Ù_<Ãjå¨àëì†hEÄÇKH=p®YﬂT9$‡«rÊ˛Ñ	g;∂ΩÓäa8i£j‡,?ŒõfCΩ<∏U™ﬁ´•˘e˘e¬ÉÔÅÈÏıMÕÓ¯r(†£ıu˜ÔøÏ:ö«:ò»|Æ^~»uTkÂÀ<êUR◊6Ã|`Æ´ÎÄˇz©ai1è” Ç:Y£QﬂZe»…59CéÅ{¯pHOÙ—–°∏‘†7‘Ói„ö**öÔ÷GÌRhµ
°,.∞8ä≥CÀç≥˝j˝{Ñ\±{éã“ôU¥Fµ•Ûπ‚ÕY´#◊≤êºíŸ2ßËÉüVˆ¡Ky+qBº∑êlÚbﬁÔ∏ıÂaïÀ˙ê%oxDtö‰±””´2tÈÆªEFÈ˙ª5˜zoI˙õØ›æ»5TÍ4¬ﬂa†/ª£!¸‰G˛9‘…+ƒ…/`óöKIŒØZoÉÚ"{Rs“Õnã≥ªœ∏$¶ŸOú`ﬁc≈`√D≈zÿÓ‚í”J˙¢ ¢Cà·gtÔÏ—'IŸi9iÇ#&ì¥à]4´⁄4|˚#òÿ^≈„SUØjimljiQ÷G)£5Jﬁú¯Œo‰ÒÚc;I™<K˛ÏÛ®JÚ;∏°‘®Ô¿≈Ù’/6m{‹Ûòˇ•dÉÌ%9t~Y¡¡˝ÏpÿQ˜’Oµµ¿tLLUê„tW—û‘‰åêƒÇˆ¸±póπf}º“€[‚ÇÑøRR≥ﬂ€˛ÑÃoe˝k– 3yC"«œ— º∏%∏¿lÂI◊¡Dòò2`	„®=qÈ´~êÉ‰z›ñçãºq'ä©‚∏i1Û7=$iáÄ“1[¢ »Là·‰tjÅ$ZﬂE|È¯‰¬ä˝Ö˙Ç·48ì⁄ªÍLÃ ∂ﬂ¿:‡Ô˙^[Ëµ‹œW#‰“U˜qY"πá7ô;Wa;H}ﬁÿj^}/x(ª˚yÈ;ø>#ÍFÅu7Wµ/%1®<ıh[u£±7º’≈é5û°¬Ø527w&<`Œü©®}7[√Î‘πªŸ®Ü‰ÊŒ ¶∂õØ◊o¥∑Òõ∑˙¨˙L,U’ïË«∫º„ÊSﬁ¬◊∑dt≥M⁄
ÂÆÑ–0˚ocﬂøw˜‘øØmiÒ™·ùöBt≥R,ÓÑô¨∏¨ò8÷ßawˇgÓú?¬GVì»¯∑s∫î‚ÍÚ¬ÖÂ¬(å ¥æó†»¸ã|ì,ß7„õdùÍo"-9ahvp≈Ø˛ﬂÑﬁ$Cï™d∑∂Àœ}zÓ“‡qæÄŒ÷e«≈≤;„é_ª2:–nûΩ»@™
çÁí2ÀÜ‚∆˝Õà‡±°Cq™È I∞∆mïÆ3t4:\\-‹á>ÛºÈbPôB\ˇtÙÃ–ôo'e' ˘$M°€(gÌèyﬁ˚†¯·òñêH›5Ôﬂ_Ë ⁄⁄£ßµü˙pÔπ⁄}f7’BSQ“˛I=W]îËT-T∫’ÕkDô%Æû~‹û¨¢2°¥H_ 6ƒU©√ˆ®#¬:}@è|˜ıÒõA†˙êj©ÎÈ`;tµelºäW´î¨áNP∏õ›ÆÄW,é;Ô√πmG+_ù 5yΩ`zƒ¸WÄ ]πÁ

endstream
endobj

124 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFIO+AdvP44F905/FontFile3 123 0 R/Flags 34/Descent -204/FontBBox[-156 -239 989 802]/Ascent 737/CapHeight 722/XHeight 466/ItalicAngle 0/CharSet(/space/S/t/a/p/h/y/hyphen/l/o/c/u/s/r/e/E/n/P/d/m/g/i/A/b/C/v)>>
endobj

125 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 39 0 R/LastChar 110/Widths[281 0 281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 781 833 0 0 0 0 0 0 812 0 0 0 0 760 0 0 666 0 0 0 0 0 0 0 0 0 0 0 0 0 614 0 0 666 572 0 0 687 0 0 0 0 0 687]/BaseFont/EMCFMN+AdvP42982E/FirstChar 44/Encoding/WinAnsiEncoding>>
endobj

126 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 87 0 R/LastChar 121/Widths[281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 447 0 0 500 0 0 0 0 0 0 0 0 0 0 0 0 0 447 0 385 447 447 0 447 447 218 0 0 218 666 447 447 447 0 281 385 281 447 0 0 0 385]/BaseFont/EMCGAN+AdvP43C3B4/FirstChar 45/Encoding/WinAnsiEncoding>>
endobj

127 0 obj
<</Length 676/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\7M/gHV$rfI`6U1315ADRY2BZFdK:Ef,b'>Uuc`>leG`;D>Y6daNnA3!He1r3d
m4tb;_kq2ui.:s9/*j/,19bn'euf[c_WM=lHfC=*n/OV/#DqH4HMGmhh_h:U/do1Q
1P&7s(Fp9u$hFVoQO#*,7'Hi\NCD.4XBR@q#toiDHOso_)lSPr*bsPn==3E&22`8M
$\_D%.-7-:&1mgC.ubUmGd)IQ)M14uM0O0"HE8MkP=eHP8r\B8j4?d>SQh3q_lI#o
3XSfjPP5R,>nXonWdX#e=?6FVQdK;Gj&sc$1gp4>]gWTZOYf4LBuoda]<r$eC\ikI
&E9<;\cM+9h[Zt^)oK2R2ho68psrD$/A6n,lS.?BV_kjHpfi?EVM>`R-?G=3%W4a5
:M&7lCA?!WgPR_U.Zh.D6CU@m1)Y1M_S:A4(j7_V)?B!ki'ng!:OScGP)meV`j$ii
/e'%ERf6'u(9ZQ2O7<htC_UYjMH<5,<U1T@Db-`,koiU$+cfga:&f0.,cfYDr]'\^
"h;IE)_UQQZ)3e1e!@.%,:d=1NEgX)7_GQd%e6SV::a<G30b5k`6AYU1Y=j(bV>I)
'ef"1o)PsTI6@d;Ikeo'YfI3s=7hcjb*Q2npUq.(_QWFLqK'K"0=JLhj]VP0:?eRl
TcA!0T)eqL#!4m~>
endstream
endobj

128 0 obj
<</Length 646/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\79<uGX%-.='oQ@ad$h7!s4(d?DolSR^,>3V"LZj(o6uuFG6bSH`3F<^u,I-Qe
:3mFc:8/sq2a3I065,:'WH:aG9Y+Xl$%BsJKgq;r^rcld&4OhCCT/;df?B0^NGXf%
$#n0tL#'&QZ,Ek,BISdPNK@;WCiC2dG]ec2PDtZNmdZPYQo-bLE!i/$aQ2Ptjl,=i
%`AEW1/'l>fV4M(]<Z0F]^q`AWBiR1h^Rk29W*shCXfk6:YZ@9DS4XGPhnp"T9>QJ
,];1%]H%f=?VluNEE&^tNQCZ7AV':2pdt_NC-8=!C&F=W;&GM8X/QBdRK"OS'43a=
B"#-&bClY:&866i7q<$VGLZS;YHd-jWlB>;f(eKU//Dt28`)Q)ml'8KND'C$i=[dX
1C(gH_Z[WPA`8+3pIsN^^loZP/nr6@SJl(u2)/3<n_2U9@I;7hmmbJ5=$j0k<o\VV
<JHE#Im<XsCj^W$$)a)r2OO/^KiHSkW@qAuMoa.9gO[FAYY\e6bflO+(bAGDY.`@F
'6&#8.#bC@Vo3l&@6UpBBV-H_ETtp8JH/=b@VEX;ARoe/(P*."6XqQmd[L+mQ=Ehs
WDqGRhLJ_,1"mn$<pphk?0(\ljQ\Tj6t9%]5"k5Y^$us?iHi)p~>
endstream
endobj

129 0 obj
<</Length 672/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z]"M/L6c#XnXk5KN:mg*S]d$pKkIe^@IlLh#S,0-]rrOn+@9Kl=[HcbfVK\1ON-
lH:jH6;d=LX%GFi*Fltn)0lXh?"O4)RgnW#]To-K\R4:>!QMOoEXMq?8!i-nip?ru
jujh,CtG]>re6MaAS$gSc.*Gfj2pdmW8'4(3#n^jr_O.d8sd%0RBB)n>=78E.E3)M
(gb79.:'&/\'3(JH1cs0\]l!>8*#=YitV6GBYU&!_rr!*lr+u9P6Pg$CIU:!<s@s2
KXIS'Z-e5GH_tu?EsQmkN/7XSIU*o/$Nl6'$D5SmpoErl%o=r'p+'phK/St<H`oPF
p"n5>j\-&ND*Z*bAsp.]Q=8FLK*2hRXB$iNGIU&P#c(ci^dHNq]#=Q^(eNfK(u>9;
2]7gZ4ORf53"2p9[d*NCbd\Ofk:p7qj^o2a;tI`-rbn?O1iG&lDm8-22MTUa1S>[+
>k^^faEin*:YF^!1lm=]>;Pno[F6O/JHS"$UT&Ksd/r/PBW.u<gd[H=gT\lq<]OFM
8;HbpXE9XkrL87q8KUS:887PU(D5b!NO`8.:=tue9+-[Q$0raQH8WZX_JB,8)sBtQ
$nIRo-_Sm&VQ3i=T,EonR]4jb1snKsEdqL"8]E?S'BuT32NX+GmW=B"l:SH[e:lfT
PP?!qFPSie~>
endstream
endobj

130 0 obj
<</Length 646/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;ZD/>EZlX#g<0"aE;[[N?'&AKC,J@><^b798+X$lk4_B*78uFObR&!%<B0@?M9)u
I`VAdJp9@!H9rNC@(oHn@?E,2\4/&.kPZ!&EPrEh]3tI%e#5?fo.hC(2>56RiO4G.
IUZWF@>(J+E@+qfREd\>.P_2HK41I1kGp3>VBZN8gpr+3&7^F57c$?TP/%Vf?)+'k
Y?6.*F2H4/9Q$=f:Fd"`+tuAlq5MkI6AU#0)=<(+Ni.Pu'2I88FW"VMn(*9s,l"LQ
R?qf'b:D7Pb"QUQ_Q)BoDM_b4b/BAs#>8SQ9N\U!U+)>B'ATQtTuKV#H:4P;Y@uIg
?R^uPbR$F7UTD71];b60e3.!2Ni@[U"n85m"Y[IiT]Z69,#/JeUP5+47g!a+AZa?E
"1Lo[/fq+59WB5TG9F[.LkD-lBU"]s["j_GQZp2a@)#kI>n#:qjb\>`@'US/.#"7"
%_m%h]Z0BIID't<KtL/!\p*ulb+IJ,R5:mUqPOd1S]"$m5^KLD0++-]7>@[q>IO2e
hq[Q;SUG,N,@p%IJqp2C)$U%KQFnkd<41!4=RGbb/2MljW6]8?B:Ab9!/Pu(qDR4D
jFrF"]rK(o@!QSSHLeB\GqSsC_:kqEF^N+`s4U`XL[d/#.g$N_~>
endstream
endobj

131 0 obj
<</Length 598/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\7>8"gr#jhLCaE9P-Be7-l;TqY/Ho,P*fNhiToJ`MrAZgf3?am@PIbR2'YMTP`
MgZ6@rco;S&?,;$*5cms<%V'kB-"`A0!)qb$_kjPWZ8@"!O8`7!!,UP8]nFM\=k=d
AL^rR?No&)NX8rqn(AG*56SVaJ\?u>cd@eRjLD)gb-Hm4;C(BbIoQEJ*,6GoKc>f9
JU6j=mZnhE^ch0"Qb,Z\UWi6J756/R:HU!k>e\*"o!i1sG0in*TuUeu6&,bC'>2<\
$Z)G/YPj#&S"M($8J`r^MM4hb2c=,-A]T*9F!?,a@iO%"l&f-#bD>2=itKpR)$*NG
J.,:oS'A9lLaQ!d=Z)3s>VEg3BNe/DC>TN<,H/hlJ?-Jje$?LU?B$q=UAcc`%K]/N
>+Hnm0'4BO`57F5VsWF+QA-4me4!/12m"*6K;6su8Y2jgZbY%[,O"HA-*GLua!GtV
T*QFlMi!='GrK0^QeWu,!l^Y?k?#(sbCJ&j_+ht]`=W;_Z#FLMbs[3lV=e&(ke-M>
(36LqZA7_nbJ!$X@`XU.3GleTMXMlCQ7S#L>i9s+:s[\,>Nrf9J[O$IrU$Do#653b,f9~>
endstream
endobj

132 0 obj
<</Length 629/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\7>E6TD%*\Z'kj,>"2Lt04@ft+Ng\"&U"ip37'-d!1ECFC+8=/%i"*2+6,$SF"
hNu.;lX-6kShXt9rZPrEi7a['ScM)[PnEAA*e/)rNd/)HnJXJr?`j.#O^q.1-8Z1/
O\ZRf"d8!<IMF9&dqIpG>au^0e$K>Qqn,+h<(#thbkLi.,o+jO[6X39i$WVX_#0qs
\r?A_?HY%1U7LCR&/57J856o->WT,s95+&UM-=LZrItP,%a,IC:a]EM,Co2F'RO'5
R,O<!;j:Q(^fp#(*k#]%do]/;XKG]\l,VXGg4r_p@!K:40s7]f<3PEW<`LV)C\>Zl
)JQAE5+F7A;Ud=3^qdU'@!(Qd)UUPZ*oH\oZGPdO8B:P&NdT>0A;&8k\5+A#c$A7K
e7H;:6BCIH-`Qek?%a4?GKUcndN8Y9)T*eGg5J(qY6Jq6BbXH]QARI/7-K2-?fNcd
G#;t364XR\L>TqO1g,%2U_0caa:9)kTO331bTonm"ZCC;If<O,-ZEk4<%>9a)ot#=
+dX`l7^c^*]L6,s<-k,Y)%p\32Csn0E%>/EhBKN#Yaq;3lE9lD+&C5KN#)H11)ifZ
QC_`aOfX:m>sN4V7N,(mqN"nZ$ij*.(46~>
endstream
endobj

133 0 obj
<</Length 503/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\7NR#Ea#lNQZ"aQXll0;7/kFh++7C"JH#^8ed>,#LpJ!ZQZ`p%bQ/*=>.<P[pE
s0:#'bH8/gYpp&g!jr`u>i3mlOp"g4)Fk6r_o$dbf]CUe=?]UHXY;K1=EhIDBR`<L
.5G;`e55G&2"jI`_E.Wpg7YfC6ZmVa;:@.-2S&97BWdR\!ehn8Fc2SY^.^DTa,V0]
erX\5H*'D(>349iPUj(_hiY/fUK4Oa*9e2lkOR<O:i8m562Zh%+XkIB>7#VQ2.elO
QgJb3e8c_QQK`4f+=0X/,RB#.>LCbdoiuI8%->;RlW_4pBX:ZfMV$AV91+g7$<Ug$
RE6sW&&Z)Sp<=K_jPh[C;hKaVb\Fqn#Y/1CbEn0nb5HX3#\u!79?W#34C\ak0`@-J
#5efp4BEUnii"BdZ,nsD=an?l,[,,],oXSQGBYXn7':0L1npk^LCm3bN@l[mg;!8j
G<_3$1r6i+W(7oOYD`ghj_@8)gg_G6rrE+%e;+b~>
endstream
endobj

134 0 obj
<</Length 498/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\6m1+_%%-7@oOOl3aJqICa]@%QA2Z=h)G@-AhFhLR&dFtX7W2nHVkJi5I4E[7O
p[d$k=>C!U5E>Zbd#F]EcO@\-%)]EhX!H0Y61t$@_H?o=?an8sS^f9<?a&?uPpogA
?8Z"Gh.8N%0C%$3lP=#dI`gM`KSI(cCmU&j?$*5rUu)s>:$.SSY8'f%l,ICO\')`Q
?2:Weh,cakhPQUj=At^Vg?%[ff[b-3/R:Xg0@Qc&Qm;keIb`mp+M;!YRksP9e\XSI
Xubq^akZYNR63.F,FP:C[29jq!`!T,=&oUDig[T,(tLFJf\rq#qnStgr>[@F9DQ+>
:Q3';lq\,eC&[cMS1Al-q5N[((haEp#1Bfps0[&S0O(Rp$gZ*o-sRT<@o*kMUP[%/
RF5BmMp"aS?\j9orJ\Y89r<foMc*%/^%=3B%0"5BEFlJj)lnLtePK@&16^g>>WB8K
j&o]p4<Ci<$8Po2Y$lLFWIOkC4U(nM!T`/~>
endstream
endobj

135 0 obj
<</Length 559/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z\7m1+ak%.sL*OOmWEN(UYH[09jAX?X-!oY*#<[J$fT[_:H2j77LZCZ`YF#>.lp
g#KM@=LV.@igG=56.+%=(u.5%Sek2m'p"in@nIR)g1T.0I:8ZU/a>(.lV'BNC)Ot4
&4kX51FEH*BEeSSGE<Kb:>D;@O@Rn_m;g=u)@4m(DS.u/LnT/^nq]^sXQ!(JZYo^4
504-`p.;s\1$h$ERn;!cfiNKbK)W`u.s'B6cY*RLXp#AajgR/3VP^DIKnFsR\FuFh
9-G'JRn1QS67`ThQoPE>-\9R$8siET5m2R"kt3W;_-IQ).E60cQJ>R5]YXOpm2HP4
(o!J&Y#Sa77<c]c`9W"$$tepp+(`^sY>)UO,bpYk,iZ(0#j_7L56_=d!39!q=1S]A
*8V[R.i0HnKT_aDNj,<L168gkZ&3AKNOOu#5IW%XfBuJf0!pnk4EC&"L#N1)/MCjB
W54M6M:";iG`:6SVi"#1K1rBT7^,qL!J]"#ad%F>AFM"`P%nbRE0Ftd_@rd$A8#'0
$>R9F3^9DmK%=8=H2aj@T)erh`HjH~>
endstream
endobj

136 0 obj
<</Length 457/Filter[/ASCII85Decode/FlateDecode]/BitsPerComponent 8/ColorSpace 114 0 R/Width 76/Height 99>>
stream
8;Z]";%CJt#X`h9$g'L6[^Abl#8l0D21/(4$-)[8R^Vp[G^4)^OJ0t>"`bY'lt7[2
URBg&WW*,Qi[^t;bTH70Yb1d$K1;=HkG`:Ch'^Y9KcNNe#rQpa&r7pg,$*>>K$(;,
GZi4H[\7'^:1kmd<N"O4rN[;O1j82/CQ(.?1@EK`OX;#]3HOJ*<NUn0[3aRt7]`&:
U@/!],tN*<f`3P!Z04Zq+KkOt2aiMuWO']=o2Q/J2UiGq$<Sd1\jjK`S5o#)irXi^
]L3)!;_9Q_"r.>-qr2+eg4?:)K,R_ha*pYS%fsO6r8S_4Dq7A=02Pt<mlspVhdgCo
A,Whb)F\Rl?ERXPquRW2_JG!=q3BAfg$3<o^#+*LILTB]0B*mZ"W@KE3B+Ti#JWs8
'*n6sO&*E]aEgK!AqDn_;>!-&\F&mmVPIkF4]gDR.or`RZ!t]4i]R9SQ!;6~>
endstream
endobj

137 0 obj
<</Nums[0 138 0 R]>>
endobj

138 0 obj
<</St 39/S/D>>
endobj

139 0 obj
<</Type/Pages/Count 10/Kids[144 0 R 1 0 R 4 0 R 7 0 R 10 0 R 13 0 R 16 0 R 40 0 R 69 0 R 88 0 R]>>
endobj

140 0 obj
<</Type/Metadata/Subtype/XML/Length 3487>>
stream
<?xpacket begin="Ôªø" id="W5M0MpCehiHzreSzNTczkc9d"?>
<x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 4.0-c320 44.284297, Sun Apr 15 2007 17:19:00">
   <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
      <rdf:Description rdf:about=""
            xmlns:xap="http://ns.adobe.com/xap/1.0/">
         <xap:CreateDate>2019-02-12T04:37:11+05:30</xap:CreateDate>
         <xap:CreatorTool>Arbortext Advanced Print Publisher 9.0.114/W</xap:CreatorTool>
         <xap:ModifyDate>2019-02-12T04:37:11+05:30</xap:ModifyDate>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:pdf="http://ns.adobe.com/pdf/1.3/">
         <pdf:Producer>Acrobat Distiller 8.1.0 (Windows)</pdf:Producer>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:dc="http://purl.org/dc/elements/1.1/">
         <dc:format>application/pdf</dc:format>
         <dc:title>
            <rdf:Alt>
               <rdf:li xml:lang="x-default">WOUND-2019-0946-ver9-Sen_2P 39..48</rdf:li>
            </rdf:Alt>
         </dc:title>
      </rdf:Description>
      <rdf:Description rdf:about=""
            xmlns:xapMM="http://ns.adobe.com/xap/1.0/mm/">
         <xapMM:DocumentID>uuid:8323e7a8-718c-4560-bad3-0d08812e4e1c</xapMM:DocumentID>
         <xapMM:InstanceID>uuid:101545c9-935c-445b-b478-6adc6d30ae28</xapMM:InstanceID>
      </rdf:Description>
   </rdf:RDF>
</x:xmpmeta>
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                                                                                                    
                           
<?xpacket end="w"?>
endstream
endobj

141 0 obj
<</CreationDate(D:20190212043711+05'30')/Creator(Arbortext Advanced Print Publisher 9.0.114/W)/Producer(Acrobat Distiller 8.1.0 \(Windows\))/ModDate(D:20190212043711+05'30')/Title(WOUND-2019-0946-ver9-Sen_2P 39..48)>>
endobj

142 0 obj
<</Linearized 1/L 264882/O 144/E 53502/N 10/T 261994/H[1316 513]>>
endobj

143 0 obj
<</Type/Catalog/Metadata 140 0 R/Pages 139 0 R/PageLabels 137 0 R>>
endobj

144 0 obj
<</Type/Page/CropBox[0 0 612 792]/Parent 139 0 R/Contents[157 0 R 158 0 R 159 0 R 161 0 R 162 0 R 166 0 R 177 0 R 178 0 R]/Rotate 0/MediaBox[0 0 612 792]/Thumb 127 0 R/Resources 145 0 R>>
endobj

145 0 obj
<</XObject<</Im1 184 0 R/Im2 185 0 R>>/Font<</F1 146 0 R/F2 147 0 R/F3 148 0 R/F4 149 0 R/F5 150 0 R/F6 151 0 R/F7 160 0 R/F8 163 0 R/F9 167 0 R/F10 168 0 R>>/ProcSet[/PDF/Text/ImageB]/ExtGState<</GS1 155 0 R>>>>
endobj

146 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 156 0 R/LastChar 222/Widths[281 0 281 0 0 0 0 552 0 0 0 0 0 552 281 0 0 0 0 0 0 718 0 666 718 614 552 0 0 281 0 666 552 0 781 781 614 0 666 666 614 0 0 0 0 0 0 0 0 0 0 0 0 552 0 500 614 552 0 614 614 281 0 0 0 0 614 614 0 0 385 500 385 614 552 885 0 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 614]/BaseFont/EMCFFD+AdvUN-Bold/FirstChar 44/Encoding/MacRomanEncoding>>
endobj

147 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 152 0 R/LastChar 121/Widths[281 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 0 0 0 0 0 718 666 666 718 614 552 781 718 281 0 666 552 947 781 781 614 0 666 666 614 781 718 1000 0 666 0 0 0 0 0 0 0 552 614 500 614 552 333 0 0 281 0 0 0 947 614 614 614 0 385 500 385 614 552 0 0 552]/BaseFont/EMCFFE+AdvP4B3A35/FirstChar 44/Encoding/WinAnsiEncoding>>
endobj

148 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 187 0 R/LastChar 121/Widths[552 0 281 0 281 281 552 552 552 0 552 0 552 0 552 552 281 0 0 0 0 0 0 718 666 666 718 614 0 0 0 281 0 666 552 947 781 781 0 0 666 666 0 781 666 1000 0 0 0 0 0 0 0 0 0 552 614 500 614 552 0 614 614 281 0 0 0 0 614 614 614 0 385 0 333 614 0 833 0 552]/BaseFont/EMCFFF+AdvUnivers/FirstChar 42/Encoding/WinAnsiEncoding>>
endobj

149 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 189 0 R/LastChar 121/Widths[281 281 281 0 0 552 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 666 0 666 718 614 0 0 718 281 0 0 0 0 0 0 0 0 0 614 0 718 0 1000 0 0 0 0 0 0 0 0 0 500 0 500 552 552 333 552 552 218 0 0 218 885 552 552 552 0 333 500 333 552 500 0 0 500]/BaseFont/EMCFFG+AdvPAC3B/FirstChar 44/Encoding/WinAnsiEncoding>>
endobj

150 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 153 0 R/LastChar 223/Widths[552 833 0 0 333 333 0 0 281 333 281 281 552 552 552 552 552 552 552 552 552 552 281 281 0 0 0 0 0 718 718 718 781 718 666 781 833 406 552 781 666 947 812 781 666 781 718 625 666 812 718 979 0 0 0 0 0 0 0 0 0 552 552 447 572 500 333 541 614 312 291 593 312 885 614 500 572 552 447 458 385 614 541 781 541 541 479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 0 0 0 0 552 1000 0 0 208 208 0 0 0 0 0 0 0 0 614 614]/BaseFont/EMCFFH+AdvP3DB462/FirstChar 36/Encoding/MacRomanEncoding>>
endobj

151 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 154 0 R/LastChar 42/Widths[1000]/BaseFont/EMCFFI+AdvPi1/FirstChar 42/Encoding/WinAnsiEncoding>>
endobj

152 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFE+AdvP4B3A35/FontFile3 179 0 R/Flags 32/Descent -199/FontBBox[-145 -239 1000 770]/Ascent 722/CapHeight 722/XHeight 502/ItalicAngle 0/CharSet(/space/H/u/m/a/n/W/o/d/s/I/t/B/r/e/colon/A/U/p/C/i/f/E/N/T/R/O/D/S/P/L/F/V/G/Y/M/comma/K/b/v/c/y)>>
endobj

153 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFH+AdvP3DB462/FontFile3 180 0 R/Flags 34/Descent -204/FontBBox[-187 -239 1000 812]/Ascent 737/CapHeight 722/XHeight 464/ItalicAngle 0/CharSet(/space/A/two/zero/one/eight/r/e/t/o/s/p/c/i/v/a/n/l/y/f/M/d/b/fi/h/period/m/w/u/g/dollar/nine/six/H/x/comma/I/hyphen/k/C/U/F/five/endash/four/T/N/quoteright/parenleft/parenright/R/P/O/percent/z/j/three/W/D/K/semicolon/colon/seven/S/B/E/G/slash/Q/J/q/sterling/L/fl/V/quoteleft/emdash)>>
endobj

154 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFI+AdvPi1/FontFile3 181 0 R/Flags 34/Descent -207/FontBBox[13 -323 958 824]/Ascent 712/CapHeight 0/XHeight 714/ItalicAngle 0/CharSet(/asterisk)>>
endobj

155 0 obj
<</Type/ExtGState/OPM 1/OP false/BG2/Default/op false/SA false/UCR2/Default/SM .02>>
endobj

156 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFD+AdvUN-Bold/FontFile3 182 0 R/Flags 32/Descent -199/FontBBox[-145 -218 1000 770]/Ascent 722/CapHeight 722/XHeight 502/ItalicAngle 0/CharSet(/space/E/D/I/T/O/R/A/L/S/i/g/n/fi/c/a/e/colon/t/d/v/s/F/u/r/o/K/y/w/C/h/period/comma/P/three/nine/N)>>
endobj

157 0 obj
<</Length 696/Filter/FlateDecode>>
stream
HâÑS…n€@Ω˚+t3˚í[‚$çª†@Ì á†’€Sƒí!…)Ú≥˘ñpfîä¢ÖÅCìè‰„#-(˛˙›ÏÏ„äªa&)hÈ
•pna4h∆
På2WÙ~∂}·÷c"Ö(%êJ»)‰r=;ªa+÷€ì‡§Lu&3X[a¿*ãQá-÷õ¯˘={ ◊WÀı∑ÔÀã≤≤ …óÚ«˙¬ÒGãJ’W{{:‘%ziÀJâ	˜›©mÜ¯äÈu€DSÉ#À1y9(ryÍ?ÂùßàÀ"nÜΩHh8π;6ıËÜ%ãÓpÙm äQ∞‰tànÖV∑Õñ ◊√rKÇå~òöY2,ì1ŸolhJAc#d±«∆ÎÿÖdàÙÚtö¨|õ0-(«MB2†1nA;ÓIÅ¥îG$¬Ê|^Æ˝µ4ìúq
3∞àd:e|à·g72∑å:”dlTΩ7¨¨%ùÃebílÑM±ì)ÜPÜ±§@µ§·Æ¸±Ó«Éo«86Ò∑∑:ı;ﬂ?#√åÃ—âC≤DŒÎD:Ó´é°î‹µ·…˜Ëd„sÊüë[_?é˚º}û÷˚ΩoáàÒÜ
∏Ô¢º9e}(D^`CæüÁût.⁄÷«Ó1…)q—ì“˛≈%TöóˇpcH#\ÊÊ∫	c◊W°≠˚‡∑©∞√¬ÕS›n¸ê≈,Hhs€:Î=ªY‘Ωü47›üßπNÖ'ÛΩIFÂË\xvmxŸîïCÙX™¨9ü∞‘§_
R”¨∫7õQ\≠v‚8º^û§À)≥Ÿ÷§˜cﬂGø”&8R‡∞V˝¯<úå„Œt“O™¯Íõ∞â·ïJ~˙÷ølB›á»Cå·$4∏µÇ;≈≥„éÛxÀL
èôå˚zå(^ ﬂ!,©
endstream
endobj

158 0 obj
<</Length 674/Filter/FlateDecode>>
stream
HâLSMì€ ΩÁW‰∞≤≥fÉÒWÓùù∂3ΩÂ÷Ÿ±qLã¡c∏˚g˜∑TB±€BÙÙÙÙ˙V≈Ò⁄r.öBœ«Îó{>]^ﬂJJ	~>Á•~≤ÜÁß,/*.Ÿh¨5ﬁaÿäM⁄OVCTÊº`ÉÍ(ÿÍ◊|tÅ?´â√vˆ3æ8Û:›˙%&`f\Ø€¿Å'»ˇ–ùi’¨©îd≠ÒÙ~˝~»$ÆÍc&∏(dIuàfTQ‚ra=UíÄ§⁄%&é%Lπƒ±∫Ì0{gZ îD:}gq÷*é⁄≈W¿€YπªÓ±`˝ÏG<◊ ¡SﬁpA	…nª<†BÙâÔı¯=]*ﬁú2ôKﬁlØ8∆5¸jÓ4ÄaıüIªÄ≠Hƒf´F0WQ[2ø¿1,Û≤ÑRÓ¢À˚ÏΩµ~E ﬂ>TÅ2ùQ7°Ôù\Ô}§Fk∂ÿVœ·Ö∫k∂Ÿ•îÇCuÑ˘Œ$£D±6MËyUÛCß<Õ,êæS!¯÷¿å:∫)6p¿¨0©h@Ûml4èù$yAVM¬'±π:ç.aÆ+=pPﬁ:Çﬂ\Û∆›ÒF‡‰âó¨.P«˜xç≠lJﬂ∞‡Kz¶¡KÏH›09õ¸î˝£∑XÖ˛≈ªùuÎÔŒƒ‰)*ìcıŒÙüÌbc}ñúÜp9ˆ-H?`ƒq¿425KãÏDÖ√x‹¢õ¸ß√}™ì√wZqHÑ◊zç[í¸7ä–)"°x$≠íºÏ+ìR˛¶Éâò¡iØ~∂›j∫TCÄ¯£˙çg˘ˇr≈6Ã@µ
p<ßñç†À-D…“8À÷á«ﬁdìÉ(ƒπ'fR‚¥@nÁG,(•@ã ZKÀOÔ«ø $3`L
endstream
endobj

159 0 obj
<</Length 705/Filter/FlateDecode>>
stream
HâåT±r€0›Û:–ΩòïDRî∫ÂöÀ%íûOùö¥D«l%RGQq˝ó]˙?H´πv y0( è õœnÚUæjˆ5≠À¢\e;õ<£%Ø™ÁÕ´f∏¯F∂∫’6¨7¨»©$W›ã≤≠û>Æü	,œ(/3—;ge5ìˇ·}:xgMÄYÄG7€nÇSŒ)# k4söÎ¬b*4£wª^ò+© ∆.ÖVVÅÂ¬A˚£ôtrï‰†Uß»wSQ!k∂⁄ *g@Ëçnú{å≥tΩÉúØ∂”æ?˚å_JZë÷ŸŒ`PP° ^ŸÁs Ê{ÔÜ\ìAıv>∆_‚G	¡%´"Szö.SfÅ‰÷º.ÉjÁzîßcO∂d}â* A›ôitX`!$êÅ;th¬3Ox1Vê6IsK†`ùE5"kÃÂgı)$‹`…†®»¢& wCb% htG"°∫˝bΩ}<_VËC2k ≤≥Í∞xg" c«ë8√Óvsõ
©Å‹†¸Ø) œLKú˛9Í6ËÓï)ñÃvŒk’P¡lΩÀ≈Ø¢ÄØAóùÈ{h:%Ÿù“ëú¶‰ä4Hô√m5πèÅ§ìÎŒN¡Ñ9Ë)E»X6èÂ›∆	˚ù<‰ë‹ﬂ›>Æ_…mı§ïè¨x	%q>Ï°«»ô@z∞–ùh2! ˆ›¿ πH#Ë≠˛Ú∞m |$≤Óò`ÈÕÑ“q^AŒ≤UY-âùXhÅA?;¢ÎÊ˚[ä2!™¥ƒ7sòc„d ^â⁄¬æ¬–æÒu%ºˇ_!&K"Ã'Ef¡«ù.d◊æ(±Ê4c∑hQúøRí$5≠ÍÒ(”ë∞sìkM« 3å™Îß’ 1·^
endstream
endobj

160 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 191 0 R/LastChar 119/Widths[500 447 0 666 333 0 0 0 0 0 614 0 0 552 0 500 0 552 781]/BaseFont/EMCFFJ+AdvP3E7757/FirstChar 101/Encoding/WinAnsiEncoding>>
endobj

161 0 obj
<</Length 641/Filter/FlateDecode>>
stream
HâÑT¡n€0ΩÁ+|¥áZ≥dKñvVh¥¿‡ùÜT[ôç≈V À	Ú˜#-9m∞C.§I=Ú=íiwπ$\qû‰î–™‰Isø˚ô⁄}ñ≥™ 4=€eÍfJI™Ù¨ù”ìüCT§çä‘Èhù¡$AT:{∑¥~q¶√(≈¥„—Y›ˆË3¬R=u>é÷˘¡N⁄Ø
>”…Ã~4ìœ^ö«]ÛZ¶,/KJ –:%8≠vÊnç§¶[ZçHw!(Bù≤dêÁÃ
¨Æ g6⁄µ=Y·?~•	Mö˝N%òH
¯EIVR&%-/Í§°ìoÊrŒ@6ñZ◊Õü"êX	»DêÕVÇîå≤[î~5P‚\n*É#à¸∫∏Œ 	. ˇ6Üt—FÍ¶µìáv^Së‰8Ø›%¯">≈˛r-0z;Âw⁄˝•)⁄ º”√4LøB⁄;AØjG˛Ï _qµ—Gs”êÒöP.U†ˇ‘|æˇÒ•y»¸Ù9P¢4¡ÖRàÄÛ˙°6êÖäu¿(	Ø™
 V≤Œús∆l\;\p¥XÍ{s[ZYÉRÒŸÏ◊Ωƒ\q}≈azy–js± ™Xû¨s•≤ëÊﬂ∏∂TD^/â j;™(Ã;ÄØ`}ÔåˆË¡b‡≤V)÷R®P‡à˚∑ëÖ◊Â-Z5<?.Øá°›ºﬁËÉÔ—c$éN(æ¡^˚æÕK ÄÜäõv¡PºŸ”–ô/úŸ€ô⁄ìqQhxÖÜ6e†	”Ωv9–l˚∞V
Â∆£n˝ø»" ï∫h{g'§áz∆ªòIà“¥Èç[uƒÊ†aâˇP!>l«"”ΩuŸKÚGÄ 	{I}
endstream
endobj

162 0 obj
<</Length 720/Filter/FlateDecode>>
stream
HâlTªn1ÏıjÇà‡˚QHe ù:√uG[NGÅGŸp>÷ﬂí]RÜå@P°%πú›ùﬁ˛a√∂;Nπrªˇµy$aûÛj À∞“SOÚ3FäZR‚ö/eå+l(Nj∆)óeäe≠aôÜß˝√fˇÄÍ1;Â5U‰«cX“Z”ÿ∑89Ñ5≠∏∞_yE/ Ûem(Ω1g|oÏ-Cïaßπ•Üå˘tûSÔs•-›Rß¥⁄2¯AKV¯-Wñ2√ûZa∂˚”Üaˇg√UÜŸñ¸sm®„BC∂¶ÃZéÈèdèc`QÌïó⁄™Ì8Ù∆î˚èº#ŒpA*C‚ÑàJKç¿–Ñ+Au#N∑éúK~MSª†®$aÈWπúw7*ßP1≈[HA]§wÄﬁ∆MOJZ”ÚÇ+JHe.‘#∆Vd<ñºªGÓÇ Hc‡v„7Z=ÉÊ8s;ºvn¿æÃ˘f‹ó∞åaÆ«/»7JP4…q¶8Ê%üﬁ)Æ9\˙ŸÙ’ÿkpq-y=«±¶◊x£ ,a~oñëí—n)W t‰wú¿•≠5—ﬂ‡_†[Äø∞∆zoÁ\@^mH0Æ0∆V[πø®ò÷hWx:¸”á∆N(˜î+¡∑‡ß≠ÈË/y‡®AIq‡®¸˙ΩŒ°ZZﬁÊY2•°±Ç:*/∞âéé˚-”ŸTŒ7-;¡¨A¡;ÙøeDw¯B;<v Îf„à9·>Ô40“≤A98`~Ù&ë—ﬁ ∏	3©xKêp»XûìKÌ∏ä8*n∫ùRGòÁÑ≥ÿÊ_˜†9|ƒZM7!5tvà–ö$Òcºé
¶Jí⁄ßG"«0u ÁÆ≤sX&Æ˝£c†vÏü†ÙΩ˜uæÓ»Ê(Õú}Â¨I°Is	CwŒ]H|ë@¬û∂ˇ ¸`X˛
endstream
endobj

163 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 164 0 R/LastChar 180/Widths[218 0 0 0 0 447 447 218 0 0 447 447 0 614 0 218 218 447 0 218 281 218 333 447 447 447 447 447 447 447 447 447 447 218 218 0 447 0 385 802 552 500 500 552 447 385 552 552 218 447 500 385 781 614 552 447 552 500 500 447 552 500 833 500 500 447 0 0 0 0 500 0 447 447 385 447 447 281 447 447 218 218 385 218 666 447 447 447 447 281 385 281 447 385 666 385 385 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 218 218 0 0 0 500 1000 0 0 0 0 0 0 0 0 218 0 0 0 0 0 0 0 281 0 0 0 0 281 0 0 0 0 0 0 281]/BaseFont/EMCFGK+AdvUniversCL/FirstChar 25/Encoding 165 0 R>>
endobj

164 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFGK+AdvUniversCL/FontFile3 183 0 R/Flags 32/Descent -194/FontBBox[-156 -239 1000 770]/Ascent 722/CapHeight 722/XHeight 505/ItalicAngle 0/CharSet(/space/S/u/b/m/i/t/e/d/f/o/r/p/l/c/a/n/J/y/one/five/comma/two/zero/nine/period/A/v/s/asterisk/C/colon/D/g/I/hyphen/U/H/h/W/seven/N/four/six/parenleft/k/at/parenright/K/G/M/R/w/j/semicolon/three/endash/F/E/V/eight/P/O/L/B/q/z/Y/T/question/slash/dieresis/fi/ampersand/underscore/Q/Z/x/quoteleft/quoteright/dollar/acute/X/emdash/numbersign/dotlessi/fl/equal)>>
endobj

165 0 obj
<</Type/Encoding/Differences[19/Lslash/lslash/minus/fraction/breve/caron/dotlessi/dotaccent/hungarumlaut/ogonek/ring/fi/fl]/BaseEncoding/WinAnsiEncoding>>
endobj

166 0 obj
<</Length 687/Filter/FlateDecode>>
stream
HâÑTMo€0ΩÁW¯ê5‘Ç%Y_˜aáªÂ÷ˆ‡:n¢¬Ö„,˚ô˝I{îì°≈69Ñ¢H>Ú= ª˚MUîJ™®M±˚∫y†4
UIE/]+îíÅñ4	e••Qäß›˝∆ÀP€∫®s2z¨4>çÑËk_ÏÜi±{›†TÌ*ü£o∂éFM°+/ç∂ë√Ë{«¿Åˆ	¿55s'Jµ¨©ùNByÈhe]qÃõ®hF{4¡xÂ<G]ªààˇ4atFß‹nieÂT¸<‰À4ã“Uéöæg√”e:`„Âê[:]aË çPÖ«C«F§=.ÈeûVéˆ8©i´ÉPWReÙï‹‡‚ä˚úzë„z&’–(Jÿ^ 3ÒAKO["w„…… Ø∑¿»π<|ü‘—4ﬁÒùCÿM¥∂?sã$é\ˇ¿%-2Ö∆r˙–◊g>º’“|÷ﬂs∆o˝‚òàaÂDgºôé›∞“”çx«Yê1√≠ÂCÜﬂ}ËÂòòt}d]¸tûπFMáƒÌ∑Mœ;¿Ñ]&ætf}∫9qéA\~\ÀÔŸX°¥5œ›
±`©˛¢«πøÚ÷1.◊¥ÆB˛5ªpŒfiÛ(ÀëÕöÕÅUÃ_Í~æ±d„_/“ûÅ\f>K¸Úl∫BØÀ?ﬂóÉ∂2Ö2l˚ü˜Öu1÷◊áZ’˙KYiUªÄﬂŒ`#ÃÀq5Ä"ÁÅOñ¶πÉv∆E3]Có∑Ü®I›xuqÔn;±√”È∫[8Ëh’«!ÅÆb\—ie|ﬂÀªm|Ä‹œBQÍÒ(∆G_‡˜|ÈÚ¿≥˙«t8B¢|SCÖf¸SMûeå4¢ﬂƒãXzì∆C@Êƒ=¬≈kä>ixﬂÍZˆ°ø±µâ;ÒT¸` Ç2
endstream
endobj

167 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 174 0 R/LastChar 188/Widths[500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 270 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 770]/BaseFont/EMCFGL+AdvP4C4E74/FirstChar 2/ToUnicode 175 0 R/Encoding 176 0 R>>
endobj

168 0 obj
<</Type/Font/Subtype/Type1/FontDescriptor 170 0 R/LastChar 170/Widths[552 0 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 791]/BaseFont/EMCFGM+AdvPSSym/FirstChar 60/ToUnicode 171 0 R/Encoding 172 0 R>>
endobj

169 0 obj
<</Subtype/Type1C/Length 279/Filter/FlateDecode>>
stream
hﬁbd`ab`ddpıuvs˜’vL)ÆÃââ˝êÊ˚Ì˙{˚ØÛø⁄Xœ_Ï˛˛@$√	Wå≤ÚÖ›lååL¨ Nôﬂ˘æ˜Ò˝ÿ≥Ù{ïËè÷ﬂU¨'Ÿˇ∏~è˛ƒ &H(˚c˛˜¢ZøW±˙≤ˇp˝˝àALêHz—!†l»èV∂∫,∏î˝\˝„‡—∂•Õ´3VÜÓPÍå≤pÌ˛myÃ˘ÇÂwÓôÌﬁ”≥Æg>G[g~uaqiB¢˝‰‘Ì~óó~Á]µÒÃ›Ôqìù9˛ƒ:ä˛˛Æ˜[˜{0Í}”øıÄ"¡@®Ñ¡rõ≈æ€|óB˝[ˆ∑¬iê∏@Ä ≥õö´

endstream
endobj

170 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFGM+AdvPSSym/FontFile3 169 0 R/Flags 6/Descent -226/FontBBox[-177 -291 1083 1010]/Ascent 754/CapHeight 673/XHeight 772/ItalicAngle 0/CharSet(/space/ordfeminine/greater/daggerdbl/less)>>
endobj

171 0 obj
<</Length 240/Filter/FlateDecode>>
stream
hﬁTPªnƒ Ï˘ä-/J¡„R§∞êNæDrëá‚Kz÷R„¬¿÷E)@≥≥Ã0ª¥ÌŒù≥	Ë{Ù∫«Éu&‚Ïó®Æ8Z\Ä±:ÌUΩı§–,Ó◊9·‘π¡C”˙ëõsä+û9ªgw@ﬂ¢¡h›áˇ¸ DøÑÉ∫§É°Ìã
ØjB†U˜G^÷Ä jÕ˜ØΩ¡9(çQπ°9j	çR–ôˇ=Ú∞)ÆÉ˛Vël/;∂2c‹S∆è"c¡œ∏e˛tí$˚Ì ‚\æ•‘KåyÄ∫ï≥¥oã>î<Âê_ Tq 

endstream
endobj

172 0 obj
<</Type/Encoding/Differences[60/less 62/greater 130/daggerdbl 170/ordfeminine]>>
endobj

173 0 obj
<</Subtype/Type1C/Length 297>>
stream
  EMCFGL+AdvP4C4E74 ¯w˛R˙Ó˘ñ’ﬁ‰ã˜º C15AdvP4C4E74   á  K û  jà sê«¯à˜ç√ÒÁ‹˜˜ 3‡!%0;˚ ‚5ı˙|˜#˜£ëí¶ù©≥°©ü¥îêáíÄpç3L˚p|~äÄÄ°á•z™xó~ñÄM…~c§ñèíêè~Øk∑q≠qúÉî˘ïì†ã°ütãÖ˜¢˜3˘eìãüuwãuÖ˛AÉãv°üã¢ë˘ñ˘C˜€öûãüüxã}¸Î}xãwwûãö¯Í˚Vôûãüüxã|¸È|xãwwûãô

endstream
endobj

174 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFGL+AdvP4C4E74/FontFile3 173 0 R/Flags 4/Descent -249/FontBBox[-20 -958 1114 770]/Ascent 750/CapHeight 717/XHeight 705/ItalicAngle 0/CharSet(/space/j/C15/onequarter)>>
endobj

175 0 obj
<</Length 228/Filter/FlateDecode>>
stream
hﬁTêMk√0ÜÔ˛:∂Ï‡$á¬ ∂îA[K”ÌÓÿJfhl£8á¸˚⁄nËÿ¡¬˙x§W‚M{l≠	¿œ‰Tác5·ÏR=é∆BYÅ6*l^∂jíxÑªu8µvpP◊å_br¥¬Ó„ı•ÿ?ëF2vÑ›µ¸˛âÅnÒ˛Ü⁄ ∆õOÈø‰Ñ¿ˆªÆ° ~πvg/í¥#B}êÍ^	@´ˇÁXı ˙A˝Jbè ¢8º	ñÅ¯oã‹Vë:§µûb‘BuÊ›≥ú$ƒX|û«;üÊ¶«Ó {3kˇ

endstream
endobj

176 0 obj
<</Type/Encoding/Differences[2/C15 106/j 188/onequarter]>>
endobj

177 0 obj
<</Length 707/Filter/FlateDecode>>
stream
HâlTÀn€0ºÎ+x$Éàüízk„mzi=9»2]´àïÂ˘˚ŒÍë∆Ha¿|ÕŒpwá*n£Ñ≈J™\Vl¢X&öUtœ˚Óx¨∑èœ"ˆﬁ…úo˛BUûéÅ∂rﬁÌiL±[∂4Àd∆Î∂V>‚‰°ú¡F:âá‚6*.&ÂgïNƒ'°d «æEÏXáñ2éµv9V‰r∞√Å◊‡ÈÖ5≤	3Æ]÷G"HY÷áÚÖ≤1Dá0›kÆBÊÛ•
*7Û´” %$-ÌH—©„=6∫ßzvr¢Hefùe	~^Ê©Œô1âLºg©ìIbSV4–+◊¢¯},"kºL«¨Œd™4£F$û)Î•5B¥èÆüßÍ„Œ1+èKëªÀô“ZZóÆ|gòûˇ`~GJ'î¸îÖ≤V&@XÉ‘rèHî˛®öËÍs£ÿ¶ãæEäËÍF1≈ä}Di„Jk0µËëÚ§™¨LΩ3TÉ{~}([tPô…;ºˇ"1Éí„w°Ωƒ‹"î=l¶‚^›d≥Få¶Á∆0å:≥ñ⁄uœÔN€¶GbD| µ…4öæÔöÊòˆßÌc]ïc›ëbÓ¡}[∂ßrx¶•Bòr§öëª4J07ÆÄå#wË\˚YÓ}UÖ~údl2{3CÜOıq>P§ﬁPNÊïíJ%ËWJØÑñº»ÜdH≤·rCM˘ı2vB)2˛∞¨ÉPfß§˚Æ›Ö∂
ÔDlÒtﬂtûáæ\¡£P¥”–+’‰j Ò$ÏÙ¶≠üzp~Üˇ,î„ó+›Áe∑ Ú¯Mïh\/øº°]=Ö†€ëë1tÒ˛|BÒ˚r
Báa?	ï&∞l	„_0»ÑöK_)\Ò”≤f¢rä|<áö°éÌÍö~¯£A|ÌÒÌ(‚á gt'˜Å˝` öÂ2w
endstream
endobj

178 0 obj
<</Length 543/Filter/FlateDecode>>
stream
HâdSÀnAºœWÃ±' ÛﬁüBÄHD{±8õÉ,~)_ôÓ}Y—J–[=U›]=[|e≈ñI•C‰≈ä-`PVGëÈ #îB©· ˛~$–… )˜Zi‡ü§≠b,Ö÷àoE@Fu™ÖÇÃ·∂ì<àFπ<æÈç€T%4’Yã	õã Å’R‰“√Û~€‚j-áa§Éˇ§¶¯ÔàÁÇQF|/Í) ó…(ùÌñ]°m#x%2„¨ZÙ∑–ºî’ßK·ÑùúÍ.Â{πıÈA‘≈z_◊º¯¡êù\ûsÖO{ßeäNsìd≤mﬂ1Eﬁ√ì(ûê´.fÉ	5µΩW2Fó∏≈©M¥ƒõñmXA¶5â’ÜX.⁄‰∏u“ÖTì–ﬁıßÉˆo·Vd÷bshü"Î¨¥“Ÿ|:§ó'ÙoFË≤u¥ÖªŸı|2¢7çD¬y2ùOPèˆˇytCÃà÷5Ó+û!Æ5V2ÏüœáÕœ_«v^’¥ÓÒ˙Ñç”ôøÔ¶“©ubFÈ‘4‡Ò\◊Å…Úpn0˝™Íä_o «Ú@WS0ÆV¥∞››·l|’åg@+©UL=Ãx›ü™µ§*tö|Q…ÖzåQ¡˛0Õ7úy\x4ëÁËàˆÅÔòF\oálﬂê‡≠DáiY‰ûW(Èít.5´∆œ%˜¸r“Hü_ÌXoº3|∏gﬂ·ˇ “gÕ∂
endstream
endobj

179 0 obj
<</Subtype/Type1C/Length 2154/Filter/FlateDecode>>
stream
hﬁ|UPWÌ¶_úE•«8M∫'Zä|∆A¯T¸‡'%∏ é"å3»*˛≤
3“†ƒ]ï®øà‡*¢Ÿ“çtMPq≈“hV¥+&j¸¿ZknOÓò⁄◊ñï⁄™˝‘´ö˜˙æwÔ=ÔºsÔhùñ—h4}&L7q‚Ñ»‰º“å·)±…±q™5T4Jhêa˘Ok|daÂØaWÔ-°Å7˚0Zçf«æq≈ŒU.G¡‚ÛêE·Êa	∂¯(˙õ0ÃúúWúk7œZÂ.±/sõß-*v9ã]9%ˆº°fsra°y¶ÍÂ6œ¥ªÌÆRjÕ,rî⁄]n≥√mŒ1ªÏÍÈ≤ÁôK\9yˆe9Æ•Ê‚|s∫£®∏dï”nôlß!í'ôsäÚ¨≈.≥ÉFrØ»u;Ú9.á›=ÙﬂÓ¡hË`z1å¿0ÙLÀƒ≤L"√§∞L*√L`fÈò&íÚ¿Ëñ	a"ÈwÛ\ÆØY†i÷¥kæ‘j¥Ωµ„µãµ«¥ﬂ$|p(†+‡']¢.KwëÌÕŒf˜±œI?b%…YÚOnWÃù·^Í-˙tΩÛuò¡–Ä¸KÔ@ãCà°?ˆ≈˛ÙUˇvm¯‚åm`a·89átä&XÎÀg1ù‡é◊˘,lÑ¸+hgeÚ€YC∏!àáŸ–ãªufùÕ6]äÑΩ†Éá1‘‘q‘9cFÅ3U™ÚèÁ!†&üÖÅ¶WìÆDÔeÓÊæÓö‡}|∑˘r˜ΩŒ'Ü:_à≤Üá)hºéâ⁄-òÄXm`áD0˛¶‘Iò@∆VgM*†∂‚{z ¥èOMÎïËú æã@∫|Cê3!Á§s∫,é$hEä÷K`ÖÃ µ&®E3ËpÖGD/1d_2*ÂÑè!⁄È‹£·>˘WÉJå‘ˆ)µ~
)pïZÛ_Ás0(ßaèQ\ynn˘Tﬂõ“C—ƒ_ÎÅ˜æ˘¢–*AÅ$/ÚW–.‡@úÉ≠ÿ
Ûba‡Gkk˛$]‹|~Î˘ùzxçüaê˙ 4œh¿`ıÂ„0l¡–Ç÷7πñ˘Úyu	V ∏~˘Rt2ÅZøéÖLÇ'îÅ∞Ó∞8Ö`v∞
^9b§¿Ø)/ﬁ:·[ÊcxŸ√˙ÜA4çáCõ=äë Îh–A œDña÷kÜûÍ≈‡À5“ìÉ¸W8èîÀﬁ˚A=÷‚∆™\Ù_ÀC900‡@‚±ú„—Å`pîKææ:∞B3cpù,h)¢œ¡áËdëŸ‡4¬a`9à€¸Ù3A
-8ºZD7	ΩÔ˛A%Ë1ƒDüV◊W)R>ñR3…uo´3Õî∂»1…+¢ë`êl‰¨Á≥k’•÷•nO”√XR‘∫·õäSÎ∫7›¬w∂ÎeÓ·ÓˆÀOLÜ}[1òÊ˘‚-…J∑≤ùáA®πCÅ¡®*«≥z\‚Â’/7å0çIX951´≠kãà1S7B`:$`ÖËvòDGFmÉ4µ~¬÷øõÆ\j¸ÎÌ„)[DCˆvÏRˇı2∞î™Èæ ±Úg˙¶˛P0 £0jU©ATB—Íü«·l≠0éÒÃïy™\ç0ö¿nµH-g¯Ø©Øò°\cq4ç¯é¬$ûZîVáØVÒxfÂ4-b0˙O≥êDãEıBPÔoU˝˚®ß«©"€j§w˘ê@•R∆b,°òæ∆p¯ZUT˙ÀXZœ‡C>£ jÀ)l<yÔGÔ9J{(Û{=;?;'úˇ8∑TZ¿Mó«VM_ÆèŒ[=b±)¸∆ú'◊œÌΩtDîI©\RS"Ç@<ıïıﬁ˝z8»A$≤«gŒ)wÁäãJúyﬁt=ïƒ®Â;>ª˜t[Ãò1Îc"ùœ:Eå¿H~Iï√≥DÑ"Ôì˜Ó3…$£˘‚Ú¬:!xFA?åûõYòS,y‡0F∆*n∏À√Ø™£naàÄ·Iÿ_∑Ò]Òn'Ñlñp0…ıñÕú!§y°Ô©JÈ∏\AWÖK;ÁÁV´ùK}µÌ·”{#&NtF$FÆ¯ïÖêIÈ>YúyxÆÄ—£∞
»wRB¬:.¯ºYíâ[.ë›*\Os’ëfìOã≠–ΩP¿7oj™<,V6U4Æm–õ3∫…"†%ıâ£:#!	üµBv	íµv˘ π¬òﬂ∑wH›∫r˝ŸN·V˝ºŸíÔ¬}__Î,Æq
øŒäk•§∞€˛¡°˛æ;öTæêˇÚjΩﬁpUÒÚ~/µz9¥ÇìGÜØv(§[Æn¬rK>qÚ¥e˝¥Ãj	/®&ÓøòZ´OÆn/î⁄Zg	c,K] ˝≤^X(—&îMÙˇEÌ‚vzö ã∑VEõØ∫eQ∑÷ê≠tP¶!&ú∂⁄¬i7â¡òÁf∞ÅÌ˘è#˙YcW˝ÉGèÍ„Fé\gµÆy–EÊ´Ÿ¢àº§∆±ƒ‰ˇéf®óπå¶ˇ)Çô∫ˇòûßq‰¸öúRSµ0Kı!ìÍÊöÜèÍ?iﬁ±_÷w@í$ß˝vÈ(ΩáT}œ™ÍöØË‘?ºa-Ô±ÿ7k >,}Z"5V‹,[d +,À]∏xœÒ*%Çú¸èlÉ©¥d`kˆ]SÛÓm'é4≠q»*Äj
 ¨7q®Ÿ??È™´€)~ÀyWØˆ¨Ê˛n◊5	÷€ç,X8å»dápî≥F™∞™FO£∑QØD”:i„R<πøY $Øπ‹Êï†çöÓreÚ“è
≈î]œÚœwN7ûjíh=`§R/ã)>|¨v<VÎün´⁄P¥–˝¶°ÃÒ{”p&ÂÖ¿fﬂd√h◊9‚„ˇ%¿ …åª8

endstream
endobj

180 0 obj
<</Subtype/Type1C/Length 5453/Filter/FlateDecode>>
stream
hﬁîXXg∑dfê‡çcô—oà∆¨à]4àD¡àÄ(∞ J§JÔÕPÈM‹ï≤ ¨¬R≈ﬁ≈hliìx’îˇ˘6ˇsgëΩ1ˇΩ˜ŸÁô]fæ9Á=Á;Ô˚ùÉ¶Ü∂ñÜ¶¶Êÿ5õÃ÷ÆµòeÍjΩ‡ì’©ÔNÊYM~≤ﬁxlÖèÏ%`Èh∞ì3ôY0VCKSsõƒÃ? <–kóg∞æ”G'˝˘Àñ.ö≠æ.∫.S_óÕ◊7u˜wÛ–ﬂÏ·§øn∑ƒ?0¿?pG∞á˚\}}S__}µç }è è¿P·Ók844Öè°©°£•1j¥∆‘Ò¶åÜõÜÜüñF∫ÜÜ• _C[É“ÿß9G”I3]≥UÛ[ÕüµFjM‘≤◊ä’∫3b√àtmmÌ:bD$íKI9EPbJ©3B«OÁíŒ‡»#œÈjÈ∫È∂Í™ﬁq{G•ó®˜b‘ÇQi£Æà¨Eq¢FØ3˙÷ªÏªc¥∆8å)Û|¨Ûÿî˜tﬁs~Ø¯=g5Æl–≥Ë0∫{¸ÏÒ&Nÿ8·áâˆª'ûù8á±H5U˚kË[öèîú Îa‰¡µ^€Cú]‹#“≠Ñ—åŸˇË–º∑Ú8û|A’{"–èãqKsdºjÎõkdÌóÕ?«:4ƒXÉöñ∞p¶L>≤|±)cËõ·◊ºñ0ÀÕmL”ëòüF;ö∂\fÓı5‹(@"òÀ?¥£]¸,$ˆ¨∑S~Y,WÌSÈ¡b
Î·…Xœ¥«ˆŒo†	„aLÒß•…%\BeU !∂ıh±T e¶´t˛òHtì¸ÇA	Åïx
ç«L≈úÉèÔ˚6ﬂ-@eaUQ’	:πëQÃ#ï5Ω≤◊˘6Læ´∏vØ∆¢˜ÒL"∏”hLÕƒ"”ù~’mÁûÄ√@õÃUåD*üﬁä˛i†Ò‰EÊ¢WãÉ∑_ÄØª4¯Ë˛˝˚Q∆˛Ïå,6;+%…€’∆“â·ˇÇ˙E4ûì?Lcåe¬˜Ñß®ñ¬f„˘x5ÉWﬂ√Ü∞`˜∫–0¡@&ƒjÃ`c·{¬L‰G¡Çg˜¿V3∞⁄Ê„œ SøƒáÄ\xH»?9é4dﬁ¡ô§ÓÁ¥ó,@.óIÂrôóóøøó⁄§o4}ãÑä¡D¬Ñáß4∂∏ÉÕ¡åÓÄ9XÄ≈J∞¿Fÿh%∂¿4ki9u˝∆çSk∞≤¢∞œñ5ü|≤Â:¯{ô˝åväL\é∂ãyVπÜ\üòwÖ„Ô{RV[ç√V¶ÎàR'$8p"~;,¢-cR7±8ûî’¥u Z:†˚cSÁOËbÌ¨Åß-ûchQÁvº°æ≤	›6ia}ßÔq“i…Ï][4õ–W[≥v:AºUûÑÑÒì¿ö6îXÃwj™AÚsëWòFü*o◊@w…ú´´`.LÙh?ﬂp…†eR˜*.Ù√¿»ô˝˙xÅì˛VèoÖºR&G«$9i◊ëK◊îªÊ.Ò∑6BŸë¨_bbhTYbWz8K ~)∑öÕâ‡"å†m”‚6"w1¥+Ω»m±π}‹usèÅœ©÷¨3ŸùHB‚Tª	[h¢p»IÇ‡ëâ/ê"XƒG'U˜«ı∞0Ìÿ/≈π©Y)©1…I!\R®O≤+kÎîìÎ…ÂzÁ$≤Òd∫A,&bﬂ◊âOãgˆFîU¨T i≠¢®Ö˝µe˛¨πûbçïvçRÆˆT y!ÙC~Ó;±ﬁ€`$ËˇÚ=L4˜[å\vDGHêà◊Êo–>áööeıGŒiXçß„iò≈áÃ[x¨Ç…èÉâ0rŸ#¨kfÁπq'J'ag÷E–Öwÿc˘1ë\Ëﬁ4o¶Y•GœuYµ¬‹˙ˆw?µ›˙‚qΩ≈T$:√ª”«+$Ne üLº∆˛J‚Ixﬂ\,û≈xîÌjÌ®¨˘
Ï+œ
˚r5R1Nõ“≠Xœüfπr.Y.Y;rtD∑˘zE˚¶Î~(ù˙8dµù!#§U{#Ë˚Îò¯Ãµz:∏∑ˇ:#fú0¿có,—GÌ¯9˝†•Ìf∫‚ìR$f°ÒcCÀæZy⁄1Ll„å0]∑πwÄπqY~ıvü¯c!3·wÔL€ÄuÒ;¨[|Q)ó_qP ‘ÔëÓÚ˜Ÿπ‡âœMò.‰êÅC0s,«´dC}<è|`∫}çé"ú˝}€≠ªWœòÃõÈ≤j©°œï_’L˚ú7Ë/0PˆUö⁄ocÂˇáË%¸≈ø€µ$çáR%iï±#ØÉ)ÿ_û/C“ªTëXó»ﬂìù¿edÖ≈pFI⁄ÜÁç‚pŸ‡ÅE8Eı˚ﬁÌæ˛ˆ˚&A §“@ÇR •íµ@Ê†›\\vÈªä¥†‘∏ß¿s;3œe;6¸43· 8Bü$[ ‚$úJJI"‚‹ë≠ø^ˆGì+xJ1óI=Õø€ˇÛÌ™˚xRâHPQt¶Tñ!eaˆe_<OûçE&	z9Qz–êÓp2?d√bcºà3ÊKœYpÊÁ∫}œ¬™üû¬‚*Œ˘ Åﬂ3üâß≥&Ê«ÆyqﬁWRÓﬁd¿Í|3a‹e¸û‘Äd4¥û§Ë≈ë¡eo¡zá˝õï◊ÆsÁœ…‘àÚ˝÷˙::oø∏OcÒ◊÷˘t„Å¸ª`kﬁáGƒÆt∂BÓéëx
kù›( ~´aìpPù^g˚ËP˝r1Tù§Ó4ŸqJ∏/&?Jñx,dwA"ŸXú}∂u'`◊£Cà’sR˙?“}™‹Fnå-ïqP˛lXøa„;Ò0.—˛Ê‡\∫€a}Â'oÕÍÉ{≤ãΩ‹±yD#ì’˘≈µË™&ñë◊ãb$úÑZ¥ŸÎÂΩôÁgÒ(<Z.xåÇFuûÖ#˛>º†qŒ´©¥%›#
/•e-Ë§˘'2ÜBÿﬂÔø∂EØﬁáJÑ7èˇœ_Ω)`π	R⁄&›2~≤âtˆ∂f◊ÿÙ5‰Ê‰rEÖ)EÏÒ™:Eõè‘eì◊&;¨Ûù-h\ºZ⁄’ 5∑\`xÊÔ∂Ö<:
ª]Aˆï«ÖEDFD,¬ú˛?F0áîyò·\¢0ºhoôÊã∂à·{%∫'33äãÃå(jƒ)ÛDò
Ô˜ûËn∏ù5IâœQ¢ò∑W⁄˜VöóÎ∂l˝≤“¯ñø	â®‰¡ÇN'ÒæÖ¿y‚˛a+)¨aîàƒPØ§ﬁœäoˇé·#2)H¯c!QKB¯‡B"Suì¸3íØï6ofæ_âs˚ì¯€oi˘ŒÛ¸[:•ö¬7ÿM\Bˆ’§Ó>ƒ©B®Â^FiÇü&%•ü/øœk3)ﬁJ≈
^NˆÊ»ã§®H⁄ò◊ï≠£ƒçîêÍçß{aKºª≈Aƒsò.KXn8‚C„∆Éû∞;é¬#ÑJ2¿v0ØwàÇ
ËrèîV√;FmJ? ~u9W~íS g>c‡›˘∑«ˇ!∞è†œfÂ¸´„`zúùà(_k«8FŸÏEQaÓIv´[FÜèPÉ¡¥mrºw Rr9à€3@º∏’cAó˘'åïÂY•®4´8´ [ÎÂ(÷>d˙zÄ ‰T¸8˙ç`ßE.ﬂ±}auuª‘ ∆$!C¯pÈÈƒˆ10Ú.Á:6pwÇª≈æÍRØºÛ‰µV€≈‹êÜk“Öy'ûu§ ê,pø∑òôÓÏäÇ32¸ˇI√ˇ*ŸÇSàél∆láßv{üa¥ˆÇ'!ÕSºˆ∞·1◊√π‡«a˜∑µ/90I®ù…9?ùm<•è@*Rd«ªŒ£ªÏ6Wö±òûoä¨}ÕF˙q∞xq-\Íæôôªﬁ~Û—◊∞h7ÚHÕ∆çD©ºA8û¿¬¸áO‡ù_Ìna≤é√Ü≠ƒú√{⁄∫ô3mgü¬∏¨ÖG4(
’F„·Â˙·R-ßî˘%Õ?∑/√≥´ÑEëPO®ûêë∏ûPê0ª™˝¡œls~îòSïø˝PAó˝U–˝¬t≤‡c¨±Œ•Ë®rmNÏ∏«zØˆı+:ôQxL‹$Ë‚∆«?ÄÇJÍª¸ˆü≥ê◊S¬!-òÿüf.Â`ü
´ΩGÚﬂ≤≤ ¨Wä©Êã©Na©b®Ù±9ÔH$ó$ï1%yç®G9‘DˆÓÏt•∑'Ô`"S˜&á!¨£öJ‰÷„ıàÿÊ∏˙j¶<ß§’)Òqqy¥(5‰ '˝Î©>PØöƒ/&dI5˘LQ^^µ: π¿”Œúdè"º˛O(I¯êO#2IX®JSˇµíøXÛeE˝%µ•R¬àÛCËôfû∂òr˜ûÜZi]K@’Œîî}˚R–æî‘}ilj⁄˛‹Ü÷˛sB”åAA„≠{∞ﬁ∆9ÃíK^∑Æ^=‹€Ü∂’ˆ∞'é∂î¶ÌèÁ‚ìbÿ‡hY9◊úSªômi«4ejµ…´lwS}uq#™
©*`äºrO∂{¬´µóôm€$vØÌ¸LŸ¶’Hî?hFÀ»Üí‘ NµèrI^Áà…û{Ñ}So¿%F˚3¿‹Èﬂ|`mÁª5àKá'$^OsU©4û‚hπzµ„9ò˙ùÁnﬁÏ¥ƒ˙¬Ã≈30ù∂€Âd…Œuπ%Ù¢#;‹´ì∆ÑrQ˛Iﬁåß4LﬁZ*oÓ¥Ω8ÎŒ∆+∞Ó¨c:€Û}È√UﬂKT8?ùÍˆwêZ±XsŒla“boM˙JWÌ˘C\ÊBVÁ
 ,˛@78â¬ˆÒƒU"ç—vk≥O∂ù®˚ÃçÅ.kå`Ê¸N°·£$”ﬂHOr=˘Ò@œŒw~{åÛ™ ÷˘∏Ï0aW¨?:\1•–Õº∆KwŸã«˚ƒ'ªçØ⁄B„>G¸DËuº¢c%»_ï
	)â.îs5h)±÷Q
Ê)èù?Xîè¢#S˜0˛’AµÚ √W◊∂∆Ôöc”´Ù∂∏í#ï%U@˝ˆ§®∆ÑfˇjÆ§∞∏ ø,z€)∂™‚†¨—´¬7`g∏ß7wƒ√5œâùe∞Uò‡eégÑ›†VEy∏2é2ÔŒapHqtı`÷ûóÄ	|‡Ùãké≠˙®
>•ùΩÌÏú?noËÎk˜6DóU,Ì.Ù•x¨ßÏÿë≤#ùU(´˘hf3˚s}∞'Zè∆Cû¬8,oÍôı›96ÎWπ£t¯ùƒñÒÑ§ùzY7◊©?Û◊∂‘˝ßo˜5{¨G8b¯π0eè(ÁçËˆ·ùÌ¶‹£‚=ê∑ä˛|èQj”w¿ùˆñ44H•RoÔÄ o°Ìü⁄JZ?…%&FÔçac£≥pÂÖô’LMpπè_pÆÕC⁄Oú:‘Vã:\Ü◊•∞≠ ˆƒK∞ëÇvˇ›Ú"®ÁW–ı§º45F`UL'z,¡ßQˇ[†?RŒΩˇb"7~b*ìíàvI†BAZfáπú∆lúxÛ‚±¶é™ìôì∏ÑR'A(Ô·$ºÕÊ 7‰Vn¸ø«C∫"t8ßQ‘”Â÷[nÛ7£”—mf¨áUƒR1ó˛â◊
0õ_¬ƒΩ/M˙®MøkB˝“∫≥ˇı˝í@∆´Á>‘çûés˝uv'?'EÎ	€%'ﬂ0˚∆6ôΩÚÜŸ7û’Õ±&R√\-ÑÖÕa2D—`‘”u·Bœvı?O∂o‹Ë–Fh˙xåÓbAP¶‹5}WÄ&ûÇß¨¿öj
ÎøHïÒáô‘¶C]~WX†o˝
,Õ˛kX9lÛÁ“œ˘Á‚@A ∂Yb∂}H ∫Œ‹Ë~èËn?áFsV Üˆº<ôZÁ;´˙d\&^G˛Õ!DUÂı8Ç<ISºó∆˙bKÒ9–á… Û∑o+7·…jE|{Ÿ◊(vën9áπg‘É∞¯e¶ì{cR¢√ô›ákõ€=Î]åó€«
¨{gàu"ºnÒh©óKëªÿ“~—⁄√‚G°‹Á·ƒÌ∆Ìå√ñ=.mΩÚ0y‚Õçd]+·•ËâÓaÙ=˝Ãπ›¥î3®$6Ô9‘»twVµ=h∑1≠Dç∞\ËpG9øÑæèÔí˚\.ˇ´Ìå…@r[Ù‚Œë≤.›`†ƒ ñP…KBÒà˜ìt°∏!ƒ÷5õ)5À›Ãp„ûÜÎÆQÍtK‰√UôN}pzÎÛÀΩóÎPÊbA∏Û	ÖÂï]ÕÒ„)ºYÇ& iL£XJAj·¶º<Î(*V‡XI©»ã€~àc’Huü=>#.…™;N∞
Ï(°∫+íwGßE≈®[K>-ÅVLÁuÀî•Ö«‘¥€,9H…ãˆ∆¶á∆ÌÊV`OCà +ì*Úòä¸l%*R‡`I	YWîòœ·ƒy¬ÇÑ*5Ü“πM®TÅ˝%Ö§</…G8ÛÁ´êÉ\›'àG-YZöóÕ≠75yB$¶‰`
dU#ô«I»÷Ù¢ÿ¢°ï5ôàﬂ«‚b#í\S'I¿S·C$	íüW\\ ›∏{Qûü»ƒ'&á#	d+b»¿¿¸c>~ñ
^ôÚÉ≈≠B\nî⁄ˇ7C˛ÀjB"ì¬˜:s+±÷Ç˝ˇ#áq˛·Œ«<Å5\6ª≤……Ÿ˘\nn^9SVÈÔÌÏe◊‘˘Â•+`˛ÇÒpµ¢£¥¢KÌÀQÂÙ∫ÈßŸ˝’WŸG$ÆUç#<˘	T>¨¶)Àƒ≥,E
b:éhƒPÒÿòÖª4∞d≈÷‚ﬁLxzxj*ıı;‡À:xxou:Ó◊¶h*V∂pæ«O˘˜±?ˆ‹xxêÛ*&Ï}Ω6∞«‚r'Óê<_©`öRÂ…rãÿÑ‹{7ÊtÛEó‚ÚÈÊ›(|S∫≥ÛpHÉ≤Zq¸é≈eA+®•&X«±–πƒaYâ{È“≤√5≤⁄»j‚ÀñU´œ9m°‰Ò◊Ø§$KÚÍ(7.›ì/ª˚uﬁO°‚l¨R7Òñê`t˘Ïç∫ö∏8¥7"√áÒ´	=rÏ‡ëÊ[⁄±°±æ -˛sƒî‡ÀUËJ(ıÚKuˇ\TZûä∞6ÖªT"˙m8\_√˜˙)±4ä»	 ÒgÒ,µNÚÑÅª6ﬂ{V’+4æü	øè:˚Ô(Rƒwç4¶ˇ[Ä Ó#ºb

endstream
endobj

181 0 obj
<</Subtype/Type1C/Length 293/Filter/FlateDecode>>
stream
hﬁ,äøJ√@ áõ‚•ÉRQ®ãè‡‰#àXË à≥£ã≥bKìªÊÔ]z¶È].óÊ.)¡gprƒ…≈…—gà÷≈¸æÌ˚˝å∆F≥aF˚‰Ù∏€Ì]ﬁû]ÆKÁ{kO˝~,œﬁ¿ÀˆÎŒ]˝ºªZˇüõç¶a4ø⁄Kª~®?;éG""À±}†`ÙÒÄÙipãPô|¡™T-
9ÀÛ<+ÑdYíM‰HsF´±¬e®B›;sÁ˝b1Z ATXÜÎHQ†Me…J∆'3ûßRH¡X°äRñ¢L5Øx…Ê¸q@	$√¿ÚpëÉ"‚ÆÔaèxë3∂(åÌƒûZ‹N˘0Î=›ËÎ¬e(µR8(Å1ä˝R4ÜdÑWÜ†˝'¿ x≤áï

endstream
endobj

182 0 obj
<</Subtype/Type1C/Length 1860/Filter/FlateDecode>>
stream
hﬁåUPT◊æªÏªoQ∫RŸ∑	˚Ã{dq≥ÂßFtMåb0ÄíAó0†nÑò4Ñ]y†4çf’4ZóSMcbU¨X$öÜH*:÷âì`%`MìÛ»Y¶Ω€i3Èù˚«ôwÓπﬂ˘Œ˘ÓπOCtZ¢—h¶?µrÈ≤eOF/ŸXûùaµo-ŸË˜>¨äA&úç[~®öxã˚Û4ò˛Û=3Ù©”˝{SJ4lëü2ç#!f	'dV ±2WClZ2OKÏÑ<©%ÀµdïÜ<ÀëÁŸLHKNtÑcßdRN˙»-Õ4M¶¶Q„’Ùh>—¸†ù¢}L[Æm π[u&›&›Ô∏i‹2n=˜7¿˝ì¶”◊È:Ãõ¯dæ ˜≠¡–ä¬
S°û√9‘ œõ C0î7dÇ’F7åÊÄ$ÇåC†≤ˆB¬oeÖ⁄Ò“®¶‡#-8}V&>R+Åïûvuüy_Ï9∂!':∫ziù…5ﬁ≠∞òWÆ}6w”≈…ê’ãú’tØ å"ÏÙ¿+êˆL0c H¨é⁄ë(†Ω«ﬂÏÏñÓﬁ≈q}Ÿ…ﬂ◊ o@ø–ﬂr˘≥Åñïii€≤SónÎÈó~¬BT*¸ó?@ú©¨t—s»L≈¶	áÈﬂûtp∞éﬂAß–1Ï„ó&åjï +j–tìE‹d≈$,ƒ¬ªòõ Lü¿äfìhJC^∆c"j∑B¬˝˚≠ê ⁄ë”)nŸü—©é	√“ï£hDﬁåºìŸtEZ@—ÜA∏)ºÏÜ0ŸdÜ&æÏí–MÕΩ&µÇp≤°èŸ>xnBêo;5dAôâ˘ﬁcﬁ˜¿˝ÃÎòt∞
7O8¥M:¿Fó`€è_™N°–‰”qêMÒ§:¬á+(÷‡ ÁbÄjßâÅ}¨é˘„ê}"ﬂ4·¿Ÿæèxó[’+–lıoTQ‡Ñoîc1jË™Å@<AH¿j∂&`¡x®ñ'Bt`=Üaå¡[ò±¢u´7Çè1cïÕ‡4Ap<ƒÌæs2Cä'p~ÉÑ•ì »è	∑Î@ÁE£ôıNÁç´ìXq≈Ã&z≈›ÌL3ß=Ìñ–D1HâÙ¨Î◊YMÕ©Õ©˚“ÙêB∑t◊˛µÊÙ´„ªqÍ>Ω¬ﬂyßÔÚ]3DbH7≥<˙O«‘quü ≥Q3ƒàŒ¡πv&∏§º˚€§Àïj„Õãí∂ØLŒÎﬁ#a,≈‘ùòI"ÿ ¶ûf„€P€*ØÙ<ıÊ_Ãız/^Î*¥ÔëÕ˚¸dã}c˛b†ò…u”/‚(¸Rx¶ﬁñ∏°ƒ{Í∆˜Ós¨Ç,v8sN<ø?ø\^«ØRRÍWΩ§èŸXˇ¢9Í”úªWŒÓÌîZÆî5ñI RóßŒ„n—√Q¢ë;ëùS]ö/î97∫”ıÜ0µÆ0•aÓ EåZå°˛uÜ(êÆ_„n#hæªbu¶òÊÜê”uró“ A˝bÔÅ‹¸ø>k†I¯bÔù{7éZñ-sZí£_ªÛÖ%ê-∏Ë©≠ŸmkDåYà°à¬UVA‰¿è\ÍêZ™î)•X®´£æ≥√<°E{E‘√P(tÏjØkìÍ⁄kº;Zı_nx¢›*¢uÍ1^çÜ≈8⁄¡˚diﬁéó∂ØΩ—7 èÎ.(û≥W≈Aœ⁄,?±∞W¯‹sÎÊMO¬í‘™Ñ§§™[kkùÄñL=[˙¬°Â"ÜŸQ`«)”r∆≈Ûø9”∆∏Ÿ˜4ÕB*Êxﬂ%c8E±¶:!@ßÎAof¯%&∏¿*'O} ~Ó…»nêÒX`ò?‡jØnìa9û+¶¨€úW"ª⁄1 ?;˝™[π¡¢∫y¥ÅS@ÊÉ¿3∏b∂ÉQ˛=∏@ˇ?ÿFŒ–¨∞˛Cl®DLåbÛã±ﬂÑA"$~Û=ƒJ>Œ4Ïπ˝ı◊û∏™‚l∂™€√í∑ùgŸG„ÜrsÉ/Çcj+¥°£±u´Á›é∑[˝ Ñ“≈J⁄+≈ı.Zˇ«ÆJÆ™ †ÊÒèäÛ0$/Ôîﬂ+ìΩ5üUò7ñT‰?ˇ‚°Æz	eäºÚ˜ı(éÄπ¥2<É›ÎØõ;ﬁŸ{≤≥Ω™HÒÁo`˘#Ô„.5-´ ›·ÊÊ“óºª≤“U)Æy˝‡«2Ï n9∞Úh…ÊÊ∞©·&v]ÍΩ.Ø€´Wc–Ç=º›ïˇ¬:qI’Â∑=ÃuùØPäU"Ÿé:˛ }‡=›.≥izŒƒ&RU7á3?aÍ`Ñ√yÏ7÷¶Òw?Å>Í3∞õj‡q
I>7	ÙÍˆÍ?M· é¬?F$ç˙w$CÓªÈ®ÖqÁS»Òπ”p5Î(Ö›À˝ë~‚~’kôÍµˇ£:ﬁòtjƒW„1|›òÚ·wØÈG¯&Á÷Fßà	Ø⁄pfìº8Úö/ÇÏ4™ﬂ
ˇ` úRˆB

endstream
endobj

183 0 obj
<</Subtype/Type1C/Length 3980/Filter/FlateDecode>>
stream
hﬁåW	TT◊ñ≠Çz˜1†æ¬T˘ﬂ+Q˘"à  (£àÄåÇ"hApj¢¢îP®qFì &A¢ÅRQú¡‡úƒéâL‚?Ø˛)∫˚˙◊ÔﬂΩVw/÷‚›wﬂπÁû≥œ>˚ﬁíJdf©T:jÊº–YC≤J‚ÚJ≤5E°ë¶˘1¢J*é±Q†n˛{©a/•vPÔ∞kÃﬂ3©¥ÊXh· µöº•π≈j◊L7µ∑øﬂ˙ﬂﬂ[íUòë≠é][TúΩ¢H=ß ≥P≥≤Pì^úùÂ©Vá‰Á´cL´ä‘1ŸEŸö:˚jcu^ë:]≠…^öGWj≤≥‘≈öÙ¨ÏÈöÂÍ¬ud^AaÒ⁄ïŸìfgS!≥‘ÈYì5Í<Í©ËÕå¢º¨ºtM^vëÁød"ë“?âL*ae[;	/ë®UíÈ*…
3…zâd≥D¢ïHvI$IâLB$Yí“9“DÈiìÙâÙÈò±fØôeòïö5öÀÃ›ÃWò_2$õ){_ˆâÏÇlÄ…|∆<!æ§ò#Á»Mv4Î√±iÏ6v€≈>±p∑H∞h≤îX∆YfYÓ¥¸ƒÚ´◊¨¨¨2≠4V¨Ì≠¨?∞˛ﬁ∆ ¶‘ÊòM´Õ[ô≠ùmÇÌ€≥rô|ÅºP~J˛»Œ“Œ≈.≈nõ›	ªnª!{{˚ŸˆãÏsÏW·πZ~Rqû‹ÄıÃ ôâÎôNrçé%µmÃx“vÃs”–â‹-ìH¬PÀë[√„P:v"Îíêí¥c‘‰≠·Òï6Ó]◊O≤È§“DW.ÒdFÛW õM«/TÛü‚3Æ3Ø5#P¥,ˆV>AˆguO'ÿ*¡˛çœßµpî˝¶¨nëø≤óÏ ˚‰Àh±√‚rf$ÎıŒúÖj%Z¶§Òÿ¬˙Ì^€ˆÉ2Ç†≤=
ÿ-¸¥OY9|.˙ÅúK\Ω"FÂ€ˆ¸—©˚⁄Ñ˝\⁄˘‹On)ıßNv˜…Y≤0=.ìáå°‹=2F2M?ÓÑQù h∑	…∫xÉ ÉÈªp•Â'%X∆4z£y\2ö˚µ‰úçÊßD&/Cô'ˇ¥¯«oØ‘‹Ï·ÂÍ±ô˚íËa3É»’`ixãKBÁ•ËéûJtiFß”¯˛,… ßU‡nJòpú¡â.’S€Ft:ÅŒ8Aân´–-ù®Ìi¯K38Åã<óÇ{8Ûr–à„¢aDj·  pÃ^&ÅÖ15ÅH⁄
z`dél;∆¨gædqÃ€ Km`hp„Ücõmä-∂¿&ÆScXπ˙k≈◊˝!Dæª•4n1Òán—¢Iƒµx_ﬂ◊⁄z}#zÛxåEÔç©©·˚¿õ"n·0º'°£ÄYt¨@á
 G&≤‡Xì0úó'÷rßè˙Qs£ÖqHoòÀÊ.IÕKYn!˘õ	¨áﬂœu=WÇµ˚±Ä œtx=π’‹ŸﬂŸ≥—”UËãìq@´è9πÁd2⁄(CVÕ˜\zæ_«S
8lª∂* ˙[0Íﬁö;Ó{˚Ì°C_ﬂ•¨ö{-Q:⁄¯jæó‹*oËT}s"9x‹¢≈„ﬂ‰˜`	‚$FgúDÙbÁApπ1õY U8C3Óu¯”ù∑â1\\aiN¶ :®È¿ØçÚn∂mO«—VòW˚˙˙Ω=Ÿ…/øıù@£ëó_åk∏X<ÿ	„1Xê√wPÃ˘muC	éÆÅiª¿∫ΩÌ´{«P¬w¡M§⁄ƒ.î®–s˘ú&‡ÖZ7ÇIµ`cÌÖ0úï§Y∏ä◊ng.≤/t‡ 67ñÑÔ‡Â'é¥,rdnXn∞ezÒk"Ãhn  Æ¡{ı_~˜]}Çˇ‘ï1SÑ[%‹„Éµ7æQˆn3¬†≠hX;Û·Z^ße<JJg˛UÈu%‡>G@Ú‰aÈèC|(ﬁÂº/ﬂΩΩ˚òÅŸÓ)”
#Ωi^˘pèsﬂ¯Ì¿`Õ‡/¿V¯¶lCs¥ ‚πˆ∂É-
:Ç˘[´Ép§jFaÀıJDVUÁÉ•
BvÄ™ÖG,ñ=«0TÁNF9∫∂ÑÅ=ˇ~¬Ÿ0M’ü˛ì«eÇûEgtM]	éêΩ»ıêA‹SñˆÇTî¿¨Ï@ß•awP
tjww_S›ÆZ<W¿HßFÙW˙≤eÙ ﬂ*x	‹¬Çœ˚¸
&ˇyˆ√Ï‹eπ(+ò+§≠ŒœòßÇ¯ï;Sísxë
]Ω0Ö)üœ|p˙‘˛¶œÑÙ}'6üQΩÄë4© ÿÄ¡˜0S–ßafÇNÖ’5∞Ω*$Ô9hûHQ¡ô®gò†ÜÒ0Û)≠≈ÉQqT=¨Ûﬂ¨Æ≠€}tWù'Ù1qD´°Ãê√·ö°¶ótAç§cò>ÇorÙ3j8êãåéÄù—É6s(åù9xF≤ÁÆj—∆ø r≤Pg§S∂ónÇ‚âÊ≤«˚¥_û≠—?V¬»gê·1e(áÙ“TAA¿Ï=ﬂà±óéúâ…[√Ç˜A‡yaÒ‹û‚ßB-pq:˙¯∑˙ÈSÖ^r•ú?Ûµ81Qá≥ ü7≈/º∏¬¢1€÷$bº0çDƒs‡O†‡∞¢µ]Vò*`,ëﬂ¶ŸÂ¿„<-∞£w¿a®Ì`Â˙kä^x≈XLg :∞€ÑéË}ë€êó≤9NÖ^:(™sµÙ·ı€gI4(PWÖı Ø¬çu∏’®^á`„µæ=Ôı
0Ñ9Ò‡¬öb£†ÆõYØ!'∞	"Ür®d~3ùeÂı∞ÑWÉ¯‘ÉgL„≈À∆÷#q≈|óÕyTN
ëËX®1fê‡	ë£ë~OOP|0Zx@ùR∫äD—Åõ^√[àãA•0∏“UCÆÃ◊rÆån»ïÓÈL0gHÕh	Ê‘JMã·s´0ådu:¯bàcû—xálàVãgr∆mÿb5ÿ√˜™8‡°C„0NKØ
«G(^Úu0!Q≥1ˇUÒxy/Ö˙;ê∞ˇ‚*•ÍT◊›—."Ω¥hV§˚Àw–ô%Àgh=ºﬂâv’Îá¨W‡Éóúãkqé∞ z9\[â*®<T[YyÄØ¨©©8†æG≠éÈ;}‡ñ©o’u∞ëñÈe≠Ü›øs î†ê_)TfU°ÕÆããD€∞µ°A	{Àˆπ‚uÏ≥˙˙Ô)ìsœ–„ìiΩ‡w7e‡HnüZ„ä∂©öâ¬8ó≈h±ë˚c˘¥’¨—°íØ›µ‘oX¸q•–MÈóë:π≤˚É¸ÇcÀ.Oá±*qıMÌıûOØ‡ﬂ_ı7Â√≥‹˘π>ﬁGGcåQÙº ¨√Ëa√h8RŒDi’¢~Nòü€ äµ∆EÏ§
T‚úP ß√˘Uıs‘0ÿ†df†=Hiãi[œ£“¥Jòæ∫FòæŒx˘’Õ†0µ∫ÛêÇ°M5ã⁄FÙ≤5—ƒôoòÚ<BCÄY¯åñÃ5S·>„}Ê6¡4—¢‡9ıà>ÿÅì†cX2V–äI C`®^á ¢? J`â1Äëü¶˛‚·2ã˜çOô0Q›Å˜Yü27Y™ÂhœµÀìh√¿Tjö@¢qÛç‰&psbÁÖœ+¯¢Ï@ÒŒ£*~ÓÂ.ë≤ûäìçJ®fÅªs·Î”≥›∑R±÷ü˛†s∞>5ÑOgù7c¯Aú©|˝lÙ˜óŒn;…Î®C[ÿœıÔ«g`^ÂÜVhUÓAOi8ÚZ‹œ]‘±ãè∂˜®`¬ª0Ãøﬂ”—/&≥$9_†LÉ¢á|ŸuÂoïØ„ÈπÒπ;ÁüıUÖ«¨
]%l»÷&)—Åñ	Çø¯©∆lÂ£IT˘;IÅ*⁄Û∂O˙v]ﬂ}Xh⁄‚PìÍ˙·¥»rz Ê6ssSè¬|∞™¯ôûL™Wﬁ,⁄≈ßƒ`ôÕuìÚ∫Úè⁄ï≥h<ƒj+ôS˘©áRT8π˝)w„xpÈi>“vB–U2rQ[8pØ úÅL‘lt·—û≈IèÛˇvı3êWÛëdVeNÚtï«önßÿ6»ˆ˝Ù”¡Ÿ(„Âiø*Ùb Û6ÁG‰x≈˘næµùËJﬂ—mR°|ÀÎ…¬_íÔ“öeâKπ]ôc—u[qiñP¥i˘≤$ÖÒœ?oÎ`‘Xj8
WÎõè-T9Áñl÷«oﬂéñJîÌApn£G˝1ZtØéDÀÿ%wÔ†H-‹v‘F®`¸«W¡\ŸcïGum¸|S·pÉ¶≥©„∆·∏˘<æ–É»^›:ƒg≠H/‡µp2⁄$_j™o¢.⁄®c˚JÆ?$òíÍ°®„åŸ9õWáÏ‰ìXÌŒ:mΩÍ—æ+MÇ¯î≠Ü±/ÕÙózh†Ω1ËœåÖè®∂Ω…Ã$»"F+FFøto»â6)/<∏√]=ﬁﬂﬂs06©í«!=‹aˇÂ]¥aÔñßuOQ≈.)H“ÌÎRé'™b3Û3äÌÂxcï~òí7∏ˇ-±K4ìùfUœ˝‡(Äî^ôcLÙçBG•ÙR}!¨xq•Ïó~Ëà£K˝\]KÔ√hp<pˇ 2;8«Å√µ”ß˛˘=.±X
\;∑`(BD∑ùI>—¥ÆI\Î>{u;ËìôT≤hπÈ")áÏfÓeª¸è.¿Ç≤bÆñ=ßYrdæ
'l¢Üπ7Ω◊Ä_◊ßÔõË©e∞Boxç≠´™≠™£\ZSzpá<ºpÓ·˛"ï∞"Y#hM◊≤g”puåP∂~‹–r≠./¢äÔ!ÀØOx=bô'OoH´?∆— ÿ¬eÇﬁ:sùè"ÍÌ-â U=Ì¸‚GAûˆLL·pàùw$˜Ó{ÔWV‰œ≥⁄Î∑ØV%o©Ì`ÄÚlÙ*f\@2≠Ë-älnApÄo’ã~çFÎ|˙Î[>·u±ÁE™"˙€‘n.w£éπN¢éY@–ŒBE‘D7≈mÚB3È¨π1å™&‘$ö cå2È¨LåbBà˙ÂC_"®œΩä>BØÓÖ`éÖT˚–é“Í≠gÊê	3ô^‹®ò:‡€≈≈c∏ŸÜìSk£è…èùË√–ò|iLÚ›
8ﬁÜ9“≈âL;ÓKÜE,ÊòÆw"Ûﬂ⁄Sáî‹ˇ›ÚˇYÄC∆ÓÕAUùJmõ±ú‚öv[Ï‚⁄	åÉø0SÈè Ò◊˚[ó·ß‹0ˆÀ˛^⁄ˆÔ•ˇµÅÂbÏ(⁄`ˇ)¿ ª’®Z

endstream
endobj

184 0 obj
<</Type/XObject/Subtype/Image/Length 7904/Filter/DCTDecode/BitsPerComponent 8/ColorSpace/DeviceGray/Width 250/Height 300>>
stream
ˇÿˇÓ Adobe dÄ    ˇ€ C 		



ˇ¿ , ˙ ˇƒ “            	
 s !1AQa"qÅ2ë°±B#¡R—·3b$rÇÒ%C4Sí¢≤cs¬5D'ì£≥6Tdt√“‚&É	
ÑîEF§¥V”U(Ú„Ûƒ‘‰ÙeuÖï•µ≈’ÂıfvÜñ¶∂∆÷Êˆ7GWgwáóß∑«◊Á˜8HXhxàò®∏»ÿË¯)9IYiyâô©π…ŸÈ˘*:JZjzäö™∫ ⁄Í˙ˇ⁄   ? ıNlŸ≥fÕõ6lŸ≥f¿˜∫ïÖíª∏HÙ20Q¯·˜Ê?ì¨Åıu(6ÏÆE˘Û˘|˜Ü‘ﬁ™0˝∂e˜‚ç˘Â‰p!»ƒ˛–eßÎ…&ùÁü*j≠o©@≈∫/®µ˝xu—Lú‚pËz2öå~lŸ≥fÕõ6lŸ≥fÕõ6lŸ≥fÕÑ~bÛßóºøn”jWi^´QÀÓÆr5ŒW˘^»òÙxÕ‘£˘ˆÜs˛r≥Õ∑ÅÖî)lB¨’ŒgÊÕ?;k≠[ÌFW@vNFÉ#”Í⁄Ñ˚À31˘‡gwmÀrÑÚßF#€Î⁄•©orÒë–Éí;ŒÃ;$€kWÉˆCdÛ…?Ûì~s“Ô#]ROØ€3#H∆†w#=m‰ø9È>k—·‘t˘+®.ï›I…lŸ≥fÕõ6lŸ≥fÕõ6lÿŸ$H–ª∞UIŒA˘«˘Â•˘gMí”JòM™=Tq?cﬂ<}Ê;kﬁaªkçJÂÂv5•M0É’zÌ◊-I¶¯◊jÌZc*√-\ûgmºN5]O]éS©S∑LV)8˝=Û™˛I~jﬂyO[äêµåÕI#'m˚Á∑Ù]bœW”°æ¥p †Ç<{‡ÏŸ≥fÕõ6lŸ≥fÕõ6l)Û'ö4.ÿ=Óß:√ÇE{”<ü˘´ˇ 9-¨Î3i˙}>§sÆÏ>c8n•™ﬂ_Ã”]JdvÍI'ı‡#^π\¿;‚°‘åcFIÆaÉ„\≥|s4doåhÿv‹Âiæ`’≈RVâñEŸá|ıG¸„/Ê¨ë–5)Ë:[=ŒzeYYC)™ëPrÛfÕõ6lŸ≥fÕõ6lƒÄ*v„˘…ÔÃ´ΩCÃRhíkhJ»Gs\‡Uoø,rÔöéNW¢YÄ¶Ç¡€`ß≈§ª.‚ò†“Xò∞“††ﬂõIa˚=:Â¶òN€‡;Ω-îÏ0æ[gCZbub¥¡∫6≥u•_EsnÂ6™i–Áø&<‰æiÚU•„?)£úÄı¯v…ÊlŸ≥fÕõ6lŸ≥fÕúìÛÔÛé€…+YŸ∞ìY∫R#OÂS∑/ûxÉT’nµ;ÈØnúΩƒÏZG&¶∏zıﬂ§Ì‹ˆ√}7Hö‚ÑÇ…ßï‡ TUæXsoÂh–Ç?B*è≥\oËde‹S+ÙPåTkiÒêy7‘bV†ZbWlM€.¥x8ù∞äÔJU?‹¬ÒΩ√;á¸„ÊtöôWFºò˛èΩ"8√Ö]ªÁµ—“DWBUXt#/6lŸ≥fÕõ6lŸ∞ª™&ï£ﬁjNºí“&ïó«àÆ|Ò¸ÀÛÖˇ ö¸Ÿy©]π)Í0∑Bj+∞sód¸„A—‰ªªZä®‹ÁC≤—“*|4‡µâ8)wÈô¢@jzbMˆÈâ…4¿”¿	ÿ`f∑'«í*m„Än-ˆ8Qugπ4¬SMı oÑV◊È˜â4D§ë0da±g±ˇ Áˇ =mµªHtb`óë ê»ÁÌxÔ‡Ç*GélŸ≥fÕõ6lŸ≥d7ÛÉQKÀΩmÿ–…m"/ÃÆ|Îëã39;±Æ4ù∆”≠ZiBÅ◊:7ñ4Ë≠÷§|T…ó∂	gl∞‚Ç∏‚ √N%'é'R€ÅÂFÆÿîÇÉ~∏V´‡)‘Pú+πE=FEµ€Í(†8Üá™Õ•jV◊—≥∑ëd¢öWâ≠3ËèÂõmºœ‰Ì?Qâá®ÒèY+R≠‡r[õ6lŸ≥fÕõ6lÂøÛëéÀ˘szß%a¯gÇÄ4«FúöÉ$∫õr–‰„L& ‹û∏iœï1u'é4±;bG\T¬kàMÜˆ∆òˆ®ƒ]=1	£®ÆNïsLp(∏[>Êò[©@&ÄÉÿmëQñbù7€=1ˇ 8óÁπ£‘§Ú‘ÕXß¯“ΩäéŸÎ<Ÿ≥fÕõ6lŸ≥gˇ ú≥øû”»,FÇi¯? ô‚ÅV4¡∂∞ÄGéI¨ÂX¢P>—…ù#∞Îá
~N∏ÙûAµ*1u®zqÎ”ıM1'ì±9B§{fhÍ+·ÅgU•0∂ÂkL.ùPå+πåÚ€ÃÇî=Ú3´Z™NxÁUˇ úaµ2˛gZ∞ƒëÌûÂ 3fÕõ6lŸ≥fÕú˛s‰[ ;›ÒÍƒ®k·Ç-€ç	ÎáZz¥å+íΩ.›ÜÁ¶¶’≈©Ç!RzoÇ£ÑÉæ˛ÿÁåûõ`Ybpk€24ÑèXäìÄÓΩ0ÆÌ€¶ŒNôçj0=Õ
◊ækI˚∞›∆v/˘ƒãìŒFç£F˘åˆ^lŸ≥fÕõ6lŸ≥ÜŒ[ o"Ÿ◊µœœq´‡®!¬ùra†ijH„$h®´ç≥Vßa∂∑Äz|é	ÜHk@@ß|àÓH5Ôã“ï˚±	`n+\ˆ‹E@ﬂX…;ådˆß®ÔÖ◊lA€f≤4‹aU‘|äSÊmÈÖ:≤÷ù˚˛p˛æ±{!˚`–}ŸÍúŸ≥fÕõ6lŸ∞≠´ÿiVèu{(ä5©Ôûyˇ úàÛÊâÊ?(Ckbıö)ÀˆÆyu’ë™E0ﬂG∑ıdPFOÌ-¬@
Pc»jPÀorƒSeÀÿo∏“&†Ó0ñ[ùF4V>˝±êy™xüÉí¨<rE•yÆ9ò5¶G¨€‹?déò$—‘Â¡$ìï4h∏¢SSÄÆR!÷ô’£Ç§‘drÍï¬˝MknNuè˘ƒΩm·Û°”?fu-˜ˆ^lŸ≥fÕõ6l¶`™XÙßËœ3˛vyÓÛU’_Nµìçïæ‘≠*{◊9ZC5ƒ∑
ï≤+ÊÌi(5C€¸≠d	FŸ1T¢“òå≤˙F¥€MØ§gâÿ`9º◊l?ñ$|…µ¯6˜_{s¶‹1ÊÅ˛’1x·Å˘£‘{aıå±WÒSqí>Â∫¯p¿_"mÖ˙é™;S	Æı˘í#Cëãﬂ1ﬂª§·t∫é©5j§åK’Ω.Ñå◊DΩõ‡t9Í˘≈ÔÀõm7HO0ºjÛ›éI+}•Ë3–y≥fÕõ6lŸ±ó∞H<QøVxÛŒ˙xè\ªRjLå-,ë⁄Ñj FÎ—$˙iaπlwñ#„j≠í5ßÜ'whç˘æ“ÊõëæG•ﬁ≈áè∆Ö¸0GòtKÕ&x©)í,7zfÅ®Î	qqÂ	À‚4ÈÅ≠›≠edôI¶ƒƒÀ'4Øre•4≤D¨:⁄ù€€çŒFÓ5ô$rÚ8yÿS’Í{Ò™÷ÄUá·è[®+D†«É^á
ÔR©¡h”=—˘3dñüó*F0ﬂ3ìlŸ≥fÕõ6lÿŸà9=ö˝Ÿ‰>›AuÊªØCh√Rû„ÆDu∑i Ü#Ò(©¶"π“
∞´`≠"J…|6èb0YU)Ju¿70ä#obì„Z{„^Ó⁄Êﬂ“òÛE˚ ˆÃ∑≠inmÙ˘8#u uÆ]A,ç˚—V&µ¶∂”f1Å∆ã„íΩ*‘¡j6ÈëÔ6ŒÏ@ôï@AÒuÆ.˙eÀiÔ{Î|jiÈ˜¬óö‚aFƒ»ƒÔÇ5[ç:H“rU‹á∆∏˚y‹†Â€°ÕpÏ0˚@‘g´øÁ?5ì]“‡ÚÌÃB+´4„2ÅZÁoÕõ6lŸ≥fÕâ‹ä€ ta¯gè5¯$∑Û5‹Rèè’cøπ¬8ï˛@˝OéeâÄåÅv9Jäõù∞D[ú,)å∏≥/∏4¬ã˝-ÿØ/|'})|JA≈Ìtˆ˚1≠â√4SÍMÒ¥√¨£=ÜèKääd?Õ0)<A´&∞AÅYjRpŒ[uéh^#π
K8Æxî,àv¶◊§õUôeô«$˚4€≥∂e@÷ôÆ·°Â∂v?˘∆Keèœ
«Ì€o£=n+MÛfÕõ6lŸ≥e8™0Ògíø7-Æl|Îy ä Pxç5´Kl∑â¥ÉÌl∏kË≥w'|r6ÿ¥nA:	(FR)SñËÆª5åt‰Àâ˙q% c^Â+«ıbÒ∞*0¬(îF|ND|Àd≥çà¬x¡on¯1Ì'U‰çT?≤za=ıåÑíRüÍ‡4≥r{˝8+—h÷¥¿W‚ﬂ;˜¸„ñÆÆµIu‡¿[⁄Eóπ,3”9≥fÕõ6lŸ≥gùˇ Á |º!÷◊U‰O◊ß√éŸÀ˝fKRÉ•)â)C\•j∞¶àåZ)~*`ƒbpt<Bä‚wR¢≠0äˆÂ‰óäv¡ZT+ %˜5√Bê°È”€…¸5»Áò”w≤/k≈0-ˆ‰é(èêmÅÆ-S√Ê0∂‚ﬁ5o≥Lp™Sl'º?ZÌû ¸ÉÚ¥/ëmnQÀI©(öPE(zPgJÕõ6lŸ≥fÕõ8Ô¸‰%£=ïÑï€ô¬eâñﬁb›ö`i	Åkã!†≈·mΩÒh§®pd2`â& 
µCÇı´véúí í<õäÍÔß≥≈ <∑*|p∫3Î‚OP[÷ﬂ∆∏s§kÀ4\ãQ«⁄\ÆÎV»Í≤µ9˜ƒú@ˆ|„<Ö*h˜%·‡w=0dPa>†åFÃı$b:.ô˙WÃ6:p<DÛ"iûÚÚﬁéö6ág¶#Û[X¬ÈZañlŸ≥fÕõ6lÿAÁ_)€˘óGí…»IË}	Eo‰ˆê∫à‘TjWi%Ñd4ÅAîu9ô‡∂≤Û°ihºm†î§J{ÖÒΩz‡à»=1Uÿ◊æ(≥∞ÿ‚7·TÔÖÒ0ûC+ùó†√õkÖXˆÒ∆\« ¸j+ÿ‡	-¯/›zaq≤ûcƒ·e›¥íNZ‡Ú#¶]≥\≠aV˝◊\<”&1H™M«öPÎRkÖZÉ‘PdzrVC‡r[˘¢¶±˘ãot∑a˛ƒ◊=¨:Ÿ≥fÕõ6lŸ≥f¿öºﬁÜôs/ÚFÕ˜Ò_òÓ]{Põ˘Â' Bı4¡1π ÌÉCÄª˜∆J‡/√ÖW|¯˚`'‘"Ö8ñ•pvõ´Ÿ≤ïıEG\˙NŸÖ+∂<›@À@√¯‚l+V, ¬mAK hkOåÍ(œ«rv√[=H2Òn∏€ŸA å"º‹ì”%?íz¸˙Ê¨®úæ¥D‰ÊôÌ±–fÕõ6lŸ≥fÕõ6‘ÌÕ∆üq Î"˚∆xßÕp_0Í0Cƒa2»U∂¡q\C‹‡—(+æ&”Ç@¿˜€«∂5ß´1‰*<1h<ªê»éRΩÜèEøAŒ2Gbq≤ZjCNü,<˙àNﬂKw4d‰	∆E¨ ~-◊ﬂ¬·œ v8ºrîmºpk?$¬Àïy¶X£ùç§Áz¸ò¸î’Ìu{m{[âß¶$∑Z’πu≥—y≥fÕõ6lŸ≥fÕÄı[∂∂µgCGÌû?¸ ≤ö2›O(©∏bÁﬂ|á◊n∏¥.™@=∞I∏Pbf_àcßö´CåµÅLõw¡È†+◊ã|.G∂=µ``gø»Ç	=∂¬[˘§vﬁ0p¶k*ø®VáXâ|[‰ <qeúî•pÎÚÓ√ÙóûÙò
ApÜJ
ÄµÔû·ÇÇÖ5
£ÿcÛfÕõ6lŸ≥fÕÄıK·ijŒÔ¯âŒw¨yé˙kÑçﬂ‡Â∏Œa˘Õ£N¬ﬂT∑^HèAÔúë©ˆó° ¶ÿ‰'l≈æ*åz’∞\$ Ø|QX÷£rr¶¥g¶Àeπ‰03⁄ƒábjq/E™jk·àJü<2Ω@(‘9rO]˚åÀ-VµÈûÑˇ úcÚ\ºÆ<Àubî†‰:2˜œDÊÕõ6lŸ≥fÕõ4—√I!‚ã‘úäÍÑóó\Ü÷Ë~r9≠yzGùÓ†?	_≥˛V4j∫sÈ∑j=P(+ÚŒ-Êˇ !j:U„≤!hXí’ëVW*AVA  Â1 fY®A¡1 *+Ç”pÌæ,ì ÔÅÆ≈Zt¿“@“/ øNú™”sÄÁG]#…Aâ§åNMˇ -ˇ .µè:jkù#∑ÖÉM#t†5œjhZMæï•[XAF∞F®B
¿PüßÊÕõ6lŸ≥fÕõ¶G<¡|'ëm‚j™ˇ y‡pæ%¶‘€§uZ7Cëo0iSZ‹}nEÍH∆…igØi∆) ˙ äﬂ9ô¸îê]∫Ãûõ◊fÆC5è/]È¿H√îˆ\oÑrTl`?∂-µ`KÄb‚Ê55ÔÅÁ∫‰€w826"0€	Ô]Cì€
.g©€…!&òc°h˜⁄Œ•õbÜKâÕ ªwœi˛Q~^≈‰ˇ /GÔ}*É;|˜¶O3fÕõ6lŸ≥fÕâ‹A!S˙≤	)znI˝x.˙ò…†éh H*áb2{gq§_z±W—c\¶ÿyÇ¡çÆ«∏9Œ5-€ ˙v¢ß–ìeb>œ∏ŒyÊø%_Ë“zäæ≠ìÔ£}èJ”"ç≠{ÿõV7≈£∏©£Ï›±‚B*yc=b∏&]HÈZaEÂÿcˆ∞∂Iy∂ÿ≈]˜ÌûÑˇ úVÚ•µÕıÊΩ0¨÷áåvmézyiM≤ÛfÕõ6lŸ≥fÃHp≤ˇ X∑A$˛ÚZe¬K[p"ÕRiÙ‡’PLuFoó~ÿQ≥éÊ›£êTv9o¨ÈWÑÄxWq‚0f±emÊ4¥t*z‰gñ≈õM’!ı-ò—ïª{‰Ãüï\ƒ⁄ÜÄ¸„?B:äÁ5æ”nÏe1]BcphA¿r@ª˛8ì√'Éà: +Å§Iª∂xÈ‘◊µ6Ã†ì≈w'=˘Ê!†XI¬ëJG®ﬁÁ•t›B◊P¥K´Wı!q∂	Õõ6lŸ≥f∆K<Q/)(Ò8_qØ⁄BõÂÑ◊ö›ÃÏV¥ÑÙß\
üàûΩ˚‡ªF=0XÀ¶lcÙﬂ
ı=>;®çF˝éG·éÁLúJ>(kF√’4Õ/Ã0íî[ê>oûDüÆyrr‡-ÎÒ“¥¶/wiÂØ3Ba∫çbùÖPrØœ9Øö,5-&F{aÍ€÷É|Çj>µë·qD?ò·s_@EF„∂ñÌAÄÂïœLfÁÆLø/|¥˙≠ƒ≥∫÷(êÔÔù…À¥˜s—j‘ZÙ€;Gë¸≈m¶€ã+ót›Ös¢G"HäËj¨*∂;6lŸ≥fÕêõãÀãôÚ4=AÈÙ`~$ıﬁôD–Äz`∏ñ¢Ω±xàÂ∑lÒ‡ˆÀ∆≤‘`ijª◊ Olí≥#}á˘dnˆ¬ÔKúI	%kP√√ﬂÏ5;MNÕ9FV˛Û7î¶≤îﬁX◊”ñﬂh`ø-Í∞j05ç˘˝‚ä]Ny∑Ú˙ ebb¬€÷ï#9ò+.-˘‹ißöÃM◊ËªâÌ•0‹D—J6*¬òÊÉZÈ”\9Ç Éìë·ù∑Úä…SD∫ ˚‡K¶˙æ£,´–I¸s¢hÔ›ÄÊ4˜=Ú∏ÍÕ•›À^¬Ówjˆ8Õõ6lŸ≥dd†¶Yzu¿ı‰˛ÿe(@∏˛<~!ä€J™~–ÈÇv«08‚E1	Tö‡Töäoÿ‚%·ôM¥Ù©W#⁄ûç=îﬁΩΩxPFi:‰WJ-Æˆc±ØûFº€Â˘lnE˝Ä‚§◊‡ÌÉ¸ªÊào¢wîæ.á◊|∫—ˇ §⁄w‹®»?ò<ë¢yíéx÷€P˝âÄ°'‹Á‘ø-¸≈ßjOe·ïò Gœ&⁄WëﬂFÚºç<ë=ı∆€8;˙‰ªÚﬁ⁄;MÊ,fcRQXÑ:¥g–ªì∫Ã£Ò…oï.È˚∫¸4´ÓLê:\!!î’u&˛VÛ¥W(∂◊Õ∆a∞sﬂÊrdéé°êÇß°y≥fÕõ b £Íxbk∫¸∞môW¯%©J`Q)ÜÈ±;·∏‹Ÿ∑ a·òTbsA#ÆA·^£fgV‚x õ°˜J◊·õN‘>Ñ¯Uõˆ©Åµç	·Âqi∫ıeæâ®Es	≥ª°=>.˛ŸÛGîfµs}ß◊Ä5*ΩΩÒﬁ\Ûuie®ù˙+∂j˛_IT‹⁄¸∆û¿ˇ 2µ=Z˜W˙≠£ì&äÍzúâ]_˘äﬁﬂ“íw`:Çz`/Ã∫Œùpf±ù£îüåWÌ„|Ë˛YÛnüÆÈ˜VóA©˝¶å˛—^ß$^_‘L0G#ÇƒÚ4ŒÇ‹Ÿ¨´∏¶„ B‹g„Zﬂ<ô˘wÕ◊@AuY!=ˆ…ıµÂΩÂ∫ÀÇØ∏ﬂfÕõ6BeÖà€¶!5Dg«£î5≈-´Ì–‡˜;Tw¿WT>«A©ò¢
P±\ö¥Ù˝‹G‹‡ùgSÙáòƒÌımEèÔSÂÜñ3º¨C/jÚÕy)Ê:w9Ûáı‰YÌèßs·áz`M/ÕÔh>•©ß∆ø®z`´Ì5.iß7%;—|F)eØSkxõçânî¬Ìc…ˆ˜ÁÎ∫kÖjUÄÒŒyØ~eﬂh∞\hêRÎt2ı·ÿåÊˆ˛´Ûyâi‚åû‰·®⁄àë´ë‘Ö6«4Ñ9„-k^ÿoñı	H‘t…˜äΩr{ÂçX_Y≈g*qΩé°◊¶„€:'ñu^)ıiˆjÒ·µÌõùF¯»ÆZúHﬂæ¥’Ô-$o1R:j>ÏòË~}å€àØÖg^Ø–ñÿj6ó–âm‰ΩÈÿ‡úŸ≤0®º<p‘5É Bƒ3GÇlÄÂCÉ›(µ¬Î†j1ˆº\t`¥@GJb3@@0/’÷ªÌ·ÜVQãë€p¨§v¬÷ú•|zaò|ø†,ﬁ=∞üC÷Æ4”gz	Ö∂Ë+ﬂ%óze¶ßl'∑°vRΩ>úÊ}¸¡ì…Vr€Çdªî
?f¢ïŒ-•jPj/qwtÂÆ«vÆHÆµ"+X¢å7ë˚üıp#[Yjœ,Ë‹"ç*A;ê6¿◊^P1X˝y6PﬂhÉÇ<ügu¶^√3ûvwk∏€<«§À£j„S≤
0Q–‘aøó55MÍé<OO“¨[Î:zHMX

à—B:ÙÀ{t'Å¯_«J√%Q_
Ôá~_◊Æ-^6>ööîÏs¢Èæj”.—y»±Heç*p·YXSPzºãF‡öbéÇõ·=¸^å‚A–ÌãZ–∂ÿ4ìJ`¡M«LF… …Ïp·T®ƒ‰Q]Ò'∑ pxJF%∆á|x¥~X¬ÇX∂Ì‘·6≠ÂËµHäVó1ä°˛oëÛ6°Âgí⁄v¯òl{ˆ# óv÷ﬁdûs™‹ºúê∑áÜ¯OÁoÀf“Ï"’Ù¬DÓ‰^Ä˚g?øπvê3+–aáóıWé‰ RËˇ ®ﬂl=ºΩ∏æï¨mk¡G¬≤Ì@;⁄^´óo&ù©12H·°e‹/ZW:-¬KÀ÷◊äÖRı€¶Ë÷W˙}‘Ü-ÏÂÍ<	Îù3 ≤ñ∂hÿ◊¿b◊IÈ‹=éí…n‚¯#ÆG¬”€N]›¶‰z∑l4≤åD=&N	0Q¸;´{·¶ïÊmR—˝"˛£& Ø–å8ˇ Í_ÔÑÈÔ◊B§‚Â™¿∑Ò∂5Íª‡[Uæ`@¿7d¶ÉØÀÌfË	ïC/,m≤Ú?,E"„\•P‡HÇWx6Fh›AŒmÁè,‹jHu9ΩÃP?…]ÜœÀÀ™€ããsK®Ö<NH¥UkÌ2ÎDæZ ¬∞Œe¨~_≈yß^M „5ë$èM2aÈ≤´E˝·ÿ∂÷Ønæºìó5Ópd±•Ì∏sªZÁH¸•÷†π±üAªﬁ >ân¯Æ≠ÌçÈáëXëπ‚Kºõxí\SRWqá⁄íu?F	“ﬂî`Wu√L2x◊Æπ”£êã∆Ù•U·0£≤råQ‹†SÃüeºq/OSˇ ç2q˚;eA‘◊5◊˜/Ú¬Ω/ó6√UÔÖ◊˝vƒmøkÂÇ≠yr√(πq5Èè∑ˆ≈køLcÒß≈”∂õÏöt¬Ì˝]ºpE≈8]pñÛ–´r˚¯Î“ôœ4œ¨âe˝_´Ú˝Ìzdä?K¸I•OWâı)”.˝/[W„˛Ûq≠>yÀ|≈˙3Î1˝G˚æˇ <åj^è÷´ˆi¯‡Ωè/éæÖv˘`ππ˛ó∂ˇ s˙◊!^5Îù_]Áı+?Ø”Î˛ö˙‘˘c|Åıè”O«˚™w…ﬁ£◊nô¥Æ^¶›;·˙t«ömâÀËˇ ª~å+ºÙ}U˙ø˜ò∑˙W·¯ÁˇŸ

endstream
endobj

185 0 obj
<</Type/XObject/Subtype/Image/Length 7830/Filter/DCTDecode/BitsPerComponent 8/ColorSpace/DeviceGray/Width 103/Height 202>>
stream
ˇÿˇÓ Adobe dÄ    ˇ€ C 		



ˇ¿    g ˇƒ “            	
 s !1AQa"qÅ2ë°±B#¡R—·3b$rÇÒ%C4Sí¢≤cs¬5D'ì£≥6Tdt√“‚&É	
ÑîEF§¥V”U(Ú„Ûƒ‘‰ÙeuÖï•µ≈’ÂıfvÜñ¶∂∆÷Êˆ7GWgwáóß∑«◊Á˜8HXhxàò®∏»ÿË¯)9IYiyâô©π…ŸÈ˘*:JZjzäö™∫ ⁄Í˙ˇ⁄   ? Ùwôº”Öı6W˜Ñ¶{{PÖÀ*?mêt\-ˇ Íøı)jˇ ’\ﬂ„ùW˛•-_˛˙´õ¸s™ˇ ‘ß´ˇ ¿Aˇ Uséu_˙îµ¯?ÍÆoÒŒ´ˇ RûØˇ ˝UÕ˛9’ÍS’ˇ ‡ ˇ ™πø«:Ø˝JZø¸ıW7¯ÁUˇ ©OWˇ ÄÉ˛™Êˇ Íøı)Íˇ ’\ﬂ„ùW˛•-_˛˙´õ¸s™ˇ ‘ß´ˇ ¿Aˇ Up√GÛdßóÆuòlÓ[’Ïú'Æ^⁄°ê ≈y¥·úˇ Â$Ú˝¥%ˇ ®i2[õ6˘èŒ>VÚ‹æª©€ÿ!Uï¿vˇ U]æÅú√Xˇ ú´¸Ω¥rñ◊⁄ëX÷?#+ˇ Ö¬o˙ç3ïOñ.Ω?Ê˙¬W˛!O«Ù_˘ èÀªŸ;¯ot∆&Ö‰çeå|⁄&fˇ ÖŒ£†yßÀûaµ˙÷â®¡®A˚MÜ+˛≤˝•˙FfÕêü!ˇ  %´Ãvßˇ 'ü?:<Ã<ØÅØõVΩØ'’Q∏≥ÚÖíÅ®‘˚UÈêo˙HøÍRπˇ §Åˇ T≥–⁄Eˇ Rïœ˝$˙•ÄÔ=ˇ 2<Û4zêÙ4ÎŸÅ˙≈€∞ï„NúÉ≤§qÚöæŸ‘º≠‰]QÕ⁄ΩÔùº„3~ÛG“]ùDüÔπÆ[ìüpª˚dﬂ@Ú«Êî∂¸Ù?&y{…÷]R{¯ƒ˜AÀ/ÍΩ÷QÜ«E¸ﬂÂ¿˛`˘’Èı_´[˘SÖ%Ûñ?2°∂ı|√‰≠Œxﬁ[≠->ØvWπFã”z¸î‰CCÚèñ5´„q˘qÆﬁycÕˆ‰ü˛®Ê)K©¬ÒÂ˛´ÔíÌ+˛r;Ã˛TñmÛCöMV÷Ån ·∏˛gV"6ØgCC·Ü_Ù7>Tˇ ´ˇ ¸?ÛVo˙ü)ˇ ’éˇ ˛˘´%ﬁCÛø¸™ù[Ã^ì˝_˝…ÍÖG>y∏Wß*mã˛nØòY¸∏æ\Ù?MõŸ>•ı°Xyz^Ïkëü™ˇ ŒNx˘˛LﬂUˇ úú˛o/ˇ ¿èÈÅÔ|´ˇ 9Ø√˙'W’tÕ#I∏ _ﬁiˇ ‚ˆîPøÃ|ÈÅ<ª>ï¢‹ÀÂè…Ω-_Wã˜zøõØ+h_ΩfßÔ˘	¸√V¸øÚ‹2$ﬂöuª÷5	~%”#ô†ÜßzEioYX|Ü3¸˘"„˛‘=˘k6ù)¸‹©À«È?óﬁ[ï‰∏¸¨ÛùŒë©CÒ6ô$Õ=π#~3ZO˚’1Ñ˛c∑“º«®√ÂﬂÕ9<±Á&†—ºŸdimr√Ï“M∑ØÏ9˘8>;˛r.∆”f“to0•ùb∂’Ôö6ñHÅ¯I‰Ë›<E|qﬂUˇ úÉ;Ñ¸¥øÂR/˙©ïı˘»C∑¯gÀ*|x≈ˇ 5dØ»i´ˇ  ¨’ì—ÉÙÕu1ız´˝jØSßßÍmÚ≈?8-Ù+üÏÛ¥zCﬁ∏ºugB–r(—¸c‚ßLâˇ Öˇ ÁøÂ∫˙J‘?Æoø¸„∑¸∑Oˇ IZáıÃ|≠ˇ 8ÍA˙rƒ≠CßﬂíΩWV∂èBÚ ˝‰˚Gu´√Igj|PŸâ_˜‰Ïˇ fß|òË~UÚ˛á2 8d?ﬁ\^y	Ídô˘H‰ˇ îÿkÖ:Áï4q)®Ÿ£Ã¥1]•c∏çáFéd„"ÏrØ€«ag&Å˘ÅÈﬂ)›¸6öÏëÚöß√ÿàU[˘'@+—®z≈ Ûè`SÙΩ·ßJ›ﬂ„áïÁ@ﬂS∫où›˛8y_˛qﬂæ°pﬂ;≠C˙‰ß»phˇ Ú´5h9ü–’‘„Á…ÎıZ∏Ø/∑_Oø\4Û¯º:◊î≈ëå]~êì“3cØ’§˚Ahza°ãœî⁄m,œ9ˇ Ê¨ØGœøÔ˝/˛EOˇ 5Â|˝ˇ -_¸äü˛k¡V£ÕÍ)rt˘Oc≠‡y‚¸º≈˛˚¥ˇ Éó˛iÕÀÃ_ÔªO¯9Êå‹º≈˛˚¥ˇ Éó˛i¿˜#Œ—ŒüÔÍ	ú˛1ûªÀ¶˘Á?¸’õ”Ûœ˚ÛLˇ Äü˛j«ÛøÛÈüˇ ÕXE‰1u˛’á¡ıØ≠Í{–˙~ß™˝∫ÒÂà˛kç8‹yhjWicıÈ={àÿ´†ÙÑ2ÇF¯KÈ˛W‘œˇ IÕΩ? ﬂ˙ôÔøÈ"o˘£7ß˘[ˇ S=ˇ ˝$Mˇ 4aÜã˛B-;Õó±Ã˝Óä´˘ÍúNJFCˇ Sﬂ¸éÉ˛hÀlC˛ö+Ø˘¸—ó˙>/˙ònø‰lÛFF5Ô8πÙuO5ﬁ¥Àπç.IÙDúF˙ïøı3ﬂˇ “DﬂÛF_ ˇ ˙ö/ˇ È"o˘£0_ ˙ˇ  Qˇ IÕk‰?© µ’ø~ˇ Qı5?Ùöû~ó'˝Á.º∏Ô\˘°%ƒwæX{k!®Œ∑“≤jRCıwÿ◊m∫‡“^hˇ ©
ﬂ˛ILﬂ§¸—ˇ Rø¸í˛ôøI˘£˛§+∫/Èä[ÍZ˜™œê£Ùk”Ú˙9
dÅf“
Ç|±:í7_™C∑‹Ÿ~Æèˇ RÃˇ Ùâ¸’îe“ $yfrGAıHwˇ Ü¬ùK]7’|Ö£˚&QcÓBäbcSÛ?!AÙz_ÛN_È?2ˇ ‘Ö¸íˇ ösOÃuﬂ»0˝ó¸”ã˘Êˇ ïu´?’≠Îjmı©ÀõüG√Ø√õÛi$yº∂±ﬂ6C}'Ê%D_∏}…˘d{ÍzØ˛\8?‰{ˇ ÕYæ•™ˇ Â√É˛Gø¸’ñ,ucø¸¨(?‰{ÕX§z‘s#«˘Él\ƒ4≈îüuf ‰Ú—|ÔıtÂw¶\ö~#òr˜¢Ω>Ï[èùøﬂöo¸ˇ ÛV!|æw≤{¶ZPΩ9O„Òøø “√Æ<åÌ˘ÖjçHYxè† cEÆ∂Ú°€ˇ »„ˇ 5f˙ûπˇ óﬂ˛Gü˘´,YÎïˇ …áoˇ #œ¸’Ü˛CYÂYÍÀıµı}ML}~ø.O˚Í¯W‚∆~sÀa^_í˛∏≥[◊ı†F‡Ã=ÿ7mÚ	˙_ÚÁ˛¨_Ùò¶Q’ˇ .˚y~Î˛ìÙÕ˙_ÚÛ˛•˚ü˙L?”+Ù«Â˜˝K◊?ÙöﬂÛNK<∑q˘auiEº∫“$]ﬁ÷[…£ZûÍ ¡[Ãñ£˛ö	Ó#7¸◊Ñﬁd∫¸Æ∑µ‚nÓıyÈm‹“- fn+ë_”óﬂı/\ˇ “kÕ9øL~_‘Ωsˇ I≠ˇ 4Ê˝1˘}ˇ Rıœ˝&∑¸”òjˇ óﬂı/\ˇ “kÕ99ÚñüÚ©ui=ı:jmËr¯Ω/åÁ„«j‚ﬂús^B<Ω-úâ“^πäI
–n¶OÉßéCN˘„˛Æ6?Ú2√/Ùˇ ûÍ·aˇ ßÂ˛üÛœ˝\,?‡Ù¸ﬂß¸Ûˇ W¯=?$˛M◊|”9ñ+Õ2”Zç72⁄…h%BzU`§}Ÿ)˙˝˜˝Jr¡⁄ÕyÛ~ØÊÙí8Ï¥€M∏{âl˝i)÷ú€à,ç~òÛÔ˝\,‰nüîuo>˙XX˝È„+ÙØü?Í„eˇ #¨2∆´Á ˇ «FÀ˛GXd≥»r] ™’§Êø[ˇ rmÍU8zïsZ˝är˙1üû"e°ÇÎ◊õF0ãtT~9Ã}/.ˇ øÔ?‰L?ıW7•Âﬂ˜˝Á¸âá˛™ÊÙ¸ª˛ˇ ºˇ ë0ˇ ’\ﬁóóﬂ˜üÚ&˙´ÜæY:$ZºO∑w§N6éÌ‡Bï?≤¸d;qLÍáHÛHã’>sQ^E˛´o«ç+ZÚÈú£ÃRË∑:¥Ú‹kö¨µ£^#‘ÏÅ§ÌAL-Ùºª˛ˇ ºˇ ë0ˇ ’\ØKÀøÔ˚œ˘˝UÀÙºª˛ˇ ºˇ ë0ˇ ’\¬/.◊˚˚œ˘˝UŒó‰A¸©ÌXUΩOSﬁÉó>Ù≠+O|óyœ…6k∂µ∑º∏ö‹ZJeç‡*	%JÔ…[«"ﬂÚ¢t˙∫ﬂˇ ¡Cˇ TÛ â–ÍÎˇ ˝SÕˇ *'Aˇ ´≠ˇ ¸?ıO7¸®ù˛Æ∑ˇ Pˇ ’<ﬂÚ¢t˙∫ﬂˇ ¡Cˇ TÚøÂDhıuøˇ Çã˛©Âˇ  â–ÍÎˇ ˝SÕˇ *'Aˇ ´≠ˇ ¸?ıO7¸®ù˛Æ∑ˇ Pˇ ’<ﬂÚ¢t˙∫ﬂˇ ¡Cˇ TÛ â–ÍÎˇ ˝S…Nè‰ù?KÚ•œñ°∏ôÌnRty‹Ø™>≤bPµ∂€"ˇ õ?õ◊?ó∫«óbüJ[ΩZò¡sÎ⁄‹´†oÉÉ¯ê¯áCù(EF‡Ù9¸€¸∆ãÚ˚…“ÎÌj/gı¢∂µ¥/Èâ$ï∑´—È≈õßl&¸ì¸Âô6∫Ø≠ß.˜Kñ5{q)óîr©*ı)0"ô”3ôÈú7∑Á%ˇ Â˛ü•§∂Z\M%ˆØÎ£")e¶“»ÌxÂ˛R˛o‹y˜YÛ&ù.ñöx–fXREò e¨í•H(ú∫Ø~π“Ûú~r˛mO˘wâ$:bÍ_•ÓöŸÉÃaÙ¬Ö<Ö˘}¨5¸“¸“–.Ù(ı=R9.g∫ì—±±Çû§≤»Ó€*®˚MúŸ<;/£[ù/Ú∂ÁÍrQ<œ/&S–Ô´.?˘…m{C‘ÏÌ?0|ëwÂ€k∆∑·Ÿ–vf‚Ëúïzû,HéwZ/G÷Êæè~•G4Ø*¯S9g¸‰ﬂïO~SÍ3FúÆ¥fMF
∑æÄˇ ûN«Ë…‰øöƒˇ ñ:®ÓÁÍÀmvkSÎ[~ÂÎÓ≈9}9 ˇ Á"ù¸◊˘ô‰oÀ∏(Âú^Í
ª—$n54˛Xbî˝8Õ»øÛïW˙p/Õˆﬁ•∫“âÍHæ¢–∆hdQ˛∂w˝sVµ—Ùk˝ZËÒ∂∞∑ñÊbv¯bBÁıgˇ úN“.Øm|ÕÁÕ@rΩ◊ÔZ8‰=x£eß±ñZ±¿_ÛäøÚó˛bÃb‘EŒz;<Òˇ 9Å˛Ò˘3˛⁄RƒS7¸Â«mÁOÀã˝@¢¡|ˇ Zv“kwn}©¡I˙z÷ˆŒÓ%ñ“xÓ"`dâ’‘É–Ç§åá~n˛XZ~c˘b=‚˘¥ÔJÂ.íÈ"0(éÖx≥'⁄„í/–M˛˝ı¶Âı®}wàÁ_G“ıx◊ØÌR∏:˛ ⁄˛∆Ê∆Ây€]DNû)"ïaÙÉú˛qfÚ„D‘|„˘w|«Î%ÛOná∫r0HGµQ˝ñ¸§ˇ ù◊˛rŒ>uoﬁÿË¡¨tÈ;Tü´°Û ?Ï∞G¸Ânüs•IÂ/?ÿ)ZÚ√+éºYÑÒW€îLøÏ∞€˛r_œÒ~OB∫|úüÕmo®^≠n‡N‰|—Bˇ ≤Œâ˘_ÂaÂoÀ˝C+∆k[T7>Û…˚…è¸åsû`¸§¸®”ø0<◊ÁDº’oÙø—◊¨Pÿ:ß?ZyÎœí∑NgRˇ °LÚÔ˝Mö˜¸èã˛©Á.¸Ò¸û”/«ñÓ,ıçCSmB˚“tøëPG≈™úUhMs‘|Ú˜í<—¶Øó<––:^0kH^UäT|*áÊ9SoñrYøÁ|≥≥i~e’lTùì˜MM¸Qb»«üˇ +ø0)ºº|ŸÂØ<_›[ÿÀ∫≥õòP≤8EbÜI"u‰T2≤ÁzãŒ“K˘R|Íë©òh≠™òw·Í%©ôì∆úÖ2[ûZ¸Í‘Óˇ ,ø;Õ÷*Dc“gâïOn^çO˙Æ∞»s¢Œ+˘`Ëˇ ïv˜ÚèÙ≠vy/§sˆåuÙ¢ØÕSó”íﬂŒ_+ˇ âø,µ˝)ù¡∂kãA‘˙÷ﬂæéû‰•>úÚ˜ÂŒ©w˘ïÊøÀ*\%èïbí[æF™È¶`O∑ß1gµsŒÛäåßŒòî “Ò+O˘àπœGÁû?Á0X?%‘Å˛‰§Î˛™büÛîN±ßÎæNÛ˝Ö§ópy~‰}w“ò¬ ìF∆ÄÒV‚ÀÀ†4…ü¸Âo‰›ƒ$∫ÖÕ§Ño÷≤ñLBE˚é@?:=¸≥Áœ*?ì<ìÓ´©jì¿¨V›ïJG ê*´|eô’GŸ˙sµA‰À»&èìê/◊éÇ˙a}y-Møá®Ÿ5»_î¸√oÊÀˇ 1izÊól5-jRYzL¢ehKy◊‘_U„€º´˘∫⁄óÊuÔìKä◊CÅÆ≠4}J64û„N}f Ä=CJxdóSÛùÃ_ò˙Gìl≠R‡]Ÿ\j:≠À1ﬁﬁ2#áäÅBdî”~ÿ}ô¢iÃ◊0Z[Yµ8¥…q–∞j‡∏n ùKC"J†–≤0a_£∑≤“Ï•o´A¥∑ØÈ¢F“æÙ ∑\ÍGÍ˘PE*+O`{˚]*„ÄøÜ	Ω:ºBuF„Aª/0iNÁä{kî&)d˚,PÜ#J·Uﬂï<ö≈Óo4}9âﬁI¶∂ÄıÒf\"“µΩ.”Û#¸%•ivVˆ-£~ñ∂™à≈˛µıNë®^4ﬁµ…∂l„æv◊a¸Ω¸–ΩÛ,ÁÜõÊ-‡À_≤⁄Üé¶XáÕ‡~.º∑sÂ "y≤U'U–55ùfA≥4zºúo√}øÍ‰œÚ∑éΩÁ_;y‹ê\^&â§»7U”Wååø‰…;±˙1øööué≥˘Ö˘y°j–≠÷ây>•5’î¶∞Õ-Ω†hDëÙ~%ã qA—º≥˘Ótœ.Ÿ≈¶i◊˛\k´˚+UÙ·i¢Ω	¶5¯U∏±Z”|1Ûı?Âk~Z˛ˇ ’Ä˘˝G”ù˛r'X
¿≤yb–8§y!°˙¸’Ú˛ïÊÃﬂÀ≠/VáÎ:|≠´<ˆƒêízV®Íé⁄B 9/Cﬂ7ñ4-Àüû⁄Üó†Ÿ≈¶i∑^[ÜÓ‚ ’Dpµ¬^¥k/¶ø.ï¸”∞≤÷1?/ºø¨D∑:Ï⁄î˜VRü‹œ=µ®kuëz?ƒÖ8À~YÚÁóøÁ!.ÏÙ8¨-ÊÚ¿ûkKq¬%ëØÇÚX«¬úïEh7Îù{6F<—Âo"y‡ù\ÜRMhÓ$¥ë$HáÅêF ÀÕFÿå0◊†Ú÷•jﬁX÷	#÷!ñ!¶… Gû%_ﬁPUœw+”ÚﬂñÙ_-h∂˙.âl-4€P¬≥SõbYÀ1%òùŒÛWí¸∑Ê´HmµÀO¨≠¥ûµ¨™ÚC,2PØ8Ââë––ˆ8 ﬂóﬁTÚ≈’’Êìj‚˛ıU.ØÆgöÍ·—I*ÜYﬁG‚	Ë/Êˇ *ycÃZrGÊ€Ÿ?÷°π<[∫)¨©4lèµ!∫aGñ<ü˘oÂàßÛVé"Ü+õ@nµπ.§ùe∂’ı$ûi0ÔÃûûŸ ∏—4=OS“µÈ"YÔ4≈ï¥ª•v¢≠‘a$+ƒÒ`È„_lpÚÓéæbo1˜0ˆÇ¡Æπ6ˆ¬OT'Ò˚{÷ï¿ækÚgñ¸◊e¶ªf.c∑êOk"ª≈,2Å@ÒK#£Pˆ8À_ñûMÚﬁ©.≠§Ÿ<z§õkãÈßû‚i#g#ÃÚ<înrQõ8∆ôÊ≈Úˇ ÁÊ'˚Ü’5crtçÙªSr#·e˛Ì!óçk¯ÔåªÛHÛÁáêﬂÙFß•}^€V’-ç±ìù∫ˇ wVnTß≈Ùdõœøò⁄∂ìÊ˝? ∫CÈVw7RjWZñπ;Clë,¢é5BåÚ;T˝ÆÉ~[~`jc‘ıÌS˝6°°Ωπ˙ˆë3Mg<7QóBÖ™  QïÖNkû|Û‘>b’lm•Úﬁçke ãOáZº"ÓpÍ¨p»=4f<WêÆÈæl>m¸ûõÃMoıI5*ÈÂ∂Ã$âë∏AQ…=∞á@‘”Jˇ úg≤‘û“Ù≥Ú Ã÷W+Œ	Ç[rÙ‰^Í‘°yÁO<^˘cÚ≠|”ßÿ√5ÃpX¥Vîá˝!‚èÇÒ‹ $¯pæo9~dË:ﬂócÛMñë˙/Ã7À¶”ﬁ‡‹[O4o$\ö_ÇU¨|X®oÁﬂ8Î∫V≠Âˇ .˘v÷⁄„]Û≥à$æg[ha¥ã’öG¸lh@UÀ>rÛª~cO‰ﬂ3YÈ»b“JE}ß4≈e≠¿ÑÓîﬁ£ÁAÕêﬂ+˘[V”ø1<ÎÆ‹¨cO◊úl^Æ~´lbóö”·¯∫c<«ÂMbˇ Û? b∑XŒô£A®«|ÃÙp◊Q*E≈iÒnª·GÊëıõØ<È˛m”ÙM?Ã–Eß>ô{£j.ë¬hÁÖÂéh˘…M@ÿ·ßÂ∆ÖÊKÕb˚U“4ø/⁄^òN—¥ƒâö%â[‘yÓ"äQùõa∏\â«‰?5È«ô#O(ËﬁgÉ]‘gø∑÷oÁH‰ç.@çƒoÆÀ(æôÈ·ío#y3[—ø' Ú•ÍD∫ºvvÃë?(Dì4• z}üåb»˙˜¸®S‰Æ1~ú˝tﬁˇ uıè´˙tı)ˆyw¶-ÁÔ&köﬂÂB˘f¡b:®ãOBÆ¸c≠¥∞ºühÕ0wÊïımvÛ RÈÎM]∂‘o}F‚EºQ»¨Wc…™„l&¸”∑æ∑ÛwíuΩÌg◊¨ßΩÇÀGºï≠≈Ïw‘ô"ò#™Iß1ÀcÖUªÛEÁÁı’«òlmÙ€ÉÂÄ ±∂üÎF(ææ(fî,kÕ€ë¢äRôÿsg,∑÷?2º·Ê2[h:Âüó¥è/_~åDk!{s4âHÚ9íDTRd¢—rE‰+œÃ‘5ΩÕÈ–”§ÄÈöÌº⁄+»¶èìèL≥ÄÒ0‚‘4¡∫˜ÊWê<ø˙?ZÛçÖı5¥”"»°∑÷µP|[loÏµ8oln#∫≥∏P\B¡„u=Yj»Ïﬂöüñ–j≠§ÕÊ]:=AdÙZ›Æ#K^>ô5‚ø≥Z‡ﬂ:_›ÿ˘nÊÍ”T¥—ÁFà&£~ºÌ–4™§8™˝∞xÆ˝H√[˝B«N≥ö˙˛‚;K;u/=ÃÃ#çu,Ã@ÙÃ!˘ÜÙÿËöıñ°zam»“^¨´Z∞#º›˘ØÂo*˘ßG–5k®-€SIÂ∏πötâmcâFÚ´vô‘¢Ô‘b˛f_ÀO4yf“ˇ ]ö ˚ÀÚMÿ_ººbıùåQòßFR¨Ãx|-øL~ÖÂüÀÔ&j	k•€€È∫û∏≈c#=Õ—ÅKïVôûGÆÙÉ%Y≥ãMß~T˘ØŒ>eìRöo+yìJΩ˙ç‰∂˙£ÈÚ]∆±)ä‰¢<j¡’®	€sÜ_îWoùº·ÂÌ;]πÛñ¥ƒ”‰±ª∫∫≠˜»”B≥Ô»| “ø3Úﬁ˚Àvûf¸∆èZ∏≥ÉR>`ïÂ[«â$6Üﬁ/@üPÇc„^=∫‡ü»a1¸§◊˚á∫’J„˛¯7sz<}øñù≤/‰}KÚ“/˘«H°Û+[Ooï¿÷ÏQ„[«úJÊT…$ıŸ˛Œ‡÷ô*¸Ìí?%.‰â$ä]5£éj˙ä¶ÍÍI‰_|ﬂÛë´9¸∑™ºq€.ß¶µÙì)xVvúödyF≠ƒ∏ØL#π∂ño;˘*}cÕö’‘Ó⁄U¶ëß∫œ7+iDiÊpëzf•òR†aˇ Ê,öm∑ÊßÂÕŒ†–√j_VéIÁ(©»Ÿ|
Ã˚n~»√K±°~g˛WÍ6˙Z¥zv´Õµîí éìA#$r®R√àö0 G\Ñ~XyÇ„œû~“u{µoW ^_⁄Ç˜^±y1Ü‰|ƒvßÔŒﬂõıø#y/]∏:ŒÖa®‹ÅA=Õ¥R…A∞ŸKSÈ:&ç£Z˝SH∞∑”ÌkÀ–µâ!J“ï‚ÅE}≥‰o&kóky¨hVç⁄ ‚Ê⁄)d†Ë92ìAÜˆˆ÷ˆ–GomAoÑä‘"*çÇ™≠ 	dÚë‰’K…Â˝9ıN^ß◊Z÷/>º˘ïØ/~∏m®i÷ç´⁄_€Ewk!RLã"1VµVl¿ä\€[][…muOo*îñT::û™ ’|'—ºã‰ΩÈÆÙ}
√O∫`A∏∂∂ä)(zéJ†–‡›kÀ˙ªiı=kO∑‘≠]Dì a—Äph}Ò“[6ü§<-ú
ˆ–≤ÿXÇ-‡‰´GTVÙ÷ªT)ßÜE+ºï©yv€Z‘5ël∫Ôòıu-B+*ò"ÁEéfTf‡£v Tìì|Ÿ≥fÕõ6lŸ≥fÕüˇŸ

endstream
endobj

186 0 obj
<</Subtype/Type1C/Length 2375/Filter/FlateDecode>>
stream
hﬁTV{XWüÑÃù†±ÓDÃËL@çàAEm+"à&Úhe—Z[§íÄ-*U¥µ∂–≠ãIL+≠è>W>≈¢¬RÏ”b[yT √7•A¡™’<ì=·€Ω±˚Ì∂ﬂ¸qÁ‹sŒùÛ¯ùﬂ£R2
Ö‚ë¯eq			”b◊nI[ü≥%Î≈Mﬁ› Y•E#æ¸ØÌÓÿK£Å≥g¬à¸Gº∫ë0eÙaF2å√åV1<√åcòÒJ&H≈&L≈D*òh%≥P≈$*ôd%Û$√§)òÛ√Ñ”Ô3*ÜcÊ3À®ºû©dö£ë
õ‚7ÂReñrè≤œ'‹gõœ^üC>>óUJU∞ ™:«∞&6ó≠ I#oín.êsqÁ∏kj_ıbu©˙¨/ÁÌª’∑t8K„1k†IÆÂAüXïÄ∆D0.±ﬁ√@|¥å]»¡‹Å(µY.É±g~[",xâΩ∆Qøœ—üo#†ãjB7`•F°GyµPË∂∏o∏û˝ñ¿~w=´ÅÓtW≠C+–PâX´*¡0¨+Æí¢T†µa“Ã(¶"èºRª{lêZI#Î‹â|(±nòd {mwH@}˘ˇ<wZÌπ1¿i‰◊ªylwëÊÛ0F4\WüΩp§Í'®¢Ø` ˙Á°øS$-;kÎ⁄Öãf«•oÀ~·9)
ôêSß©ç≤ô”@$º¬√lhb˜`ÈE*?Ë÷ÀkÇ9tz÷∞Q∞É©ôÚ¯ÔÍ⁄Í´\=7√<+ÚŸKù"`‚ù˚0∆Œøá„„”÷•≠óÏ.ˆ∂s/D¡D°ÈLÆŸ!“rE¥Í1{%Z0ú∆9∞Z§ïÅ˛z[fî1>=vvÚ≈+W€œ]ì@È|‹bÀí¯‰ö´Ì?nº÷túàq?cSR 
†I_§Ñª©ı”â.Œ¡uΩ}æ≠Kcpl]0é–' 3Îúπ˚UQ# €˘ŸÈ…sf[∫~¯§Æ„÷G…E‘¡≈Èìp‹ij:"A≥≥ÕﬁX^ﬁÍ¥ Áx£p¢êîQq¡)Tı.y Ÿg!‚`Aƒ Õ¿€|y<ˇﬂˆÉ⁄ÛøwçT⁄Ô ÖÖ[‰;§ãÇ‡«n´'x~ÿ¬¬ê€ááqxè≈2¢YÈn¸IqÎ∂0]X‚∂∞b˝	ÃÙDÛg>⁄u†J∫~Ï´7tΩ+~
?@ìΩtËã¶k:–£‚3ÙÒÌaÄ.ÊëéÊúô3M9èI8èûÎ!WÚÖ¿OjCi∑ãﬁ|31^áœta,‰@ h:¡Ô-1à<VüıòÄœ–Ω©0∂í""·Í’’	%M$≈\˘ÌÀÃÃc“ôe˚Lâ∫ƒS∆21sCZfàÄ!$4äá§’u©§æJ=ÿ˙∞0QW‘*¶V-*It©q—ËÂJm7√–”ç=êC›ûï√ñáÉì™u[BΩÔÀaπVÀA∑g,ÅQû◊·:ã	~â-,¥<4ìÀÈQ=nˇálqÔ–∏-4kÃ¸Ã⁄	ÆïfqÒ∞e¿-∫º2,≤}tqã¨ãhÂõtL=}vÂ>zÚ∞•Gvªà¨∏Yw[®IÛh§PÕá¸AòV∞—∂Ác~∆†U‘Bx-Eæ	Lµ8√—∞ıhB”–ÉA§yòΩÖã!‡SttÂ∫'^\â>E"“ç†(æ∆VS||]•uW ﬁ•%˚û.ÕP? ymot^.¸°‡ìYá’.Ó∆°∫÷õ:òÑc™—Ôaõ†ì∂ık∞ÚΩîfò&@Ñûß·-≈%ªp¸…|(µ‰G]˜ùÚKó€6Ã›M	Ä‚ƒÔ+çNJ≈åÜß6¬»<±±†~}º.$tSå!•˙û]‘4∫Á”™Ñz2˙€bëHb[¡ﬂ&…°ûDìlwë¿
V‹I6I≥\˛‘Àw/xÜΩ%^fC	ºÂ∏í¿˚Ô¯ r¥¿H†J⁄àπ‘|¨£ PÇQû_Ωû—ÚØ,<>Óπ˝ªxõ*5ÚX∞Ò·Æ-T	Ofú¯ÊJ«·˙b©¥Ö«ë8&ßﬁzˆf˚◊ÂNH.‚‹Ï wmV:ﬂ›]*4[≠£∂L;8–üò<%j-*ãƒRÁ¸¯ÿg¬o%+fIåY∞õüû=Yè‹∆˚}∑O‰ÿ‰È"û¬EºΩÑÜ≤e”¶6“>Û0!Ë’g2oN¶$Ük…V[Æ=WºK4ò'?}<(äÊµ
KäSöë•DËs£ÿΩRâ+ZõiåŸù^∆>’yª≠‚Y3ù1=ÑC	ﬂwlêñï9âåq˙Fî>˚Aüßa)o'çÎÕGLPK±∆7‡òz•ÂOJÆ"RºÄΩCÏ«m:∑_º  Å¥®îI˛Ã®[_9(ÖíÖÖñı±Ç¡z˚÷õRãÍ«O[;Æ^:õA”‡æ≥b|ÓWGYëì—'wà˛)ò√ÔxÌ∏›%~ÚB⁄°ßõãÉ1∞	ò˛Õï£çR1ÂJ€.T° $Æ.o›IøÑjg«j`0Lq≈ÙßRJÄeZxõ;ˆ˜”eu‚{µı«´Í˚ë'"ux∂~·z3o‚∏ÖiyOZE;‘ÑQ¶ÛíE≤VvÑy‹ﬂ‰Û¿ﬁG÷{êIv·G?îìªÂeà55u∂]∫ÔO=3G¬ˆ~‡ 
gîfØåœ3?/⁄Ω.Úc¢QIˇhå]®ÄàÈΩÓå—†ƒâﬁŸÔÛ™z)£±UzΩ%Yd-Ωƒˇ„’Å∆èg¥'âÔg1IØlyÈCñ¸?ÅÛÕõ„(~àÌ{÷@\πÆ\gÆZCŸ0\¸–·fµ[‹pW—~©ó+|›Y $ò≤^ïÏwhæ˝4˘ÄRŸ≈/‚∫ù,^ÊKÏÔnﬂ…?∫„†MΩÛ»{é#BŸ·gôtô€π}´}ªê≥·›”t–ª…¡^‚Pm£ÃÃÖÂ≤zé∆ˇ8ØG ÀOãÈ[ˇ∫u≠`‹⁄|SÇ≥aÿ√Ö4Œºÿ|ÙBµËä˝Ö÷öh@ÂŒ°∆1ΩwDYYœ‚hB≈)^—Oû¬NˆN∑„·tkÂÔ∞˚z"XÔÏ«ÀV#WS˜`Ç≥<zå†ﬁÅ≤<∂«1çÇW#˛wˇ ∏,˛¸

endstream
endobj

187 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFF+AdvUnivers/FontFile3 186 0 R/Flags 32/Descent -199/FontBBox[-156 -229 1000 791]/Ascent 722/CapHeight 722/XHeight 502/ItalicAngle 0/CharSet(/space/C/h/a/n/d/K/period/S/e/one/comma/two/asterisk/A/D/V/N/E/I/W/O/U/R/L/M/eight/B/o/p/y/r/i/g/t/zero/nine/b/c/colon/slash/w/u/four/six)>>
endobj

188 0 obj
<</Subtype/Type1C/Length 1790/Filter/FlateDecode>>
stream
hﬁåTPî«˛Ó∏›;@NÇ~∏∆≈  O¿X@ÇƒCÖãXlaíD– •ViDò "T(∆@GîXßb≈Ç
¢Fƒ(¡Lt£¡‘h—®ÔwÛ3›√∂Ig⁄iÁõù˘vﬂ›}ü˜ŸÁyUíF-©T*«≈¶»®®hﬂÖÈ˘Ò#å÷5WÖM2†'ñN◊‰ò∑ë¡…`Û“ÆÈ∫'k–ˆ_;%ï¯$µ‰§í^ë$µ‰≠í%iû$ÖHíà/¢íI#%h§ïí‰.≤IâJŒ“,)@Z!ÌñŒ©UÀUõUøWùTOS'™w™—&¬¶—Êû∆]”§—<%íIêÔi<›Nˇ¢Â⁄dmë∂oÍSÙ)`ˇ•Ñ©‰-§} Eÿ*C5≠Ô'XME<⁄∞Ô+2ü=‰+Ú@ÀÖCΩ'–e\Ìrô¬ls1—ü≠âMã›§”+EÎ93˘	Åî√0Oì>ÓCÜìPä@˝F>Dø‹;tÓ6Ó]Zƒ7¢#~ÜU(ÖñDªË·[(Ä*ﬂ´_b…@1±ÖDH?¡Drç"3gêjâœÄæ5g+ße0Ïù›Év≥—£pÂZé…©Ω	9t“ 8tÒ≈tnF@⁄|Ü¶|Ø6^G≈üâ›ÃxóÎïó!º_Ü© #Úò¬/v=ı[ÉY:\öé⁄c
[dˆë—OdÖD
[!ÙP⁄Õ≈@5Ëq+”√1Â∏µ|Àd⁄üx2¡·⁄uDëhùà,§7XsÖÆ√C¢Ã†F|Hë~¢¨•4áàeΩCbÚbo
ºa sñu¡<ãXÛ‹Éü ÜJKÑˇqX´˚∫qÏ√Ï∆Áπ?)‰ˇmΩ ê¢s:m‡o·k∞ TÈÁ
Ndmé‘Õ)ÙHe>m`”,hA˚º/B@À¿<ª`Ó°	&vö3d/À:Çsﬁπà"DÇò”Œ)Î/K&AÁ∑^C{ÜˆÒ_ÄÛ~…$zs∞Ÿ—Ï.W“„Ó‰.Ö¢Æ8ä}„û§úÜö=I≈'ìl1â¢Ì¢∆Q™˜;Éõ‹N`¸’W;uØ'ﬁùŸõ´€8tCòl,õ∑€òΩ‰óââ%—:Ô¸ÅÑ˚lp∏„ÿA^˝>©§%… ≠>\›˘AG7lsÌ«ÀªÖÍ|Á•{dKt∞˘l„EvÌ»∆◊∑pëL9cÚÛ}ã<z{†ßgs|9˚8NÙÊY–vÚ•4™0vU8õìÒhp†ç<e∑èf,¯ç )ˆ»H7≈°J¿DmLπﬂƒ¸ÆÔP∂|<ÛxÓë≠†vu÷tÄ¨<sYFMÿU^N˙r„⁄bDÊ úÜÜ\ºRŒo64ÿ÷ﬂ√ﬂ+
9mµ·‹√Î`2Ü˝'åwz`“YG£÷G%-b8y˝ΩÁM¸√^˘Îñ´∑≤Ôè}J∏æbUPZ◊Kê“˙K‰≥˙›Go±∫˙ÚÚZ^{äTæ_»ÇR”É
yûôE∑¨ cÙUKÇ ë≤w~åj™s¡f¥ëè6]5®H›}x;Ñ ; »˘úîv#Cø töÄ9#ªµ‡À.è¥˜Âï¥¿èÑØg±1M˝ª≥ÓycÔ|√∫Z´Op–üŸ˚¥˘—%Ëq©È®Ì‹}XgÇ8)$∏ÏÖ˙È8FÓ5‹~ƒnu$Ò(´W‡
9_∑<1Ñ-çÀ6≠‚ÂTÔÒJÖÏf©û+§6»ãÈÊ7»ê5÷ı„[ı 9(õMÙ›¨Ìi•È!WóˇñÎ#èJä_…?-˝˘â∞¢©n]«‰ˇze˝ÚÔHÙ ®í˝çhár¡Ó~#øﬂtÏ¿AH`?⁄˘p‘@£åÅBK.9\åìË
ÅÉ+∏¥r1÷¿4ÍM°Ÿ«Õóø[!ÚΩ3}Ûπ¡
úb}^ÁbP	ÖÛt4	Û.kÌy˚:ÉYw`&8µp0¥‰à+ºYÃÇ∑„ìÄZñ∂--#V¨5ê
ΩÚÉ˝˝óÓ
qÌ®®ÂıÁﬁ_ÖkRybfvíÆú˛Ëÿ?*æwW‰ˇ·‹·¬ë¢œ∑àµx≥q},ã65◊
•†M˛7iwÿ3–ùÚØÌ…˝„™}Ët Î∑{nË˙Í/4üegÚ„J˘e˙¨¡(_Ä{¶{ûU˙æ0Mé.Ÿ4¶∞¶˝U’Mº∂õl/.™(b´ú¨Â◊‡Ó∆h◊%Ö˛g[ıˇ7A˝Z»íÁöBºÿÎi›w˘U!ÀDÉæBño)Baó/∂ú‚ïÂø~—z¨.ø≠∏
ì[´r∫z(D8H°O®p	≈,¡¡J0±µ"8f©@[L üR%‹ºƒ⁄›k-!aJà∞›ü¶¬M˘Ô Pz 

endstream
endobj

189 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFG+AdvPAC3B/FontFile3 188 0 R/Flags 32/Descent -191/FontBBox[-145 -239 1135 750]/Ascent 722/CapHeight 722/XHeight 502/ItalicAngle 0/CharSet(/space/one/D/e/p/a/r/t/m/n/o/f/S/u/g/y/comma/I/d/i/U/v/s/H/l/h/C/W/period/two/E/hyphen/A/c)>>
endobj

190 0 obj
<</Subtype/Type1C/Length 1162/Filter/FlateDecode>>
stream
hﬁLRQLSWæ≠ﬁ{ï ÿ™áı‹ƒ,ôqc¢så,líä
ë¿¬Ñπ¬∞pKÈlπµ≠0ÇµJÂ^ŒmaäîÄ3É±±•U∂8XLdÀ‚Ê≤ò-¡∑á=ÏÈT;óΩÏ<¸_æÔˇæˇˇèéŸ¨gt:]NiÖÂ·Ú=%b[’˛“¬¬Ööó∫Lﬁ∂d/πº÷ˇÃÕ‚ŒÌ∏ˇπæºÕÁ0zùÓÛ)ã‰È:-~·’¶›BA—€^”j·F-“j—ﬁçZ îàR£]®Ó˘ÌnüP÷⁄$y=í◊Ê∑ã˘ÇP‚r	}|Ç◊Ó≥{€(ZesŸ¸ŒVIp˙õ‡˜⁄Dª€Ê=%HÕ¬1
˚;<v°‰à`kﬂêºÇìJ}g}N—iÛ:Ìæ¸ˇçBüé9Ãa òr¶ä©fé3µÃáÃV::£gXÊ+›~›}=Ø?™ü€¥y”«õ~5‚à1”ãò1Í	æcˆ(=ã©¥º“(2£7#It◊pörü˜BæÜppzT’{îï«πhtMÇ'É¡cKNôVfn‰N°h ÏÊ™ªª¨ıÑ¸Ê%ÂAd—˚"©ToË&hCmªaöSS—πÅCˇ©è"M¿—,À(;r3hëT‰Ç˛—ÿÖ2hÃTcÊ/Su\±ñÚÓZs?) 4ú‚ﬂ;9	1‰—¯5t,^íı√Èç(ìπ◊P]3K\EwO¯8pK‡jﬂíö0ﬂ]ÈÎ˛ˆ{#íÍ’b$£_Ã¢m-—:–Ííeî›.Ÿƒ-Üƒˇ6ÆÑ∆g˘xÀS£k#F<é‚`!•(	√ËøÒnÕ«—Xà+ <$ª˘ä@ÿ¢q)ä∆)ß‹‚‡=àó˘Âı±yöWkd‘ã*™•NèÜÂ*H≤x•…¶‘Å:BMgÒÀ√Í#ç[+ ı@¨QQ#Â>°\#^≈€ûö*;C%öS2Åí q[QnSß¢Óœæá¯ˇÌ(˙ES–"[A-ù…A’+1πÜÆvØd¬&Ú
y°Ä$obÛ>ºø˚~º˝-l ·ßNŒ^‹E≤˜∏	G∂¡Üw`=Œ˘Ò·*mêé…&Õ6~ûUîòvì†∫ 3?8S«¡√ô÷Ú ˙Ü @B]B'Æ#agOrÆÓ¡X;$Ø„J65∂˚3˜è≤…}Êö˜{k≠çëì@‚’BÚ_’![Ãï:%í‘)~KQnQß“¿mò—ﬂ·ü\⁄U®6±”\Ôd{≠ñ>¬ ¬X˙"V%;)ÆŒ≥sÍ≈KO¿‚∫û≥vÜJiÀ4^ôpA&è]û∏r–9OÀ~ ∫U‰§;JOÙ¯·s=g!—ëŸ]xÑ^\ŒùCK⁄BOXeê(˘%'Gzƒ+Ø±∆g„ô3gMƒ¥æïïπb<œˆ]∏<î;y}ß	ÎN“ﬂu¢YEﬁπ“yÙ*ƒÃ˙ÛÏ=g„5VÂ≤∆.q8+≥g$LG^¢*+µsªˇªﬂΩ±sÌÌ!œh!àöòŸ ˇ` T›

endstream
endobj

191 0 obj
<</Type/FontDescriptor/StemV 0/FontName/EMCFFJ+AdvP3E7757/FontFile3 190 0 R/Flags 34/Descent -13/FontBBox[-156 -260 1020 729]/Ascent 486/CapHeight 692/XHeight 493/ItalicAngle 0/CharSet(/space/r/e/v/i/w/o/f/t/h)>>
endobj

192 0 obj
<</Length 418/Filter/FlateDecode/I 536/L 520/S 336/T 468>>
stream
x⁄b```f``≠d`c`pe`@ V†(« á5 ±†#üKÉwc5´;É0´·MU°]_K≠≠N9¿Ä01´$ùíù6ª∞∑¯≤∆ìÈπ'x&vß.ªì∞À’ÎÛk6ﬂ≤TΩ3±[¡®˝rÃÊ«kOä˝©íÙÎA√ÕÃÌ@ë€3û¿eA*NJÏ;√È‚f<ô_*Í≥◊Ù¥ÌÚªÆ¡˙ga_^®…ﬂ¡.`KÇåéFAA¡¥¥ééAA7ê8à2:ÄÚ¢°°1c®BFà†n ’¿¿&Ÿ“ z±Ö–Œ"ÊÌÄ¥€Ç]aƒ¿ÀrCó≈D¥a#´ÑˇÇLˆyéVÃ‹&aèÆ±
,m=• »ÿ¯"¢Ò◊øÉ,/ƒ~2\ÿ∆í—Òk'´ [˝çøÚ\∫!î<±˘ ‘¿)qú√± ¢©¬ÍqÁ*ÀÉõ¶"á|=ÛE= ÕéÜH ≈àA∑˜^ﬂ€ªFO3ƒÈd`~{
§à›Ä∏óÅ˘OTﬂkÄ  Kóß„
endstream
endobj

193 0 obj
<</Length 2>>
stream
q

endstream
endobj

194 0 obj
<</Length 3>>
stream

Q

endstream
endobj

195 0 obj
<</Length 59>>
stream

q
45.43 31.47998 160.93 409.82 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

196 0 obj
<</Length 60>>
stream

q
220.07 31.47998 161.58 409.82 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

197 0 obj
<</Length 60>>
stream

q
395.42 31.47998 161.56 409.82 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

198 0 obj
<</Length 2>>
stream
q

endstream
endobj

199 0 obj
<</Length 3>>
stream

Q

endstream
endobj

200 0 obj
<</Length 55>>
stream

q
64.9 47.75 161.58 345.07 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

201 0 obj
<</Length 58/Filter/FlateDecode>>
stream
x⁄„*‰221–32U01◊33100T043‘3µP03∞ QE©\\@A rWÄ0ä“ú∏π a√√
endstream
endobj

202 0 obj
<</Length 56>>
stream

q
415.6 47.87 161.65 678.71 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

203 0 obj
<</Length 2>>
stream
q

endstream
endobj

204 0 obj
<</Length 3>>
stream

Q

endstream
endobj

205 0 obj
<</Length 59>>
stream

q
44.72 33.58002 161.68 692.99 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

206 0 obj
<</Length 60>>
stream

q
219.51 32.78998 162.22 693.79 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

207 0 obj
<</Length 60>>
stream

q
394.51 32.78003 162.56 693.79 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

208 0 obj
<</Length 2>>
stream
q

endstream
endobj

209 0 obj
<</Length 3>>
stream

Q

endstream
endobj

210 0 obj
<</Length 60>>
stream

q
64.34 217.09003 162.15 509.48 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

211 0 obj
<</Length 58>>
stream

q
239.33 217.38 162.58 509.19 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

212 0 obj
<</Length 58>>
stream

q
415.04 387.97 162.16 338.61 re
h
1 1 1 RG 1 1 1 rg B
Q

endstream
endobj

xref
0 213
0000000000 65535 f 
0000000016 00000 n 
0000000159 00000 n 
0000000303 00000 n 
0000019279 00000 n 
0000019422 00000 n 
0000019577 00000 n 
0000039414 00000 n 
0000039557 00000 n 
0000039701 00000 n 
0000056456 00000 n 
0000056602 00000 n 
0000056748 00000 n 
0000074470 00000 n 
0000074616 00000 n 
0000074749 00000 n 
0000091133 00000 n 
0000091461 00000 n 
0000091673 00000 n 
0000091883 00000 n 
0000092089 00000 n 
0000092295 00000 n 
0000092523 00000 n 
0000092753 00000 n 
0000092982 00000 n 
0000093274 00000 n 
0000093566 00000 n 
0000093859 00000 n 
0000094152 00000 n 
0000094365 00000 n 
0000094577 00000 n 
0000094787 00000 n 
0000094969 00000 n 
0000095151 00000 n 
0000095351 00000 n 
0000095552 00000 n 
0000095752 00000 n 
0000095908 00000 n 
0000111344 00000 n 
0000112481 00000 n 
0000112726 00000 n 
0000113103 00000 n 
0000113312 00000 n 
0000113520 00000 n 
0000113728 00000 n 
0000114063 00000 n 
0000114397 00000 n 
0000114730 00000 n 
0000115064 00000 n 
0000115398 00000 n 
0000115732 00000 n 
0000115898 00000 n 
0000116062 00000 n 
0000116395 00000 n 
0000116729 00000 n 
0000117063 00000 n 
0000117397 00000 n 
0000117731 00000 n 
0000117911 00000 n 
0000118092 00000 n 
0000118279 00000 n 
0000118464 00000 n 
0000118649 00000 n 
0000118832 00000 n 
0000119094 00000 n 
0000119356 00000 n 
0000119618 00000 n 
0000119879 00000 n 
0000119990 00000 n 
0000142184 00000 n 
0000142477 00000 n 
0000142629 00000 n 
0000142781 00000 n 
0000142959 00000 n 
0000143136 00000 n 
0000143312 00000 n 
0000143485 00000 n 
0000143658 00000 n 
0000143862 00000 n 
0000144065 00000 n 
0000144267 00000 n 
0000144525 00000 n 
0000144783 00000 n 
0000145041 00000 n 
0000145299 00000 n 
0000145422 00000 n 
0000167626 00000 n 
0000169179 00000 n 
0000169436 00000 n 
0000169806 00000 n 
0000169996 00000 n 
0000170186 00000 n 
0000170329 00000 n 
0000170472 00000 n 
0000170673 00000 n 
0000170875 00000 n 
0000171076 00000 n 
0000171313 00000 n 
0000171550 00000 n 
0000171787 00000 n 
0000172013 00000 n 
0000172238 00000 n 
0000172464 00000 n 
0000172647 00000 n 
0000172829 00000 n 
0000173011 00000 n 
0000173188 00000 n 
0000173365 00000 n 
0000173545 00000 n 
0000173726 00000 n 
0000173907 00000 n 
0000174097 00000 n 
0000174287 00000 n 
0000174421 00000 n 
0000190957 00000 n 
0000191008 00000 n 
0000191523 00000 n 
0000191780 00000 n 
0000191969 00000 n 
0000192197 00000 n 
0000192406 00000 n 
0000192927 00000 n 
0000193841 00000 n 
0000194201 00000 n 
0000196530 00000 n 
0000196798 00000 n 
0000197111 00000 n 
0000197460 00000 n 
0000198280 00000 n 
0000199070 00000 n 
0000199886 00000 n 
0000200676 00000 n 
0000201418 00000 n 
0000202191 00000 n 
0000202838 00000 n 
0000203480 00000 n 
0000204183 00000 n 
0000204784 00000 n 
0000204823 00000 n 
0000204856 00000 n 
0000204973 00000 n 
0000208539 00000 n 
0000208775 00000 n 
0000208860 00000 n 
0000208946 00000 n 
0000209152 00000 n 
0000209383 00000 n 
0000209972 00000 n 
0000210367 00000 n 
0000210772 00000 n 
0000211149 00000 n 
0000211837 00000 n 
0000211993 00000 n 
0000212297 00000 n 
0000212787 00000 n 
0000212995 00000 n 
0000213098 00000 n 
0000213405 00000 n 
0000214172 00000 n 
0000214917 00000 n 
0000215693 00000 n 
0000215906 00000 n 
0000216618 00000 n 
0000217409 00000 n 
0000218052 00000 n 
0000218616 00000 n 
0000218789 00000 n 
0000219547 00000 n 
0000220092 00000 n 
0000220486 00000 n 
0000220851 00000 n 
0000221098 00000 n 
0000221409 00000 n 
0000221508 00000 n 
0000221872 00000 n 
0000222101 00000 n 
0000222400 00000 n 
0000222477 00000 n 
0000223255 00000 n 
0000223869 00000 n 
0000226110 00000 n 
0000231650 00000 n 
0000232029 00000 n 
0000233976 00000 n 
0000238043 00000 n 
0000246106 00000 n 
0000254095 00000 n 
0000256557 00000 n 
0000256902 00000 n 
0000258779 00000 n 
0000259075 00000 n 
0000260324 00000 n 
0000260555 00000 n 
0000261068 00000 n 
0000261120 00000 n 
0000261173 00000 n 
0000261283 00000 n 
0000261394 00000 n 
0000261505 00000 n 
0000261557 00000 n 
0000261610 00000 n 
0000261716 00000 n 
0000261844 00000 n 
0000261951 00000 n 
0000262003 00000 n 
0000262056 00000 n 
0000262166 00000 n 
0000262277 00000 n 
0000262388 00000 n 
0000262440 00000 n 
0000262493 00000 n 
0000262604 00000 n 
0000262713 00000 n 

trailer
<</Size 213/Info 141 0 R/Root 143 0 R/ID[<061289FF9A6E289C72D0897DA2C84731><C7D2554F9C11BCB517D561B15E8C7B0F>]>>
startxref
262822
%%EOF
